Medicine name,EML section,Formulations,Indication,ATC codes,Combined with,Status,clean_name,match_aliases
BCG vaccine,Recommendations for all immunization programmes,All vaccines should comply with the WHO requirements for biological substances.,Need for immunization against tuberculosis,L03AX03,,Added,bcg vaccine,"['vaccine', 'bcg', 'bcg vaccine']"
Japanese encephalitis vaccine,Recommendations for certain regions,All vaccines should comply with the WHO requirements for biological substances.,Need for immunization against certain single viral diseases,"J07BA02, J07BA03",,Added,japanese encephalitis vaccine,"['encephalitis', 'japanese encephalitis vaccine', 'vaccine', 'japanese']"
Medicines for COVID-19,Medicines for COVID-19,Refer to WHO living guidelines,COVID-19,,,Added,medicines for covid-19,"['covid-19', 'medicines', 'for', 'medicines for covid-19']"
abacavir,Antiretrovirals > Nucleoside/Nucleotide reverse transcriptase inhibitors,Oral > Solid: 300 mg tablet (as sulfate),"Human immunodeficiency virus disease without mention of associated disease or condition, clinical stage unspecified",J05AF06,,Added,abacavir,['abacavir']
abacavir + lamivudine,Fixed-dose combinations of antiretrovirals,"Oral > Solid: 120 mg (as sulfate) + 60 mg tablet (dispersible, scored)","Human immunodeficiency virus disease without mention of associated disease or condition, clinical stage unspecified",J05AR02,,Added,abacavir + lamivudine,"['lamivudine', 'abacavir + lamivudine', '+', 'abacavir']"
abiraterone,Hormones and antihormones,Oral > Solid: 250 mg; 500 mg,Malignant neoplasms of prostate,L02BX03,,Added,abiraterone,['abiraterone']
acamprosate calcium,Medicines for alcohol use disorders,Oral > Solid > tablet: 333 mg,Disorders due to use of alcohol,N07BB03,,Added,acamprosate calcium,"['acamprosate', 'acamprosate calcium', 'calcium']"
acetazolamide,Ophthalmological preparations > Miotics and antiglaucoma medicines,Oral > Solid: 250 mg,Primary open-angle glaucoma,S01EC01,,Added,acetazolamide,['acetazolamide']
acetic acid,"Ear, nose and throat medicines [c]",Local > Otological > drops: 2% in alcohol,Infectious diseases of external ear,S02AA10,,Added,acetic acid,"['acetic', 'acetic acid', 'acid']"
acetylcysteine,Antidotes and other substances used in poisonings > Specific,"Parenteral > General injections > IV: 200 mg per  mL in 10 mL ampoule
Oral > Liquid: 10%; 20%","Exposure to or harmful effects of undetermined intent of analgesics, antipyretics or nonsteroidal anti-inflammatory drugs",V03AB23,,Added,acetylcysteine,['acetylcysteine']
acetylsalicylic acid,Antimigraine medicines > For treatment of acute attack,Oral > Solid: 300 to 500 mg,Migraine,N02BA01,,Added,acetylsalicylic acid,"['acetylsalicylic acid', 'acid', 'acetylsalicylic']"
acetylsalicylic acid,Anti-platelet medicines,Oral > Solid: 100 mg,Acute myocardial infarction,B01AC06,,Added,acetylsalicylic acid,"['acetylsalicylic acid', 'acid', 'acetylsalicylic']"
acetylsalicylic acid,Anti-platelet medicines,Oral > Solid: 100 mg,Cerebral ischaemic stroke,B01AC06,,Added,acetylsalicylic acid,"['acetylsalicylic acid', 'acid', 'acetylsalicylic']"
acetylsalicylic acid,Medicines for juvenile joint diseases,"Oral > Solid: 100 to 500 mg
Local > Rectal > Suppository: 50 to 150 mg",Acute rheumatic fever without mention of heart involvement,N02BA01,,Added,acetylsalicylic acid,"['acetylsalicylic acid', 'acid', 'acetylsalicylic']"
acetylsalicylic acid,Medicines for juvenile joint diseases,"Oral > Solid: 100 to 500 mg
Local > Rectal > Suppository: 50 to 150 mg",Mucocutaneous lymph node syndrome,N02BA01,,Added,acetylsalicylic acid,"['acetylsalicylic acid', 'acid', 'acetylsalicylic']"
acetylsalicylic acid,Medicines for juvenile joint diseases,"Oral > Solid: 100 to 500 mg
Local > Rectal > Suppository: 50 to 150 mg",Juvenile idiopathic arthritis,N02BA01,,Added,acetylsalicylic acid,"['acetylsalicylic acid', 'acid', 'acetylsalicylic']"
acetylsalicylic acid,Non-opioids and non-steroidal anti-inflammatory medicines (NSAIMs),"Oral > Solid: 100 to 500 mg
Local > Rectal > Suppository: 50 to 150 mg",Pain,N02BA01,,Added,acetylsalicylic acid,"['acetylsalicylic acid', 'acid', 'acetylsalicylic']"
acetylsalicylic acid + atorvastatin + ramipril,Fixed-dose combinations for prevention of atherosclerotic cardiovascular disease,Oral > Solid > tablet: 100 mg + 20 mg + 2.5 mg; 100 mg + 20 mg + 5 mg; 100 mg + 20 mg + 10 mg; 100 mg + 40 mg + 2.5 mg; 100 mg + 40 mg + 5 mg; 100 mg   + 40 mg + 10 mg,Atherosclerotic chronic arterial occlusive disease,C10BX06,,Added,acetylsalicylic acid + atorvastatin + ramipril,"['acetylsalicylic acid + atorvastatin + ramipril', '+', 'atorvastatin', 'ramipril', 'acid', 'acetylsalicylic']"
acetylsalicylic acid + atorvastatin + ramipril,Fixed-dose combinations for prevention of atherosclerotic cardiovascular disease,Oral > Solid > tablet: 100 mg + 20 mg + 2.5 mg; 100 mg + 20 mg + 5 mg; 100 mg + 20 mg + 10 mg; 100 mg + 40 mg + 2.5 mg; 100 mg + 40 mg + 5 mg; 100 mg   + 40 mg + 10 mg,Chronic ischaemic heart disease,C10BX06,,Added,acetylsalicylic acid + atorvastatin + ramipril,"['acetylsalicylic acid + atorvastatin + ramipril', '+', 'atorvastatin', 'ramipril', 'acid', 'acetylsalicylic']"
acetylsalicylic acid + atorvastatin + ramipril,Fixed-dose combinations for prevention of atherosclerotic cardiovascular disease,Oral > Solid > tablet: 100 mg + 20 mg + 2.5 mg; 100 mg + 20 mg + 5 mg; 100 mg + 20 mg + 10 mg; 100 mg + 40 mg + 2.5 mg; 100 mg + 40 mg + 5 mg; 100 mg   + 40 mg + 10 mg,Cerebral ischaemic stroke,C10BX06,,Added,acetylsalicylic acid + atorvastatin + ramipril,"['acetylsalicylic acid + atorvastatin + ramipril', '+', 'atorvastatin', 'ramipril', 'acid', 'acetylsalicylic']"
acetylsalicylic acid + simvastatin + ramipril + atenolol + hydrochlorothiazide,Fixed-dose combinations for prevention of atherosclerotic cardiovascular disease,Oral > Solid > tablet: 100 mg + 20 mg + 5 mg + 50 mg + 12.5 mg,Atherosclerotic chronic arterial occlusive disease,,,Added,acetylsalicylic acid + simvastatin + ramipril + atenolol + hydrochlorothiazide,"['simvastatin', 'acetylsalicylic acid + simvastatin + ramipril + atenolol + hydrochlorothiazide', 'hydrochlorothiazide', '+', 'acid', 'ramipril', 'atenolol', 'acetylsalicylic']"
acetylsalicylic acid + simvastatin + ramipril + atenolol + hydrochlorothiazide,Fixed-dose combinations for prevention of atherosclerotic cardiovascular disease,Oral > Solid > tablet: 100 mg + 20 mg + 5 mg + 50 mg + 12.5 mg,Chronic ischaemic heart disease,,,Added,acetylsalicylic acid + simvastatin + ramipril + atenolol + hydrochlorothiazide,"['simvastatin', 'acetylsalicylic acid + simvastatin + ramipril + atenolol + hydrochlorothiazide', 'hydrochlorothiazide', '+', 'acid', 'ramipril', 'atenolol', 'acetylsalicylic']"
acetylsalicylic acid + simvastatin + ramipril + atenolol + hydrochlorothiazide,Fixed-dose combinations for prevention of atherosclerotic cardiovascular disease,Oral > Solid > tablet: 100 mg + 20 mg + 5 mg + 50 mg + 12.5 mg,Cerebral ischaemic stroke,,,Added,acetylsalicylic acid + simvastatin + ramipril + atenolol + hydrochlorothiazide,"['simvastatin', 'acetylsalicylic acid + simvastatin + ramipril + atenolol + hydrochlorothiazide', 'hydrochlorothiazide', '+', 'acid', 'ramipril', 'atenolol', 'acetylsalicylic']"
aciclovir,Antiherpes medicines,"Parenteral > General injections > IV: 250 mg in vial powder for injection (as sodium salt)
Oral > Liquid: 200 mg per 5 mL
Oral > Solid: 200 mg tablet",Zoster,J05AB01,,Added,aciclovir,['aciclovir']
aciclovir,Antiherpes medicines,"Parenteral > General injections > IV: 250 mg in vial powder for injection (as sodium salt)
Oral > Liquid: 200 mg per 5 mL
Oral > Solid: 200 mg tablet",Varicella,J05AB01,,Added,aciclovir,['aciclovir']
aciclovir,Antiherpes medicines,"Parenteral > General injections > IV: 250 mg in vial powder for injection (as sodium salt)
Oral > Liquid: 200 mg per 5 mL
Oral > Solid: 200 mg tablet",Herpes simplex infections,J05AB01,,Added,aciclovir,['aciclovir']
aciclovir,Ophthalmological preparations > Anti-infective agents,Local > Ophthalmological > Ointment: 3% w/w,Herpes simplex keratitis,S01AD03,,Added,aciclovir,['aciclovir']
aclidinium,Antiasthmatic and medicines for chronic obstructive pulmonary disease,,Chronic obstructive pulmonary disease,,,Added,aclidinium,['aclidinium']
activated charcoal,Antidotes and other substances used in poisonings > Non-specific,Oral > Other: powder,"Unspecified injury, poisoning or certain other consequences of external causes",A07BA01,,Added,activated charcoal,"['charcoal', 'activated', 'activated charcoal']"
adalimumab,Immunomodulators for non-malignant disease,Parenteral > General injections > SC: 40 mg per 0.8 mL; 40 mg per 0.4 mL; 10 mg per 0.2 mL; 20 mg per 0.4 mL,Axial spondyloarthritis,L04AB04,,Added,adalimumab,['adalimumab']
adalimumab,Immunomodulators for non-malignant disease,Parenteral > General injections > SC: 40 mg per 0.8 mL; 40 mg per 0.4 mL; 10 mg per 0.2 mL; 20 mg per 0.4 mL,Crohn disease site,L04AB04,,Added,adalimumab,['adalimumab']
adalimumab,Immunomodulators for non-malignant disease,Parenteral > General injections > SC: 40 mg per 0.8 mL; 40 mg per 0.4 mL; 10 mg per 0.2 mL; 20 mg per 0.4 mL,Rheumatoid arthritis,L04AB04,,Added,adalimumab,['adalimumab']
adalimumab,Medicines for juvenile joint diseases,Parenteral > General injections > SC: 40 mg per 0.8 mL; 40 mg per 0.4 mL; 10 mg per 0.2 mL; 20 mg per 0.4 mL,Juvenile idiopathic arthritis,L04AB04,,Added,adalimumab,['adalimumab']
afatinib,Targeted therapies,,Other specified malignant neoplasms of bronchus or lung,,,Added,afatinib,['afatinib']
albendazole,Intestinal anthelminthics,"Oral > Solid > tablet: 400 mg (chewable, scored)",Echinococcosis,P02CA03,,Added,albendazole,['albendazole']
albendazole,Intestinal anthelminthics,"Oral > Solid > tablet: 400 mg (chewable, scored)",Enterobiasis,P02CA03,,Added,albendazole,['albendazole']
albendazole,Intestinal anthelminthics,"Oral > Solid > tablet: 400 mg (chewable, scored)",Trichuriasis,P02CA03,,Added,albendazole,['albendazole']
albendazole,Intestinal anthelminthics,"Oral > Solid > tablet: 400 mg (chewable, scored)",Hookworm diseases,P02CA03,,Added,albendazole,['albendazole']
albendazole,Intestinal anthelminthics,"Oral > Solid > tablet: 400 mg (chewable, scored)",Cysticercosis,P02CA03,,Added,albendazole,['albendazole']
albendazole,Intestinal anthelminthics,"Oral > Solid > tablet: 400 mg (chewable, scored)",Ascariasis,P02CA03,,Added,albendazole,['albendazole']
albendazole,Cysticidal medicines,"Oral > Solid > tablet: 400 mg (chewable, scored); 200 mg (chewable)",Other specified echinococcosis,P02CA03,,Added,albendazole,['albendazole']
albendazole,Cysticidal medicines,"Oral > Solid > tablet: 400 mg (chewable, scored); 200 mg (chewable)",Cysticercosis of central nervous system,P02CA03,,Added,albendazole,['albendazole']
albendazole,Antifilarials,"Oral > Solid > tablet: 400 mg (chewable, scored)",Lymphatic filariasis,P02CA03,,Added,albendazole,['albendazole']
alcohol based hand rub,Disinfectants,Local > Topical > Solution: 80% v/v ethanol; 75% v/v isopropyl alcohol,Denatured alcohol,D08AX08,,Added,alcohol based hand rub,"['alcohol based hand rub', 'rub', 'alcohol', 'hand', 'based']"
all-trans retinoic acid,Targeted therapies,Oral > Solid: 10 mg capsule,Acute myeloid leukaemia with recurrent genetic abnormalities,L01XF01,,Added,all-trans retinoic acid,"['all-trans retinoic acid', 'all-trans', 'retinoic', 'acid']"
allopurinol,Medicines used to treat gout,Oral > Solid: 100 mg,Gout,M04AA01,,Added,allopurinol,['allopurinol']
allopurinol,Supportive medicines,Oral > Solid: 100 mg; 300 mg,Tumour lysis syndrome,M04AA01,,Added,allopurinol,['allopurinol']
alteplase,Thrombolytic medicines,Parenteral > General injections > IV: 10 mg in vial powder for injection; 20 mg in vial powder for injection; 50 mg in vial powder for injection,Cerebral ischaemic stroke,B01AD02,,Added,alteplase,['alteplase']
amidotrizoate,Diagnostic agents > Radiocontrast media,Parenteral > General injections > unspecified: 140 to 420 mg iodine per  mL in 20 mL ampoule (as sodium or meglumine salt),Amidotrizoate,V08AA01,,Added,amidotrizoate,['amidotrizoate']
amikacin,Ophthalmological preparations > Anti-infective agents,,Other specified conjunctivitis,,,Added,amikacin,['amikacin']
amikacin,Ophthalmological preparations > Anti-infective agents,,Infectious blepharitis,,,Added,amikacin,['amikacin']
amikacin,Antituberculosis medicines,Parenteral > General injections > unspecified: 250 mg per  mL in 2 mL vial (as sulfate),Multi-drug resistant Mycobacterium tuberculosis,J01GB06,,Added,amikacin,['amikacin']
amikacin,Access group antibiotics,"Parenteral > General injections > unspecified: 250 mg per  mL in 2 mL vial (as sulfate); 50 mg per  mL in 2 mL vial (as sulfate)
Parenteral > General injections > unspecified: 250 mg per  mL in 2 mL vial (as sulfate)",Neutropenia (high-risk),J01GB06,,Added,amikacin,['amikacin']
amikacin,Access group antibiotics,"Parenteral > General injections > unspecified: 250 mg per  mL in 2 mL vial (as sulfate); 50 mg per  mL in 2 mL vial (as sulfate)
Parenteral > General injections > unspecified: 250 mg per  mL in 2 mL vial (as sulfate)",Acute pyelonephritis (severe),J01GB06,cefotaxime,Added,amikacin,['amikacin']
amikacin,Access group antibiotics,"Parenteral > General injections > unspecified: 250 mg per  mL in 2 mL vial (as sulfate); 50 mg per  mL in 2 mL vial (as sulfate)
Parenteral > General injections > unspecified: 250 mg per  mL in 2 mL vial (as sulfate)",Acute pyelonephritis (severe),J01GB06,ceftriaxone,Added,amikacin,['amikacin']
amikacin,Access group antibiotics,"Parenteral > General injections > unspecified: 250 mg per  mL in 2 mL vial (as sulfate); 50 mg per  mL in 2 mL vial (as sulfate)
Parenteral > General injections > unspecified: 250 mg per  mL in 2 mL vial (as sulfate)",Inflammatory and other diseases of prostate (severe),J01GB06,cefotaxime,Added,amikacin,['amikacin']
amikacin,Access group antibiotics,"Parenteral > General injections > unspecified: 250 mg per  mL in 2 mL vial (as sulfate); 50 mg per  mL in 2 mL vial (as sulfate)
Parenteral > General injections > unspecified: 250 mg per  mL in 2 mL vial (as sulfate)",Inflammatory and other diseases of prostate (severe),J01GB06,ceftriaxone,Added,amikacin,['amikacin']
amikacin,Access group antibiotics,"Parenteral > General injections > unspecified: 250 mg per  mL in 2 mL vial (as sulfate); 50 mg per  mL in 2 mL vial (as sulfate)
Parenteral > General injections > unspecified: 250 mg per  mL in 2 mL vial (as sulfate)",Sepsis without septic shock,J01GB06,cloxacillin,Added,amikacin,['amikacin']
amiloride,Diuretics,Oral > Solid: 5 mg (hydrochloride),Oedema,C03DB01,,Added,amiloride,['amiloride']
amiloride,Diuretics,Oral > Solid: 5 mg (hydrochloride),Ascites,C03DB01,,Added,amiloride,['amiloride']
amiodarone,Antiarrhythmic medicines,"Parenteral > General injections > IV: 50 mg per  mL in 3 ampoule (hydrochloride)
Oral > Solid: 100 mg (hydrochloride); 200 mg (hydrochloride); 400 mg (hydrochloride)",Cardiac arrhythmia,C01BD01,,Added,amiodarone,['amiodarone']
amitriptyline,Medicines for other common symptoms in palliative care,Oral > Solid: 25 mg; 10 mg; 75 mg,Palliative care,N06AA09,,Added,amitriptyline,['amitriptyline']
amitriptyline,Medicines for depressive disorders,Oral > Solid: 25 mg; 75 mg,Depressive disorders,N06AA09,,Added,amitriptyline,['amitriptyline']
amlodipine,Antihypertensive medicines,"Oral > Solid: 5 mg (as maleate, mesylate or besylate)",Essential hypertension,C08CA01,,Added,amlodipine,['amlodipine']
amodiaquine,Antimalarial medicines > For curative treatment,Oral > Solid: 153 mg (as hydrochloride); 200 mg (as hydrochloride),Malaria due to Plasmodium falciparum,P01BA06,,Added,amodiaquine,['amodiaquine']
amodiaquine,Antimalarial medicines > For curative treatment,Oral > Solid: 153 mg (as hydrochloride); 200 mg (as hydrochloride),Malaria due to Plasmodium vivax,P01BA06,,Added,amodiaquine,['amodiaquine']
amodiaquine + sulfadoxine + pyrimethamine,Antimalarial medicines > For chemoprevention,Oral > Solid: 76.5 mg (as hydrochloride) [3] + 250 mg + 12.5 mg [1] dispersible tablets in co-package; 153 mg (as hydrochloride) [3] + 500 mg + 25 mg [1] dispersible tablets in co-package,Malaria,"P01BA06, P01BD51",,Added,amodiaquine + sulfadoxine + pyrimethamine,"['sulfadoxine', 'pyrimethamine', 'amodiaquine', 'amodiaquine + sulfadoxine + pyrimethamine', '+']"
amoxicillin,Access group antibiotics,"Oral > Liquid: 125 mg per 5 mL (as trihydrate) powder for oral liquid; 250 mg per 5 mL (as trihydrate) powder for oral liquid
Parenteral > General injections > unspecified: 250 mg in vial (as sodium) powder for injection; 500 mg in vial (as sodium) powder for injection; 1 g in vial (as sodium) powder for injection
Oral > Solid > dispersible tablet: 250 mg (scored) (as trihydrate); 500 mg (scored) (as trihydrate)
Oral > Solid > dosage form: 250 mg (as trihydrate); 500 mg (as trihydrate)
Oral > Liquid: 125 mg per 5 mL (anhydrous) powder for oral liquid; 250 mg per 5 mL (anhydrous) powder for oral liquid
Oral > Solid > dosage form: 250 mg (as trihydrate); 500 mg (as trihydrate); 1 g (as trihydrate)",Acute pharyngitis,J01CA04,,Added,amoxicillin,['amoxicillin']
amoxicillin,Access group antibiotics,"Oral > Liquid: 125 mg per 5 mL (as trihydrate) powder for oral liquid; 250 mg per 5 mL (as trihydrate) powder for oral liquid
Parenteral > General injections > unspecified: 250 mg in vial (as sodium) powder for injection; 500 mg in vial (as sodium) powder for injection; 1 g in vial (as sodium) powder for injection
Oral > Solid > dispersible tablet: 250 mg (scored) (as trihydrate); 500 mg (scored) (as trihydrate)
Oral > Solid > dosage form: 250 mg (as trihydrate); 500 mg (as trihydrate)
Oral > Liquid: 125 mg per 5 mL (anhydrous) powder for oral liquid; 250 mg per 5 mL (anhydrous) powder for oral liquid
Oral > Solid > dosage form: 250 mg (as trihydrate); 500 mg (as trihydrate); 1 g (as trihydrate)",Periapical abscess without sinus,J01CA04,,Added,amoxicillin,['amoxicillin']
amoxicillin,Access group antibiotics,"Oral > Liquid: 125 mg per 5 mL (as trihydrate) powder for oral liquid; 250 mg per 5 mL (as trihydrate) powder for oral liquid
Parenteral > General injections > unspecified: 250 mg in vial (as sodium) powder for injection; 500 mg in vial (as sodium) powder for injection; 1 g in vial (as sodium) powder for injection
Oral > Solid > dispersible tablet: 250 mg (scored) (as trihydrate); 500 mg (scored) (as trihydrate)
Oral > Solid > dosage form: 250 mg (as trihydrate); 500 mg (as trihydrate)
Oral > Liquid: 125 mg per 5 mL (anhydrous) powder for oral liquid; 250 mg per 5 mL (anhydrous) powder for oral liquid
Oral > Solid > dosage form: 250 mg (as trihydrate); 500 mg (as trihydrate); 1 g (as trihydrate)",Acute sinusitis,J01CA04,,Added,amoxicillin,['amoxicillin']
amoxicillin,Access group antibiotics,"Oral > Liquid: 125 mg per 5 mL (as trihydrate) powder for oral liquid; 250 mg per 5 mL (as trihydrate) powder for oral liquid
Parenteral > General injections > unspecified: 250 mg in vial (as sodium) powder for injection; 500 mg in vial (as sodium) powder for injection; 1 g in vial (as sodium) powder for injection
Oral > Solid > dispersible tablet: 250 mg (scored) (as trihydrate); 500 mg (scored) (as trihydrate)
Oral > Solid > dosage form: 250 mg (as trihydrate); 500 mg (as trihydrate)
Oral > Liquid: 125 mg per 5 mL (anhydrous) powder for oral liquid; 250 mg per 5 mL (anhydrous) powder for oral liquid
Oral > Solid > dosage form: 250 mg (as trihydrate); 500 mg (as trihydrate); 1 g (as trihydrate)",Acute otitis media,J01CA04,,Added,amoxicillin,['amoxicillin']
amoxicillin,Access group antibiotics,"Oral > Liquid: 125 mg per 5 mL (as trihydrate) powder for oral liquid; 250 mg per 5 mL (as trihydrate) powder for oral liquid
Parenteral > General injections > unspecified: 250 mg in vial (as sodium) powder for injection; 500 mg in vial (as sodium) powder for injection; 1 g in vial (as sodium) powder for injection
Oral > Solid > dispersible tablet: 250 mg (scored) (as trihydrate); 500 mg (scored) (as trihydrate)
Oral > Solid > dosage form: 250 mg (as trihydrate); 500 mg (as trihydrate)
Oral > Liquid: 125 mg per 5 mL (anhydrous) powder for oral liquid; 250 mg per 5 mL (anhydrous) powder for oral liquid
Oral > Solid > dosage form: 250 mg (as trihydrate); 500 mg (as trihydrate); 1 g (as trihydrate)",Chronic obstructive pulmonary disease with acute exacerbation,J01CA04,,Added,amoxicillin,['amoxicillin']
amoxicillin,Access group antibiotics,"Oral > Liquid: 125 mg per 5 mL (as trihydrate) powder for oral liquid; 250 mg per 5 mL (as trihydrate) powder for oral liquid
Parenteral > General injections > unspecified: 250 mg in vial (as sodium) powder for injection; 500 mg in vial (as sodium) powder for injection; 1 g in vial (as sodium) powder for injection
Oral > Solid > dispersible tablet: 250 mg (scored) (as trihydrate); 500 mg (scored) (as trihydrate)
Oral > Solid > dosage form: 250 mg (as trihydrate); 500 mg (as trihydrate)
Oral > Liquid: 125 mg per 5 mL (anhydrous) powder for oral liquid; 250 mg per 5 mL (anhydrous) powder for oral liquid
Oral > Solid > dosage form: 250 mg (as trihydrate); 500 mg (as trihydrate); 1 g (as trihydrate)",Sepsis without septic shock,J01CA04,gentamicin,Added,amoxicillin,['amoxicillin']
amoxicillin,Access group antibiotics,"Oral > Liquid: 125 mg per 5 mL (as trihydrate) powder for oral liquid; 250 mg per 5 mL (as trihydrate) powder for oral liquid
Parenteral > General injections > unspecified: 250 mg in vial (as sodium) powder for injection; 500 mg in vial (as sodium) powder for injection; 1 g in vial (as sodium) powder for injection
Oral > Solid > dispersible tablet: 250 mg (scored) (as trihydrate); 500 mg (scored) (as trihydrate)
Oral > Solid > dosage form: 250 mg (as trihydrate); 500 mg (as trihydrate)
Oral > Liquid: 125 mg per 5 mL (anhydrous) powder for oral liquid; 250 mg per 5 mL (anhydrous) powder for oral liquid
Oral > Solid > dosage form: 250 mg (as trihydrate); 500 mg (as trihydrate); 1 g (as trihydrate)",Bacterial pneumonia (Community-acquired pneumonia - mild to moderate),J01CA04,,Added,amoxicillin,['amoxicillin']
amoxicillin,Access group antibiotics,"Oral > Liquid: 125 mg per 5 mL (as trihydrate) powder for oral liquid; 250 mg per 5 mL (as trihydrate) powder for oral liquid
Parenteral > General injections > unspecified: 250 mg in vial (as sodium) powder for injection; 500 mg in vial (as sodium) powder for injection; 1 g in vial (as sodium) powder for injection
Oral > Solid > dispersible tablet: 250 mg (scored) (as trihydrate); 500 mg (scored) (as trihydrate)
Oral > Solid > dosage form: 250 mg (as trihydrate); 500 mg (as trihydrate)
Oral > Liquid: 125 mg per 5 mL (anhydrous) powder for oral liquid; 250 mg per 5 mL (anhydrous) powder for oral liquid
Oral > Solid > dosage form: 250 mg (as trihydrate); 500 mg (as trihydrate); 1 g (as trihydrate)",Bacterial pneumonia (Community-acquired pneumonia - severe) [children],J01CA04,gentamicin,Added,amoxicillin,['amoxicillin']
amoxicillin,Access group antibiotics,"Oral > Liquid: 125 mg per 5 mL (as trihydrate) powder for oral liquid; 250 mg per 5 mL (as trihydrate) powder for oral liquid
Parenteral > General injections > unspecified: 250 mg in vial (as sodium) powder for injection; 500 mg in vial (as sodium) powder for injection; 1 g in vial (as sodium) powder for injection
Oral > Solid > dispersible tablet: 250 mg (scored) (as trihydrate); 500 mg (scored) (as trihydrate)
Oral > Solid > dosage form: 250 mg (as trihydrate); 500 mg (as trihydrate)
Oral > Liquid: 125 mg per 5 mL (anhydrous) powder for oral liquid; 250 mg per 5 mL (anhydrous) powder for oral liquid
Oral > Solid > dosage form: 250 mg (as trihydrate); 500 mg (as trihydrate); 1 g (as trihydrate)","Acute malnutrition in infants, children or adolescents (uncomplicated) [children]",J01CA04,,Added,amoxicillin,['amoxicillin']
amoxicillin,Access group antibiotics,"Oral > Liquid: 125 mg per 5 mL (as trihydrate) powder for oral liquid; 250 mg per 5 mL (as trihydrate) powder for oral liquid
Parenteral > General injections > unspecified: 250 mg in vial (as sodium) powder for injection; 500 mg in vial (as sodium) powder for injection; 1 g in vial (as sodium) powder for injection
Oral > Solid > dispersible tablet: 250 mg (scored) (as trihydrate); 500 mg (scored) (as trihydrate)
Oral > Solid > dosage form: 250 mg (as trihydrate); 500 mg (as trihydrate)
Oral > Liquid: 125 mg per 5 mL (anhydrous) powder for oral liquid; 250 mg per 5 mL (anhydrous) powder for oral liquid
Oral > Solid > dosage form: 250 mg (as trihydrate); 500 mg (as trihydrate); 1 g (as trihydrate)","Acute malnutrition in infants, children or adolescents (complicated) [children]",J01CA04,,Added,amoxicillin,['amoxicillin']
amoxicillin,Access group antibiotics,"Oral > Liquid: 125 mg per 5 mL (as trihydrate) powder for oral liquid; 250 mg per 5 mL (as trihydrate) powder for oral liquid
Parenteral > General injections > unspecified: 250 mg in vial (as sodium) powder for injection; 500 mg in vial (as sodium) powder for injection; 1 g in vial (as sodium) powder for injection
Oral > Solid > dispersible tablet: 250 mg (scored) (as trihydrate); 500 mg (scored) (as trihydrate)
Oral > Solid > dosage form: 250 mg (as trihydrate); 500 mg (as trihydrate)
Oral > Liquid: 125 mg per 5 mL (anhydrous) powder for oral liquid; 250 mg per 5 mL (anhydrous) powder for oral liquid
Oral > Solid > dosage form: 250 mg (as trihydrate); 500 mg (as trihydrate); 1 g (as trihydrate)",Bacterial meningitis,J01CA04,,Added,amoxicillin,['amoxicillin']
amoxicillin + clavulanic acid,Access group antibiotics,"Parenteral > General injections > IV: 500 mg (as sodium salt) + 100 mg (as potassium salt) powder for injection; 1000 mg (as sodium salt) + 200 mg (as potassium salt) powder for injection
Oral > Liquid: 125 mg (as trihydrate) + 31.25 mg (as potassium salt) / 5 mL powder for oral liquid; 250 mg (as trihydrate) + 62.5 mg (as potassium salt) / 5 mL powder for oral liquid
Oral > Solid > dispersible tablet: 200 mg (as trihydrate) + 28.5 mg (as potassium salt); 250 mg (as trihydrate) + 62.5 mg (as potassium salt)
Oral > Solid > tablet: 500 mg (as trihydrate) + 125 mg (as potassium salt); 875 mg (as trihydrate) + 125 mg (as potassium salt)
Oral > Solid > tablet: 500 mg (as trihydrate) + 125 mg (as potassium salt)",Bacterial pneumonia (Community-acquired pneumonia - severe) [children],J01CR02,,Added,amoxicillin + clavulanic acid,"['amoxicillin + clavulanic acid', 'amoxicillin', 'clavulanic', '+', 'acid']"
amoxicillin + clavulanic acid,Access group antibiotics,"Parenteral > General injections > IV: 500 mg (as sodium salt) + 100 mg (as potassium salt) powder for injection; 1000 mg (as sodium salt) + 200 mg (as potassium salt) powder for injection
Oral > Liquid: 125 mg (as trihydrate) + 31.25 mg (as potassium salt) / 5 mL powder for oral liquid; 250 mg (as trihydrate) + 62.5 mg (as potassium salt) / 5 mL powder for oral liquid
Oral > Solid > dispersible tablet: 200 mg (as trihydrate) + 28.5 mg (as potassium salt); 250 mg (as trihydrate) + 62.5 mg (as potassium salt)
Oral > Solid > tablet: 500 mg (as trihydrate) + 125 mg (as potassium salt); 875 mg (as trihydrate) + 125 mg (as potassium salt)
Oral > Solid > tablet: 500 mg (as trihydrate) + 125 mg (as potassium salt)",Peritonitis (mild-moderate),J01CR02,,Added,amoxicillin + clavulanic acid,"['amoxicillin + clavulanic acid', 'amoxicillin', 'clavulanic', '+', 'acid']"
amoxicillin + clavulanic acid,Access group antibiotics,"Parenteral > General injections > IV: 500 mg (as sodium salt) + 100 mg (as potassium salt) powder for injection; 1000 mg (as sodium salt) + 200 mg (as potassium salt) powder for injection
Oral > Liquid: 125 mg (as trihydrate) + 31.25 mg (as potassium salt) / 5 mL powder for oral liquid; 250 mg (as trihydrate) + 62.5 mg (as potassium salt) / 5 mL powder for oral liquid
Oral > Solid > dispersible tablet: 200 mg (as trihydrate) + 28.5 mg (as potassium salt); 250 mg (as trihydrate) + 62.5 mg (as potassium salt)
Oral > Solid > tablet: 500 mg (as trihydrate) + 125 mg (as potassium salt); 875 mg (as trihydrate) + 125 mg (as potassium salt)
Oral > Solid > tablet: 500 mg (as trihydrate) + 125 mg (as potassium salt)",Acute sinusitis,J01CR02,,Added,amoxicillin + clavulanic acid,"['amoxicillin + clavulanic acid', 'amoxicillin', 'clavulanic', '+', 'acid']"
amoxicillin + clavulanic acid,Access group antibiotics,"Parenteral > General injections > IV: 500 mg (as sodium salt) + 100 mg (as potassium salt) powder for injection; 1000 mg (as sodium salt) + 200 mg (as potassium salt) powder for injection
Oral > Liquid: 125 mg (as trihydrate) + 31.25 mg (as potassium salt) / 5 mL powder for oral liquid; 250 mg (as trihydrate) + 62.5 mg (as potassium salt) / 5 mL powder for oral liquid
Oral > Solid > dispersible tablet: 200 mg (as trihydrate) + 28.5 mg (as potassium salt); 250 mg (as trihydrate) + 62.5 mg (as potassium salt)
Oral > Solid > tablet: 500 mg (as trihydrate) + 125 mg (as potassium salt); 875 mg (as trihydrate) + 125 mg (as potassium salt)
Oral > Solid > tablet: 500 mg (as trihydrate) + 125 mg (as potassium salt)","Bacterial cellulitis, erysipelas or lymphangitis",J01CR02,,Added,amoxicillin + clavulanic acid,"['amoxicillin + clavulanic acid', 'amoxicillin', 'clavulanic', '+', 'acid']"
amoxicillin + clavulanic acid,Access group antibiotics,"Parenteral > General injections > IV: 500 mg (as sodium salt) + 100 mg (as potassium salt) powder for injection; 1000 mg (as sodium salt) + 200 mg (as potassium salt) powder for injection
Oral > Liquid: 125 mg (as trihydrate) + 31.25 mg (as potassium salt) / 5 mL powder for oral liquid; 250 mg (as trihydrate) + 62.5 mg (as potassium salt) / 5 mL powder for oral liquid
Oral > Solid > dispersible tablet: 200 mg (as trihydrate) + 28.5 mg (as potassium salt); 250 mg (as trihydrate) + 62.5 mg (as potassium salt)
Oral > Solid > tablet: 500 mg (as trihydrate) + 125 mg (as potassium salt); 875 mg (as trihydrate) + 125 mg (as potassium salt)
Oral > Solid > tablet: 500 mg (as trihydrate) + 125 mg (as potassium salt)",Chronic obstructive pulmonary disease with acute exacerbation,J01CR02,,Added,amoxicillin + clavulanic acid,"['amoxicillin + clavulanic acid', 'amoxicillin', 'clavulanic', '+', 'acid']"
amoxicillin + clavulanic acid,Access group antibiotics,"Parenteral > General injections > IV: 500 mg (as sodium salt) + 100 mg (as potassium salt) powder for injection; 1000 mg (as sodium salt) + 200 mg (as potassium salt) powder for injection
Oral > Liquid: 125 mg (as trihydrate) + 31.25 mg (as potassium salt) / 5 mL powder for oral liquid; 250 mg (as trihydrate) + 62.5 mg (as potassium salt) / 5 mL powder for oral liquid
Oral > Solid > dispersible tablet: 200 mg (as trihydrate) + 28.5 mg (as potassium salt); 250 mg (as trihydrate) + 62.5 mg (as potassium salt)
Oral > Solid > tablet: 500 mg (as trihydrate) + 125 mg (as potassium salt); 875 mg (as trihydrate) + 125 mg (as potassium salt)
Oral > Solid > tablet: 500 mg (as trihydrate) + 125 mg (as potassium salt)",Infectious cystitis,J01CR02,,Added,amoxicillin + clavulanic acid,"['amoxicillin + clavulanic acid', 'amoxicillin', 'clavulanic', '+', 'acid']"
amoxicillin + clavulanic acid,Access group antibiotics,"Parenteral > General injections > IV: 500 mg (as sodium salt) + 100 mg (as potassium salt) powder for injection; 1000 mg (as sodium salt) + 200 mg (as potassium salt) powder for injection
Oral > Liquid: 125 mg (as trihydrate) + 31.25 mg (as potassium salt) / 5 mL powder for oral liquid; 250 mg (as trihydrate) + 62.5 mg (as potassium salt) / 5 mL powder for oral liquid
Oral > Solid > dispersible tablet: 200 mg (as trihydrate) + 28.5 mg (as potassium salt); 250 mg (as trihydrate) + 62.5 mg (as potassium salt)
Oral > Solid > tablet: 500 mg (as trihydrate) + 125 mg (as potassium salt); 875 mg (as trihydrate) + 125 mg (as potassium salt)
Oral > Solid > tablet: 500 mg (as trihydrate) + 125 mg (as potassium salt)",Peritoneal abscess (mild-moderate),J01CR02,,Added,amoxicillin + clavulanic acid,"['amoxicillin + clavulanic acid', 'amoxicillin', 'clavulanic', '+', 'acid']"
amoxicillin + clavulanic acid,Access group antibiotics,"Parenteral > General injections > IV: 500 mg (as sodium salt) + 100 mg (as potassium salt) powder for injection; 1000 mg (as sodium salt) + 200 mg (as potassium salt) powder for injection
Oral > Liquid: 125 mg (as trihydrate) + 31.25 mg (as potassium salt) / 5 mL powder for oral liquid; 250 mg (as trihydrate) + 62.5 mg (as potassium salt) / 5 mL powder for oral liquid
Oral > Solid > dispersible tablet: 200 mg (as trihydrate) + 28.5 mg (as potassium salt); 250 mg (as trihydrate) + 62.5 mg (as potassium salt)
Oral > Solid > tablet: 500 mg (as trihydrate) + 125 mg (as potassium salt); 875 mg (as trihydrate) + 125 mg (as potassium salt)
Oral > Solid > tablet: 500 mg (as trihydrate) + 125 mg (as potassium salt)",Neutropenia (low-risk),J01CR02,,Added,amoxicillin + clavulanic acid,"['amoxicillin + clavulanic acid', 'amoxicillin', 'clavulanic', '+', 'acid']"
amoxicillin + clavulanic acid,Access group antibiotics,"Parenteral > General injections > IV: 500 mg (as sodium salt) + 100 mg (as potassium salt) powder for injection; 1000 mg (as sodium salt) + 200 mg (as potassium salt) powder for injection
Oral > Liquid: 125 mg (as trihydrate) + 31.25 mg (as potassium salt) / 5 mL powder for oral liquid; 250 mg (as trihydrate) + 62.5 mg (as potassium salt) / 5 mL powder for oral liquid
Oral > Solid > dispersible tablet: 200 mg (as trihydrate) + 28.5 mg (as potassium salt); 250 mg (as trihydrate) + 62.5 mg (as potassium salt)
Oral > Solid > tablet: 500 mg (as trihydrate) + 125 mg (as potassium salt); 875 mg (as trihydrate) + 125 mg (as potassium salt)
Oral > Solid > tablet: 500 mg (as trihydrate) + 125 mg (as potassium salt)",Other specified pneumonia (Hospital-acquired pneumonia),J01CR02,,Added,amoxicillin + clavulanic acid,"['amoxicillin + clavulanic acid', 'amoxicillin', 'clavulanic', '+', 'acid']"
amoxicillin + clavulanic acid,Access group antibiotics,"Parenteral > General injections > IV: 500 mg (as sodium salt) + 100 mg (as potassium salt) powder for injection; 1000 mg (as sodium salt) + 200 mg (as potassium salt) powder for injection
Oral > Liquid: 125 mg (as trihydrate) + 31.25 mg (as potassium salt) / 5 mL powder for oral liquid; 250 mg (as trihydrate) + 62.5 mg (as potassium salt) / 5 mL powder for oral liquid
Oral > Solid > dispersible tablet: 200 mg (as trihydrate) + 28.5 mg (as potassium salt); 250 mg (as trihydrate) + 62.5 mg (as potassium salt)
Oral > Solid > tablet: 500 mg (as trihydrate) + 125 mg (as potassium salt); 875 mg (as trihydrate) + 125 mg (as potassium salt)
Oral > Solid > tablet: 500 mg (as trihydrate) + 125 mg (as potassium salt)",Bacterial pneumonia (Community-acquired pneumonia - mild to moderate),J01CR02,,Added,amoxicillin + clavulanic acid,"['amoxicillin + clavulanic acid', 'amoxicillin', 'clavulanic', '+', 'acid']"
amoxicillin + clavulanic acid,Access group antibiotics,"Parenteral > General injections > IV: 500 mg (as sodium salt) + 100 mg (as potassium salt) powder for injection; 1000 mg (as sodium salt) + 200 mg (as potassium salt) powder for injection
Oral > Liquid: 125 mg (as trihydrate) + 31.25 mg (as potassium salt) / 5 mL powder for oral liquid; 250 mg (as trihydrate) + 62.5 mg (as potassium salt) / 5 mL powder for oral liquid
Oral > Solid > dispersible tablet: 200 mg (as trihydrate) + 28.5 mg (as potassium salt); 250 mg (as trihydrate) + 62.5 mg (as potassium salt)
Oral > Solid > tablet: 500 mg (as trihydrate) + 125 mg (as potassium salt); 875 mg (as trihydrate) + 125 mg (as potassium salt)
Oral > Solid > tablet: 500 mg (as trihydrate) + 125 mg (as potassium salt)",Bacterial pneumonia (Community-acquired pneumonia - severe),J01CR02,clarithromycin,Added,amoxicillin + clavulanic acid,"['amoxicillin + clavulanic acid', 'amoxicillin', 'clavulanic', '+', 'acid']"
amoxicillin + clavulanic acid,Access group antibiotics,"Parenteral > General injections > IV: 500 mg (as sodium salt) + 100 mg (as potassium salt) powder for injection; 1000 mg (as sodium salt) + 200 mg (as potassium salt) powder for injection
Oral > Liquid: 125 mg (as trihydrate) + 31.25 mg (as potassium salt) / 5 mL powder for oral liquid; 250 mg (as trihydrate) + 62.5 mg (as potassium salt) / 5 mL powder for oral liquid
Oral > Solid > dispersible tablet: 200 mg (as trihydrate) + 28.5 mg (as potassium salt); 250 mg (as trihydrate) + 62.5 mg (as potassium salt)
Oral > Solid > tablet: 500 mg (as trihydrate) + 125 mg (as potassium salt); 875 mg (as trihydrate) + 125 mg (as potassium salt)
Oral > Solid > tablet: 500 mg (as trihydrate) + 125 mg (as potassium salt)",Bacterial infection of joint,J01CR02,,Added,amoxicillin + clavulanic acid,"['amoxicillin + clavulanic acid', 'amoxicillin', 'clavulanic', '+', 'acid']"
amoxicillin + clavulanic acid,Access group antibiotics,"Parenteral > General injections > IV: 500 mg (as sodium salt) + 100 mg (as potassium salt) powder for injection; 1000 mg (as sodium salt) + 200 mg (as potassium salt) powder for injection
Oral > Liquid: 125 mg (as trihydrate) + 31.25 mg (as potassium salt) / 5 mL powder for oral liquid; 250 mg (as trihydrate) + 62.5 mg (as potassium salt) / 5 mL powder for oral liquid
Oral > Solid > dispersible tablet: 200 mg (as trihydrate) + 28.5 mg (as potassium salt); 250 mg (as trihydrate) + 62.5 mg (as potassium salt)
Oral > Solid > tablet: 500 mg (as trihydrate) + 125 mg (as potassium salt); 875 mg (as trihydrate) + 125 mg (as potassium salt)
Oral > Solid > tablet: 500 mg (as trihydrate) + 125 mg (as potassium salt)",Other specified prophylactic measures,J01CR02,,Added,amoxicillin + clavulanic acid,"['amoxicillin + clavulanic acid', 'amoxicillin', 'clavulanic', '+', 'acid']"
amoxicillin + clavulanic acid,Access group antibiotics,"Parenteral > General injections > IV: 500 mg (as sodium salt) + 100 mg (as potassium salt) powder for injection; 1000 mg (as sodium salt) + 200 mg (as potassium salt) powder for injection
Oral > Liquid: 125 mg (as trihydrate) + 31.25 mg (as potassium salt) / 5 mL powder for oral liquid; 250 mg (as trihydrate) + 62.5 mg (as potassium salt) / 5 mL powder for oral liquid
Oral > Solid > dispersible tablet: 200 mg (as trihydrate) + 28.5 mg (as potassium salt); 250 mg (as trihydrate) + 62.5 mg (as potassium salt)
Oral > Solid > tablet: 500 mg (as trihydrate) + 125 mg (as potassium salt); 875 mg (as trihydrate) + 125 mg (as potassium salt)
Oral > Solid > tablet: 500 mg (as trihydrate) + 125 mg (as potassium salt)",Osteomyelitis or osteitis,J01CR02,,Added,amoxicillin + clavulanic acid,"['amoxicillin + clavulanic acid', 'amoxicillin', 'clavulanic', '+', 'acid']"
amoxicillin + clavulanic acid,Access group antibiotics,"Parenteral > General injections > IV: 500 mg (as sodium salt) + 100 mg (as potassium salt) powder for injection; 1000 mg (as sodium salt) + 200 mg (as potassium salt) powder for injection
Oral > Liquid: 125 mg (as trihydrate) + 31.25 mg (as potassium salt) / 5 mL powder for oral liquid; 250 mg (as trihydrate) + 62.5 mg (as potassium salt) / 5 mL powder for oral liquid
Oral > Solid > dispersible tablet: 200 mg (as trihydrate) + 28.5 mg (as potassium salt); 250 mg (as trihydrate) + 62.5 mg (as potassium salt)
Oral > Solid > tablet: 500 mg (as trihydrate) + 125 mg (as potassium salt); 875 mg (as trihydrate) + 125 mg (as potassium salt)
Oral > Solid > tablet: 500 mg (as trihydrate) + 125 mg (as potassium salt)",Acute otitis media,J01CR02,,Added,amoxicillin + clavulanic acid,"['amoxicillin + clavulanic acid', 'amoxicillin', 'clavulanic', '+', 'acid']"
amoxicillin + clavulanic acid,Antituberculosis medicines,"Oral > Liquid: 250 mg (as trihydrate) + 62.5 mg (as potassium salt) / 5 mL powder for oral liquid
Oral > Solid > tablet: 500 mg (as trihydrate) + 125 mg (as potassium salt)",Multi-drug resistant Mycobacterium tuberculosis,J01CR02,,Added,amoxicillin + clavulanic acid,"['amoxicillin + clavulanic acid', 'amoxicillin', 'clavulanic', '+', 'acid']"
amphotericin B,Antifungal medicines,Parenteral > General injections > IV: 50 mg in vial powder for injection (liposomal complex); 50 mg in vial powder for injection (as sodium deoxycholate),Blastomycosis,J02AA01,,Added,amphotericin b,"['amphotericin b', 'amphotericin', 'b']"
amphotericin B,Antifungal medicines,Parenteral > General injections > IV: 50 mg in vial powder for injection (liposomal complex); 50 mg in vial powder for injection (as sodium deoxycholate),Cryptococcosis,J02AA01,,Added,amphotericin b,"['amphotericin b', 'amphotericin', 'b']"
amphotericin B,Antifungal medicines,Parenteral > General injections > IV: 50 mg in vial powder for injection (liposomal complex); 50 mg in vial powder for injection (as sodium deoxycholate),Candidosis,J02AA01,,Added,amphotericin b,"['amphotericin b', 'amphotericin', 'b']"
amphotericin B,Antifungal medicines,Parenteral > General injections > IV: 50 mg in vial powder for injection (liposomal complex); 50 mg in vial powder for injection (as sodium deoxycholate),Coccidioidomycosis,J02AA01,,Added,amphotericin b,"['amphotericin b', 'amphotericin', 'b']"
amphotericin B,Antifungal medicines,Parenteral > General injections > IV: 50 mg in vial powder for injection (liposomal complex); 50 mg in vial powder for injection (as sodium deoxycholate),Histoplasmosis,J02AA01,,Added,amphotericin b,"['amphotericin b', 'amphotericin', 'b']"
amphotericin B,Antifungal medicines,Parenteral > General injections > IV: 50 mg in vial powder for injection (liposomal complex); 50 mg in vial powder for injection (as sodium deoxycholate),Sporotrichosis,J02AA01,,Added,amphotericin b,"['amphotericin b', 'amphotericin', 'b']"
amphotericin B,Antifungal medicines,Parenteral > General injections > IV: 50 mg in vial powder for injection (liposomal complex); 50 mg in vial powder for injection (as sodium deoxycholate),Aspergillosis,J02AA01,,Added,amphotericin b,"['amphotericin b', 'amphotericin', 'b']"
amphotericin B,Antileishmaniasis medicines,Parenteral > General injections > IV: 50 mg in vial powder for injection (liposomal complex); 50 mg in vial powder for injection (as sodium deoxycholate),Visceral leishmaniasis,J02AA01,,Added,amphotericin b,"['amphotericin b', 'amphotericin', 'b']"
ampicillin,Access group antibiotics,"Parenteral > General injections > unspecified: 500 mg in vial (as sodium salt) powder for injection; 1 g in vial (as sodium salt) powder for injection
Oral > Liquid: 125 mg per 5 mL (anhydrous) powder for oral suspension
Oral > Solid: 250 mg (anhydrous); 500 mg (anhydrous)",Bacterial pneumonia (Community-acquired pneumonia - severe) [children],J01CA01,gentamicin,Added,ampicillin,['ampicillin']
ampicillin,Access group antibiotics,"Parenteral > General injections > unspecified: 500 mg in vial (as sodium salt) powder for injection; 1 g in vial (as sodium salt) powder for injection
Oral > Liquid: 125 mg per 5 mL (anhydrous) powder for oral suspension
Oral > Solid: 250 mg (anhydrous); 500 mg (anhydrous)","Acute malnutrition in infants, children or adolescents (complicated) [children]",J01CA01,gentamicin,Added,ampicillin,['ampicillin']
ampicillin,Access group antibiotics,"Parenteral > General injections > unspecified: 500 mg in vial (as sodium salt) powder for injection; 1 g in vial (as sodium salt) powder for injection
Oral > Liquid: 125 mg per 5 mL (anhydrous) powder for oral suspension
Oral > Solid: 250 mg (anhydrous); 500 mg (anhydrous)",Peritonitis (mild-moderate),J01CA01,gentamicin,Added,ampicillin,['ampicillin']
ampicillin,Access group antibiotics,"Parenteral > General injections > unspecified: 500 mg in vial (as sodium salt) powder for injection; 1 g in vial (as sodium salt) powder for injection
Oral > Liquid: 125 mg per 5 mL (anhydrous) powder for oral suspension
Oral > Solid: 250 mg (anhydrous); 500 mg (anhydrous)",Peritonitis (severe),J01CA01,gentamicin,Added,ampicillin,['ampicillin']
ampicillin,Access group antibiotics,"Parenteral > General injections > unspecified: 500 mg in vial (as sodium salt) powder for injection; 1 g in vial (as sodium salt) powder for injection
Oral > Liquid: 125 mg per 5 mL (anhydrous) powder for oral suspension
Oral > Solid: 250 mg (anhydrous); 500 mg (anhydrous)",Peritoneal abscess (mild-moderate),J01CA01,gentamicin,Added,ampicillin,['ampicillin']
ampicillin,Access group antibiotics,"Parenteral > General injections > unspecified: 500 mg in vial (as sodium salt) powder for injection; 1 g in vial (as sodium salt) powder for injection
Oral > Liquid: 125 mg per 5 mL (anhydrous) powder for oral suspension
Oral > Solid: 250 mg (anhydrous); 500 mg (anhydrous)",Peritoneal abscess (severe),J01CA01,gentamicin,Added,ampicillin,['ampicillin']
ampicillin,Access group antibiotics,"Parenteral > General injections > unspecified: 500 mg in vial (as sodium salt) powder for injection; 1 g in vial (as sodium salt) powder for injection
Oral > Liquid: 125 mg per 5 mL (anhydrous) powder for oral suspension
Oral > Solid: 250 mg (anhydrous); 500 mg (anhydrous)",Sepsis without septic shock,J01CA01,gentamicin,Added,ampicillin,['ampicillin']
ampicillin,Access group antibiotics,"Parenteral > General injections > unspecified: 500 mg in vial (as sodium salt) powder for injection; 1 g in vial (as sodium salt) powder for injection
Oral > Liquid: 125 mg per 5 mL (anhydrous) powder for oral suspension
Oral > Solid: 250 mg (anhydrous); 500 mg (anhydrous)",Bacterial meningitis,J01CA01,,Added,ampicillin,['ampicillin']
anastrozole,Hormones and antihormones,Oral > Solid: 1 mg tablet,Other specified malignant neoplasms of breast,L02BG03,,Added,anastrozole,['anastrozole']
anastrozole,Hormones and antihormones,Oral > Solid: 1 mg tablet,Malignant neoplasms of breast,L02BG03,,Added,anastrozole,['anastrozole']
anidulafungin,Antifungal medicines,,Systemic or invasive candidosis,,,Added,anidulafungin,['anidulafungin']
ansuvimab,Medicines for Ebola virus disease,Parenteral > General injections > IV: 400 mg powder for injection,Ebola virus disease,J06BD04,,Added,ansuvimab,['ansuvimab']
anti-D immunoglobulin,Human immunoglobulins,"Parenteral > General injections > IV: 250 µg in single-dose vial
Parenteral > General injections > IM: 250 µg in single-dose vial",Rh incompatibility reaction,J06BB01,,Added,anti-d immunoglobulin,"['immunoglobulin', 'anti-d', 'anti-d immunoglobulin']"
anti-D immunoglobulin,Human immunoglobulins,"Parenteral > General injections > IV: 250 µg in single-dose vial
Parenteral > General injections > IM: 250 µg in single-dose vial",Maternal care for red cell antibodies,J06BB01,,Added,anti-d immunoglobulin,"['immunoglobulin', 'anti-d', 'anti-d immunoglobulin']"
anti-rabies immunoglobulin,Human immunoglobulins,"Parenteral > General injections > IM: 150 IU per  mL in vial
Parenteral > Locoregional injections > Other: 150 IU per  mL in vial",Rabies,J06BB05,,Added,anti-rabies immunoglobulin,"['immunoglobulin', 'anti-rabies immunoglobulin', 'anti-rabies']"
anti-rabies virus monoclonal antibodies,"Immunologicals > Sera, immunoglobulins and monoclonal antibodies",Parenteral > Locoregional injections > Intradermal: 40 IU per  mL in 1.25 mL vial (human); 40 IU per  mL in 2.5 mL vial (human); 100 IU per  mL in 2.5 mL vial (human); 300 IU per  mL in 10 mL vial (murine); 600 IU per  mL in 1 mL vial (murine); 600 IU per  mL in 2.5 mL vial (murine); 600 IU per  mL in 5 mL vial (murine),Rabies,,,Added,anti-rabies virus monoclonal antibodies,"['antibodies', 'anti-rabies', 'monoclonal', 'anti-rabies virus monoclonal antibodies', 'virus']"
anti-tetanus immunoglobulin,Human immunoglobulins,Parenteral > General injections > IM: 500 IU in vial,Tetanus,J06BB02,,Added,anti-tetanus immunoglobulin,"['immunoglobulin', 'anti-tetanus', 'anti-tetanus immunoglobulin']"
antivenom immunoglobulin,"Immunologicals > Sera, immunoglobulins and monoclonal antibodies",Parenteral > General injections > IV: ,"Harmful effects of or exposure to noxious substances, chiefly nonmedicinal as to source, not elsewhere classified",,,Added,antivenom immunoglobulin,"['antivenom immunoglobulin', 'immunoglobulin', 'antivenom']"
apixaban,Medicines affecting coagulation,,Venous thromboembolism,,,Added,apixaban,['apixaban']
apixaban,Medicines affecting coagulation,,Other specified atrial fibrillation,,,Added,apixaban,['apixaban']
aprepitant,Antiemetic medicines,"Oral > Liquid: 125 mg powder for oral suspension (in sachet)
Oral > Solid: 80 mg; 125 mg; 165 mg",Nausea or vomiting,A04AD12,,Added,aprepitant,['aprepitant']
aripiprazole,Medicines for psychotic disorders,,Schizophrenia or other primary psychotic disorders,,,Added,aripiprazole,['aripiprazole']
arsenic trioxide,Cytotoxic medicines,Parenteral > General injections > IV: 1 mg per  mL concentrate for solution for infusion; 2 mg per  mL concentrate for solution for infusion,Acute myeloid leukaemia with recurrent genetic abnormalities,L01XX27,,Added,arsenic trioxide,"['arsenic', 'arsenic trioxide', 'trioxide']"
artemether,Antimalarial medicines > For curative treatment,Parenteral > General injections > IM: 80 mg per  mL in 1 mL ampoule (oily injection),Malaria due to Plasmodium falciparum,P01BE02,,Added,artemether,['artemether']
artemether,Antimalarial medicines > For curative treatment,Parenteral > General injections > IM: 80 mg per  mL in 1 mL ampoule (oily injection),Malaria due to Plasmodium vivax,P01BE02,,Added,artemether,['artemether']
artemether + lumefantrine,Antimalarial medicines > For curative treatment,Oral > Solid: 20 mg + 120 mg tablet; 20 mg + 120 mg dispersible tablet,Malaria due to Plasmodium falciparum,P01BF01,,Added,artemether + lumefantrine,"['artemether', 'lumefantrine', 'artemether + lumefantrine', '+']"
artemether + lumefantrine,Antimalarial medicines > For curative treatment,Oral > Solid: 20 mg + 120 mg tablet; 20 mg + 120 mg dispersible tablet,Malaria due to Plasmodium vivax,P01BF01,,Added,artemether + lumefantrine,"['artemether', 'lumefantrine', 'artemether + lumefantrine', '+']"
artesunate,Antimalarial medicines > For curative treatment,"Parenteral > General injections > IV: 60 mg in ampoule containing anhydrous artesunic acid with a separate ampoule of 5% sodium bicarbonate solution
Oral > Solid: 50 mg tablet
Local > Rectal > Other: 50 mg capsules; 200 mg capsules; 100 mg capsules",Malaria due to Plasmodium falciparum,P01BE03,,Added,artesunate,['artesunate']
artesunate,Antimalarial medicines > For curative treatment,"Parenteral > General injections > IV: 60 mg in ampoule containing anhydrous artesunic acid with a separate ampoule of 5% sodium bicarbonate solution
Oral > Solid: 50 mg tablet
Local > Rectal > Other: 50 mg capsules; 200 mg capsules; 100 mg capsules",Malaria due to Plasmodium vivax,P01BE03,,Added,artesunate,['artesunate']
artesunate + amodiaquine,Antimalarial medicines > For curative treatment,Oral > Solid: 25 mg + 67.5 mg tablet; 50 mg + 135 mg tablet; 100 mg + 270 mg tablet,Malaria due to Plasmodium falciparum,P01BF03,,Added,artesunate + amodiaquine,"['artesunate', 'artesunate + amodiaquine', '+', 'amodiaquine']"
artesunate + amodiaquine,Antimalarial medicines > For curative treatment,Oral > Solid: 25 mg + 67.5 mg tablet; 50 mg + 135 mg tablet; 100 mg + 270 mg tablet,Malaria due to Plasmodium vivax,P01BF03,,Added,artesunate + amodiaquine,"['artesunate', 'artesunate + amodiaquine', '+', 'amodiaquine']"
artesunate + mefloquine,Antimalarial medicines > For curative treatment,Oral > Solid: 25 mg + 55 mg tablet; 100 mg + 220 mg tablet,Malaria due to Plasmodium falciparum,P01BF02,,Added,artesunate + mefloquine,"['artesunate', 'mefloquine', '+', 'artesunate + mefloquine']"
artesunate + mefloquine,Antimalarial medicines > For curative treatment,Oral > Solid: 25 mg + 55 mg tablet; 100 mg + 220 mg tablet,Malaria due to Plasmodium vivax,P01BF02,,Added,artesunate + mefloquine,"['artesunate', 'mefloquine', '+', 'artesunate + mefloquine']"
artesunate + pyronaridine tetraphosphate,Antimalarial medicines > For curative treatment,Oral > Solid: 60 mg + 180 mg tablet; 20 mg + 60 mg granules,Malaria due to Plasmodium falciparum,P01BF06,,Added,artesunate + pyronaridine tetraphosphate,"['tetraphosphate', 'pyronaridine', 'artesunate', '+', 'artesunate + pyronaridine tetraphosphate']"
artesunate + pyronaridine tetraphosphate,Antimalarial medicines > For curative treatment,Oral > Solid: 60 mg + 180 mg tablet; 20 mg + 60 mg granules,Malaria due to Plasmodium vivax,P01BF06,,Added,artesunate + pyronaridine tetraphosphate,"['tetraphosphate', 'pyronaridine', 'artesunate', '+', 'artesunate + pyronaridine tetraphosphate']"
ascorbic acid,Vitamins and minerals,Oral > Solid: 50 mg,Scurvy,A11GA01,,Added,ascorbic acid,"['ascorbic', 'ascorbic acid', 'acid']"
asparaginase,Cytotoxic medicines,"Powder for injection: 10 000 IU in vial.
Parenteral > General injections > unspecified: 10000 IU in vial powder for injection","Lymphoid leukaemia, not elsewhere classified",L01XX02,,Added,asparaginase,['asparaginase']
atazanavir + ritonavir,Antiretrovirals > Protease inhibitors,Oral > Solid: 300 mg (as sulfate) + 100 mg tablet (heat stable),"Human immunodeficiency virus disease without mention of associated disease or condition, clinical stage unspecified",J05AR23,,Added,atazanavir + ritonavir,"['atazanavir', 'atazanavir + ritonavir', 'ritonavir', '+']"
atenolol,Antihypertensive medicines,"Oral > Solid: 50 mg; 100 mg
",Essential hypertension,,,Added,atenolol,['atenolol']
atoltivimab + maftivimab + odesivimab,Medicines for Ebola virus disease,Parenteral > General injections > IV: 241.7 mg + 241.7 mg + 241.7 mg in 14.5 mL vial,Ebola virus disease,,,Added,atoltivimab + maftivimab + odesivimab,"['odesivimab', 'atoltivimab + maftivimab + odesivimab', '+', 'maftivimab', 'atoltivimab']"
atorvastatin,Lipid-lowering agents,,Mixed hyperlipidaemia,,,Added,atorvastatin,['atorvastatin']
atorvastatin,Lipid-lowering agents,,Coronary atherosclerosis,,,Added,atorvastatin,['atorvastatin']
atorvastatin + perindopril + amlodipine,Fixed-dose combinations for prevention of atherosclerotic cardiovascular disease,Oral > Solid > tablet: 20 mg + 5 mg + 5 mg; 20 mg + 10 mg + 10 mg; 40 mg + 5 mg + 5 mg; 40 mg + 10 mg + 10 mg,Chronic ischaemic heart disease,C10BX11,,Added,atorvastatin + perindopril + amlodipine,"['amlodipine', 'perindopril', 'atorvastatin + perindopril + amlodipine', '+', 'atorvastatin']"
atorvastatin + perindopril + amlodipine,Fixed-dose combinations for prevention of atherosclerotic cardiovascular disease,Oral > Solid > tablet: 20 mg + 5 mg + 5 mg; 20 mg + 10 mg + 10 mg; 40 mg + 5 mg + 5 mg; 40 mg + 10 mg + 10 mg,Atherosclerotic chronic arterial occlusive disease,C10BX11,,Added,atorvastatin + perindopril + amlodipine,"['amlodipine', 'perindopril', 'atorvastatin + perindopril + amlodipine', '+', 'atorvastatin']"
atorvastatin + perindopril + amlodipine,Fixed-dose combinations for prevention of atherosclerotic cardiovascular disease,Oral > Solid > tablet: 20 mg + 5 mg + 5 mg; 20 mg + 10 mg + 10 mg; 40 mg + 5 mg + 5 mg; 40 mg + 10 mg + 10 mg,Cerebral ischaemic stroke,C10BX11,,Added,atorvastatin + perindopril + amlodipine,"['amlodipine', 'perindopril', 'atorvastatin + perindopril + amlodipine', '+', 'atorvastatin']"
atracurium,Muscle relaxants (peripherally-acting) and cholinesterase inhibitors,"Parenteral > General injections > IV: 10 mg per  mL (besylate)
",Muscle relaxants,M03AC04,,Added,atracurium,['atracurium']
atracurium,Muscle relaxants (peripherally-acting) and cholinesterase inhibitors,"Parenteral > General injections > IV: 10 mg per  mL (besylate)
",Muscle relaxants,,,Added,atracurium,['atracurium']
atropine,Antidotes and other substances used in poisonings > Specific,Parenteral > General injections > unspecified: 1 mg in 1 mL ampoule (atropine sulfate),Exposure to or harmful effects of undetermined intent of pesticides,A03BA01,,Added,atropine,['atropine']
atropine,Preoperative medication and sedation for short-term procedures,Parenteral > General injections > unspecified: 1 mg in 1 mL ampoule (atropine sulfate),Parasympatholytics [anticholinergics and antimuscarinics] and spasmolytics,A03BA01,,Added,atropine,['atropine']
atropine,Diagnostic agents > Ophthalmic medicines,,Cycloplegic drug,,,Added,atropine,['atropine']
atropine,Ophthalmological preparations > Mydriatics,Local > Ophthalmological > Solution (eye drops): 0.1% (sulfate); 0.5% (sulfate); 1% (sulfate),Anterior uveitis,S01FA01,,Added,atropine,['atropine']
azathioprine,Immunomodulators for non-malignant disease,"Parenteral > General injections > IV: 50 mg in vial powder for injection (as sodium salt); 100 mg in vial powder for injection (as sodium salt)
Oral > Liquid: 10 mg per  mL
Oral > Solid > tablet: 25 mg; 50 mg (scored)
Oral > Solid > tablet: 50 mg (scored)",Failure or rejection of transplanted organs or tissues,L04AX01,,Added,azathioprine,['azathioprine']
azathioprine,Disease-modifying anti-rheumatic drugs (DMARDs),Oral > Solid > tablet: 50 mg (scored),"Rheumatoid arthritis, serology unspecified",L04AX01,,Added,azathioprine,['azathioprine']
azathioprine,Disease-modifying anti-rheumatic drugs (DMARDs),Oral > Solid > tablet: 50 mg (scored),Psoriatic arthritis,L04AX01,,Added,azathioprine,['azathioprine']
azithromycin,Ophthalmological preparations > Anti-infective agents,Local > Ophthalmological > Solution (eye drops): 1.5% eye drops,Trachoma,S01AA26,,Added,azithromycin,['azithromycin']
azithromycin,Watch group antibiotics,"Oral > Liquid: 200 mg per 5 mL (anhydrous) powder for oral liquid
Oral > Solid > dosage form: 250 mg (anhydrous); 500 mg (anhydrous)",Trachoma,J01FA10,,Added,azithromycin,['azithromycin']
azithromycin,Watch group antibiotics,"Oral > Liquid: 200 mg per 5 mL (anhydrous) powder for oral liquid
Oral > Solid > dosage form: 250 mg (anhydrous); 500 mg (anhydrous)",Cholera,J01FA10,,Added,azithromycin,['azithromycin']
azithromycin,Watch group antibiotics,"Oral > Liquid: 200 mg per 5 mL (anhydrous) powder for oral liquid
Oral > Solid > dosage form: 250 mg (anhydrous); 500 mg (anhydrous)",Cholera [children],J01FA10,,Added,azithromycin,['azithromycin']
azithromycin,Watch group antibiotics,"Oral > Liquid: 200 mg per 5 mL (anhydrous) powder for oral liquid
Oral > Solid > dosage form: 250 mg (anhydrous); 500 mg (anhydrous)",Paratyphoid fever,J01FA10,,Added,azithromycin,['azithromycin']
azithromycin,Watch group antibiotics,"Oral > Liquid: 200 mg per 5 mL (anhydrous) powder for oral liquid
Oral > Solid > dosage form: 250 mg (anhydrous); 500 mg (anhydrous)",Yaws,J01FA10,,Added,azithromycin,['azithromycin']
azithromycin,Watch group antibiotics,"Oral > Liquid: 200 mg per 5 mL (anhydrous) powder for oral liquid
Oral > Solid > dosage form: 250 mg (anhydrous); 500 mg (anhydrous)",Chlamydia trachomatis,J01FA10,,Added,azithromycin,['azithromycin']
azithromycin,Watch group antibiotics,"Oral > Liquid: 200 mg per 5 mL (anhydrous) powder for oral liquid
Oral > Solid > dosage form: 250 mg (anhydrous); 500 mg (anhydrous)",Typhoid fever,J01FA10,,Added,azithromycin,['azithromycin']
azithromycin,Watch group antibiotics,"Oral > Liquid: 200 mg per 5 mL (anhydrous) powder for oral liquid
Oral > Solid > dosage form: 250 mg (anhydrous); 500 mg (anhydrous)",Gonococcal infection,J01FA10,ceftriaxone,Added,azithromycin,['azithromycin']
azithromycin,Watch group antibiotics,"Oral > Liquid: 200 mg per 5 mL (anhydrous) powder for oral liquid
Oral > Solid > dosage form: 250 mg (anhydrous); 500 mg (anhydrous)",Infectious gastroenteritis or colitis without specification of infectious agent,J01FA10,,Added,azithromycin,['azithromycin']
azithromycin,Watch group antibiotics,"Oral > Liquid: 200 mg per 5 mL (anhydrous) powder for oral liquid
Oral > Solid > dosage form: 250 mg (anhydrous); 500 mg (anhydrous)",Gonococcal infection,J01FA10,cefixime,Added,azithromycin,['azithromycin']
barium sulfate,Diagnostic agents > Radiocontrast media,Oral > Liquid: Aqueous suspension,Barium sulfate with suspending agents,V08BA01,,Added,barium sulfate,"['sulfate', 'barium sulfate', 'barium']"
beclometasone,Antiasthmatic and medicines for chronic obstructive pulmonary disease,"
Respiratory > Inhalation > aerosol: 50 µg per  dose (dipropionate); 250 µg per  dose (dipropionatae)",Asthma,,,Added,beclometasone,['beclometasone']
beclometasone + formoterol,Antiasthmatic and medicines for chronic obstructive pulmonary disease,,Asthma,,,Added,beclometasone + formoterol,"['beclometasone', 'beclometasone + formoterol', '+', 'formoterol']"
bedaquiline,Antituberculosis medicines,Oral > Solid: 100 mg tablet; 20 mg tablet,Multi-drug resistant Mycobacterium tuberculosis,J04AK05,,Added,bedaquiline,['bedaquiline']
bendamustine,Cytotoxic medicines,Parenteral > General injections > unspecified: 45 mg per 0.5 mL; 180 mg per 2 mL,Chronic lymphocytic leukaemia or small lymphocytic lymphoma,L01AA09,,Added,bendamustine,['bendamustine']
bendamustine,Cytotoxic medicines,Parenteral > General injections > unspecified: 45 mg per 0.5 mL; 180 mg per 2 mL,Follicular lymphoma,L01AA09,,Added,bendamustine,['bendamustine']
benzathine benzylpenicillin,Access group antibiotics,Parenteral > General injections > IM: 1.2 million IU in vial (≈ 900 mg) powder for injection; 2.4 million IU in vial (≈ 1.8 g) powder for injection,Congenital syphilis [children],J01CE08,,Added,benzathine benzylpenicillin,"['benzathine benzylpenicillin', 'benzathine', 'benzylpenicillin']"
benzathine benzylpenicillin,Access group antibiotics,Parenteral > General injections > IM: 1.2 million IU in vial (≈ 900 mg) powder for injection; 2.4 million IU in vial (≈ 1.8 g) powder for injection,Syphilis,J01CE08,,Added,benzathine benzylpenicillin,"['benzathine benzylpenicillin', 'benzathine', 'benzylpenicillin']"
benznidazole,American trypanosomiasis,Oral > Solid > tablet: 100 mg (scored); 50 mg (scored); 12.5 mg,Chagas disease,P01CA02,,Added,benznidazole,['benznidazole']
benzoyl peroxide,Dermatological medicines > Medicines affecting skin differentiation and proliferation,"Local > Topical > Cream: 5%
Local > Topical > Lotion: 5%",Acne,D10AE01,,Added,benzoyl peroxide,"['benzoyl', 'benzoyl peroxide', 'peroxide']"
benzyl benzoate,Dermatological medicines > Scabicides and pediculicides,Local > Topical > Lotion: 25%,Pthiriasis,P03AX01,,Added,benzyl benzoate,"['benzoate', 'benzyl benzoate', 'benzyl']"
benzyl benzoate,Dermatological medicines > Scabicides and pediculicides,Local > Topical > Lotion: 25%,Pediculosis corporis,P03AX01,,Added,benzyl benzoate,"['benzoate', 'benzyl benzoate', 'benzyl']"
benzyl benzoate,Dermatological medicines > Scabicides and pediculicides,Local > Topical > Lotion: 25%,Pediculosis capitis,P03AX01,,Added,benzyl benzoate,"['benzoate', 'benzyl benzoate', 'benzyl']"
benzyl benzoate,Dermatological medicines > Scabicides and pediculicides,Local > Topical > Lotion: 25%,Scabies,P03AX01,,Added,benzyl benzoate,"['benzoate', 'benzyl benzoate', 'benzyl']"
benzylpenicillin,Access group antibiotics,"Parenteral > General injections > unspecified: 600 mg in vial powder for injection (=1 million IU as sodium or potassium salt); 3 g in vial powder for injection (=5 million IU as sodium or potassium salt)
Parenteral > General injections > unspecified: 600 mg in vial powder for injection (= 1 million IU as sodium or potassium salt); 3 g in vial powder for injection (= 5 million IU as sodium or potassium salt)",Bacterial pneumonia (Community-acquired pneumonia - severe) [children],J01CE01,gentamicin,Added,benzylpenicillin,['benzylpenicillin']
benzylpenicillin,Access group antibiotics,"Parenteral > General injections > unspecified: 600 mg in vial powder for injection (=1 million IU as sodium or potassium salt); 3 g in vial powder for injection (=5 million IU as sodium or potassium salt)
Parenteral > General injections > unspecified: 600 mg in vial powder for injection (= 1 million IU as sodium or potassium salt); 3 g in vial powder for injection (= 5 million IU as sodium or potassium salt)",Congenital syphilis [children],J01CE01,,Added,benzylpenicillin,['benzylpenicillin']
benzylpenicillin,Access group antibiotics,"Parenteral > General injections > unspecified: 600 mg in vial powder for injection (=1 million IU as sodium or potassium salt); 3 g in vial powder for injection (=5 million IU as sodium or potassium salt)
Parenteral > General injections > unspecified: 600 mg in vial powder for injection (= 1 million IU as sodium or potassium salt); 3 g in vial powder for injection (= 5 million IU as sodium or potassium salt)",Syphilis,J01CE01,,Added,benzylpenicillin,['benzylpenicillin']
benzylpenicillin,Access group antibiotics,"Parenteral > General injections > unspecified: 600 mg in vial powder for injection (=1 million IU as sodium or potassium salt); 3 g in vial powder for injection (=5 million IU as sodium or potassium salt)
Parenteral > General injections > unspecified: 600 mg in vial powder for injection (= 1 million IU as sodium or potassium salt); 3 g in vial powder for injection (= 5 million IU as sodium or potassium salt)","Acute malnutrition in infants, children or adolescents (complicated) [children]",J01CE01,gentamicin,Added,benzylpenicillin,['benzylpenicillin']
benzylpenicillin,Access group antibiotics,"Parenteral > General injections > unspecified: 600 mg in vial powder for injection (=1 million IU as sodium or potassium salt); 3 g in vial powder for injection (=5 million IU as sodium or potassium salt)
Parenteral > General injections > unspecified: 600 mg in vial powder for injection (= 1 million IU as sodium or potassium salt); 3 g in vial powder for injection (= 5 million IU as sodium or potassium salt)",Sepsis without septic shock,J01CE01,gentamicin,Added,benzylpenicillin,['benzylpenicillin']
benzylpenicillin,Access group antibiotics,"Parenteral > General injections > unspecified: 600 mg in vial powder for injection (=1 million IU as sodium or potassium salt); 3 g in vial powder for injection (=5 million IU as sodium or potassium salt)
Parenteral > General injections > unspecified: 600 mg in vial powder for injection (= 1 million IU as sodium or potassium salt); 3 g in vial powder for injection (= 5 million IU as sodium or potassium salt)",Bacterial meningitis,J01CE01,,Added,benzylpenicillin,['benzylpenicillin']
betamethasone,Dermatological medicines > Anti-inflammatory and antipruritic medicines,"Local > Topical > Cream: 0.1% (as valerate)
Local > Topical > Ointment: 0.1% (as valerate)",Pruritus due to skin disorder,D07AC01,,Added,betamethasone,['betamethasone']
betamethasone,Dermatological medicines > Anti-inflammatory and antipruritic medicines,"Local > Topical > Cream: 0.1% (as valerate)
Local > Topical > Ointment: 0.1% (as valerate)",Psoriasis of unspecified type,D07AC01,,Added,betamethasone,['betamethasone']
betamethasone,Dermatological medicines > Anti-inflammatory and antipruritic medicines,"Local > Topical > Cream: 0.1% (as valerate)
Local > Topical > Ointment: 0.1% (as valerate)",Dermatitis or eczema,D07AC01,,Added,betamethasone,['betamethasone']
betamethasone,Dermatological medicines > Anti-inflammatory and antipruritic medicines,"Local > Topical > Cream: 0.1% (as valerate)
Local > Topical > Ointment: 0.1% (as valerate)",Lichen planus,D07AC01,,Added,betamethasone,['betamethasone']
bevacizumab,Ophthalmological preparations > Anti-vascular endothelial growth factor (VEGF) preparations,Parenteral > Locoregional injections > Intravitreal: 25 mg per  mL,Age related macular degeneration,S01LA08,,Added,bevacizumab,['bevacizumab']
bicalutamide,Hormones and antihormones,Oral > Solid: 50 mg,Malignant neoplasms of prostate,L02BB03,,Added,bicalutamide,['bicalutamide']
biperiden,Medicines for parkinsonism,"Parenteral > General injections > IV: 5 mg per  mL in 1 mL ampoule (lactate)
Oral > Solid: 2 mg tablet (hydrochloride)",Parkinson disease,N04AA02,,Added,biperiden,['biperiden']
bisacodyl,Laxatives,,Constipation,,,Added,bisacodyl,['bisacodyl']
bisoprolol,Antianginal medicines,Oral > Solid: 1.25 mg; 5 mg,Angina pectoris,C07AB07,,Added,bisoprolol,['bisoprolol']
bisoprolol,Medicines used in heart failure,Oral > Solid: 1.25 mg; 5 mg,Heart failure,C07AB07,,Added,bisoprolol,['bisoprolol']
bisoprolol,Antihypertensive medicines,Oral > Solid: 1.25 mg; 5 mg,Essential hypertension,C07AB07,,Added,bisoprolol,['bisoprolol']
bisoprolol,Antiarrhythmic medicines,Oral > Solid: 1.25 mg; 5 mg,Cardiac arrhythmia,C07AB07,,Added,bisoprolol,['bisoprolol']
bleomycin,Cytotoxic medicines,Parenteral > General injections > unspecified: 15000 IU in vial (as sulfate),Germ cell tumour of testis,L01DC01,,Added,bleomycin,['bleomycin']
bleomycin,Cytotoxic medicines,Parenteral > General injections > unspecified: 15000 IU in vial (as sulfate),Kaposi sarcoma of unspecified primary site,L01DC01,,Added,bleomycin,['bleomycin']
bleomycin,Cytotoxic medicines,Parenteral > General injections > unspecified: 15000 IU in vial (as sulfate),Hodgkin lymphoma,L01DC01,,Added,bleomycin,['bleomycin']
bleomycin,Cytotoxic medicines,Parenteral > General injections > unspecified: 15000 IU in vial (as sulfate),Other specified malignant neoplasms of the ovary,L01DC01,,Added,bleomycin,['bleomycin']
bortezomib,Targeted therapies,Parenteral > General injections > unspecified: 3.5 mg in vial powder for injection,Plasma cell myeloma,L01XG01,,Added,bortezomib,['bortezomib']
bromocriptine,Medicines for disorders of the pituitary hormone system,,Other specified benign neoplasm of endocrine glands,,,Added,bromocriptine,['bromocriptine']
budesonide,Antiasthmatic and medicines for chronic obstructive pulmonary disease,Respiratory > Inhalation > aerosol: 100 µg per  dose; 200 µg per  dose,Asthma,R03BA02,,Added,budesonide,['budesonide']
budesonide,"Ear, nose and throat medicines [c]",Local > Nasal > Spray: 100 µg per  dose,Allergic rhinitis,R01AD05,,Added,budesonide,['budesonide']
budesonide + formoterol,Antiasthmatic and medicines for chronic obstructive pulmonary disease,Respiratory > Inhalation > dry powder: 100 µg + 6 µg per dose; 200 µg + 6 µg per dose,Asthma,R03AK07,,Added,budesonide + formoterol,"['formoterol', '+', 'budesonide', 'budesonide + formoterol']"
budesonide + salmeterol,Antiasthmatic and medicines for chronic obstructive pulmonary disease,,Asthma,,,Added,budesonide + salmeterol,"['salmeterol', 'budesonide + salmeterol', 'budesonide', '+']"
bumetanide,Medicines used in heart failure,,Heart failure,,,Added,bumetanide,['bumetanide']
bumetanide,Diuretics,,Anuria or oliguria,,,Added,bumetanide,['bumetanide']
bumetanide,Diuretics,,Oedema,,,Added,bumetanide,['bumetanide']
bupivacaine,Local anaesthetics,"Parenteral > Locoregional injections > Spinal anaesthesia: 0.5% in 4 mL ampoule (hydrochloride) + 7.5% glucose solution
Parenteral > General injections > unspecified: 0.25% in vial (hydrochloride); 0.5% in vial (hydrochloride)",Local anaesthetics,N01BB01,,Added,bupivacaine,['bupivacaine']
buprenorphine,Medicines for opioid use disorders,,Opioid dependence,,,Added,buprenorphine,['buprenorphine']
bupropion,Medicines for nicotine use disorders,Oral > Solid: 150 mg sustained-release (hydrochloride),Nicotine dependence,N06AX12,,Added,bupropion,['bupropion']
cabergoline,Medicines for disorders of the pituitary hormone system,Oral > Solid > tablet: 0.5 mg; 1 mg,Other specified benign neoplasm of endocrine glands,G02CB03,,Added,cabergoline,['cabergoline']
caffeine citrate,Medicines administered to the neonate [c],"Parenteral > General injections > IV: 20 mg per  mL (equivalent to 10 mg caffeine base per mL)
Oral > Liquid: 20 mg per  mL (equivalent to 10 mg caffeine base per mL)",Apnoea of newborn,N06BC01,,Added,caffeine citrate,"['caffeine', 'citrate', 'caffeine citrate']"
calamine,Dermatological medicines > Anti-inflammatory and antipruritic medicines,Local > Topical > Lotion: ,Pruritus,D02AB,,Added,calamine,['calamine']
calcipotriol,Dermatological medicines > Medicines affecting skin differentiation and proliferation,"Local > Topical > Cream: 50 µg per  mL (0.005%)
Local > Topical > Lotion: 50 µg per  mL (0.005%)
Local > Topical > Ointment: 50 µg per  mL (0.005%)",Psoriasis of unspecified type,D05AX02,,Added,calcipotriol,['calcipotriol']
calcitriol,Dermatological medicines > Medicines affecting skin differentiation and proliferation,,Psoriasis of unspecified type,,,Added,calcitriol,['calcitriol']
calcium,Vitamins and minerals,Oral > Solid: 500 mg (elemental calcium),Calcium deficiency,A12AA20,,Added,calcium,['calcium']
calcium folinate (leucovorin calcium),Cytotoxic medicines,"Oral > Solid: 15 mg tablet
Parenteral > General injections > unspecified: 3 mg per  mL in 10 mL ampoule
Parenteral > General injections > unspecified: 3 mg per  mL in 10 mL ampoule; 7.5 mg per  mL in 2 mL ampoule; 10 mg per  mL in 5 mL ampoule
Oral > Solid > tablet: 15 mg; 5 mg; 25 mg",Burkitt lymphoma including Burkitt leukaemia,V03AF03,,Added,calcium folinate (leucovorin calcium),"['(leucovorin', 'folinate', 'calcium', 'calcium folinate (leucovorin calcium)', 'calcium)']"
calcium folinate (leucovorin calcium),Cytotoxic medicines,"Oral > Solid: 15 mg tablet
Parenteral > General injections > unspecified: 3 mg per  mL in 10 mL ampoule
Parenteral > General injections > unspecified: 3 mg per  mL in 10 mL ampoule; 7.5 mg per  mL in 2 mL ampoule; 10 mg per  mL in 5 mL ampoule
Oral > Solid > tablet: 15 mg; 5 mg; 25 mg",Malignant neoplasm metastasis in large intestine,V03AF03,,Added,calcium folinate (leucovorin calcium),"['(leucovorin', 'folinate', 'calcium', 'calcium folinate (leucovorin calcium)', 'calcium)']"
calcium folinate (leucovorin calcium),Cytotoxic medicines,"Oral > Solid: 15 mg tablet
Parenteral > General injections > unspecified: 3 mg per  mL in 10 mL ampoule
Parenteral > General injections > unspecified: 3 mg per  mL in 10 mL ampoule; 7.5 mg per  mL in 2 mL ampoule; 10 mg per  mL in 5 mL ampoule
Oral > Solid > tablet: 15 mg; 5 mg; 25 mg",Malignant trophoblastic neoplasms of placenta,V03AF03,,Added,calcium folinate (leucovorin calcium),"['(leucovorin', 'folinate', 'calcium', 'calcium folinate (leucovorin calcium)', 'calcium)']"
calcium folinate (leucovorin calcium),Cytotoxic medicines,"Oral > Solid: 15 mg tablet
Parenteral > General injections > unspecified: 3 mg per  mL in 10 mL ampoule
Parenteral > General injections > unspecified: 3 mg per  mL in 10 mL ampoule; 7.5 mg per  mL in 2 mL ampoule; 10 mg per  mL in 5 mL ampoule
Oral > Solid > tablet: 15 mg; 5 mg; 25 mg",Osteosarcoma of bone and articular cartilage of unspecified sites,V03AF03,,Added,calcium folinate (leucovorin calcium),"['(leucovorin', 'folinate', 'calcium', 'calcium folinate (leucovorin calcium)', 'calcium)']"
calcium folinate (leucovorin calcium),Cytotoxic medicines,"Oral > Solid: 15 mg tablet
Parenteral > General injections > unspecified: 3 mg per  mL in 10 mL ampoule
Parenteral > General injections > unspecified: 3 mg per  mL in 10 mL ampoule; 7.5 mg per  mL in 2 mL ampoule; 10 mg per  mL in 5 mL ampoule
Oral > Solid > tablet: 15 mg; 5 mg; 25 mg",Malignant neoplasms of rectum,V03AF03,,Added,calcium folinate (leucovorin calcium),"['(leucovorin', 'folinate', 'calcium', 'calcium folinate (leucovorin calcium)', 'calcium)']"
calcium folinate (leucovorin calcium),Cytotoxic medicines,"Oral > Solid: 15 mg tablet
Parenteral > General injections > unspecified: 3 mg per  mL in 10 mL ampoule
Parenteral > General injections > unspecified: 3 mg per  mL in 10 mL ampoule; 7.5 mg per  mL in 2 mL ampoule; 10 mg per  mL in 5 mL ampoule
Oral > Solid > tablet: 15 mg; 5 mg; 25 mg",Malignant neoplasms of colon,V03AF03,,Added,calcium folinate (leucovorin calcium),"['(leucovorin', 'folinate', 'calcium', 'calcium folinate (leucovorin calcium)', 'calcium)']"
calcium gluconate,Antidotes and other substances used in poisonings > Specific,Parenteral > General injections > IV: 100 mg per  mL in 10 mL ampoule,Hypermagnesaemia,A12AA03,,Added,calcium gluconate,"['calcium', 'calcium gluconate', 'gluconate']"
calcium gluconate,Vitamins and minerals,Parenteral > General injections > IV: 100 mg per  mL in 10 mL ampoule,Tetany due to acute calcium deficiency,A12AA03,,Added,calcium gluconate,"['calcium', 'calcium gluconate', 'gluconate']"
canagliflozin,Oral hypoglycaemic agents,,Type 2 diabetes mellitus,,,Added,canagliflozin,['canagliflozin']
capecitabine,Cytotoxic medicines,Oral > Solid > tablet: 150 mg; 500 mg,Other specified malignant neoplasms of breast,L01BC06,,Added,capecitabine,['capecitabine']
capecitabine,Cytotoxic medicines,Oral > Solid > tablet: 150 mg; 500 mg,Malignant neoplasm metastasis in large intestine,L01BC06,,Added,capecitabine,['capecitabine']
capecitabine,Cytotoxic medicines,Oral > Solid > tablet: 150 mg; 500 mg,Malignant neoplasms of rectum,L01BC06,,Added,capecitabine,['capecitabine']
capecitabine,Cytotoxic medicines,Oral > Solid > tablet: 150 mg; 500 mg,Malignant neoplasms of colon,L01BC06,,Added,capecitabine,['capecitabine']
carbachol,Ophthalmological preparations > Miotics and antiglaucoma medicines,,Acute angle closure with pupillary block,,,Added,carbachol,['carbachol']
carbachol,Ophthalmological preparations > Miotics and antiglaucoma medicines,,Ocular hypertension,,,Added,carbachol,['carbachol']
carbachol,Ophthalmological preparations > Miotics and antiglaucoma medicines,,Primary open-angle glaucoma,,,Added,carbachol,['carbachol']
carbamazepine,Medicines for bipolar disorders,Oral > Solid > tablet: 100 mg (scored); 200 mg (scored); 400 mg,Bipolar or related disorders,N03AF01,,Added,carbamazepine,['carbamazepine']
carbamazepine,Antiseizure medicines,"Oral > Liquid: 100 mg per 5 mL
Oral > Solid > tablet: 100 mg (scored); 200 mg (scored); 100 mg (chewable); 200 mg (chewable); 400 mg (scored)",Epilepsy or seizures,N03AF01,,Added,carbamazepine,['carbamazepine']
carbetocin,Uterotonics,Parenteral > General injections > IV: 100 µg per  mL (heat stable),Postpartum haemorrhage,H01BB03,,Added,carbetocin,['carbetocin']
carbimazole,Thyroid hormones and antithyroid medicines,,Thyrotoxicosis,,,Added,carbimazole,['carbimazole']
carboplatin,Cytotoxic medicines,Parenteral > General injections > IV: 50 mg per 5 mL; 150 mg per 15 mL; 450 mg per 45 mL; 600 mg per 60 mL,Other specified gliomas of brain,L01XA02,,Added,carboplatin,['carboplatin']
carboplatin,Cytotoxic medicines,Parenteral > General injections > IV: 50 mg per 5 mL; 150 mg per 15 mL; 450 mg per 45 mL; 600 mg per 60 mL,Other specified carcinomas of ovary,L01XA02,,Added,carboplatin,['carboplatin']
carboplatin,Cytotoxic medicines,Parenteral > General injections > IV: 50 mg per 5 mL; 150 mg per 15 mL; 450 mg per 45 mL; 600 mg per 60 mL,Retinoblastoma,L01XA02,,Added,carboplatin,['carboplatin']
carboplatin,Cytotoxic medicines,Parenteral > General injections > IV: 50 mg per 5 mL; 150 mg per 15 mL; 450 mg per 45 mL; 600 mg per 60 mL,Other specified malignant neoplasms of bronchus or lung,L01XA02,,Added,carboplatin,['carboplatin']
carboplatin,Cytotoxic medicines,Parenteral > General injections > IV: 50 mg per 5 mL; 150 mg per 15 mL; 450 mg per 45 mL; 600 mg per 60 mL,Malignant neoplasms of nasopharynx,L01XA02,,Added,carboplatin,['carboplatin']
carboplatin,Cytotoxic medicines,Parenteral > General injections > IV: 50 mg per 5 mL; 150 mg per 15 mL; 450 mg per 45 mL; 600 mg per 60 mL,"Malignant neoplasms of kidney, except renal pelvis",L01XA02,,Added,carboplatin,['carboplatin']
carboplatin,Cytotoxic medicines,Parenteral > General injections > IV: 50 mg per 5 mL; 150 mg per 15 mL; 450 mg per 45 mL; 600 mg per 60 mL,Malignant neoplasms of breast,L01XA02,,Added,carboplatin,['carboplatin']
carboplatin,Cytotoxic medicines,Parenteral > General injections > IV: 50 mg per 5 mL; 150 mg per 15 mL; 450 mg per 45 mL; 600 mg per 60 mL,Osteosarcoma of bone and articular cartilage of unspecified sites,L01XA02,,Added,carboplatin,['carboplatin']
carboplatin,Cytotoxic medicines,Parenteral > General injections > IV: 50 mg per 5 mL; 150 mg per 15 mL; 450 mg per 45 mL; 600 mg per 60 mL,"Malignant neoplasms of lip, oral cavity or pharynx",L01XA02,,Added,carboplatin,['carboplatin']
carboplatin,Cytotoxic medicines,Parenteral > General injections > IV: 50 mg per 5 mL; 150 mg per 15 mL; 450 mg per 45 mL; 600 mg per 60 mL,Malignant neoplasms of cervix uteri,L01XA02,,Added,carboplatin,['carboplatin']
carboplatin,Cytotoxic medicines,Parenteral > General injections > IV: 50 mg per 5 mL; 150 mg per 15 mL; 450 mg per 45 mL; 600 mg per 60 mL,Other specified malignant neoplasms of the ovary,L01XA02,,Added,carboplatin,['carboplatin']
carboplatin,Cytotoxic medicines,Parenteral > General injections > IV: 50 mg per 5 mL; 150 mg per 15 mL; 450 mg per 45 mL; 600 mg per 60 mL,Germ cell tumour of testis,L01XA02,,Added,carboplatin,['carboplatin']
carvedilol,Antianginal medicines,,Angina pectoris,,,Added,carvedilol,['carvedilol']
carvedilol,Medicines used in heart failure,,Heart failure,,,Added,carvedilol,['carvedilol']
carvedilol,Antihypertensive medicines,,Essential hypertension,,,Added,carvedilol,['carvedilol']
carvedilol,Antiarrhythmic medicines,,Cardiac arrhythmia,,,Added,carvedilol,['carvedilol']
caspofungin,Antifungal medicines,,Systemic or invasive candidosis,,,Added,caspofungin,['caspofungin']
cefalexin,Access group antibiotics,"Oral > Liquid: 125 mg per 5 mL (anhydrous) powder for oral liquid; 250 mg per 5 mL (anhydrous) powder for oral liquid
Oral > Solid: 250 mg (as monohydrate)
Oral > Solid: 250 mg (as monohydrate); 500 mg (as monohydrate)
Oral > Solid > dispersible tablet: 125 mg; 250 mg","Bacterial cellulitis, erysipelas or lymphangitis",J01DB01,,Added,cefalexin,['cefalexin']
cefalexin,Access group antibiotics,"Oral > Liquid: 125 mg per 5 mL (anhydrous) powder for oral liquid; 250 mg per 5 mL (anhydrous) powder for oral liquid
Oral > Solid: 250 mg (as monohydrate)
Oral > Solid: 250 mg (as monohydrate); 500 mg (as monohydrate)
Oral > Solid > dispersible tablet: 125 mg; 250 mg",Chronic obstructive pulmonary disease with acute exacerbation,J01DB01,,Added,cefalexin,['cefalexin']
cefalexin,Access group antibiotics,"Oral > Liquid: 125 mg per 5 mL (anhydrous) powder for oral liquid; 250 mg per 5 mL (anhydrous) powder for oral liquid
Oral > Solid: 250 mg (as monohydrate)
Oral > Solid: 250 mg (as monohydrate); 500 mg (as monohydrate)
Oral > Solid > dispersible tablet: 125 mg; 250 mg",Acute pharyngitis,J01DB01,,Added,cefalexin,['cefalexin']
cefazolin,Access group antibiotics,Parenteral > General injections > unspecified: 1 g in vial (as sodium salt) powder for injection,Other specified prophylactic measures,J01DB04,metronidazole,Added,cefazolin,['cefazolin']
cefazolin,Access group antibiotics,Parenteral > General injections > unspecified: 1 g in vial (as sodium salt) powder for injection,Other specified prophylactic measures,J01DB04,,Added,cefazolin,['cefazolin']
cefazolin,Access group antibiotics,Parenteral > General injections > unspecified: 1 g in vial (as sodium salt) powder for injection,Bacterial infection of joint,J01DB04,,Added,cefazolin,['cefazolin']
cefazolin,Access group antibiotics,Parenteral > General injections > unspecified: 1 g in vial (as sodium salt) powder for injection,Osteomyelitis or osteitis,J01DB04,,Added,cefazolin,['cefazolin']
cefiderocol,Reserve group antibiotics,Parenteral > General injections > IV: 1 g in vial (as sulfate tosylate) powder for injection,Carbapenem-resistant Pseudomonas aeruginosa,J01DI04,,Added,cefiderocol,['cefiderocol']
cefiderocol,Reserve group antibiotics,Parenteral > General injections > IV: 1 g in vial (as sulfate tosylate) powder for injection,Carbapenem resistant Enterobacterales,J01DI04,,Added,cefiderocol,['cefiderocol']
cefixime,Watch group antibiotics,"Oral > Liquid: 100 mg per 5 mL powder for oral liquid
Oral > Solid: 200 mg (as trihydrate); 400 mg (as trihydrate)",Infectious gastroenteritis or colitis without specification of infectious agent,J01DD08,,Added,cefixime,['cefixime']
cefixime,Watch group antibiotics,"Oral > Liquid: 100 mg per 5 mL powder for oral liquid
Oral > Solid: 200 mg (as trihydrate); 400 mg (as trihydrate)",Gonococcal infection,J01DD08,azithromycin,Added,cefixime,['cefixime']
cefotaxime,Watch group antibiotics,"Parenteral > General injections > unspecified: 250 mg in vial powder for injection (as sodium salt)
Parenteral > General injections > unspecified: 250 mg in vial powder for injection (as sodium salt); 500 mg in vial powder for injection (as sodium salt); 1 g in vial powder for injection (as sodium salt); 2 g in vial powder for injection (as sodium salt)",Bacterial meningitis,J01DD01,,Added,cefotaxime,['cefotaxime']
cefotaxime,Watch group antibiotics,"Parenteral > General injections > unspecified: 250 mg in vial powder for injection (as sodium salt)
Parenteral > General injections > unspecified: 250 mg in vial powder for injection (as sodium salt); 500 mg in vial powder for injection (as sodium salt); 1 g in vial powder for injection (as sodium salt); 2 g in vial powder for injection (as sodium salt)",Acute pyelonephritis (severe),J01DD01,amikacin,Added,cefotaxime,['cefotaxime']
cefotaxime,Watch group antibiotics,"Parenteral > General injections > unspecified: 250 mg in vial powder for injection (as sodium salt)
Parenteral > General injections > unspecified: 250 mg in vial powder for injection (as sodium salt); 500 mg in vial powder for injection (as sodium salt); 1 g in vial powder for injection (as sodium salt); 2 g in vial powder for injection (as sodium salt)",Inflammatory and other diseases of prostate (severe),J01DD01,amikacin,Added,cefotaxime,['cefotaxime']
cefotaxime,Watch group antibiotics,"Parenteral > General injections > unspecified: 250 mg in vial powder for injection (as sodium salt)
Parenteral > General injections > unspecified: 250 mg in vial powder for injection (as sodium salt); 500 mg in vial powder for injection (as sodium salt); 1 g in vial powder for injection (as sodium salt); 2 g in vial powder for injection (as sodium salt)",Bacterial pneumonia (Community-acquired pneumonia - severe) [children],J01DD01,,Added,cefotaxime,['cefotaxime']
cefotaxime,Watch group antibiotics,"Parenteral > General injections > unspecified: 250 mg in vial powder for injection (as sodium salt)
Parenteral > General injections > unspecified: 250 mg in vial powder for injection (as sodium salt); 500 mg in vial powder for injection (as sodium salt); 1 g in vial powder for injection (as sodium salt); 2 g in vial powder for injection (as sodium salt)",Bacterial pneumonia (Community-acquired pneumonia - severe),J01DD01,clarithromycin,Added,cefotaxime,['cefotaxime']
cefotaxime,Watch group antibiotics,"Parenteral > General injections > unspecified: 250 mg in vial powder for injection (as sodium salt)
Parenteral > General injections > unspecified: 250 mg in vial powder for injection (as sodium salt); 500 mg in vial powder for injection (as sodium salt); 1 g in vial powder for injection (as sodium salt); 2 g in vial powder for injection (as sodium salt)",Other specified pneumonia (Hospital-acquired pneumonia),J01DD01,,Added,cefotaxime,['cefotaxime']
cefotaxime,Watch group antibiotics,"Parenteral > General injections > unspecified: 250 mg in vial powder for injection (as sodium salt)
Parenteral > General injections > unspecified: 250 mg in vial powder for injection (as sodium salt); 500 mg in vial powder for injection (as sodium salt); 1 g in vial powder for injection (as sodium salt); 2 g in vial powder for injection (as sodium salt)",Peritoneal abscess (mild-moderate),J01DD01,metronidazole,Added,cefotaxime,['cefotaxime']
cefotaxime,Watch group antibiotics,"Parenteral > General injections > unspecified: 250 mg in vial powder for injection (as sodium salt)
Parenteral > General injections > unspecified: 250 mg in vial powder for injection (as sodium salt); 500 mg in vial powder for injection (as sodium salt); 1 g in vial powder for injection (as sodium salt); 2 g in vial powder for injection (as sodium salt)",Peritoneal abscess (severe),J01DD01,metronidazole,Added,cefotaxime,['cefotaxime']
cefotaxime,Watch group antibiotics,"Parenteral > General injections > unspecified: 250 mg in vial powder for injection (as sodium salt)
Parenteral > General injections > unspecified: 250 mg in vial powder for injection (as sodium salt); 500 mg in vial powder for injection (as sodium salt); 1 g in vial powder for injection (as sodium salt); 2 g in vial powder for injection (as sodium salt)",Peritonitis (mild-moderate),J01DD01,metronidazole,Added,cefotaxime,['cefotaxime']
cefotaxime,Watch group antibiotics,"Parenteral > General injections > unspecified: 250 mg in vial powder for injection (as sodium salt)
Parenteral > General injections > unspecified: 250 mg in vial powder for injection (as sodium salt); 500 mg in vial powder for injection (as sodium salt); 1 g in vial powder for injection (as sodium salt); 2 g in vial powder for injection (as sodium salt)",Peritonitis (severe),J01DD01,metronidazole,Added,cefotaxime,['cefotaxime']
cefotaxime,Watch group antibiotics,"Parenteral > General injections > unspecified: 250 mg in vial powder for injection (as sodium salt)
Parenteral > General injections > unspecified: 250 mg in vial powder for injection (as sodium salt); 500 mg in vial powder for injection (as sodium salt); 1 g in vial powder for injection (as sodium salt); 2 g in vial powder for injection (as sodium salt)",Sepsis without septic shock,J01DD01,,Added,cefotaxime,['cefotaxime']
cefotaxime,Watch group antibiotics,"Parenteral > General injections > unspecified: 250 mg in vial powder for injection (as sodium salt)
Parenteral > General injections > unspecified: 250 mg in vial powder for injection (as sodium salt); 500 mg in vial powder for injection (as sodium salt); 1 g in vial powder for injection (as sodium salt); 2 g in vial powder for injection (as sodium salt)",Acute pyelonephritis (mild to moderate),J01DD01,,Added,cefotaxime,['cefotaxime']
cefotaxime,Watch group antibiotics,"Parenteral > General injections > unspecified: 250 mg in vial powder for injection (as sodium salt)
Parenteral > General injections > unspecified: 250 mg in vial powder for injection (as sodium salt); 500 mg in vial powder for injection (as sodium salt); 1 g in vial powder for injection (as sodium salt); 2 g in vial powder for injection (as sodium salt)",Inflammatory and other diseases of prostate (mild to moderate),J01DD01,,Added,cefotaxime,['cefotaxime']
cefotaxime,Watch group antibiotics,"Parenteral > General injections > unspecified: 250 mg in vial powder for injection (as sodium salt)
Parenteral > General injections > unspecified: 250 mg in vial powder for injection (as sodium salt); 500 mg in vial powder for injection (as sodium salt); 1 g in vial powder for injection (as sodium salt); 2 g in vial powder for injection (as sodium salt)",Bacterial infection of joint,J01DD01,,Added,cefotaxime,['cefotaxime']
cefotaxime,Watch group antibiotics,"Parenteral > General injections > unspecified: 250 mg in vial powder for injection (as sodium salt)
Parenteral > General injections > unspecified: 250 mg in vial powder for injection (as sodium salt); 500 mg in vial powder for injection (as sodium salt); 1 g in vial powder for injection (as sodium salt); 2 g in vial powder for injection (as sodium salt)",Osteomyelitis or osteitis,J01DD01,,Added,cefotaxime,['cefotaxime']
ceftazidime,Watch group antibiotics,Parenteral > General injections > unspecified: 250 mg in vial (as pentahydrate) powder for injection; 1 g in vial (as pentahydrate) powder for injection,Endophthalmitis,J01DD02,vancomycin,Added,ceftazidime,['ceftazidime']
ceftazidime,Watch group antibiotics,Parenteral > General injections > unspecified: 250 mg in vial (as pentahydrate) powder for injection; 1 g in vial (as pentahydrate) powder for injection,Pseudomonas aeruginosa resistant to other antibiotic,J01DD02,,Added,ceftazidime,['ceftazidime']
ceftazidime + avibactam,Reserve group antibiotics,Parenteral > General injections > IV: 2 g in vial + 0.5 g in vial powder for injection,Carbapenem-resistant Pseudomonas aeruginosa,J01DD52,,Added,ceftazidime + avibactam,"['avibactam', 'ceftazidime', '+', 'ceftazidime + avibactam']"
ceftazidime + avibactam,Reserve group antibiotics,Parenteral > General injections > IV: 2 g in vial + 0.5 g in vial powder for injection,Carbapenem resistant Enterobacterales,J01DD52,,Added,ceftazidime + avibactam,"['avibactam', 'ceftazidime', '+', 'ceftazidime + avibactam']"
ceftolozane + tazobactam,Reserve group antibiotics,Parenteral > General injections > IV: 1 g + 0.5 g powder for injection,Carbapenem-resistant Pseudomonas aeruginosa,J01DI54,,Added,ceftolozane + tazobactam,"['tazobactam', '+', 'ceftolozane + tazobactam', 'ceftolozane']"
ceftriaxone,Watch group antibiotics,"Parenteral > General injections > unspecified: 250 mg in vial powder for injection (as sodium salt); 1 g in vial powder for injection (as sodium salt)
Parenteral > General injections > unspecified: 250 mg in vial powder for injection (as sodium salt); 500 mg in vial powder for injection (as sodium salt); 1 g in vial powder for injection (as sodium salt); 2 g in vial powder for injection (as sodium salt)
Parenteral > Locoregional injections > Intravitreal: 250 mg in vial powder for injection (as sodium salt); 500 mg in vial powder for injection (as sodium salt); 1 g in vial powder for injection (as sodium salt); 2 g in vial powder for injection (as sodium salt)
Parenteral > General injections > unspecified: 250 mg in vial powder for injection (as sodium salt); 500 mg in vial powder for injection (as sodium salt); 1 g in vial powder for injection (as sodium salt)
Parenteral > General injections > unspecified: 2 g in vial; 250 mg in vial powder for injection (as sodium salt); 500 mg in vial powder for injection (as sodium salt); 1 g in vial powder for injection (as sodium salt)",Gonococcal infection,J01DD04,azithromycin,Added,ceftriaxone,['ceftriaxone']
ceftriaxone,Watch group antibiotics,"Parenteral > General injections > unspecified: 250 mg in vial powder for injection (as sodium salt); 1 g in vial powder for injection (as sodium salt)
Parenteral > General injections > unspecified: 250 mg in vial powder for injection (as sodium salt); 500 mg in vial powder for injection (as sodium salt); 1 g in vial powder for injection (as sodium salt); 2 g in vial powder for injection (as sodium salt)
Parenteral > Locoregional injections > Intravitreal: 250 mg in vial powder for injection (as sodium salt); 500 mg in vial powder for injection (as sodium salt); 1 g in vial powder for injection (as sodium salt); 2 g in vial powder for injection (as sodium salt)
Parenteral > General injections > unspecified: 250 mg in vial powder for injection (as sodium salt); 500 mg in vial powder for injection (as sodium salt); 1 g in vial powder for injection (as sodium salt)
Parenteral > General injections > unspecified: 2 g in vial; 250 mg in vial powder for injection (as sodium salt); 500 mg in vial powder for injection (as sodium salt); 1 g in vial powder for injection (as sodium salt)",Acute pyelonephritis (severe),J01DD04,amikacin,Added,ceftriaxone,['ceftriaxone']
ceftriaxone,Watch group antibiotics,"Parenteral > General injections > unspecified: 250 mg in vial powder for injection (as sodium salt); 1 g in vial powder for injection (as sodium salt)
Parenteral > General injections > unspecified: 250 mg in vial powder for injection (as sodium salt); 500 mg in vial powder for injection (as sodium salt); 1 g in vial powder for injection (as sodium salt); 2 g in vial powder for injection (as sodium salt)
Parenteral > Locoregional injections > Intravitreal: 250 mg in vial powder for injection (as sodium salt); 500 mg in vial powder for injection (as sodium salt); 1 g in vial powder for injection (as sodium salt); 2 g in vial powder for injection (as sodium salt)
Parenteral > General injections > unspecified: 250 mg in vial powder for injection (as sodium salt); 500 mg in vial powder for injection (as sodium salt); 1 g in vial powder for injection (as sodium salt)
Parenteral > General injections > unspecified: 2 g in vial; 250 mg in vial powder for injection (as sodium salt); 500 mg in vial powder for injection (as sodium salt); 1 g in vial powder for injection (as sodium salt)",Inflammatory and other diseases of prostate (severe),J01DD04,amikacin,Added,ceftriaxone,['ceftriaxone']
ceftriaxone,Watch group antibiotics,"Parenteral > General injections > unspecified: 250 mg in vial powder for injection (as sodium salt); 1 g in vial powder for injection (as sodium salt)
Parenteral > General injections > unspecified: 250 mg in vial powder for injection (as sodium salt); 500 mg in vial powder for injection (as sodium salt); 1 g in vial powder for injection (as sodium salt); 2 g in vial powder for injection (as sodium salt)
Parenteral > Locoregional injections > Intravitreal: 250 mg in vial powder for injection (as sodium salt); 500 mg in vial powder for injection (as sodium salt); 1 g in vial powder for injection (as sodium salt); 2 g in vial powder for injection (as sodium salt)
Parenteral > General injections > unspecified: 250 mg in vial powder for injection (as sodium salt); 500 mg in vial powder for injection (as sodium salt); 1 g in vial powder for injection (as sodium salt)
Parenteral > General injections > unspecified: 2 g in vial; 250 mg in vial powder for injection (as sodium salt); 500 mg in vial powder for injection (as sodium salt); 1 g in vial powder for injection (as sodium salt)",Bacterial meningitis,J01DD04,,Added,ceftriaxone,['ceftriaxone']
ceftriaxone,Watch group antibiotics,"Parenteral > General injections > unspecified: 250 mg in vial powder for injection (as sodium salt); 1 g in vial powder for injection (as sodium salt)
Parenteral > General injections > unspecified: 250 mg in vial powder for injection (as sodium salt); 500 mg in vial powder for injection (as sodium salt); 1 g in vial powder for injection (as sodium salt); 2 g in vial powder for injection (as sodium salt)
Parenteral > Locoregional injections > Intravitreal: 250 mg in vial powder for injection (as sodium salt); 500 mg in vial powder for injection (as sodium salt); 1 g in vial powder for injection (as sodium salt); 2 g in vial powder for injection (as sodium salt)
Parenteral > General injections > unspecified: 250 mg in vial powder for injection (as sodium salt); 500 mg in vial powder for injection (as sodium salt); 1 g in vial powder for injection (as sodium salt)
Parenteral > General injections > unspecified: 2 g in vial; 250 mg in vial powder for injection (as sodium salt); 500 mg in vial powder for injection (as sodium salt); 1 g in vial powder for injection (as sodium salt)",Other specified pneumonia (Hospital-acquired pneumonia),J01DD04,,Added,ceftriaxone,['ceftriaxone']
ceftriaxone,Watch group antibiotics,"Parenteral > General injections > unspecified: 250 mg in vial powder for injection (as sodium salt); 1 g in vial powder for injection (as sodium salt)
Parenteral > General injections > unspecified: 250 mg in vial powder for injection (as sodium salt); 500 mg in vial powder for injection (as sodium salt); 1 g in vial powder for injection (as sodium salt); 2 g in vial powder for injection (as sodium salt)
Parenteral > Locoregional injections > Intravitreal: 250 mg in vial powder for injection (as sodium salt); 500 mg in vial powder for injection (as sodium salt); 1 g in vial powder for injection (as sodium salt); 2 g in vial powder for injection (as sodium salt)
Parenteral > General injections > unspecified: 250 mg in vial powder for injection (as sodium salt); 500 mg in vial powder for injection (as sodium salt); 1 g in vial powder for injection (as sodium salt)
Parenteral > General injections > unspecified: 2 g in vial; 250 mg in vial powder for injection (as sodium salt); 500 mg in vial powder for injection (as sodium salt); 1 g in vial powder for injection (as sodium salt)",Paratyphoid fever,J01DD04,,Added,ceftriaxone,['ceftriaxone']
ceftriaxone,Watch group antibiotics,"Parenteral > General injections > unspecified: 250 mg in vial powder for injection (as sodium salt); 1 g in vial powder for injection (as sodium salt)
Parenteral > General injections > unspecified: 250 mg in vial powder for injection (as sodium salt); 500 mg in vial powder for injection (as sodium salt); 1 g in vial powder for injection (as sodium salt); 2 g in vial powder for injection (as sodium salt)
Parenteral > Locoregional injections > Intravitreal: 250 mg in vial powder for injection (as sodium salt); 500 mg in vial powder for injection (as sodium salt); 1 g in vial powder for injection (as sodium salt); 2 g in vial powder for injection (as sodium salt)
Parenteral > General injections > unspecified: 250 mg in vial powder for injection (as sodium salt); 500 mg in vial powder for injection (as sodium salt); 1 g in vial powder for injection (as sodium salt)
Parenteral > General injections > unspecified: 2 g in vial; 250 mg in vial powder for injection (as sodium salt); 500 mg in vial powder for injection (as sodium salt); 1 g in vial powder for injection (as sodium salt)",Typhoid fever,J01DD04,,Added,ceftriaxone,['ceftriaxone']
ceftriaxone,Watch group antibiotics,"Parenteral > General injections > unspecified: 250 mg in vial powder for injection (as sodium salt); 1 g in vial powder for injection (as sodium salt)
Parenteral > General injections > unspecified: 250 mg in vial powder for injection (as sodium salt); 500 mg in vial powder for injection (as sodium salt); 1 g in vial powder for injection (as sodium salt); 2 g in vial powder for injection (as sodium salt)
Parenteral > Locoregional injections > Intravitreal: 250 mg in vial powder for injection (as sodium salt); 500 mg in vial powder for injection (as sodium salt); 1 g in vial powder for injection (as sodium salt); 2 g in vial powder for injection (as sodium salt)
Parenteral > General injections > unspecified: 250 mg in vial powder for injection (as sodium salt); 500 mg in vial powder for injection (as sodium salt); 1 g in vial powder for injection (as sodium salt)
Parenteral > General injections > unspecified: 2 g in vial; 250 mg in vial powder for injection (as sodium salt); 500 mg in vial powder for injection (as sodium salt); 1 g in vial powder for injection (as sodium salt)",Peritonitis (mild-moderate),J01DD04,metronidazole,Added,ceftriaxone,['ceftriaxone']
ceftriaxone,Watch group antibiotics,"Parenteral > General injections > unspecified: 250 mg in vial powder for injection (as sodium salt); 1 g in vial powder for injection (as sodium salt)
Parenteral > General injections > unspecified: 250 mg in vial powder for injection (as sodium salt); 500 mg in vial powder for injection (as sodium salt); 1 g in vial powder for injection (as sodium salt); 2 g in vial powder for injection (as sodium salt)
Parenteral > Locoregional injections > Intravitreal: 250 mg in vial powder for injection (as sodium salt); 500 mg in vial powder for injection (as sodium salt); 1 g in vial powder for injection (as sodium salt); 2 g in vial powder for injection (as sodium salt)
Parenteral > General injections > unspecified: 250 mg in vial powder for injection (as sodium salt); 500 mg in vial powder for injection (as sodium salt); 1 g in vial powder for injection (as sodium salt)
Parenteral > General injections > unspecified: 2 g in vial; 250 mg in vial powder for injection (as sodium salt); 500 mg in vial powder for injection (as sodium salt); 1 g in vial powder for injection (as sodium salt)",Peritonitis (severe),J01DD04,metronidazole,Added,ceftriaxone,['ceftriaxone']
ceftriaxone,Watch group antibiotics,"Parenteral > General injections > unspecified: 250 mg in vial powder for injection (as sodium salt); 1 g in vial powder for injection (as sodium salt)
Parenteral > General injections > unspecified: 250 mg in vial powder for injection (as sodium salt); 500 mg in vial powder for injection (as sodium salt); 1 g in vial powder for injection (as sodium salt); 2 g in vial powder for injection (as sodium salt)
Parenteral > Locoregional injections > Intravitreal: 250 mg in vial powder for injection (as sodium salt); 500 mg in vial powder for injection (as sodium salt); 1 g in vial powder for injection (as sodium salt); 2 g in vial powder for injection (as sodium salt)
Parenteral > General injections > unspecified: 250 mg in vial powder for injection (as sodium salt); 500 mg in vial powder for injection (as sodium salt); 1 g in vial powder for injection (as sodium salt)
Parenteral > General injections > unspecified: 2 g in vial; 250 mg in vial powder for injection (as sodium salt); 500 mg in vial powder for injection (as sodium salt); 1 g in vial powder for injection (as sodium salt)",Peritoneal abscess (mild-moderate),J01DD04,metronidazole,Added,ceftriaxone,['ceftriaxone']
ceftriaxone,Watch group antibiotics,"Parenteral > General injections > unspecified: 250 mg in vial powder for injection (as sodium salt); 1 g in vial powder for injection (as sodium salt)
Parenteral > General injections > unspecified: 250 mg in vial powder for injection (as sodium salt); 500 mg in vial powder for injection (as sodium salt); 1 g in vial powder for injection (as sodium salt); 2 g in vial powder for injection (as sodium salt)
Parenteral > Locoregional injections > Intravitreal: 250 mg in vial powder for injection (as sodium salt); 500 mg in vial powder for injection (as sodium salt); 1 g in vial powder for injection (as sodium salt); 2 g in vial powder for injection (as sodium salt)
Parenteral > General injections > unspecified: 250 mg in vial powder for injection (as sodium salt); 500 mg in vial powder for injection (as sodium salt); 1 g in vial powder for injection (as sodium salt)
Parenteral > General injections > unspecified: 2 g in vial; 250 mg in vial powder for injection (as sodium salt); 500 mg in vial powder for injection (as sodium salt); 1 g in vial powder for injection (as sodium salt)",Peritoneal abscess (severe),J01DD04,metronidazole,Added,ceftriaxone,['ceftriaxone']
ceftriaxone,Watch group antibiotics,"Parenteral > General injections > unspecified: 250 mg in vial powder for injection (as sodium salt); 1 g in vial powder for injection (as sodium salt)
Parenteral > General injections > unspecified: 250 mg in vial powder for injection (as sodium salt); 500 mg in vial powder for injection (as sodium salt); 1 g in vial powder for injection (as sodium salt); 2 g in vial powder for injection (as sodium salt)
Parenteral > Locoregional injections > Intravitreal: 250 mg in vial powder for injection (as sodium salt); 500 mg in vial powder for injection (as sodium salt); 1 g in vial powder for injection (as sodium salt); 2 g in vial powder for injection (as sodium salt)
Parenteral > General injections > unspecified: 250 mg in vial powder for injection (as sodium salt); 500 mg in vial powder for injection (as sodium salt); 1 g in vial powder for injection (as sodium salt)
Parenteral > General injections > unspecified: 2 g in vial; 250 mg in vial powder for injection (as sodium salt); 500 mg in vial powder for injection (as sodium salt); 1 g in vial powder for injection (as sodium salt)",Endophthalmitis,J01DD04,vancomycin,Added,ceftriaxone,['ceftriaxone']
ceftriaxone,Watch group antibiotics,"Parenteral > General injections > unspecified: 250 mg in vial powder for injection (as sodium salt); 1 g in vial powder for injection (as sodium salt)
Parenteral > General injections > unspecified: 250 mg in vial powder for injection (as sodium salt); 500 mg in vial powder for injection (as sodium salt); 1 g in vial powder for injection (as sodium salt); 2 g in vial powder for injection (as sodium salt)
Parenteral > Locoregional injections > Intravitreal: 250 mg in vial powder for injection (as sodium salt); 500 mg in vial powder for injection (as sodium salt); 1 g in vial powder for injection (as sodium salt); 2 g in vial powder for injection (as sodium salt)
Parenteral > General injections > unspecified: 250 mg in vial powder for injection (as sodium salt); 500 mg in vial powder for injection (as sodium salt); 1 g in vial powder for injection (as sodium salt)
Parenteral > General injections > unspecified: 2 g in vial; 250 mg in vial powder for injection (as sodium salt); 500 mg in vial powder for injection (as sodium salt); 1 g in vial powder for injection (as sodium salt)",Bacterial pneumonia (Community-acquired pneumonia - severe),J01DD04,clarithromycin,Added,ceftriaxone,['ceftriaxone']
ceftriaxone,Watch group antibiotics,"Parenteral > General injections > unspecified: 250 mg in vial powder for injection (as sodium salt); 1 g in vial powder for injection (as sodium salt)
Parenteral > General injections > unspecified: 250 mg in vial powder for injection (as sodium salt); 500 mg in vial powder for injection (as sodium salt); 1 g in vial powder for injection (as sodium salt); 2 g in vial powder for injection (as sodium salt)
Parenteral > Locoregional injections > Intravitreal: 250 mg in vial powder for injection (as sodium salt); 500 mg in vial powder for injection (as sodium salt); 1 g in vial powder for injection (as sodium salt); 2 g in vial powder for injection (as sodium salt)
Parenteral > General injections > unspecified: 250 mg in vial powder for injection (as sodium salt); 500 mg in vial powder for injection (as sodium salt); 1 g in vial powder for injection (as sodium salt)
Parenteral > General injections > unspecified: 2 g in vial; 250 mg in vial powder for injection (as sodium salt); 500 mg in vial powder for injection (as sodium salt); 1 g in vial powder for injection (as sodium salt)",Bacterial pneumonia (Community-acquired pneumonia - severe) [children],J01DD04,,Added,ceftriaxone,['ceftriaxone']
ceftriaxone,Watch group antibiotics,"Parenteral > General injections > unspecified: 250 mg in vial powder for injection (as sodium salt); 1 g in vial powder for injection (as sodium salt)
Parenteral > General injections > unspecified: 250 mg in vial powder for injection (as sodium salt); 500 mg in vial powder for injection (as sodium salt); 1 g in vial powder for injection (as sodium salt); 2 g in vial powder for injection (as sodium salt)
Parenteral > Locoregional injections > Intravitreal: 250 mg in vial powder for injection (as sodium salt); 500 mg in vial powder for injection (as sodium salt); 1 g in vial powder for injection (as sodium salt); 2 g in vial powder for injection (as sodium salt)
Parenteral > General injections > unspecified: 250 mg in vial powder for injection (as sodium salt); 500 mg in vial powder for injection (as sodium salt); 1 g in vial powder for injection (as sodium salt)
Parenteral > General injections > unspecified: 2 g in vial; 250 mg in vial powder for injection (as sodium salt); 500 mg in vial powder for injection (as sodium salt); 1 g in vial powder for injection (as sodium salt)",Necrotising fasciitis,J01DD04,metronidazole,Added,ceftriaxone,['ceftriaxone']
ceftriaxone,Watch group antibiotics,"Parenteral > General injections > unspecified: 250 mg in vial powder for injection (as sodium salt); 1 g in vial powder for injection (as sodium salt)
Parenteral > General injections > unspecified: 250 mg in vial powder for injection (as sodium salt); 500 mg in vial powder for injection (as sodium salt); 1 g in vial powder for injection (as sodium salt); 2 g in vial powder for injection (as sodium salt)
Parenteral > Locoregional injections > Intravitreal: 250 mg in vial powder for injection (as sodium salt); 500 mg in vial powder for injection (as sodium salt); 1 g in vial powder for injection (as sodium salt); 2 g in vial powder for injection (as sodium salt)
Parenteral > General injections > unspecified: 250 mg in vial powder for injection (as sodium salt); 500 mg in vial powder for injection (as sodium salt); 1 g in vial powder for injection (as sodium salt)
Parenteral > General injections > unspecified: 2 g in vial; 250 mg in vial powder for injection (as sodium salt); 500 mg in vial powder for injection (as sodium salt); 1 g in vial powder for injection (as sodium salt)",Acute pyelonephritis (mild to moderate),J01DD04,,Added,ceftriaxone,['ceftriaxone']
ceftriaxone,Watch group antibiotics,"Parenteral > General injections > unspecified: 250 mg in vial powder for injection (as sodium salt); 1 g in vial powder for injection (as sodium salt)
Parenteral > General injections > unspecified: 250 mg in vial powder for injection (as sodium salt); 500 mg in vial powder for injection (as sodium salt); 1 g in vial powder for injection (as sodium salt); 2 g in vial powder for injection (as sodium salt)
Parenteral > Locoregional injections > Intravitreal: 250 mg in vial powder for injection (as sodium salt); 500 mg in vial powder for injection (as sodium salt); 1 g in vial powder for injection (as sodium salt); 2 g in vial powder for injection (as sodium salt)
Parenteral > General injections > unspecified: 250 mg in vial powder for injection (as sodium salt); 500 mg in vial powder for injection (as sodium salt); 1 g in vial powder for injection (as sodium salt)
Parenteral > General injections > unspecified: 2 g in vial; 250 mg in vial powder for injection (as sodium salt); 500 mg in vial powder for injection (as sodium salt); 1 g in vial powder for injection (as sodium salt)",Inflammatory and other diseases of prostate (mild to moderate),J01DD04,,Added,ceftriaxone,['ceftriaxone']
ceftriaxone,Watch group antibiotics,"Parenteral > General injections > unspecified: 250 mg in vial powder for injection (as sodium salt); 1 g in vial powder for injection (as sodium salt)
Parenteral > General injections > unspecified: 250 mg in vial powder for injection (as sodium salt); 500 mg in vial powder for injection (as sodium salt); 1 g in vial powder for injection (as sodium salt); 2 g in vial powder for injection (as sodium salt)
Parenteral > Locoregional injections > Intravitreal: 250 mg in vial powder for injection (as sodium salt); 500 mg in vial powder for injection (as sodium salt); 1 g in vial powder for injection (as sodium salt); 2 g in vial powder for injection (as sodium salt)
Parenteral > General injections > unspecified: 250 mg in vial powder for injection (as sodium salt); 500 mg in vial powder for injection (as sodium salt); 1 g in vial powder for injection (as sodium salt)
Parenteral > General injections > unspecified: 2 g in vial; 250 mg in vial powder for injection (as sodium salt); 500 mg in vial powder for injection (as sodium salt); 1 g in vial powder for injection (as sodium salt)",Sepsis without septic shock,J01DD04,,Added,ceftriaxone,['ceftriaxone']
ceftriaxone,Watch group antibiotics,"Parenteral > General injections > unspecified: 250 mg in vial powder for injection (as sodium salt); 1 g in vial powder for injection (as sodium salt)
Parenteral > General injections > unspecified: 250 mg in vial powder for injection (as sodium salt); 500 mg in vial powder for injection (as sodium salt); 1 g in vial powder for injection (as sodium salt); 2 g in vial powder for injection (as sodium salt)
Parenteral > Locoregional injections > Intravitreal: 250 mg in vial powder for injection (as sodium salt); 500 mg in vial powder for injection (as sodium salt); 1 g in vial powder for injection (as sodium salt); 2 g in vial powder for injection (as sodium salt)
Parenteral > General injections > unspecified: 250 mg in vial powder for injection (as sodium salt); 500 mg in vial powder for injection (as sodium salt); 1 g in vial powder for injection (as sodium salt)
Parenteral > General injections > unspecified: 2 g in vial; 250 mg in vial powder for injection (as sodium salt); 500 mg in vial powder for injection (as sodium salt); 1 g in vial powder for injection (as sodium salt)",Infectious gastroenteritis or colitis without specification of infectious agent,J01DD04,,Added,ceftriaxone,['ceftriaxone']
ceftriaxone,Watch group antibiotics,"Parenteral > General injections > unspecified: 250 mg in vial powder for injection (as sodium salt); 1 g in vial powder for injection (as sodium salt)
Parenteral > General injections > unspecified: 250 mg in vial powder for injection (as sodium salt); 500 mg in vial powder for injection (as sodium salt); 1 g in vial powder for injection (as sodium salt); 2 g in vial powder for injection (as sodium salt)
Parenteral > Locoregional injections > Intravitreal: 250 mg in vial powder for injection (as sodium salt); 500 mg in vial powder for injection (as sodium salt); 1 g in vial powder for injection (as sodium salt); 2 g in vial powder for injection (as sodium salt)
Parenteral > General injections > unspecified: 250 mg in vial powder for injection (as sodium salt); 500 mg in vial powder for injection (as sodium salt); 1 g in vial powder for injection (as sodium salt)
Parenteral > General injections > unspecified: 2 g in vial; 250 mg in vial powder for injection (as sodium salt); 500 mg in vial powder for injection (as sodium salt); 1 g in vial powder for injection (as sodium salt)",Bacterial infection of joint,J01DD04,,Added,ceftriaxone,['ceftriaxone']
ceftriaxone,Watch group antibiotics,"Parenteral > General injections > unspecified: 250 mg in vial powder for injection (as sodium salt); 1 g in vial powder for injection (as sodium salt)
Parenteral > General injections > unspecified: 250 mg in vial powder for injection (as sodium salt); 500 mg in vial powder for injection (as sodium salt); 1 g in vial powder for injection (as sodium salt); 2 g in vial powder for injection (as sodium salt)
Parenteral > Locoregional injections > Intravitreal: 250 mg in vial powder for injection (as sodium salt); 500 mg in vial powder for injection (as sodium salt); 1 g in vial powder for injection (as sodium salt); 2 g in vial powder for injection (as sodium salt)
Parenteral > General injections > unspecified: 250 mg in vial powder for injection (as sodium salt); 500 mg in vial powder for injection (as sodium salt); 1 g in vial powder for injection (as sodium salt)
Parenteral > General injections > unspecified: 2 g in vial; 250 mg in vial powder for injection (as sodium salt); 500 mg in vial powder for injection (as sodium salt); 1 g in vial powder for injection (as sodium salt)",Osteomyelitis or osteitis,J01DD04,,Added,ceftriaxone,['ceftriaxone']
cefuroxime,Watch group antibiotics,Parenteral > General injections > IV: 250 mg in vial (as sodium salt) powder for injection; 750 mg in vial (as sodium salt) powder for injection; 1.5 g in vial (as sodium salt) powder for injection,Other specified prophylactic measures,J01DC02,,Added,cefuroxime,['cefuroxime']
certolizumab pegol,Immunomodulators for non-malignant disease,,Axial spondyloarthritis,,,Added,certolizumab pegol,"['certolizumab', 'pegol', 'certolizumab pegol']"
certolizumab pegol,Immunomodulators for non-malignant disease,,Crohn disease site,,,Added,certolizumab pegol,"['certolizumab', 'pegol', 'certolizumab pegol']"
certolizumab pegol,Immunomodulators for non-malignant disease,,Rheumatoid arthritis,,,Added,certolizumab pegol,"['certolizumab', 'pegol', 'certolizumab pegol']"
certolizumab pegol,Medicines for juvenile joint diseases,,Juvenile idiopathic arthritis,,,Added,certolizumab pegol,"['certolizumab', 'pegol', 'certolizumab pegol']"
cetirizine,Antiallergics and medicines used in anaphylaxis,,Allergic or hypersensitivity conditions of unspecified type,,,Added,cetirizine,['cetirizine']
chlorambucil,Cytotoxic medicines,Oral > Solid: 2 mg tablet,Chronic lymphocytic leukaemia or small lymphocytic lymphoma,L01AA02,,Added,chlorambucil,['chlorambucil']
chloramphenicol,Access group antibiotics,"Parenteral > General injections > IV: 1 g in vial powder for injection (sodium succinate)
Parenteral > General injections > IM: 500 mg in 2 mL ampoule oily suspension for injection
Oral > Liquid: 150 mg per 5 mL (as palmitate)
Oral > Solid: 250 mg capsule",Bacterial meningitis,J01BA01,,Added,chloramphenicol,['chloramphenicol']
chlorhexidine,Medicines administered to the neonate [c],"Local > Topical > Solution: 7.1% chlorhexidine digluconate (delivering 4% chlorhexidine)
Local > Topical > Gel: 7.1% chlorhexidine digluconate (delivering 4% chlorhexidine)",Omphalitis of newborn,D08AC02,,Added,chlorhexidine,['chlorhexidine']
chlorhexidine,Antiseptics,Local > Topical > Solution: 5% (digluconate) for dilution,Chlorhexidine,D08AC02,,Added,chlorhexidine,['chlorhexidine']
chlorine base compound,Disinfectants,"Local > Topical > Powder: 0.1% available chlorine for solution
Local > Topical > Liquid: 0.1% available chlorine for solution
Local > Topical > Solid: 0.1% available chlorine for solution","Disinfectant, not elsewhere classified",V07AV,,Added,chlorine base compound,"['chlorine base compound', 'base', 'compound', 'chlorine']"
chloroquine,Antimalarial medicines > For chemoprevention,"Oral > Liquid: 50 mg per 5 mL syrup (as phosphate or sulfate)
Oral > Solid: 150 mg tablet (as phosphate or sulfate)",Malaria due to Plasmodium vivax,P01BA01,,Added,chloroquine,['chloroquine']
chloroquine,Antimalarial medicines > For chemoprevention,"Oral > Liquid: 50 mg per 5 mL syrup (as phosphate or sulfate)
Oral > Solid: 150 mg tablet (as phosphate or sulfate)",Malaria due to Plasmodium ovale,P01BA01,,Added,chloroquine,['chloroquine']
chloroquine,Antimalarial medicines > For chemoprevention,"Oral > Liquid: 50 mg per 5 mL syrup (as phosphate or sulfate)
Oral > Solid: 150 mg tablet (as phosphate or sulfate)",Malaria due to Plasmodium malariae,P01BA01,,Added,chloroquine,['chloroquine']
chloroquine,Antimalarial medicines > For curative treatment,"Parenteral > General injections > IV: 40 mg per  mL in 5 mL ampoule (as hydrochloride, phosphate or sulfate)
Oral > Liquid: 50 mg per 5 mL syrup (as phosphate or sulfate)
Oral > Solid: 150 mg tablet (as phosphate or sulfate); 100 mg tablet (as phosphate or sulfate)",Malaria due to Plasmodium vivax,P01BA01,,Added,chloroquine,['chloroquine']
chloroquine,Disease-modifying anti-rheumatic drugs (DMARDs),Oral > Solid: 100 mg tablet (as phosphate or sulfate); 150 mg tablet (as phosphate or sulfate),Rheumatoid arthritis,P01BA01,,Added,chloroquine,['chloroquine']
chlorothiazide,Antihypertensive medicines,,Essential hypertension,,,Added,chlorothiazide,['chlorothiazide']
chlorothiazide,Medicines used in heart failure,,Heart failure,,,Added,chlorothiazide,['chlorothiazide']
chloroxylenol,Disinfectants,Local > Topical > Solution: 4.8%,"Phenol disinfectant, not elsewhere classified",D08AE05,,Added,chloroxylenol,['chloroxylenol']
chlorpromazine,Medicines for psychotic disorders,"Oral > Liquid: 25 mg per 5 mL (hydrochloride)
Oral > Solid: 100 mg (hydrochloride)
Oral > Solid: 100 mg (hydrochloride); 10 mg (hydrochloride); 25 mg (hydrochloride); 50 mg (hydrochloride)
Parenteral > General injections > unspecified: 25 mg per  mL in 2 mL ampoule (hydrochloride)",Schizophrenia or other primary psychotic disorders,,,Added,chlorpromazine,['chlorpromazine']
chlortalidone,Antihypertensive medicines,,Essential hypertension,,,Added,chlortalidone,['chlortalidone']
chlortalidone,Medicines used in heart failure,,Heart failure,,,Added,chlortalidone,['chlortalidone']
chlortetracycline,Ophthalmological preparations > Anti-infective agents,,Other specified conjunctivitis,,,Added,chlortetracycline,['chlortetracycline']
chlortetracycline,Ophthalmological preparations > Anti-infective agents,,Infectious keratitis,,,Added,chlortetracycline,['chlortetracycline']
chlortetracycline,Ophthalmological preparations > Anti-infective agents,,Infectious blepharitis,,,Added,chlortetracycline,['chlortetracycline']
chlortetracycline,Ophthalmological preparations > Anti-infective agents,,Trachoma,,,Added,chlortetracycline,['chlortetracycline']
cholera vaccine,Recommendations for some high-risk populations,All vaccines should comply with the WHO requirements for biological substances.,Need for immunization against cholera alone,J07AE01,,Added,cholera vaccine,"['cholera', 'vaccine', 'cholera vaccine']"
ciclesonide,Antiasthmatic and medicines for chronic obstructive pulmonary disease,,Asthma,,,Added,ciclesonide,['ciclesonide']
ciclosporin,Immunomodulators for non-malignant disease,"Parenteral > General injections > IV: 50 mg per  mL in 1 mL ampoule concentrate for injection
Oral > Liquid: 100 mg per  mL
Oral > Solid > capsule: 25 mg",Failure or rejection of transplanted organs or tissues,L04AD01,,Added,ciclosporin,['ciclosporin']
ciprofloxacin,Watch group antibiotics,"Parenteral > General injections > IV: 2 mg per  mL (as hyclate)
Oral > Liquid: 250 mg per 5 mL (anhydrous)
Oral > Solid: 250 mg (as hydrochloride)
Oral > Solid > dosage form: 250 mg (as hydrochloride); 500 mg (as hydrochloride); 100 mg (as hydrochloride)
Oral > Solid > dosage form: 250 mg (as hydrochloride); 500 mg (as hydrochloride)",Acute pyelonephritis (mild to moderate),J01MA02,,Added,ciprofloxacin,['ciprofloxacin']
ciprofloxacin,Watch group antibiotics,"Parenteral > General injections > IV: 2 mg per  mL (as hyclate)
Oral > Liquid: 250 mg per 5 mL (anhydrous)
Oral > Solid: 250 mg (as hydrochloride)
Oral > Solid > dosage form: 250 mg (as hydrochloride); 500 mg (as hydrochloride); 100 mg (as hydrochloride)
Oral > Solid > dosage form: 250 mg (as hydrochloride); 500 mg (as hydrochloride)",Infectious gastroenteritis or colitis without specification of infectious agent,J01MA02,,Added,ciprofloxacin,['ciprofloxacin']
ciprofloxacin,Watch group antibiotics,"Parenteral > General injections > IV: 2 mg per  mL (as hyclate)
Oral > Liquid: 250 mg per 5 mL (anhydrous)
Oral > Solid: 250 mg (as hydrochloride)
Oral > Solid > dosage form: 250 mg (as hydrochloride); 500 mg (as hydrochloride); 100 mg (as hydrochloride)
Oral > Solid > dosage form: 250 mg (as hydrochloride); 500 mg (as hydrochloride)",Paratyphoid fever,J01MA02,,Added,ciprofloxacin,['ciprofloxacin']
ciprofloxacin,Watch group antibiotics,"Parenteral > General injections > IV: 2 mg per  mL (as hyclate)
Oral > Liquid: 250 mg per 5 mL (anhydrous)
Oral > Solid: 250 mg (as hydrochloride)
Oral > Solid > dosage form: 250 mg (as hydrochloride); 500 mg (as hydrochloride); 100 mg (as hydrochloride)
Oral > Solid > dosage form: 250 mg (as hydrochloride); 500 mg (as hydrochloride)",Typhoid fever,J01MA02,,Added,ciprofloxacin,['ciprofloxacin']
ciprofloxacin,Watch group antibiotics,"Parenteral > General injections > IV: 2 mg per  mL (as hyclate)
Oral > Liquid: 250 mg per 5 mL (anhydrous)
Oral > Solid: 250 mg (as hydrochloride)
Oral > Solid > dosage form: 250 mg (as hydrochloride); 500 mg (as hydrochloride); 100 mg (as hydrochloride)
Oral > Solid > dosage form: 250 mg (as hydrochloride); 500 mg (as hydrochloride)",Neutropenia (low-risk),J01MA02,,Added,ciprofloxacin,['ciprofloxacin']
ciprofloxacin,Watch group antibiotics,"Parenteral > General injections > IV: 2 mg per  mL (as hyclate)
Oral > Liquid: 250 mg per 5 mL (anhydrous)
Oral > Solid: 250 mg (as hydrochloride)
Oral > Solid > dosage form: 250 mg (as hydrochloride); 500 mg (as hydrochloride); 100 mg (as hydrochloride)
Oral > Solid > dosage form: 250 mg (as hydrochloride); 500 mg (as hydrochloride)",Inflammatory and other diseases of prostate (mild to moderate),J01MA02,,Added,ciprofloxacin,['ciprofloxacin']
ciprofloxacin,Watch group antibiotics,"Parenteral > General injections > IV: 2 mg per  mL (as hyclate)
Oral > Liquid: 250 mg per 5 mL (anhydrous)
Oral > Solid: 250 mg (as hydrochloride)
Oral > Solid > dosage form: 250 mg (as hydrochloride); 500 mg (as hydrochloride); 100 mg (as hydrochloride)
Oral > Solid > dosage form: 250 mg (as hydrochloride); 500 mg (as hydrochloride)",Cholera,J01MA02,,Added,ciprofloxacin,['ciprofloxacin']
ciprofloxacin,Watch group antibiotics,"Parenteral > General injections > IV: 2 mg per  mL (as hyclate)
Oral > Liquid: 250 mg per 5 mL (anhydrous)
Oral > Solid: 250 mg (as hydrochloride)
Oral > Solid > dosage form: 250 mg (as hydrochloride); 500 mg (as hydrochloride); 100 mg (as hydrochloride)
Oral > Solid > dosage form: 250 mg (as hydrochloride); 500 mg (as hydrochloride)",Cholera [children],J01MA02,,Added,ciprofloxacin,['ciprofloxacin']
ciprofloxacin,Watch group antibiotics,"Parenteral > General injections > IV: 2 mg per  mL (as hyclate)
Oral > Liquid: 250 mg per 5 mL (anhydrous)
Oral > Solid: 250 mg (as hydrochloride)
Oral > Solid > dosage form: 250 mg (as hydrochloride); 500 mg (as hydrochloride); 100 mg (as hydrochloride)
Oral > Solid > dosage form: 250 mg (as hydrochloride); 500 mg (as hydrochloride)",Peritonitis (mild-moderate),J01MA02,metronidazole,Added,ciprofloxacin,['ciprofloxacin']
ciprofloxacin,Watch group antibiotics,"Parenteral > General injections > IV: 2 mg per  mL (as hyclate)
Oral > Liquid: 250 mg per 5 mL (anhydrous)
Oral > Solid: 250 mg (as hydrochloride)
Oral > Solid > dosage form: 250 mg (as hydrochloride); 500 mg (as hydrochloride); 100 mg (as hydrochloride)
Oral > Solid > dosage form: 250 mg (as hydrochloride); 500 mg (as hydrochloride)",Peritoneal abscess (mild-moderate),J01MA02,metronidazole,Added,ciprofloxacin,['ciprofloxacin']
ciprofloxacin,"Ear, nose and throat medicines [c]",Local > Otological > drops: 0.3% (as hydrochloride),Infectious diseases of external ear,S02AA15,,Added,ciprofloxacin,['ciprofloxacin']
cisplatin,Cytotoxic medicines,"Parenteral > General injections > unspecified: 10 mg in vial powder for injection; 50 mg in vial powder for injection
Parenteral > General injections > IV: 50 mg per 50 mL; 100 mg per 100 mL; 10 mg per 10 mL; 20 mg per 20 mL",Other specified gliomas of brain,L01XA01,,Added,cisplatin,['cisplatin']
cisplatin,Cytotoxic medicines,"Parenteral > General injections > unspecified: 10 mg in vial powder for injection; 50 mg in vial powder for injection
Parenteral > General injections > IV: 50 mg per 50 mL; 100 mg per 100 mL; 10 mg per 10 mL; 20 mg per 20 mL",Other specified malignant neoplasms of the ovary,L01XA01,,Added,cisplatin,['cisplatin']
cisplatin,Cytotoxic medicines,"Parenteral > General injections > unspecified: 10 mg in vial powder for injection; 50 mg in vial powder for injection
Parenteral > General injections > IV: 50 mg per 50 mL; 100 mg per 100 mL; 10 mg per 10 mL; 20 mg per 20 mL",Other specified malignant neoplasms of bronchus or lung,L01XA01,,Added,cisplatin,['cisplatin']
cisplatin,Cytotoxic medicines,"Parenteral > General injections > unspecified: 10 mg in vial powder for injection; 50 mg in vial powder for injection
Parenteral > General injections > IV: 50 mg per 50 mL; 100 mg per 100 mL; 10 mg per 10 mL; 20 mg per 20 mL",Malignant neoplasms of nasopharynx,L01XA01,,Added,cisplatin,['cisplatin']
cisplatin,Cytotoxic medicines,"Parenteral > General injections > unspecified: 10 mg in vial powder for injection; 50 mg in vial powder for injection
Parenteral > General injections > IV: 50 mg per 50 mL; 100 mg per 100 mL; 10 mg per 10 mL; 20 mg per 20 mL",Germ cell tumour of testis,L01XA01,,Added,cisplatin,['cisplatin']
cisplatin,Cytotoxic medicines,"Parenteral > General injections > unspecified: 10 mg in vial powder for injection; 50 mg in vial powder for injection
Parenteral > General injections > IV: 50 mg per 50 mL; 100 mg per 100 mL; 10 mg per 10 mL; 20 mg per 20 mL",Osteosarcoma of bone and articular cartilage of unspecified sites,L01XA01,,Added,cisplatin,['cisplatin']
cisplatin,Cytotoxic medicines,"Parenteral > General injections > unspecified: 10 mg in vial powder for injection; 50 mg in vial powder for injection
Parenteral > General injections > IV: 50 mg per 50 mL; 100 mg per 100 mL; 10 mg per 10 mL; 20 mg per 20 mL","Malignant neoplasms of lip, oral cavity or pharynx",L01XA01,,Added,cisplatin,['cisplatin']
cisplatin,Cytotoxic medicines,"Parenteral > General injections > unspecified: 10 mg in vial powder for injection; 50 mg in vial powder for injection
Parenteral > General injections > IV: 50 mg per 50 mL; 100 mg per 100 mL; 10 mg per 10 mL; 20 mg per 20 mL",Malignant neoplasms of cervix uteri,L01XA01,,Added,cisplatin,['cisplatin']
cladribine,Medicines for multiple sclerosis,Oral > Solid > tablet: 10 mg,Multiple sclerosis,L04AA40,,Added,cladribine,['cladribine']
clarithromycin,Watch group antibiotics,"Oral > Liquid: 125 mg per 5 mL powder for oral liquid; 250 mg per 5 mL powder for oral liquid
Parenteral > General injections > unspecified: 500 mg in vial powder for injection
Oral > Solid > dosage form: 500 mg; 250 mg
Oral > Solid > dosage form: 500 mg",Bacterial pneumonia (Community-acquired pneumonia - severe),J01FA09,cefotaxime,Added,clarithromycin,['clarithromycin']
clarithromycin,Watch group antibiotics,"Oral > Liquid: 125 mg per 5 mL powder for oral liquid; 250 mg per 5 mL powder for oral liquid
Parenteral > General injections > unspecified: 500 mg in vial powder for injection
Oral > Solid > dosage form: 500 mg; 250 mg
Oral > Solid > dosage form: 500 mg",Bacterial pneumonia (Community-acquired pneumonia - severe),J01FA09,ceftriaxone,Added,clarithromycin,['clarithromycin']
clarithromycin,Watch group antibiotics,"Oral > Liquid: 125 mg per 5 mL powder for oral liquid; 250 mg per 5 mL powder for oral liquid
Parenteral > General injections > unspecified: 500 mg in vial powder for injection
Oral > Solid > dosage form: 500 mg; 250 mg
Oral > Solid > dosage form: 500 mg",Acute pharyngitis,J01FA09,,Added,clarithromycin,['clarithromycin']
clarithromycin,Watch group antibiotics,"Oral > Liquid: 125 mg per 5 mL powder for oral liquid; 250 mg per 5 mL powder for oral liquid
Parenteral > General injections > unspecified: 500 mg in vial powder for injection
Oral > Solid > dosage form: 500 mg; 250 mg
Oral > Solid > dosage form: 500 mg",Bacterial pneumonia (Community-acquired pneumonia - severe),J01FA09,amoxicillin + clavulanic acid,Added,clarithromycin,['clarithromycin']
clarithromycin,Watch group antibiotics,"Oral > Liquid: 125 mg per 5 mL powder for oral liquid; 250 mg per 5 mL powder for oral liquid
Parenteral > General injections > unspecified: 500 mg in vial powder for injection
Oral > Solid > dosage form: 500 mg; 250 mg
Oral > Solid > dosage form: 500 mg",Helicobacter pylori associated gastric ulcer,J01FA09,,Added,clarithromycin,['clarithromycin']
clindamycin,Access group antibiotics,"Oral > Liquid: 75 mg per 5 mL (as palmitate hydrochloride)
Oral > Solid: 150 mg (as hydrochloride) capsule
Parenteral > General injections > unspecified: 150 mg per  mL (as phosphate) injection
Parenteral > General injections > IV: 150 mg per  mL (as phosphate); 600 mg per 4 mL (as phosphate); 900 mg per 6 mL (as phosphate)
Oral > Liquid: 75 mg per 5 mL powder for oral liquid (as palmitate hydrochloride)
Oral > Solid: 150 mg (as hydrochloride)",Necrotising fasciitis,J01FF01,piperacillin + tazobactam,Added,clindamycin,['clindamycin']
clindamycin,Access group antibiotics,"Oral > Liquid: 75 mg per 5 mL (as palmitate hydrochloride)
Oral > Solid: 150 mg (as hydrochloride) capsule
Parenteral > General injections > unspecified: 150 mg per  mL (as phosphate) injection
Parenteral > General injections > IV: 150 mg per  mL (as phosphate); 600 mg per 4 mL (as phosphate); 900 mg per 6 mL (as phosphate)
Oral > Liquid: 75 mg per 5 mL powder for oral liquid (as palmitate hydrochloride)
Oral > Solid: 150 mg (as hydrochloride)",Bacterial infection of joint,J01FF01,,Added,clindamycin,['clindamycin']
clindamycin,Access group antibiotics,"Oral > Liquid: 75 mg per 5 mL (as palmitate hydrochloride)
Oral > Solid: 150 mg (as hydrochloride) capsule
Parenteral > General injections > unspecified: 150 mg per  mL (as phosphate) injection
Parenteral > General injections > IV: 150 mg per  mL (as phosphate); 600 mg per 4 mL (as phosphate); 900 mg per 6 mL (as phosphate)
Oral > Liquid: 75 mg per 5 mL powder for oral liquid (as palmitate hydrochloride)
Oral > Solid: 150 mg (as hydrochloride)",Osteomyelitis or osteitis,J01FF01,,Added,clindamycin,['clindamycin']
clofazimine,Antituberculosis medicines,Oral > Solid: 100 mg; 50 mg,Multi-drug resistant Mycobacterium tuberculosis,J04BA01,,Added,clofazimine,['clofazimine']
clofazimine,Antileprosy medicines,Oral > Solid: 100 mg; 50 mg,Leprosy,J04BA01,,Added,clofazimine,['clofazimine']
clomifene,Ovulation inducers,Oral > Solid: 50 mg (citrate),Female infertility without specification whether primary or secondary,G03GB02,,Added,clomifene,['clomifene']
clomipramine,Medicines for obsessive compulsive disorders,Oral > Solid: 10 mg (hydrochloride); 25 mg (hydrochloride),Obsessive-compulsive disorder,N06AA04,,Added,clomipramine,['clomipramine']
clopidogrel,Anti-platelet medicines,Oral > Solid: 75 mg; 300 mg,Acute ischaemic heart disease,B01AC04,,Added,clopidogrel,['clopidogrel']
clopidogrel,Anti-platelet medicines,Oral > Solid: 75 mg; 300 mg,Presence of coronary angioplasty implant or graft,B01AC04,,Added,clopidogrel,['clopidogrel']
clotrimazole,Antifungal medicines,Local > Topical > Other: 1% vaginal cream; 10% vaginal cream; 100 mg vaginal tablet; 500 mg vaginal tablet,Vulvovaginal candidosis,G01AF02,,Added,clotrimazole,['clotrimazole']
cloxacillin,Access group antibiotics,"Oral > Liquid: 125 mg per 5 mL (as sodium salt) powder for oral liquid
Oral > Solid: 500 mg (as sodium salt) capsule; 1 g (as sodium salt) capsule
Parenteral > General injections > unspecified: 500 mg in vial (as sodium salt) powder for injection
Oral > Liquid: 125 mg per 5 mL (as sodium salt) powder for oral liquid; 250 mg per 5 mL (as sodium salt) powder for oral liquid
Parenteral > General injections > unspecified: 500 mg in vial (as sodium salt) powder for injection; 250 mg in vial (as sodium salt) powder for injection
Oral > Solid > capsule: 500 mg (as sodium salt); 1 g (as sodium salt); 250 mg (as sodium salt)","Bacterial cellulitis, erysipelas or lymphangitis",J01CF02,,Added,cloxacillin,['cloxacillin']
cloxacillin,Access group antibiotics,"Oral > Liquid: 125 mg per 5 mL (as sodium salt) powder for oral liquid
Oral > Solid: 500 mg (as sodium salt) capsule; 1 g (as sodium salt) capsule
Parenteral > General injections > unspecified: 500 mg in vial (as sodium salt) powder for injection
Oral > Liquid: 125 mg per 5 mL (as sodium salt) powder for oral liquid; 250 mg per 5 mL (as sodium salt) powder for oral liquid
Parenteral > General injections > unspecified: 500 mg in vial (as sodium salt) powder for injection; 250 mg in vial (as sodium salt) powder for injection
Oral > Solid > capsule: 500 mg (as sodium salt); 1 g (as sodium salt); 250 mg (as sodium salt)",Osteomyelitis or osteitis,J01CF02,,Added,cloxacillin,['cloxacillin']
cloxacillin,Access group antibiotics,"Oral > Liquid: 125 mg per 5 mL (as sodium salt) powder for oral liquid
Oral > Solid: 500 mg (as sodium salt) capsule; 1 g (as sodium salt) capsule
Parenteral > General injections > unspecified: 500 mg in vial (as sodium salt) powder for injection
Oral > Liquid: 125 mg per 5 mL (as sodium salt) powder for oral liquid; 250 mg per 5 mL (as sodium salt) powder for oral liquid
Parenteral > General injections > unspecified: 500 mg in vial (as sodium salt) powder for injection; 250 mg in vial (as sodium salt) powder for injection
Oral > Solid > capsule: 500 mg (as sodium salt); 1 g (as sodium salt); 250 mg (as sodium salt)",Bacterial infection of joint,J01CF02,,Added,cloxacillin,['cloxacillin']
cloxacillin,Access group antibiotics,"Oral > Liquid: 125 mg per 5 mL (as sodium salt) powder for oral liquid
Oral > Solid: 500 mg (as sodium salt) capsule; 1 g (as sodium salt) capsule
Parenteral > General injections > unspecified: 500 mg in vial (as sodium salt) powder for injection
Oral > Liquid: 125 mg per 5 mL (as sodium salt) powder for oral liquid; 250 mg per 5 mL (as sodium salt) powder for oral liquid
Parenteral > General injections > unspecified: 500 mg in vial (as sodium salt) powder for injection; 250 mg in vial (as sodium salt) powder for injection
Oral > Solid > capsule: 500 mg (as sodium salt); 1 g (as sodium salt); 250 mg (as sodium salt)",Sepsis without septic shock,J01CF02,amikacin,Added,cloxacillin,['cloxacillin']
clozapine,Medicines for psychotic disorders,Oral > Solid: 25 mg; 50 mg; 100 mg; 200 mg,Schizophrenia or other primary psychotic disorders,N05AH02,,Added,clozapine,['clozapine']
coagulation factor IX,Coagulation factors,Parenteral > General injections > IV: 500 IU in vial powder for injection; 1000 IU in vial powder for injection,"Coagulation defects, purpura or other haemorrhagic or related conditions",B02BD01,,Added,coagulation factor ix,"['ix', 'coagulation factor ix', 'coagulation', 'factor']"
coagulation factor IX,Coagulation factors,Parenteral > General injections > IV: 500 IU in vial powder for injection; 1000 IU in vial powder for injection,Haemophilia B,B02BD04,,Added,coagulation factor ix,"['ix', 'coagulation factor ix', 'coagulation', 'factor']"
coagulation factor IX complex,Coagulation factors,,"Coagulation defects, purpura or other haemorrhagic or related conditions",,,Added,coagulation factor ix complex,"['coagulation factor ix complex', 'factor', 'complex', 'coagulation', 'ix']"
coagulation factor IX complex,Coagulation factors,,Haemophilia B,,,Added,coagulation factor ix complex,"['coagulation factor ix complex', 'factor', 'complex', 'coagulation', 'ix']"
coagulation factor VIII,Coagulation factors,Parenteral > General injections > IV: 250 IU in vial powder for injection; 500 IU in vial powder for injection; 1000 IU in vial powder for injection,Haemophilia A,B02BD02,,Added,coagulation factor viii,"['viii', 'factor', 'coagulation factor viii', 'coagulation']"
coal tar,Dermatological medicines > Medicines affecting skin differentiation and proliferation,Local > Topical > Solution: 5%,Psoriasis of unspecified type,D05AA,,Added,coal tar,"['coal tar', 'tar', 'coal']"
codeine,Opioid analgesics,Oral > Solid: 30 mg tablet (codeine phosphate),Pain,,,Added,codeine,['codeine']
colecalciferol,Vitamins and minerals,"Oral > Liquid: 400 IU per  mL
Oral > Solid: 400 IU; 1000 IU
",Calcium deficiency,A11CC05,,Added,colecalciferol,['colecalciferol']
colecalciferol,Vitamins and minerals,"Oral > Liquid: 400 IU per  mL
Oral > Solid: 400 IU; 1000 IU
",Vitamin D deficiency,A11CC05,,Added,colecalciferol,['colecalciferol']
colecalciferol,Vitamins and minerals,"Oral > Liquid: 400 IU per  mL
Oral > Solid: 400 IU; 1000 IU
",Vitamin D deficiency,,,Added,colecalciferol,['colecalciferol']
colecalciferol,Vitamins and minerals,"Oral > Liquid: 400 IU per  mL
Oral > Solid: 400 IU; 1000 IU
",Calcium deficiency,,,Added,colecalciferol,['colecalciferol']
colistin (injection),Reserve group antibiotics,"Parenteral > General injections > unspecified: 1 million IU in vial (as colistemethate sodium)
Parenteral > General injections > unspecified: 1 million IU in vial (as colistemethate sodium) (equivalent to 34 mg colistin base activity)",Carbapenem resistant Acinetobacter baumannii,J01XB01,,Added,colistin (injection),"['colistin', 'colistin (injection)', '(injection)']"
colistin (injection),Reserve group antibiotics,"Parenteral > General injections > unspecified: 1 million IU in vial (as colistemethate sodium)
Parenteral > General injections > unspecified: 1 million IU in vial (as colistemethate sodium) (equivalent to 34 mg colistin base activity)",Carbapenem-resistant Pseudomonas aeruginosa,J01XB01,,Added,colistin (injection),"['colistin', 'colistin (injection)', '(injection)']"
colistin (injection),Reserve group antibiotics,"Parenteral > General injections > unspecified: 1 million IU in vial (as colistemethate sodium)
Parenteral > General injections > unspecified: 1 million IU in vial (as colistemethate sodium) (equivalent to 34 mg colistin base activity)",Carbapenem resistant Enterobacterales,J01XB01,,Added,colistin (injection),"['colistin', 'colistin (injection)', '(injection)']"
compound sodium lactate solution,"Solutions correcting water, electrolyte and acid-base disturbances > Parenteral",Parenteral > General injections > IV: injectable solution,"Other specified disorders of fluid, electrolyte or acid-base balance",B05BB01,,Added,compound sodium lactate solution,"['compound sodium lactate solution', 'compound', 'sodium', 'solution', 'lactate']"
compound sodium lactate solution,"Solutions correcting water, electrolyte and acid-base disturbances > Parenteral",Parenteral > General injections > IV: injectable solution,Hypovolaemic shock,B05BB01,,Added,compound sodium lactate solution,"['compound sodium lactate solution', 'compound', 'sodium', 'solution', 'lactate']"
condoms,Barrier methods,-,Contact with health services for contraceptive management,,,Added,condoms,['condoms']
copper-containing intrauterine device,Intrauterine devices,-,Contact with health services for insertion of contraceptive device,G02BA02,,Added,copper-containing intrauterine device,"['intrauterine', 'device', 'copper-containing', 'copper-containing intrauterine device']"
cryoprecipitate (not pathogen-reduced),Blood and blood components,,Haemophilia A,,,Added,cryoprecipitate (not pathogen-reduced),"['(not', 'cryoprecipitate', 'cryoprecipitate (not pathogen-reduced)', 'pathogen-reduced)']"
cryoprecipitate (not pathogen-reduced),Blood and blood components,,"Coagulation defects, purpura or other haemorrhagic or related conditions",,,Added,cryoprecipitate (not pathogen-reduced),"['(not', 'cryoprecipitate', 'cryoprecipitate (not pathogen-reduced)', 'pathogen-reduced)']"
cryoprecipitate (not pathogen-reduced),Blood and blood components,,Von Willebrand disease,,,Added,cryoprecipitate (not pathogen-reduced),"['(not', 'cryoprecipitate', 'cryoprecipitate (not pathogen-reduced)', 'pathogen-reduced)']"
cryoprecipitate (not pathogen-reduced),Blood and blood components,,Obstetric haemorrhage,,,Added,cryoprecipitate (not pathogen-reduced),"['(not', 'cryoprecipitate', 'cryoprecipitate (not pathogen-reduced)', 'pathogen-reduced)']"
cryoprecipitate (pathogen-reduced),Blood and blood components,"Injection: frozen liquid in bag or lyophilized powder in vial containing:
> 50 IU Factor VIII
> 100 IU vWF
> 140 mg clottable fibrinogen per unit",Haemophilia A,B05AA02,,Added,cryoprecipitate (pathogen-reduced),"['cryoprecipitate', '(pathogen-reduced)', 'cryoprecipitate (pathogen-reduced)']"
cryoprecipitate (pathogen-reduced),Blood and blood components,"Injection: frozen liquid in bag or lyophilized powder in vial containing:
> 50 IU Factor VIII
> 100 IU vWF
> 140 mg clottable fibrinogen per unit","Coagulation defects, purpura or other haemorrhagic or related conditions",B05AA02,,Added,cryoprecipitate (pathogen-reduced),"['cryoprecipitate', '(pathogen-reduced)', 'cryoprecipitate (pathogen-reduced)']"
cryoprecipitate (pathogen-reduced),Blood and blood components,"Injection: frozen liquid in bag or lyophilized powder in vial containing:
> 50 IU Factor VIII
> 100 IU vWF
> 140 mg clottable fibrinogen per unit",Von Willebrand disease,B05AA02,,Added,cryoprecipitate (pathogen-reduced),"['cryoprecipitate', '(pathogen-reduced)', 'cryoprecipitate (pathogen-reduced)']"
cryoprecipitate (pathogen-reduced),Blood and blood components,"Injection: frozen liquid in bag or lyophilized powder in vial containing:
> 50 IU Factor VIII
> 100 IU vWF
> 140 mg clottable fibrinogen per unit",Obstetric haemorrhage,B05AA02,,Added,cryoprecipitate (pathogen-reduced),"['cryoprecipitate', '(pathogen-reduced)', 'cryoprecipitate (pathogen-reduced)']"
cyclizine,Medicines for other common symptoms in palliative care,"Oral > Solid: 50 mg tablet
Parenteral > General injections > unspecified: 50 mg per  mL",Palliative care,R06AE03,,Added,cyclizine,['cyclizine']
cyclopentolate,Diagnostic agents > Ophthalmic medicines,,Cycloplegic drug,,,Added,cyclopentolate,['cyclopentolate']
cyclopentolate,Ophthalmological preparations > Mydriatics,,Anterior uveitis,,,Added,cyclopentolate,['cyclopentolate']
cyclophosphamide,Cytotoxic medicines,"Oral > Solid: 25 mg tablet
Parenteral > General injections > unspecified: 500 mg in vial powder for injection
Parenteral > General injections > IV: 500 mg in vial powder for injection; 1 g in vial powder for injection; 2 g in vial powder for injection
Oral > Solid > dosage form: 25 mg; 50 mg",Other specified malignant neoplasms of breast,L01AA01,,Added,cyclophosphamide,['cyclophosphamide']
cyclophosphamide,Cytotoxic medicines,"Oral > Solid: 25 mg tablet
Parenteral > General injections > unspecified: 500 mg in vial powder for injection
Parenteral > General injections > IV: 500 mg in vial powder for injection; 1 g in vial powder for injection; 2 g in vial powder for injection
Oral > Solid > dosage form: 25 mg; 50 mg",Malignant trophoblastic neoplasms of placenta,L01AA01,,Added,cyclophosphamide,['cyclophosphamide']
cyclophosphamide,Cytotoxic medicines,"Oral > Solid: 25 mg tablet
Parenteral > General injections > unspecified: 500 mg in vial powder for injection
Parenteral > General injections > IV: 500 mg in vial powder for injection; 1 g in vial powder for injection; 2 g in vial powder for injection
Oral > Solid > dosage form: 25 mg; 50 mg",Follicular lymphoma,L01AA01,,Added,cyclophosphamide,['cyclophosphamide']
cyclophosphamide,Cytotoxic medicines,"Oral > Solid: 25 mg tablet
Parenteral > General injections > unspecified: 500 mg in vial powder for injection
Parenteral > General injections > IV: 500 mg in vial powder for injection; 1 g in vial powder for injection; 2 g in vial powder for injection
Oral > Solid > dosage form: 25 mg; 50 mg",Malignant neoplasms of breast,L01AA01,,Added,cyclophosphamide,['cyclophosphamide']
cyclophosphamide,Cytotoxic medicines,"Oral > Solid: 25 mg tablet
Parenteral > General injections > unspecified: 500 mg in vial powder for injection
Parenteral > General injections > IV: 500 mg in vial powder for injection; 1 g in vial powder for injection; 2 g in vial powder for injection
Oral > Solid > dosage form: 25 mg; 50 mg",Chronic lymphocytic leukaemia or small lymphocytic lymphoma,L01AA01,,Added,cyclophosphamide,['cyclophosphamide']
cyclophosphamide,Cytotoxic medicines,"Oral > Solid: 25 mg tablet
Parenteral > General injections > unspecified: 500 mg in vial powder for injection
Parenteral > General injections > IV: 500 mg in vial powder for injection; 1 g in vial powder for injection; 2 g in vial powder for injection
Oral > Solid > dosage form: 25 mg; 50 mg",Rhabdomyosarcoma primary site,L01AA01,,Added,cyclophosphamide,['cyclophosphamide']
cyclophosphamide,Cytotoxic medicines,"Oral > Solid: 25 mg tablet
Parenteral > General injections > unspecified: 500 mg in vial powder for injection
Parenteral > General injections > IV: 500 mg in vial powder for injection; 1 g in vial powder for injection; 2 g in vial powder for injection
Oral > Solid > dosage form: 25 mg; 50 mg",Hodgkin lymphoma,L01AA01,,Added,cyclophosphamide,['cyclophosphamide']
cyclophosphamide,Cytotoxic medicines,"Oral > Solid: 25 mg tablet
Parenteral > General injections > unspecified: 500 mg in vial powder for injection
Parenteral > General injections > IV: 500 mg in vial powder for injection; 1 g in vial powder for injection; 2 g in vial powder for injection
Oral > Solid > dosage form: 25 mg; 50 mg",Diffuse large B-cell lymphomas,L01AA01,,Added,cyclophosphamide,['cyclophosphamide']
cyclophosphamide,Cytotoxic medicines,"Oral > Solid: 25 mg tablet
Parenteral > General injections > unspecified: 500 mg in vial powder for injection
Parenteral > General injections > IV: 500 mg in vial powder for injection; 1 g in vial powder for injection; 2 g in vial powder for injection
Oral > Solid > dosage form: 25 mg; 50 mg",Plasma cell myeloma,L01AA01,,Added,cyclophosphamide,['cyclophosphamide']
cyclophosphamide,Cytotoxic medicines,"Oral > Solid: 25 mg tablet
Parenteral > General injections > unspecified: 500 mg in vial powder for injection
Parenteral > General injections > IV: 500 mg in vial powder for injection; 1 g in vial powder for injection; 2 g in vial powder for injection
Oral > Solid > dosage form: 25 mg; 50 mg",Other specified gliomas of brain,L01AA01,,Added,cyclophosphamide,['cyclophosphamide']
cyclophosphamide,Cytotoxic medicines,"Oral > Solid: 25 mg tablet
Parenteral > General injections > unspecified: 500 mg in vial powder for injection
Parenteral > General injections > IV: 500 mg in vial powder for injection; 1 g in vial powder for injection; 2 g in vial powder for injection
Oral > Solid > dosage form: 25 mg; 50 mg",Burkitt lymphoma including Burkitt leukaemia,L01AA01,,Added,cyclophosphamide,['cyclophosphamide']
cyclophosphamide,Cytotoxic medicines,"Oral > Solid: 25 mg tablet
Parenteral > General injections > unspecified: 500 mg in vial powder for injection
Parenteral > General injections > IV: 500 mg in vial powder for injection; 1 g in vial powder for injection; 2 g in vial powder for injection
Oral > Solid > dosage form: 25 mg; 50 mg","Malignant neoplasms of kidney, except renal pelvis",L01AA01,,Added,cyclophosphamide,['cyclophosphamide']
cyclophosphamide,Cytotoxic medicines,"Oral > Solid: 25 mg tablet
Parenteral > General injections > unspecified: 500 mg in vial powder for injection
Parenteral > General injections > IV: 500 mg in vial powder for injection; 1 g in vial powder for injection; 2 g in vial powder for injection
Oral > Solid > dosage form: 25 mg; 50 mg",Ewing sarcoma of bone and articular cartilage of unspecified sites,L01AA01,,Added,cyclophosphamide,['cyclophosphamide']
cyclophosphamide,Cytotoxic medicines,"Oral > Solid: 25 mg tablet
Parenteral > General injections > unspecified: 500 mg in vial powder for injection
Parenteral > General injections > IV: 500 mg in vial powder for injection; 1 g in vial powder for injection; 2 g in vial powder for injection
Oral > Solid > dosage form: 25 mg; 50 mg","Lymphoid leukaemia, not elsewhere classified",L01AA01,,Added,cyclophosphamide,['cyclophosphamide']
cyclophosphamide,Cytotoxic medicines,"Oral > Solid: 25 mg tablet
Parenteral > General injections > unspecified: 500 mg in vial powder for injection
Parenteral > General injections > IV: 500 mg in vial powder for injection; 1 g in vial powder for injection; 2 g in vial powder for injection
Oral > Solid > dosage form: 25 mg; 50 mg","Anaplastic large cell lymphoma, ALK-negative",L01AA01,,Added,cyclophosphamide,['cyclophosphamide']
cyclophosphamide,Cytotoxic medicines,"Oral > Solid: 25 mg tablet
Parenteral > General injections > unspecified: 500 mg in vial powder for injection
Parenteral > General injections > IV: 500 mg in vial powder for injection; 1 g in vial powder for injection; 2 g in vial powder for injection
Oral > Solid > dosage form: 25 mg; 50 mg","Anaplastic large cell lymphoma, ALK-positive",L01AA01,,Added,cyclophosphamide,['cyclophosphamide']
cycloserine,Antituberculosis medicines,Oral > Solid: 250 mg; 125 mg,Multi-drug resistant Mycobacterium tuberculosis,J04AB01,,Added,cycloserine,['cycloserine']
cytarabine,Cytotoxic medicines,"Parenteral > General injections > unspecified: 100 mg in vial powder for injection
Parenteral > General injections > unspecified: 100 mg in vial powder for injection; 100 mg per  mL in vial","Lymphoid leukaemia, not elsewhere classified",L01BC01,,Added,cytarabine,['cytarabine']
cytarabine,Cytotoxic medicines,"Parenteral > General injections > unspecified: 100 mg in vial powder for injection
Parenteral > General injections > unspecified: 100 mg in vial powder for injection; 100 mg per  mL in vial",Myeloid leukaemia,L01BC01,,Added,cytarabine,['cytarabine']
cytarabine,Cytotoxic medicines,"Parenteral > General injections > unspecified: 100 mg in vial powder for injection
Parenteral > General injections > unspecified: 100 mg in vial powder for injection; 100 mg per  mL in vial",Acute myeloid leukaemia with recurrent genetic abnormalities,L01BC01,,Added,cytarabine,['cytarabine']
cytarabine,Cytotoxic medicines,"Parenteral > General injections > unspecified: 100 mg in vial powder for injection
Parenteral > General injections > unspecified: 100 mg in vial powder for injection; 100 mg per  mL in vial",Burkitt lymphoma including Burkitt leukaemia,L01BC01,,Added,cytarabine,['cytarabine']
cytarabine,Cytotoxic medicines,"Parenteral > General injections > unspecified: 100 mg in vial powder for injection
Parenteral > General injections > unspecified: 100 mg in vial powder for injection; 100 mg per  mL in vial","Anaplastic large cell lymphoma, ALK-negative",L01BC01,,Added,cytarabine,['cytarabine']
cytarabine,Cytotoxic medicines,"Parenteral > General injections > unspecified: 100 mg in vial powder for injection
Parenteral > General injections > unspecified: 100 mg in vial powder for injection; 100 mg per  mL in vial","Anaplastic large cell lymphoma, ALK-positive",L01BC01,,Added,cytarabine,['cytarabine']
cytarabine,Cytotoxic medicines,"Parenteral > General injections > unspecified: 100 mg in vial powder for injection
Parenteral > General injections > unspecified: 100 mg in vial powder for injection; 100 mg per  mL in vial",Langerhans cell histiocytosis,L01BC01,,Added,cytarabine,['cytarabine']
dabigatran,Medicines affecting coagulation,Oral > Solid: 110 mg; 150 mg,Venous thromboembolism,B01AE07,,Added,dabigatran,['dabigatran']
dabigatran,Medicines affecting coagulation,Oral > Solid: 110 mg; 150 mg,Other specified atrial fibrillation,B01AE07,,Added,dabigatran,['dabigatran']
dacarbazine,Cytotoxic medicines,Parenteral > General injections > IV: 100 mg in vial powder for injection; 200 mg in vial powder for injection,Hodgkin lymphoma,L01AX04,,Added,dacarbazine,['dacarbazine']
daclatasvir,Medicines for hepatitis C > Pangenotypic direct-acting antiviral combinations,Oral > Solid > tablet: 30 mg (as hydrochloride); 60 mg (as hydrochloride),Chronic hepatitis C,J05AP07,,Added,daclatasvir,['daclatasvir']
daclatasvir + sofosbuvir,Medicines for hepatitis C > Pangenotypic direct-acting antiviral combinations,Oral > Solid > tablet: 60 mg + 400 mg,Chronic hepatitis C,"J05AP07, J05AP08",,Added,daclatasvir + sofosbuvir,"['daclatasvir', 'daclatasvir + sofosbuvir', '+', 'sofosbuvir']"
dactinomycin,Cytotoxic medicines,Parenteral > General injections > IV: 500 µg in vial powder for injection,Malignant trophoblastic neoplasms of placenta,L01DA01,,Added,dactinomycin,['dactinomycin']
dactinomycin,Cytotoxic medicines,Parenteral > General injections > IV: 500 µg in vial powder for injection,"Malignant neoplasms of kidney, except renal pelvis",L01DA01,,Added,dactinomycin,['dactinomycin']
dactinomycin,Cytotoxic medicines,Parenteral > General injections > IV: 500 µg in vial powder for injection,Rhabdomyosarcoma primary site,L01DA01,,Added,dactinomycin,['dactinomycin']
dactinomycin,Cytotoxic medicines,Parenteral > General injections > IV: 500 µg in vial powder for injection,Ewing sarcoma of bone and articular cartilage of unspecified sites,L01DA01,,Added,dactinomycin,['dactinomycin']
dalteparin,Medicines affecting coagulation,,Acute ischaemic heart disease,,,Added,dalteparin,['dalteparin']
dalteparin,Medicines affecting coagulation,,Venous thromboembolism,,,Added,dalteparin,['dalteparin']
dapagliflozin,Oral hypoglycaemic agents,,Type 2 diabetes mellitus,,,Added,dapagliflozin,['dapagliflozin']
dapsone,Antileprosy medicines,Oral > Solid: 100 mg tablet; 50 mg tablet; 25 mg tablet,Leprosy,J04BA02,,Added,dapsone,['dapsone']
darbepoetin alfa,Antianaemia medicines,,Anaemia due to chronic disease,,,Added,darbepoetin alfa,"['darbepoetin', 'darbepoetin alfa', 'alfa']"
darunavir,Antiretrovirals > Protease inhibitors,Oral > Solid: 75 mg; 400 mg; 600 mg; 800 mg,"Human immunodeficiency virus disease without mention of associated disease or condition, clinical stage unspecified",J05AE10,,Added,darunavir,['darunavir']
dasatinib,Targeted therapies,Oral > Solid: 20 mg tablet; 50 mg tablet; 70 mg tablet; 80 mg tablet; 100 mg tablet; 140 mg tablet,"Chronic myeloid leukaemia, not elsewhere classified",L01EA02,,Added,dasatinib,['dasatinib']
daunorubicin,Cytotoxic medicines,Parenteral > General injections > IV: 50 mg in vial (as hydrochloride) powder for injection; 20 mg in vial (as hydrochloride) powder for injection; 2 mg per  mL in vial (as hydrochloride); 5 mg per  mL in vial (as hydrochloride),Acute myeloid leukaemia with recurrent genetic abnormalities,L01DB02,,Added,daunorubicin,['daunorubicin']
daunorubicin,Cytotoxic medicines,Parenteral > General injections > IV: 50 mg in vial (as hydrochloride) powder for injection; 20 mg in vial (as hydrochloride) powder for injection; 2 mg per  mL in vial (as hydrochloride); 5 mg per  mL in vial (as hydrochloride),"Lymphoid leukaemia, not elsewhere classified",L01DB02,,Added,daunorubicin,['daunorubicin']
daunorubicin,Cytotoxic medicines,Parenteral > General injections > IV: 50 mg in vial (as hydrochloride) powder for injection; 20 mg in vial (as hydrochloride) powder for injection; 2 mg per  mL in vial (as hydrochloride); 5 mg per  mL in vial (as hydrochloride),Myeloid leukaemia,L01DB02,,Added,daunorubicin,['daunorubicin']
deferasirox,Other medicines for haemoglobinopathies,"Oral > Solid > dispersible tablet: 100 mg; 125 mg; 250 mg; 400 mg; 500 mg
Oral > Solid > tablet: 90 mg; 180 mg; 360 mg
",Other specified sickle cell disorders or other haemoglobinopathies,V03AC03,,Added,deferasirox,['deferasirox']
deferasirox,Other medicines for haemoglobinopathies,"Oral > Solid > dispersible tablet: 100 mg; 125 mg; 250 mg; 400 mg; 500 mg
Oral > Solid > tablet: 90 mg; 180 mg; 360 mg
",Thalassaemias,V03AC03,,Added,deferasirox,['deferasirox']
deferasirox,Other medicines for haemoglobinopathies,"Oral > Solid > dispersible tablet: 100 mg; 125 mg; 250 mg; 400 mg; 500 mg
Oral > Solid > tablet: 90 mg; 180 mg; 360 mg
",Thalassaemias,,,Added,deferasirox,['deferasirox']
deferiprone,Other medicines for haemoglobinopathies,,Other specified sickle cell disorders or other haemoglobinopathies,,,Added,deferiprone,['deferiprone']
deferiprone,Other medicines for haemoglobinopathies,,Thalassaemias,,,Added,deferiprone,['deferiprone']
deferoxamine,Antidotes and other substances used in poisonings > Specific,Parenteral > General injections > unspecified: 500 mg in vial powder for injection (mesilate),"Harmful effects of drugs, medicaments or biological substances, not elsewhere classified",V03AC01,,Added,deferoxamine,['deferoxamine']
deferoxamine,Other medicines for haemoglobinopathies,Parenteral > General injections > unspecified: 500 mg in vial powder for injection (mesilate),Other specified sickle cell disorders or other haemoglobinopathies,V03AC01,,Added,deferoxamine,['deferoxamine']
deferoxamine,Other medicines for haemoglobinopathies,Parenteral > General injections > unspecified: 500 mg in vial powder for injection (mesilate),Thalassaemias,V03AC01,,Added,deferoxamine,['deferoxamine']
delamanid,Antituberculosis medicines,"Oral > Solid > dispersible tablet: 25 mg
Oral > Solid > tablet: 50 mg",Multi-drug resistant Mycobacterium tuberculosis,J04AK06,,Added,delamanid,['delamanid']
dengue vaccine,Recommendations for some high-risk populations,All vaccines should comply with the WHO requirements for biological substances.,Need for immunization against certain single viral diseases,J07BX04,,Added,dengue vaccine,"['dengue vaccine', 'dengue', 'vaccine']"
desmopressin,Medicines affecting coagulation,"Parenteral > General injections > IV: 4 µg per  mL in 1 mL ampoule (acetate)
Local > Nasal > Spray: 10 µg per  dose (acetate)",Haemophilia A,H01BA02,,Added,desmopressin,['desmopressin']
desmopressin,Medicines affecting coagulation,"Parenteral > General injections > IV: 4 µg per  mL in 1 mL ampoule (acetate)
Local > Nasal > Spray: 10 µg per  dose (acetate)",Von Willebrand disease,H01BA02,,Added,desmopressin,['desmopressin']
dexamethasone,Other medicines administered to the mother,Parenteral > General injections > unspecified: 4 mg per  mL (dexamethasone phosphate (as sodium)),"Respiratory distress syndrome of the newborn, altered by maternal corticosteroid therapy",H02AB02,,Added,dexamethasone,['dexamethasone']
dexamethasone,Hormones and antihormones,"Oral > Solid: 4 mg
Parenteral > General injections > unspecified: 4 mg per  mL in 1 mL ampoule (as disodium phosophate salt)
Oral > Liquid: 2 mg per 5 mL
Oral > Solid: 2 mg; 4 mg",Plasma cell myeloma,L01AA01,,Added,dexamethasone,['dexamethasone']
dexamethasone,Hormones and antihormones,"Oral > Solid: 4 mg
Parenteral > General injections > unspecified: 4 mg per  mL in 1 mL ampoule (as disodium phosophate salt)
Oral > Liquid: 2 mg per 5 mL
Oral > Solid: 2 mg; 4 mg","Lymphoid leukaemia, not elsewhere classified",H02AB02,,Added,dexamethasone,['dexamethasone']
dexamethasone,Hormones and antihormones,"Oral > Solid: 4 mg
Parenteral > General injections > unspecified: 4 mg per  mL in 1 mL ampoule (as disodium phosophate salt)
Oral > Liquid: 2 mg per 5 mL
Oral > Solid: 2 mg; 4 mg",Burkitt lymphoma including Burkitt leukaemia,H02AB02,,Added,dexamethasone,['dexamethasone']
dexamethasone,Hormones and antihormones,"Oral > Solid: 4 mg
Parenteral > General injections > unspecified: 4 mg per  mL in 1 mL ampoule (as disodium phosophate salt)
Oral > Liquid: 2 mg per 5 mL
Oral > Solid: 2 mg; 4 mg","Anaplastic large cell lymphoma, ALK-negative",H02AB02,,Added,dexamethasone,['dexamethasone']
dexamethasone,Hormones and antihormones,"Oral > Solid: 4 mg
Parenteral > General injections > unspecified: 4 mg per  mL in 1 mL ampoule (as disodium phosophate salt)
Oral > Liquid: 2 mg per 5 mL
Oral > Solid: 2 mg; 4 mg","Anaplastic large cell lymphoma, ALK-positive",H02AB02,,Added,dexamethasone,['dexamethasone']
dexamethasone,Antiallergics and medicines used in anaphylaxis,Parenteral > General injections > unspecified: 4 mg per  mL in 1 mL ampoule (as disodium phosphate salt),Allergic or hypersensitivity conditions of unspecified type,H02AB02,,Added,dexamethasone,['dexamethasone']
dexamethasone,Medicines for other common symptoms in palliative care,"Oral > Liquid: 2 mg per 5 mL
Oral > Solid: 2 mg; 4 mg
Parenteral > General injections > unspecified: 4 mg per  mL in 1 mL ampoule (as disodium phosphate salt)",Palliative care,C05AA09,,Added,dexamethasone,['dexamethasone']
dexamethasone,Antiemetic medicines,"Oral > Liquid: 0.5 mg per 5 mL; 2 mg per 5 mL
Oral > Solid: 0.5 mg; 0.75 mg; 1.5 mg; 4 mg
Parenteral > General injections > unspecified: 4 mg per  mL in 1 mL ampoule (as disodium phosphate salt)",Nausea or vomiting,H02AB02,,Added,dexamethasone,['dexamethasone']
dextran 70,Plasma substitutes,Parenteral > General injections > IV: 6% injectable solution,Hypovolaemia,B05AA05,,Added,dextran 70,"['dextran', 'dextran 70', '70']"
diaphragms,Barrier methods,-,Contact with health services for contraceptive management,,,Added,diaphragms,['diaphragms']
diazepam,Antiseizure medicines,"
Local > Rectal > Gel: 5 mg per  mL in 0.5 mL rectal delivery system; 5 mg per  mL in 2 mL rectal delivery system; 5 mg per  mL in 4 mL rectal delivery system
Local > Rectal > Solution: 2 mg per  mL in 1.25 mL rectal tube; 2 mg per  mL in 2.5 mL rectal tube; 4 mg per  mL in 2.5 mL rectal tube",Status epilepticus,,,Added,diazepam,['diazepam']
diazepam,Antiseizure medicines,"
Local > Rectal > Gel: 5 mg per  mL in 0.5 mL rectal delivery system; 5 mg per  mL in 2 mL rectal delivery system; 5 mg per  mL in 4 mL rectal delivery system
Local > Rectal > Solution: 2 mg per  mL in 1.25 mL rectal tube; 2 mg per  mL in 2.5 mL rectal tube; 4 mg per  mL in 2.5 mL rectal tube",Status epilepticus,N05BA01,,Added,diazepam,['diazepam']
diazepam,Medicines for other common symptoms in palliative care,"Oral > Liquid: 2 mg per 5 mL
Oral > Solid: 5 mg; 10 mg
Local > Rectal > Gel: 5 mg per  mL in 0.5 mL rectal delivery system; 5 mg per  mL in 2 mL rectal delivery system; 5 mg per  mL in 4 mL rectal delivery system
Local > Rectal > Solution: 2 mg per  mL in 1.25 mL rectal tube; 2 mg per  mL in 2.5 mL rectal tube; 4 mg per  mL in 2.5 mL rectal tube
Parenteral > General injections > unspecified: 5 mg per  mL",Palliative care,N05BA01,,Added,diazepam,['diazepam']
diazepam,Medicines for anxiety disorders ,Oral > Solid: 5 mg (scored); 2 mg (scored),Anxiety,N05BA01,,Added,diazepam,['diazepam']
diazoxide,Medicines for hypoglycaemia,"Oral > Liquid: 50 mg per  mL
Oral > Solid: 50 mg",Persistent hyperinsulinaemic hypoglycaemia of infancy,V03AH01,,Added,diazoxide,['diazoxide']
diethylcarbamazine,Antifilarials,Oral > Solid: 50 mg tablet (dihydrogen citrate); 100 mg tablet (dihydrogen citrate),Lymphatic filariasis,P02CB02,,Added,diethylcarbamazine,['diethylcarbamazine']
digoxin,Antiarrhythmic medicines,"Parenteral > General injections > IV: 250 µg per  mL in 2 mL ampoule
Oral > Liquid: 50 µg per  mL
Oral > Solid: 62.5 µg; 250 µg",Cardiac arrhythmia,C01AA05,,Added,digoxin,['digoxin']
digoxin,Medicines used in heart failure,"Parenteral > General injections > IV: 250 µg per  mL in 2 mL ampoule; 100 µg per  mL in 1 mL ampoule
Oral > Liquid: 50 µg per  mL
Oral > Solid > tablet: 62.5 µg; 250 µg; 125 µg",Heart failure,C01AA05,,Added,digoxin,['digoxin']
dihydroartemisinin + piperaquine phosphate,Antimalarial medicines > For curative treatment,Oral > Solid: 40 mg + 320 mg tablet; 20 mg + 160 mg tablet,Malaria due to Plasmodium falciparum,P01BF05,,Added,dihydroartemisinin + piperaquine phosphate,"['phosphate', '+', 'dihydroartemisinin', 'dihydroartemisinin + piperaquine phosphate', 'piperaquine']"
dihydroartemisinin + piperaquine phosphate,Antimalarial medicines > For curative treatment,Oral > Solid: 40 mg + 320 mg tablet; 20 mg + 160 mg tablet,Malaria due to Plasmodium vivax,P01BF05,,Added,dihydroartemisinin + piperaquine phosphate,"['phosphate', '+', 'dihydroartemisinin', 'dihydroartemisinin + piperaquine phosphate', 'piperaquine']"
diloxanide,Antiamoebic and antigiardiasis medicines,Oral > Solid: 500 mg (furoate),Amoebiasis,P01AC01,,Added,diloxanide,['diloxanide']
dimercaprol,Antidotes and other substances used in poisonings > Specific,Parenteral > General injections > IM: 50 mg per  mL in 2 mL ampoule,"Harmful effects of or exposure to noxious substances, chiefly nonmedicinal as to source, not elsewhere classified",V03AB09,,Added,dimercaprol,['dimercaprol']
diphtheria antitoxin,"Immunologicals > Sera, immunoglobulins and monoclonal antibodies",Parenteral > General injections > IM: 10000 IU in vial; 20000 IU in vial,Need for immunization against diphtheria alone,J06AA01,,Added,diphtheria antitoxin,"['diphtheria', 'diphtheria antitoxin', 'antitoxin']"
diphtheria vaccine,Recommendations for all immunization programmes,All vaccines should comply with the WHO requirements for biological substances.,Need for immunization against diphtheria alone,J07AF01,,Added,diphtheria vaccine,"['diphtheria', 'diphtheria vaccine', 'vaccine']"
docetaxel,Cytotoxic medicines,Parenteral > General injections > IV: 20 mg per  mL; 40 mg per  mL,Other specified malignant neoplasms of breast,L01CD02,,Added,docetaxel,['docetaxel']
docetaxel,Cytotoxic medicines,Parenteral > General injections > IV: 20 mg per  mL; 40 mg per  mL,Malignant neoplasms of breast,L01CD02,,Added,docetaxel,['docetaxel']
docetaxel,Cytotoxic medicines,Parenteral > General injections > IV: 20 mg per  mL; 40 mg per  mL,Malignant neoplasms of prostate,L01CD02,,Added,docetaxel,['docetaxel']
docusate sodium,Medicines for other common symptoms in palliative care,"Oral > Liquid: 50 mg per 5 mL oral liquid
Oral > Solid: 100 mg capsule",Palliative care,A06AA02,,Added,docusate sodium,"['sodium', 'docusate', 'docusate sodium']"
dolasetron,Medicines for other common symptoms in palliative care,,Palliative care,,,Added,dolasetron,['dolasetron']
dolasetron,Antiemetic medicines,,Nausea or vomiting,,,Added,dolasetron,['dolasetron']
dolutegravir,Antiretrovirals > Integrase inhibitors,"Oral > Solid: 50 mg tablet; 10 mg tablet (dispersible, scored)","Human immunodeficiency virus disease without mention of associated disease or condition, clinical stage unspecified",J05AJ03,,Added,dolutegravir,['dolutegravir']
dolutegravir + lamivudine + tenofovir,Fixed-dose combinations of antiretrovirals,Oral > Solid: 50 mg + 300 mg + 300 mg (tenofovir disoproxil fumarate equivalent to 245 mg tenofovir disoproxil),"Human immunodeficiency virus disease without mention of associated disease or condition, clinical stage unspecified",J05AR27,,Added,dolutegravir + lamivudine + tenofovir,"['dolutegravir', 'tenofovir', 'lamivudine', '+', 'dolutegravir + lamivudine + tenofovir']"
dopamine,Medicines used in heart failure,Parenteral > General injections > IV: 40 mg per  mL in 5 mL vial (hydrochloride),Heart failure,C01CA04,,Added,dopamine,['dopamine']
dopamine,Medicines used in heart failure,Parenteral > General injections > IV: 40 mg per  mL in 5 mL vial (hydrochloride),Cardiogenic shock,C01CA04,,Added,dopamine,['dopamine']
doxorubicin,Cytotoxic medicines,"Parenteral > General injections > IV: 10 mg in vial (hydrochloride); 50 mg in vial (hydrochloride)
Parenteral > General injections > IV: 10 mg in vial (hydrochloride) powder for injection; 50 mg in vial (hydrochloride) powder for injection; 2 mg per  mL in 5 mL vial (hydrochloride); 2 mg per  mL in 25 mL vial (hydrochloride)",Malignant neoplasms of breast,L01DB01,,Added,doxorubicin,['doxorubicin']
doxorubicin,Cytotoxic medicines,"Parenteral > General injections > IV: 10 mg in vial (hydrochloride); 50 mg in vial (hydrochloride)
Parenteral > General injections > IV: 10 mg in vial (hydrochloride) powder for injection; 50 mg in vial (hydrochloride) powder for injection; 2 mg per  mL in 5 mL vial (hydrochloride); 2 mg per  mL in 25 mL vial (hydrochloride)",Hodgkin lymphoma,L01DB01,,Added,doxorubicin,['doxorubicin']
doxorubicin,Cytotoxic medicines,"Parenteral > General injections > IV: 10 mg in vial (hydrochloride); 50 mg in vial (hydrochloride)
Parenteral > General injections > IV: 10 mg in vial (hydrochloride) powder for injection; 50 mg in vial (hydrochloride) powder for injection; 2 mg per  mL in 5 mL vial (hydrochloride); 2 mg per  mL in 25 mL vial (hydrochloride)",Diffuse large B-cell lymphomas,L01DB01,,Added,doxorubicin,['doxorubicin']
doxorubicin,Cytotoxic medicines,"Parenteral > General injections > IV: 10 mg in vial (hydrochloride); 50 mg in vial (hydrochloride)
Parenteral > General injections > IV: 10 mg in vial (hydrochloride) powder for injection; 50 mg in vial (hydrochloride) powder for injection; 2 mg per  mL in 5 mL vial (hydrochloride); 2 mg per  mL in 25 mL vial (hydrochloride)",Plasma cell myeloma,L01AA01,,Added,doxorubicin,['doxorubicin']
doxorubicin,Cytotoxic medicines,"Parenteral > General injections > IV: 10 mg in vial (hydrochloride); 50 mg in vial (hydrochloride)
Parenteral > General injections > IV: 10 mg in vial (hydrochloride) powder for injection; 50 mg in vial (hydrochloride) powder for injection; 2 mg per  mL in 5 mL vial (hydrochloride); 2 mg per  mL in 25 mL vial (hydrochloride)",Follicular lymphoma,L01DB01,,Added,doxorubicin,['doxorubicin']
doxorubicin,Cytotoxic medicines,"Parenteral > General injections > IV: 10 mg in vial (hydrochloride); 50 mg in vial (hydrochloride)
Parenteral > General injections > IV: 10 mg in vial (hydrochloride) powder for injection; 50 mg in vial (hydrochloride) powder for injection; 2 mg per  mL in 5 mL vial (hydrochloride); 2 mg per  mL in 25 mL vial (hydrochloride)",Burkitt lymphoma including Burkitt leukaemia,L01DB01,,Added,doxorubicin,['doxorubicin']
doxorubicin,Cytotoxic medicines,"Parenteral > General injections > IV: 10 mg in vial (hydrochloride); 50 mg in vial (hydrochloride)
Parenteral > General injections > IV: 10 mg in vial (hydrochloride) powder for injection; 50 mg in vial (hydrochloride) powder for injection; 2 mg per  mL in 5 mL vial (hydrochloride); 2 mg per  mL in 25 mL vial (hydrochloride)","Malignant neoplasms of kidney, except renal pelvis",L01DB01,,Added,doxorubicin,['doxorubicin']
doxorubicin,Cytotoxic medicines,"Parenteral > General injections > IV: 10 mg in vial (hydrochloride); 50 mg in vial (hydrochloride)
Parenteral > General injections > IV: 10 mg in vial (hydrochloride) powder for injection; 50 mg in vial (hydrochloride) powder for injection; 2 mg per  mL in 5 mL vial (hydrochloride); 2 mg per  mL in 25 mL vial (hydrochloride)",Osteosarcoma of bone and articular cartilage of unspecified sites,L01DB01,,Added,doxorubicin,['doxorubicin']
doxorubicin,Cytotoxic medicines,"Parenteral > General injections > IV: 10 mg in vial (hydrochloride); 50 mg in vial (hydrochloride)
Parenteral > General injections > IV: 10 mg in vial (hydrochloride) powder for injection; 50 mg in vial (hydrochloride) powder for injection; 2 mg per  mL in 5 mL vial (hydrochloride); 2 mg per  mL in 25 mL vial (hydrochloride)","Lymphoid leukaemia, not elsewhere classified",L01DB01,,Added,doxorubicin,['doxorubicin']
doxorubicin,Cytotoxic medicines,"Parenteral > General injections > IV: 10 mg in vial (hydrochloride); 50 mg in vial (hydrochloride)
Parenteral > General injections > IV: 10 mg in vial (hydrochloride) powder for injection; 50 mg in vial (hydrochloride) powder for injection; 2 mg per  mL in 5 mL vial (hydrochloride); 2 mg per  mL in 25 mL vial (hydrochloride)","Anaplastic large cell lymphoma, ALK-negative",L01DB01,,Added,doxorubicin,['doxorubicin']
doxorubicin,Cytotoxic medicines,"Parenteral > General injections > IV: 10 mg in vial (hydrochloride); 50 mg in vial (hydrochloride)
Parenteral > General injections > IV: 10 mg in vial (hydrochloride) powder for injection; 50 mg in vial (hydrochloride) powder for injection; 2 mg per  mL in 5 mL vial (hydrochloride); 2 mg per  mL in 25 mL vial (hydrochloride)",Other specified malignant neoplasms of breast,L01DB01,,Added,doxorubicin,['doxorubicin']
doxorubicin,Cytotoxic medicines,"Parenteral > General injections > IV: 10 mg in vial (hydrochloride); 50 mg in vial (hydrochloride)
Parenteral > General injections > IV: 10 mg in vial (hydrochloride) powder for injection; 50 mg in vial (hydrochloride) powder for injection; 2 mg per  mL in 5 mL vial (hydrochloride); 2 mg per  mL in 25 mL vial (hydrochloride)","Anaplastic large cell lymphoma, ALK-positive",L01DB01,,Added,doxorubicin,['doxorubicin']
doxorubicin,Cytotoxic medicines,"Parenteral > General injections > IV: 10 mg in vial (hydrochloride); 50 mg in vial (hydrochloride)
Parenteral > General injections > IV: 10 mg in vial (hydrochloride) powder for injection; 50 mg in vial (hydrochloride) powder for injection; 2 mg per  mL in 5 mL vial (hydrochloride); 2 mg per  mL in 25 mL vial (hydrochloride)",Ewing sarcoma of bone and articular cartilage of unspecified sites,L01DB01,,Added,doxorubicin,['doxorubicin']
doxorubicin,Cytotoxic medicines,"Parenteral > General injections > IV: 10 mg in vial (hydrochloride); 50 mg in vial (hydrochloride)
Parenteral > General injections > IV: 10 mg in vial (hydrochloride) powder for injection; 50 mg in vial (hydrochloride) powder for injection; 2 mg per  mL in 5 mL vial (hydrochloride); 2 mg per  mL in 25 mL vial (hydrochloride)",Kaposi sarcoma of unspecified primary site,L01DB01,,Added,doxorubicin,['doxorubicin']
doxorubicin (as pegylated liposomal),Cytotoxic medicines,Parenteral > General injections > IV: 2 mg per  mL in 10 mL vial (hydrochloride); 2 mg per  mL in 25 mL vial (hydrochloride),Kaposi sarcoma of unspecified primary site,L01DB01,,Added,doxorubicin (as pegylated liposomal),"['liposomal)', 'doxorubicin', '(as', 'pegylated', 'doxorubicin (as pegylated liposomal)']"
doxycycline,Access group antibiotics,"Oral > Liquid: 25 mg per 5 mL (anhydrous); 50 mg per 5 mL (anhydrous)
Oral > Solid: 100 mg (as hyclate); 50 mg (as hyclate)
Parenteral > General injections > unspecified: 100 mg in vial powder for injection
Oral > Liquid: 25 mg per 5 mL powder for oral liquid (monohydrate); 50 mg per 5 mL (calcium)
Oral > Solid > dispersible tablet: 100 mg (as monohydrate)
Oral > Solid > dosage form: 50 mg (as hyclate); 100 mg (as hyclate)
Oral > Solid > dosage form: 100 mg (as hyclate)",Cholera,J01AA02,,Added,doxycycline,['doxycycline']
doxycycline,Access group antibiotics,"Oral > Liquid: 25 mg per 5 mL (anhydrous); 50 mg per 5 mL (anhydrous)
Oral > Solid: 100 mg (as hyclate); 50 mg (as hyclate)
Parenteral > General injections > unspecified: 100 mg in vial powder for injection
Oral > Liquid: 25 mg per 5 mL powder for oral liquid (monohydrate); 50 mg per 5 mL (calcium)
Oral > Solid > dispersible tablet: 100 mg (as monohydrate)
Oral > Solid > dosage form: 50 mg (as hyclate); 100 mg (as hyclate)
Oral > Solid > dosage form: 100 mg (as hyclate)",Chlamydia trachomatis,J01AA02,,Added,doxycycline,['doxycycline']
doxycycline,Access group antibiotics,"Oral > Liquid: 25 mg per 5 mL (anhydrous); 50 mg per 5 mL (anhydrous)
Oral > Solid: 100 mg (as hyclate); 50 mg (as hyclate)
Parenteral > General injections > unspecified: 100 mg in vial powder for injection
Oral > Liquid: 25 mg per 5 mL powder for oral liquid (monohydrate); 50 mg per 5 mL (calcium)
Oral > Solid > dispersible tablet: 100 mg (as monohydrate)
Oral > Solid > dosage form: 50 mg (as hyclate); 100 mg (as hyclate)
Oral > Solid > dosage form: 100 mg (as hyclate)",Cholera [children],J01AA02,,Added,doxycycline,['doxycycline']
doxycycline,Access group antibiotics,"Oral > Liquid: 25 mg per 5 mL (anhydrous); 50 mg per 5 mL (anhydrous)
Oral > Solid: 100 mg (as hyclate); 50 mg (as hyclate)
Parenteral > General injections > unspecified: 100 mg in vial powder for injection
Oral > Liquid: 25 mg per 5 mL powder for oral liquid (monohydrate); 50 mg per 5 mL (calcium)
Oral > Solid > dispersible tablet: 100 mg (as monohydrate)
Oral > Solid > dosage form: 50 mg (as hyclate); 100 mg (as hyclate)
Oral > Solid > dosage form: 100 mg (as hyclate)",Chronic obstructive pulmonary disease with acute exacerbation,J01AA02,,Added,doxycycline,['doxycycline']
doxycycline,Access group antibiotics,"Oral > Liquid: 25 mg per 5 mL (anhydrous); 50 mg per 5 mL (anhydrous)
Oral > Solid: 100 mg (as hyclate); 50 mg (as hyclate)
Parenteral > General injections > unspecified: 100 mg in vial powder for injection
Oral > Liquid: 25 mg per 5 mL powder for oral liquid (monohydrate); 50 mg per 5 mL (calcium)
Oral > Solid > dispersible tablet: 100 mg (as monohydrate)
Oral > Solid > dosage form: 50 mg (as hyclate); 100 mg (as hyclate)
Oral > Solid > dosage form: 100 mg (as hyclate)",Bacterial pneumonia (Community-acquired pneumonia - mild to moderate),J01AA02,,Added,doxycycline,['doxycycline']
doxycycline,Antimalarial medicines > For curative treatment,Oral > Solid: 100 mg (hydrochloride or hyclate); 100 mg dispersible tablet (as monohydrate),Malaria due to Plasmodium falciparum,J01AA02,,Added,doxycycline,['doxycycline']
doxycycline,Antimalarial medicines > For chemoprevention,Oral > Solid: 100 mg (hydrochloride or hyclate),Malaria due to Plasmodium falciparum,J01AA02,,Added,doxycycline,['doxycycline']
edoxaban,Medicines affecting coagulation,,Venous thromboembolism,,,Added,edoxaban,['edoxaban']
edoxaban,Medicines affecting coagulation,,Other specified atrial fibrillation,,,Added,edoxaban,['edoxaban']
efavirenz,Antiretrovirals > Non-nucleoside reverse transcriptase inhibitors,Oral > Solid: 600 mg tablet,"Human immunodeficiency virus disease without mention of associated disease or condition, clinical stage unspecified",J05AG03,,Added,efavirenz,['efavirenz']
efavirenz + emtricitabine + tenofovir,Fixed-dose combinations of antiretrovirals,Oral > Solid: 600 mg + 200 mg + 300 mg (tenofovir disoproxil fumarate equivalent to 245 mg tenofovir disoproxil),"Human immunodeficiency virus disease without mention of associated disease or condition, clinical stage unspecified",J05AR06,,Added,efavirenz + emtricitabine + tenofovir,"['efavirenz + emtricitabine + tenofovir', 'tenofovir', 'efavirenz', '+', 'emtricitabine']"
efavirenz + lamivudine + tenofovir,Fixed-dose combinations of antiretrovirals,"Oral > Solid: 400 mg + 300 mg + 300 mg (tenofovir disoproxil fumarate, equivalent to 245 mg tenofovir disoproxil)
","Human immunodeficiency virus disease without mention of associated disease or condition, clinical stage unspecified",J05AR11,,Added,efavirenz + lamivudine + tenofovir,"['tenofovir', 'efavirenz + lamivudine + tenofovir', 'efavirenz', 'lamivudine', '+']"
efavirenz + lamivudine + tenofovir,Fixed-dose combinations of antiretrovirals,"Oral > Solid: 400 mg + 300 mg + 300 mg (tenofovir disoproxil fumarate, equivalent to 245 mg tenofovir disoproxil)
","Human immunodeficiency virus disease without mention of associated disease or condition, clinical stage unspecified",,,Added,efavirenz + lamivudine + tenofovir,"['tenofovir', 'efavirenz + lamivudine + tenofovir', 'efavirenz', 'lamivudine', '+']"
eflornithine,Medicines for the treatment of 2nd stage African trypanosomiasis,Parenteral > General injections > IV: 200 mg per  mL in 50 mL bottle (hydrochloride),African trypanosomiasis,P01CX03,,Added,eflornithine,['eflornithine']
empagliflozin,Oral hypoglycaemic agents,Oral > Solid: 10 mg; 25 mg,Type 2 diabetes mellitus,A10BK03,,Added,empagliflozin,['empagliflozin']
emtricitabine + tenofovir,Fixed-dose combinations of antiretrovirals,Oral > Solid: 200 mg + 300 mg (tenofovir disoproxil fumarate equivalent to 245 mg tenofovir disoproxil),"Human immunodeficiency virus disease without mention of associated disease or condition, clinical stage unspecified",J05AR03,,Added,emtricitabine + tenofovir,"['emtricitabine + tenofovir', 'tenofovir', '+', 'emtricitabine']"
emtricitabine + tenofovir,Fixed-dose combinations of antiretrovirals,Oral > Solid: 200 mg + 300 mg (tenofovir disoproxil fumarate equivalent to 245 mg tenofovir disoproxil),Contact with or exposure to human immunodeficiency virus,J05AR03,,Added,emtricitabine + tenofovir,"['emtricitabine + tenofovir', 'tenofovir', '+', 'emtricitabine']"
enalapril,Antihypertensive medicines,"Oral > Liquid: 1 mg per  mL (as hydrogen maleate)
Oral > Solid > tablet: 2.5 mg (as hydrogen maleate); 5 mg (as hydrogen maleate); 10 mg (as hydrogen maleate)",Essential hypertension,C09AA02,,Added,enalapril,['enalapril']
enalapril,Medicines used in heart failure,Oral > Solid > tablet: 2.5 mg (as hydrogen maleate); 5 mg (as hydrogen maleate); 10 mg (as hydrogen maleate),Heart failure,C09AA02,,Added,enalapril,['enalapril']
enoxaparin,Medicines affecting coagulation,Parenteral > General injections > SC: 20 mg per 0.2 mL in prefilled syringe; 40 mg per 0.4 mL in prefilled syringe; 60 mg per 0.6 mL in prefilled syringe; 80 mg per 0.8 mL in prefilled syringe; 100 mg per 1 mL in prefilled syringe; 120 mg per 0.8 mL in prefilled syringe; 150 mg per 1 mL in prefilled syringe; 150 mg per 1 mL in ampoule; 20 mg per 0.2 mL in ampoule; 40 mg per 0.4 mL in ampoule; 60 mg per 0.6 mL in ampoule; 80 mg per 0.8 mL in ampoule; 100 mg per 1 mL in ampoule; 120 mg per 0.8 mL in ampoule,Acute ischaemic heart disease,B01AB05,,Added,enoxaparin,['enoxaparin']
enoxaparin,Medicines affecting coagulation,Parenteral > General injections > SC: 20 mg per 0.2 mL in prefilled syringe; 40 mg per 0.4 mL in prefilled syringe; 60 mg per 0.6 mL in prefilled syringe; 80 mg per 0.8 mL in prefilled syringe; 100 mg per 1 mL in prefilled syringe; 120 mg per 0.8 mL in prefilled syringe; 150 mg per 1 mL in prefilled syringe; 150 mg per 1 mL in ampoule; 20 mg per 0.2 mL in ampoule; 40 mg per 0.4 mL in ampoule; 60 mg per 0.6 mL in ampoule; 80 mg per 0.8 mL in ampoule; 100 mg per 1 mL in ampoule; 120 mg per 0.8 mL in ampoule,Venous thromboembolism,B01AB05,,Added,enoxaparin,['enoxaparin']
entecavir,Medicines for hepatitis B > Nucleoside/Nucleotide reverse transcriptase inhibitors,"Oral > Liquid: 0.05 mg per  mL
Oral > Solid: 0.5 mg; 1 mg",Chronic hepatitis B,J05AF10,,Added,entecavir,['entecavir']
enzalutamide,Hormones and antihormones,"
Oral > Solid: 40 mg",Malignant neoplasms of prostate,,,Added,enzalutamide,['enzalutamide']
ephedrine,Local anaesthetics,Parenteral > Locoregional injections > Spinal anaesthesia: 30 mg per  mL in 1 mL ampoule (ephedrine hydrochloride),Cardiac complications of anaesthesia during labour or delivery,C01CA26,,Added,ephedrine,['ephedrine']
epinephrine,Antiarrhythmic medicines,Parenteral > General injections > IV: 100 µg per  mL in 10 mL ampoule (as acid tartrate or hydrochloride),Cardiac arrest,C01CA24,,Added,epinephrine,['epinephrine']
epinephrine,Ophthalmological preparations > Mydriatics,Local > Ophthalmological > Solution (eye drops): 2% (as hydrochloride),Primary open-angle glaucoma,S01EA01,,Added,epinephrine,['epinephrine']
epinephrine,Antiasthmatic and medicines for chronic obstructive pulmonary disease,Parenteral > General injections > unspecified: 1 mg per  mL in ampoule (as hydrochloride or hydrogen tartrate),Asthma,C01CA24,,Added,epinephrine,['epinephrine']
epinephrine,Antiasthmatic and medicines for chronic obstructive pulmonary disease,Parenteral > General injections > unspecified: 1 mg per  mL in ampoule (as hydrochloride or hydrogen tartrate),Chronic obstructive pulmonary disease,R03AA01,,Added,epinephrine,['epinephrine']
epinephrine,Antiallergics and medicines used in anaphylaxis,Parenteral > General injections > unspecified: 1 mg in 1 mL ampoule (as hydrochloride or hydrogen tartrate),Anaphylaxis,C01CA24,,Added,epinephrine,['epinephrine']
epoetin alfa,Antianaemia medicines,,Anaemia due to chronic disease,,,Added,epoetin alfa,"['epoetin', 'epoetin alfa', 'alfa']"
epoetin beta,Antianaemia medicines,,Anaemia due to chronic disease,,,Added,epoetin beta,"['epoetin', 'beta', 'epoetin beta']"
epoetin theta,Antianaemia medicines,,Anaemia due to chronic disease,,,Added,epoetin theta,"['epoetin', 'theta', 'epoetin theta']"
equine rabies immunoglobulin,"Immunologicals > Sera, immunoglobulins and monoclonal antibodies",Parenteral > Locoregional injections > Intradermal: 150 IU per  mL in vial; 200 IU per  mL in vial; 300 IU per  mL in vial; 400 IU per  mL in vial,Rabies,J06BB05,,Added,equine rabies immunoglobulin,"['equine rabies immunoglobulin', 'immunoglobulin', 'equine', 'rabies']"
ergocalciferol,Vitamins and minerals,"
Oral > Liquid: 250 µg per  mL (10 000 IU per mL)
Oral > Solid: 1.25 mg (50 000 IU)",Calcium deficiency,,,Added,ergocalciferol,['ergocalciferol']
ergocalciferol,Vitamins and minerals,"
Oral > Liquid: 250 µg per  mL (10 000 IU per mL)
Oral > Solid: 1.25 mg (50 000 IU)",Vitamin D deficiency,,,Added,ergocalciferol,['ergocalciferol']
ergocalciferol,Vitamins and minerals,"
Oral > Liquid: 250 µg per  mL (10 000 IU per mL)
Oral > Solid: 1.25 mg (50 000 IU)",Vitamin D deficiency,A11CC01,,Added,ergocalciferol,['ergocalciferol']
ergocalciferol,Vitamins and minerals,"
Oral > Liquid: 250 µg per  mL (10 000 IU per mL)
Oral > Solid: 1.25 mg (50 000 IU)",Calcium deficiency,A11CC01,,Added,ergocalciferol,['ergocalciferol']
ergometrine,Uterotonics,Parenteral > General injections > unspecified: 200 µg in 1 mL ampoule (hydrogen maleate),Postpartum haemorrhage,G02AB03,,Added,ergometrine,['ergometrine']
erlotinib,Targeted therapies,Oral > Solid: 100 mg; 150 mg,Other specified malignant neoplasms of bronchus or lung,L01EB02,,Added,erlotinib,['erlotinib']
erythromycin,Watch group antibiotics,"Parenteral > General injections > IV: 500 mg in vial powder for injection (as lactobionate)
Oral > Liquid: 125 mg per 5 mL (as stearate or ethylsuccinate)
Oral > Solid: 250 mg (as stearate or ethylsuccinate)
",Acute pharyngitis,J01FA09,,Added,erythromycin,['erythromycin']
erythromycin,Ophthalmological preparations > Anti-infective agents,Local > Ophthalmological > Ointment: 0.5%,Chlamydial conjunctivitis,S01AA17,,Added,erythromycin,['erythromycin']
erythromycin,Ophthalmological preparations > Anti-infective agents,Local > Ophthalmological > Ointment: 0.5%,Gonococcal infection of eye,S01AA17,,Added,erythromycin,['erythromycin']
erythropoiesis-stimulating agents,Antianaemia medicines,Parenteral > General injections > unspecified: 1000 IU per 0.5 mL pre-filled syringe; 2000 IU per 0.5 mL pre-filled syringe; 3000 IU per 0.3 mL pre-filled syringe; 4000 IU per 0.4 mL pre-filled syringe; 5000 IU per 0.5 mL pre-filled syringe; 6000 IU per 0.6 mL pre-filled syringe; 8000 IU per 0.8 mL pre-filled syringe; 10000 IU per 1 mL pre-filled syringe; 20000 IU per 0.5 mL pre-filled syringe; 40000 IU per 1 mL pre-filled syringe,Anaemia due to chronic disease,"B03XA03, B03XA01, B03XA02",,Added,erythropoiesis-stimulating agents,"['agents', 'erythropoiesis-stimulating', 'erythropoiesis-stimulating agents']"
estradiol cypionate + medroxyprogesterone acetate,Injectable hormonal contraceptives,Parenteral > General injections > IM: 5 mg + 25 mg,Contact with health services for reasons associated with reproduction,G03AA08,,Added,estradiol cypionate + medroxyprogesterone acetate,"['estradiol cypionate + medroxyprogesterone acetate', 'acetate', 'medroxyprogesterone', 'cypionate', '+', 'estradiol']"
etanercept,Immunomodulators for non-malignant disease,,Axial spondyloarthritis,,,Added,etanercept,['etanercept']
etanercept,Immunomodulators for non-malignant disease,,Crohn disease site,,,Added,etanercept,['etanercept']
etanercept,Immunomodulators for non-malignant disease,,Rheumatoid arthritis,,,Added,etanercept,['etanercept']
etanercept,Medicines for juvenile joint diseases,,Juvenile idiopathic arthritis,,,Added,etanercept,['etanercept']
ethambutol,Antituberculosis medicines,"Parenteral > General injections > IV: 1000 mg per 10 mL; 2000 mg per 20 mL
Oral > Solid > dispersible tablet: 100 mg
Oral > Solid > tablet: 100 mg (hydrochloride); 400 mg (hydrochloride)",Tuberculosis,J04AK02,,Added,ethambutol,['ethambutol']
ethambutol + isoniazid + pyrazinamide + rifampicin,Antituberculosis medicines,Oral > Solid: 275 mg + 75 mg + 400 mg + 150 mg tablet,Tuberculosis,J04AM06,,Added,ethambutol + isoniazid + pyrazinamide + rifampicin,"['ethambutol', 'ethambutol + isoniazid + pyrazinamide + rifampicin', 'rifampicin', 'isoniazid', '+', 'pyrazinamide']"
ethambutol + isoniazid + rifampicin,Antituberculosis medicines,Oral > Solid: 275 mg + 75 mg + 150 mg tablet,Tuberculosis,"J04AK02, J04AC01, J04AB02",,Added,ethambutol + isoniazid + rifampicin,"['ethambutol', 'rifampicin', 'ethambutol + isoniazid + rifampicin', 'isoniazid', '+']"
ethanol,Antiseptics,Local > Topical > Solution: 70% (denatured),Denatured alcohol,D08AX08,,Added,ethanol,['ethanol']
ethinylestradiol + etonogestrel,Intravaginal contraceptives,Local > Vaginal > vaginal ring: 2.7 mg + 11.7 mg,Contact with health services for contraceptive management,G02BB01,,Added,ethinylestradiol + etonogestrel,"['ethinylestradiol', 'etonogestrel', '+', 'ethinylestradiol + etonogestrel']"
ethinylestradiol + levonorgestrel,Oral hormonal contraceptives,"Oral > Solid: 50 µg + 250 µg [4]
Oral > Solid: 30 µg + 150 µg",Contact with health services for contraceptive management,G03AA07,,Added,ethinylestradiol + levonorgestrel,"['levonorgestrel', 'ethinylestradiol', '+', 'ethinylestradiol + levonorgestrel']"
ethinylestradiol + norethisterone,Oral hormonal contraceptives,Oral > Solid: 35 µg + 1 mg,Contact with health services for contraceptive management,G03AA05,,Added,ethinylestradiol + norethisterone,"['ethinylestradiol', 'norethisterone', '+', 'ethinylestradiol + norethisterone']"
ethionamide,Antituberculosis medicines,"Oral > Solid > dispersible tablet: 125 mg
Oral > Solid > tablet: 250 mg",Multi-drug resistant Mycobacterium tuberculosis,J04AD03,,Added,ethionamide,['ethionamide']
ethionamide,Antituberculosis medicines,"Oral > Solid > dispersible tablet: 125 mg
Oral > Solid > tablet: 250 mg",Tuberculous meningitis,J04AD03,,Added,ethionamide,['ethionamide']
ethosuximide,Antiseizure medicines,"Oral > Liquid: 250 mg per 5 mL
Oral > Solid: 250 mg","Absence seizures, typical",N03AD01,,Added,ethosuximide,['ethosuximide']
etonogestrel-releasing implant,Implantable contraceptives,Implant > Subdermal: 68 mg single rod,Contact with health services for insertion of contraceptive device,G03AC08,,Added,etonogestrel-releasing implant,"['etonogestrel-releasing', 'etonogestrel-releasing implant', 'implant']"
etoposide,Cytotoxic medicines,"Parenteral > General injections > IV: 20 mg per  mL in 5 mL ampoule
Oral > Solid: 100 mg capsule
Parenteral > General injections > IV: 20 mg per  mL in 5 mL ampoule; 100 mg in vial powder for injection (as phosphate)
Oral > Solid: 100 mg capsule; 50 mg capsule",Burkitt lymphoma including Burkitt leukaemia,L01CB01,,Added,etoposide,['etoposide']
etoposide,Cytotoxic medicines,"Parenteral > General injections > IV: 20 mg per  mL in 5 mL ampoule
Oral > Solid: 100 mg capsule
Parenteral > General injections > IV: 20 mg per  mL in 5 mL ampoule; 100 mg in vial powder for injection (as phosphate)
Oral > Solid: 100 mg capsule; 50 mg capsule",Ewing sarcoma of bone and articular cartilage of unspecified sites,L01CB01,,Added,etoposide,['etoposide']
etoposide,Cytotoxic medicines,"Parenteral > General injections > IV: 20 mg per  mL in 5 mL ampoule
Oral > Solid: 100 mg capsule
Parenteral > General injections > IV: 20 mg per  mL in 5 mL ampoule; 100 mg in vial powder for injection (as phosphate)
Oral > Solid: 100 mg capsule; 50 mg capsule","Lymphoid leukaemia, not elsewhere classified",L01CB01,,Added,etoposide,['etoposide']
etoposide,Cytotoxic medicines,"Parenteral > General injections > IV: 20 mg per  mL in 5 mL ampoule
Oral > Solid: 100 mg capsule
Parenteral > General injections > IV: 20 mg per  mL in 5 mL ampoule; 100 mg in vial powder for injection (as phosphate)
Oral > Solid: 100 mg capsule; 50 mg capsule",Myeloid leukaemia,L01CB01,,Added,etoposide,['etoposide']
etoposide,Cytotoxic medicines,"Parenteral > General injections > IV: 20 mg per  mL in 5 mL ampoule
Oral > Solid: 100 mg capsule
Parenteral > General injections > IV: 20 mg per  mL in 5 mL ampoule; 100 mg in vial powder for injection (as phosphate)
Oral > Solid: 100 mg capsule; 50 mg capsule",Other specified malignant neoplasms of the ovary,L01CB01,,Added,etoposide,['etoposide']
etoposide,Cytotoxic medicines,"Parenteral > General injections > IV: 20 mg per  mL in 5 mL ampoule
Oral > Solid: 100 mg capsule
Parenteral > General injections > IV: 20 mg per  mL in 5 mL ampoule; 100 mg in vial powder for injection (as phosphate)
Oral > Solid: 100 mg capsule; 50 mg capsule",Other specified malignant neoplasms of bronchus or lung,L01CB01,,Added,etoposide,['etoposide']
etoposide,Cytotoxic medicines,"Parenteral > General injections > IV: 20 mg per  mL in 5 mL ampoule
Oral > Solid: 100 mg capsule
Parenteral > General injections > IV: 20 mg per  mL in 5 mL ampoule; 100 mg in vial powder for injection (as phosphate)
Oral > Solid: 100 mg capsule; 50 mg capsule",Germ cell tumour of testis,L01CB01,,Added,etoposide,['etoposide']
etoposide,Cytotoxic medicines,"Parenteral > General injections > IV: 20 mg per  mL in 5 mL ampoule
Oral > Solid: 100 mg capsule
Parenteral > General injections > IV: 20 mg per  mL in 5 mL ampoule; 100 mg in vial powder for injection (as phosphate)
Oral > Solid: 100 mg capsule; 50 mg capsule",Malignant trophoblastic neoplasms of placenta,L01CB01,,Added,etoposide,['etoposide']
etoposide,Cytotoxic medicines,"Parenteral > General injections > IV: 20 mg per  mL in 5 mL ampoule
Oral > Solid: 100 mg capsule
Parenteral > General injections > IV: 20 mg per  mL in 5 mL ampoule; 100 mg in vial powder for injection (as phosphate)
Oral > Solid: 100 mg capsule; 50 mg capsule","Malignant neoplasms of kidney, except renal pelvis",L01CB01,,Added,etoposide,['etoposide']
etoposide,Cytotoxic medicines,"Parenteral > General injections > IV: 20 mg per  mL in 5 mL ampoule
Oral > Solid: 100 mg capsule
Parenteral > General injections > IV: 20 mg per  mL in 5 mL ampoule; 100 mg in vial powder for injection (as phosphate)
Oral > Solid: 100 mg capsule; 50 mg capsule",Osteosarcoma of bone and articular cartilage of unspecified sites,L01CB01,,Added,etoposide,['etoposide']
etoposide,Cytotoxic medicines,"Parenteral > General injections > IV: 20 mg per  mL in 5 mL ampoule
Oral > Solid: 100 mg capsule
Parenteral > General injections > IV: 20 mg per  mL in 5 mL ampoule; 100 mg in vial powder for injection (as phosphate)
Oral > Solid: 100 mg capsule; 50 mg capsule",Hodgkin lymphoma,L01CB01,,Added,etoposide,['etoposide']
etoposide,Cytotoxic medicines,"Parenteral > General injections > IV: 20 mg per  mL in 5 mL ampoule
Oral > Solid: 100 mg capsule
Parenteral > General injections > IV: 20 mg per  mL in 5 mL ampoule; 100 mg in vial powder for injection (as phosphate)
Oral > Solid: 100 mg capsule; 50 mg capsule",Retinoblastoma,L01CB01,,Added,etoposide,['etoposide']
etoposide,Cytotoxic medicines,"Parenteral > General injections > IV: 20 mg per  mL in 5 mL ampoule
Oral > Solid: 100 mg capsule
Parenteral > General injections > IV: 20 mg per  mL in 5 mL ampoule; 100 mg in vial powder for injection (as phosphate)
Oral > Solid: 100 mg capsule; 50 mg capsule","Anaplastic large cell lymphoma, ALK-positive",L01CB01,,Added,etoposide,['etoposide']
etoposide,Cytotoxic medicines,"Parenteral > General injections > IV: 20 mg per  mL in 5 mL ampoule
Oral > Solid: 100 mg capsule
Parenteral > General injections > IV: 20 mg per  mL in 5 mL ampoule; 100 mg in vial powder for injection (as phosphate)
Oral > Solid: 100 mg capsule; 50 mg capsule","Anaplastic large cell lymphoma, ALK-negative",L01CB01,,Added,etoposide,['etoposide']
everolimus,Targeted therapies,"Oral > Solid > dispersible tablet: 2 mg; 3 mg; 5 mg
Oral > Solid > tablet: 2.5 mg; 5 mg; 7.5 mg; 10 mg",Other specified gliomas of brain,L01EG02,,Added,everolimus,['everolimus']
fentanyl,Opioid analgesics,"Local > Topical > Transdermal patch: 12 µg/hour; 25 µg/hour; 50 µg/hour; 75 µg/hour; 100 µg/hour
Oral > Solid: 100 to 800 µg sub-lingual tablet (as citrate); 200 to 1600 µg lozenge (as citrate)
Oral > Other: 200 to 1200 µg buccal film (as citrate)",Chronic cancer pain,N01AH01,,Added,fentanyl,['fentanyl']
ferrous salt,Antianaemia medicines,"Oral > Liquid: 25 mg per  mL iron (as sulfate)
Oral > Solid: 60 mg iron",Iron deficiency anaemia,"B03AA07, B03AA02",,Added,ferrous salt,"['salt', 'ferrous', 'ferrous salt']"
ferrous salt + folic acid,Antianaemia medicines,"Oral > Solid: 60 mg iron + 2.8 mg
Oral > Solid > tablet: 60 mg elemental iron + 400 µg tablet; 60 mg elemental iron + 2.8 mg","Clefts of lip, alveolus or palate","B03AD03, B03AD02, B03AD05",,Added,ferrous salt + folic acid,"['salt', 'ferrous salt + folic acid', 'ferrous', '+', 'acid', 'folic']"
ferrous salt + folic acid,Antianaemia medicines,"Oral > Solid: 60 mg iron + 2.8 mg
Oral > Solid > tablet: 60 mg elemental iron + 400 µg tablet; 60 mg elemental iron + 2.8 mg",Iron deficiency anaemia,"B03AD03, B03AD02, B03AD05",,Added,ferrous salt + folic acid,"['salt', 'ferrous salt + folic acid', 'ferrous', '+', 'acid', 'folic']"
ferrous salt + folic acid,Antianaemia medicines,"Oral > Solid: 60 mg iron + 2.8 mg
Oral > Solid > tablet: 60 mg elemental iron + 400 µg tablet; 60 mg elemental iron + 2.8 mg",Anencephaly or similar anomalies,"B03AD03, B03AD02, B03AD05",,Added,ferrous salt + folic acid,"['salt', 'ferrous salt + folic acid', 'ferrous', '+', 'acid', 'folic']"
ferrous salt + folic acid,Antianaemia medicines,"Oral > Solid: 60 mg iron + 2.8 mg
Oral > Solid > tablet: 60 mg elemental iron + 400 µg tablet; 60 mg elemental iron + 2.8 mg",Spina bifida,"B03AD03, B03AD02, B03AD05",,Added,ferrous salt + folic acid,"['salt', 'ferrous salt + folic acid', 'ferrous', '+', 'acid', 'folic']"
fexinidazole,Medicines for the treatment of 1st stage African trypanosomiasis,Oral > Solid: 600 mg,African trypanosomiasis,P01CA03,,Added,fexinidazole,['fexinidazole']
fexinidazole,Medicines for the treatment of 2nd stage African trypanosomiasis,Oral > Solid: 600 mg,African trypanosomiasis,P01CA03,,Added,fexinidazole,['fexinidazole']
fexofenadine,Antiallergics and medicines used in anaphylaxis,,Allergic or hypersensitivity conditions of unspecified type,,,Added,fexofenadine,['fexofenadine']
filgrastim,Immunomodulators,Parenteral > General injections > SC: 120 µg per 0.2 mL in prefilled syringe; 300 µg per 0.5 mL in prefilled syringe; 480 µg per 0.8 mL in prefilled syringe; 300 µg per  mL in 1 mL vial; 480 µg per 1.6 mL in 1.6 mL vial,Acquired neutropaenia,L03AA02,,Added,filgrastim,['filgrastim']
fluconazole,Antifungal medicines,"Parenteral > General injections > IV: 2 mg per  mL in vial
Oral > Liquid: 50 mg per 5 mL; 50 mg per 5 mL powder for oral liquid
Oral > Solid > capsule: 50 mg",Cryptococcosis,J02AC01,,Added,fluconazole,['fluconazole']
fluconazole,Antifungal medicines,"Parenteral > General injections > IV: 2 mg per  mL in vial
Oral > Liquid: 50 mg per 5 mL; 50 mg per 5 mL powder for oral liquid
Oral > Solid > capsule: 50 mg",Candidosis,J02AC01,,Added,fluconazole,['fluconazole']
flucytosine,Antifungal medicines,"Parenteral > General injections > IV: 2.5 g per 250 mL infusion
Oral > Solid: 250 mg capsule",Cryptococcosis,J02AX01,,Added,flucytosine,['flucytosine']
fludarabine,Cytotoxic medicines,"Parenteral > General injections > IV: 50 mg in vial (fludarabine phosphate) powder for injection
Oral > Solid: 10 mg tablet (fludarabine phosphate)",Chronic lymphocytic leukaemia or small lymphocytic lymphoma,L01BB05,,Added,fludarabine,['fludarabine']
fludrocortisone,Adrenal hormones and synthetic substitutes,Oral > Solid: 100 µg (acetate),Adrenocortical insufficiency,H02AA02,,Added,fludrocortisone,['fludrocortisone']
flunisolide,Antiasthmatic and medicines for chronic obstructive pulmonary disease,,Asthma,,,Added,flunisolide,['flunisolide']
fluorescein,Diagnostic agents > Ophthalmic medicines,Local > Ophthalmological > Solution (eye drops): 1% (sodium salt),Fluorescein,S01JA01,,Added,fluorescein,['fluorescein']
fluoride,Dental medicines and preparations,"Local > Dental > Gel: 2500 to 12500 ppm fluoride (any type)
Local > Dental > Toothpaste, cream or gel: 1000 to 1500 ppm fluoride (any type)
Local > Dental > Mouthrinse: 230 to 900 ppm fluoride (any type)
Local > Dental > Varnish: 22500 ppm fluoride (any type)",Dental caries,"A01AA01, A01AA04",,Added,fluoride,['fluoride']
fluorouracil,Dermatological medicines > Medicines affecting skin differentiation and proliferation,Local > Topical > Ointment: 5%,Plantar warts,L01BC02,,Added,fluorouracil,['fluorouracil']
fluorouracil,Cytotoxic medicines,"Parenteral > General injections > IV: 50 mg per  mL in 5 mL ampoule
Parenteral > General injections > IV: 50 mg per  mL in vial",Malignant neoplasms of nasopharynx,L01BC02,,Added,fluorouracil,['fluorouracil']
fluorouracil,Cytotoxic medicines,"Parenteral > General injections > IV: 50 mg per  mL in 5 mL ampoule
Parenteral > General injections > IV: 50 mg per  mL in vial",Malignant neoplasm metastasis in large intestine,L01BC02,,Added,fluorouracil,['fluorouracil']
fluorouracil,Cytotoxic medicines,"Parenteral > General injections > IV: 50 mg per  mL in 5 mL ampoule
Parenteral > General injections > IV: 50 mg per  mL in vial",Malignant neoplasms of breast,L01BC02,,Added,fluorouracil,['fluorouracil']
fluorouracil,Cytotoxic medicines,"Parenteral > General injections > IV: 50 mg per  mL in 5 mL ampoule
Parenteral > General injections > IV: 50 mg per  mL in vial",Malignant neoplasms of rectum,L01BC02,,Added,fluorouracil,['fluorouracil']
fluorouracil,Cytotoxic medicines,"Parenteral > General injections > IV: 50 mg per  mL in 5 mL ampoule
Parenteral > General injections > IV: 50 mg per  mL in vial",Malignant neoplasms of colon,L01BC02,,Added,fluorouracil,['fluorouracil']
fluoxetine,Medicines for depressive disorders,Oral > Solid: 20 mg (as hydrochloride),Depressive disorders,N06AB03,,Added,fluoxetine,['fluoxetine']
fluoxetine,Medicines for other common symptoms in palliative care,Oral > Solid: 20 mg (as hydrochloride),Palliative care,N06AB03,,Added,fluoxetine,['fluoxetine']
fluoxetine,Medicines for anxiety disorders ,Oral > Solid: 20 mg (as hydrochloride),Social anxiety disorder,N06AB03,,Added,fluoxetine,['fluoxetine']
fluoxetine,Medicines for anxiety disorders ,Oral > Solid: 20 mg (as hydrochloride),Generalised anxiety disorder,N06AB03,,Added,fluoxetine,['fluoxetine']
fluoxetine,Medicines for anxiety disorders ,Oral > Solid: 20 mg (as hydrochloride),Panic disorder,N06AB03,,Added,fluoxetine,['fluoxetine']
fluoxetine,Medicines for obsessive compulsive disorders,Oral > Solid: 20 mg (as hydrochloride),Obsessive-compulsive disorder,N06AB03,,Added,fluoxetine,['fluoxetine']
fluphenazine,Medicines for psychotic disorders,Parenteral > General injections > IM: 25 mg per  mL in ampoule (decanoate); 25 mg per  mL in ampoule (enanthate),Schizophrenia or other primary psychotic disorders,N05AB02,,Added,fluphenazine,['fluphenazine']
flutamide,Hormones and antihormones,,Malignant neoplasms of prostate,,,Added,flutamide,['flutamide']
fluticasone,Antiasthmatic and medicines for chronic obstructive pulmonary disease,,Asthma,,,Added,fluticasone,['fluticasone']
fluticasone + formoterol,Antiasthmatic and medicines for chronic obstructive pulmonary disease,,Asthma,,,Added,fluticasone + formoterol,"['formoterol', 'fluticasone + formoterol', 'fluticasone', '+']"
fluticasone furoate + vilanterol,Antiasthmatic and medicines for chronic obstructive pulmonary disease,,Asthma,,,Added,fluticasone furoate + vilanterol,"['vilanterol', 'furoate', 'fluticasone', 'fluticasone furoate + vilanterol', '+']"
fluvastatin,Lipid-lowering agents,,Mixed hyperlipidaemia,,,Added,fluvastatin,['fluvastatin']
fluvastatin,Lipid-lowering agents,,Coronary atherosclerosis,,,Added,fluvastatin,['fluvastatin']
folic acid,Antianaemia medicines,"Oral > Solid: 1 mg tablet; 5 mg tablet
Oral > Solid: 400 µg",Folate deficiency anaemia,B03BB01,,Added,folic acid,"['folic acid', 'folic', 'acid']"
folic acid,Antianaemia medicines,"Oral > Solid: 1 mg tablet; 5 mg tablet
Oral > Solid: 400 µg",Anencephaly or similar anomalies,B03BB01,,Added,folic acid,"['folic acid', 'folic', 'acid']"
folic acid,Antianaemia medicines,"Oral > Solid: 1 mg tablet; 5 mg tablet
Oral > Solid: 400 µg",Spina bifida,B03BB01,,Added,folic acid,"['folic acid', 'folic', 'acid']"
folic acid,Antianaemia medicines,"Oral > Solid: 1 mg tablet; 5 mg tablet
Oral > Solid: 400 µg",Cephalocele,B03BB01,,Added,folic acid,"['folic acid', 'folic', 'acid']"
fomepizole,Antidotes and other substances used in poisonings > Specific,Parenteral > General injections > IV: 5 mg per  mL in 20 mL ampoule (sulfate); 1 g per  mL in 1.5 mL ampoule (base),"Harmful effects of or exposure to noxious substances, chiefly nonmedicinal as to source, not elsewhere classified",V03AB34,,Added,fomepizole,['fomepizole']
fosfomycin (injection),Reserve group antibiotics,Parenteral > General injections > IV: 2 g in vial (as sodium) powder for injection; 4 g in vial (as sodium) powder for injection,Carbapenem resistant Acinetobacter baumannii,J01XX01,,Added,fosfomycin (injection),"['fosfomycin', '(injection)', 'fosfomycin (injection)']"
fosfomycin (injection),Reserve group antibiotics,Parenteral > General injections > IV: 2 g in vial (as sodium) powder for injection; 4 g in vial (as sodium) powder for injection,Carbapenem-resistant Pseudomonas aeruginosa,J01XX01,,Added,fosfomycin (injection),"['fosfomycin', '(injection)', 'fosfomycin (injection)']"
fosfomycin (injection),Reserve group antibiotics,Parenteral > General injections > IV: 2 g in vial (as sodium) powder for injection; 4 g in vial (as sodium) powder for injection,Carbapenem resistant Enterobacterales,J01XX01,,Added,fosfomycin (injection),"['fosfomycin', '(injection)', 'fosfomycin (injection)']"
fresh-frozen plasma,Blood and blood components,Parenteral > General injections > IV: ,Blood transfusion without reported diagnosis,B05AX03,,Added,fresh-frozen plasma,"['fresh-frozen plasma', 'plasma', 'fresh-frozen']"
furosemide,Medicines used in heart failure,"Parenteral > General injections > IV: 10 mg per  mL in 2 mL ampoule; 10 mg per  mL in 5 mL ampoule
Oral > Liquid: 20 mg per 5 mL; 50 mg per 5 mL
Oral > Solid > tablet: 40 mg; 20 mg",Heart failure,C03CA01,,Added,furosemide,['furosemide']
furosemide,Diuretics,"Parenteral > General injections > IV: 10 mg per  mL in 2 mL ampoule; 10 mg per  mL in 5 mL ampoule
Oral > Liquid: 20 mg per 5 mL; 50 mg per 5 mL
Oral > Solid > tablet: 40 mg; 20 mg",Anuria or oliguria,C03CA01,,Added,furosemide,['furosemide']
furosemide,Diuretics,"Parenteral > General injections > IV: 10 mg per  mL in 2 mL ampoule; 10 mg per  mL in 5 mL ampoule
Oral > Liquid: 20 mg per 5 mL; 50 mg per 5 mL
Oral > Solid > tablet: 40 mg; 20 mg",Oedema,C03CA01,,Added,furosemide,['furosemide']
gefitinib,Targeted therapies,,Other specified malignant neoplasms of bronchus or lung,,,Added,gefitinib,['gefitinib']
gemcitabine,Cytotoxic medicines,Parenteral > General injections > IV: 200 mg in vial powder for injection; 1 g in vial powder for injection,Other specified carcinomas of ovary,L01BC05,,Added,gemcitabine,['gemcitabine']
gemcitabine,Cytotoxic medicines,Parenteral > General injections > IV: 200 mg in vial powder for injection; 1 g in vial powder for injection,Other specified malignant neoplasms of bronchus or lung,L01BC05,,Added,gemcitabine,['gemcitabine']
gentamicin,Access group antibiotics,Parenteral > General injections > unspecified: 10 mg per  mL in 2 mL vial (as sulfate); 40 mg per  mL in 2 mL vial (as sulfate),"Acute malnutrition in infants, children or adolescents (complicated) [children]",J01GB03,benzylpenicillin,Added,gentamicin,['gentamicin']
gentamicin,Access group antibiotics,Parenteral > General injections > unspecified: 10 mg per  mL in 2 mL vial (as sulfate); 40 mg per  mL in 2 mL vial (as sulfate),"Acute malnutrition in infants, children or adolescents (complicated) [children]",J01GB03,ampicillin,Added,gentamicin,['gentamicin']
gentamicin,Access group antibiotics,Parenteral > General injections > unspecified: 10 mg per  mL in 2 mL vial (as sulfate); 40 mg per  mL in 2 mL vial (as sulfate),Peritonitis (mild-moderate),J01GB03,ampicillin,Added,gentamicin,['gentamicin']
gentamicin,Access group antibiotics,Parenteral > General injections > unspecified: 10 mg per  mL in 2 mL vial (as sulfate); 40 mg per  mL in 2 mL vial (as sulfate),Peritonitis (severe),J01GB03,ampicillin,Added,gentamicin,['gentamicin']
gentamicin,Access group antibiotics,Parenteral > General injections > unspecified: 10 mg per  mL in 2 mL vial (as sulfate); 40 mg per  mL in 2 mL vial (as sulfate),Peritoneal abscess (mild-moderate),J01GB03,ampicillin,Added,gentamicin,['gentamicin']
gentamicin,Access group antibiotics,Parenteral > General injections > unspecified: 10 mg per  mL in 2 mL vial (as sulfate); 40 mg per  mL in 2 mL vial (as sulfate),Peritoneal abscess (severe),J01GB03,ampicillin,Added,gentamicin,['gentamicin']
gentamicin,Access group antibiotics,Parenteral > General injections > unspecified: 10 mg per  mL in 2 mL vial (as sulfate); 40 mg per  mL in 2 mL vial (as sulfate),Neonatal meningitis,J01GB03,,Added,gentamicin,['gentamicin']
gentamicin,Access group antibiotics,Parenteral > General injections > unspecified: 10 mg per  mL in 2 mL vial (as sulfate); 40 mg per  mL in 2 mL vial (as sulfate),Sepsis without septic shock,J01GB03,amoxicillin,Added,gentamicin,['gentamicin']
gentamicin,Access group antibiotics,Parenteral > General injections > unspecified: 10 mg per  mL in 2 mL vial (as sulfate); 40 mg per  mL in 2 mL vial (as sulfate),Sepsis without septic shock,J01GB03,ampicillin,Added,gentamicin,['gentamicin']
gentamicin,Access group antibiotics,Parenteral > General injections > unspecified: 10 mg per  mL in 2 mL vial (as sulfate); 40 mg per  mL in 2 mL vial (as sulfate),Sepsis without septic shock,J01GB03,benzylpenicillin,Added,gentamicin,['gentamicin']
gentamicin,Access group antibiotics,Parenteral > General injections > unspecified: 10 mg per  mL in 2 mL vial (as sulfate); 40 mg per  mL in 2 mL vial (as sulfate),Bacterial pneumonia (Community-acquired pneumonia - severe) [children],J01GB03,ampicillin,Added,gentamicin,['gentamicin']
gentamicin,Access group antibiotics,Parenteral > General injections > unspecified: 10 mg per  mL in 2 mL vial (as sulfate); 40 mg per  mL in 2 mL vial (as sulfate),Bacterial pneumonia (Community-acquired pneumonia - severe) [children],J01GB03,benzylpenicillin,Added,gentamicin,['gentamicin']
gentamicin,Access group antibiotics,Parenteral > General injections > unspecified: 10 mg per  mL in 2 mL vial (as sulfate); 40 mg per  mL in 2 mL vial (as sulfate),Bacterial pneumonia (Community-acquired pneumonia - severe) [children],J01GB03,amoxicillin,Added,gentamicin,['gentamicin']
gentamicin,Access group antibiotics,Parenteral > General injections > unspecified: 10 mg per  mL in 2 mL vial (as sulfate); 40 mg per  mL in 2 mL vial (as sulfate),Gonococcal infection,J01GB03,,Added,gentamicin,['gentamicin']
gentamicin,Access group antibiotics,Parenteral > General injections > unspecified: 10 mg per  mL in 2 mL vial (as sulfate); 40 mg per  mL in 2 mL vial (as sulfate),Other specified prophylactic measures,J01GB03,,Added,gentamicin,['gentamicin']
gentamicin,Ophthalmological preparations > Anti-infective agents,Local > Ophthalmological > Solution (eye drops): 0.3% (gentamicin sulfate),Other specified conjunctivitis,S02AA14,,Added,gentamicin,['gentamicin']
gentamicin,Ophthalmological preparations > Anti-infective agents,Local > Ophthalmological > Solution (eye drops): 0.3% (gentamicin sulfate),Infectious blepharitis,S02AA14,,Added,gentamicin,['gentamicin']
glass ionomer cement,Dental medicines and preparations,Local > Dental > Powder + liquid: Single-use capsules: 0.4 g powder + 0.09 mL liquid; Multi-use bottle: powder + liquid,Dental caries,,,Added,glass ionomer cement,"['ionomer', 'glass ionomer cement', 'glass', 'cement']"
glatiramer acetate,Medicines for multiple sclerosis,"Parenteral > General injections > SC: 20 mg per  mL; 40 mg per  mL
Parenteral > General injections > SC: 20 mg per  mL in pre-filled syringe; 40 mg per  mL in pre-filled syringe",Multiple sclerosis,L03AX13,,Added,glatiramer acetate,"['glatiramer', 'acetate', 'glatiramer acetate']"
glecaprevir + pibrentasvir,Medicines for hepatitis C > Pangenotypic direct-acting antiviral combinations,"Oral > Solid: 50 mg + 20 mg granules
Oral > Solid > tablet: 100 mg + 40 mg",Chronic hepatitis C,J05AP57,,Added,glecaprevir + pibrentasvir,"['glecaprevir', 'pibrentasvir', '+', 'glecaprevir + pibrentasvir']"
gliclazide,Oral hypoglycaemic agents,Oral > Solid: 30 mg controlled-release; 60 mg controlled-release; 80 mg controlled-release,Type 2 diabetes mellitus,A10BB09,,Added,gliclazide,['gliclazide']
glucagon,Medicines for hypoglycaemia,Parenteral > General injections > unspecified: 1 mg per  mL,Hypoglycaemia in the context of diabetes,H04AA01,,Added,glucagon,['glucagon']
glucose,"Solutions correcting water, electrolyte and acid-base disturbances > Parenteral","Parenteral > General injections > IV: 5% isotonic; 10% hypertonic
Parenteral > General injections > IV: 50% hypertonic","Other specified disorders of fluid, electrolyte or acid-base balance",B05CX01,,Added,glucose,['glucose']
glucose,"Solutions correcting water, electrolyte and acid-base disturbances > Parenteral","Parenteral > General injections > IV: 5% isotonic; 10% hypertonic
Parenteral > General injections > IV: 50% hypertonic",Hypoglycaemia without associated diabetes,B05CX01,,Added,glucose,['glucose']
glucose + sodium chloride,"Solutions correcting water, electrolyte and acid-base disturbances > Parenteral",Parenteral > General injections > IV: 4% + 0.18% (equivalent to Na+ 30 mmol/L and Cl- 30 mmol/L; 5% + 0.9% (equivalent to Na+ 150 mmol/L and Cl- 150 mmol/L); 5% + 0.45% (equivalent to Na+ 75 mmol/L and Cl- 75 mmol/L),"Other specified disorders of fluid, electrolyte or acid-base balance",B05BB02,,Added,glucose + sodium chloride,"['glucose', 'sodium', '+', 'chloride', 'glucose + sodium chloride']"
glutaral,Disinfectants,Local > Topical > Solution: 2%,Glutaral nonmedicinal,V07AV,,Added,glutaral,['glutaral']
glyceryl trinitrate,Antianginal medicines,Oral > Solid: 500 µg sublingual tablet,Angina pectoris,C01DA02,,Added,glyceryl trinitrate,"['trinitrate', 'glyceryl trinitrate', 'glyceryl']"
glycopyrronium,Antiasthmatic and medicines for chronic obstructive pulmonary disease,,Chronic obstructive pulmonary disease,,,Added,glycopyrronium,['glycopyrronium']
golimumab,Immunomodulators for non-malignant disease,,Axial spondyloarthritis,,,Added,golimumab,['golimumab']
golimumab,Immunomodulators for non-malignant disease,,Crohn disease site,,,Added,golimumab,['golimumab']
golimumab,Immunomodulators for non-malignant disease,,Rheumatoid arthritis,,,Added,golimumab,['golimumab']
golimumab,Medicines for juvenile joint diseases,,Juvenile idiopathic arthritis,,,Added,golimumab,['golimumab']
goserelin,Hormones and antihormones,,Malignant neoplasms of breast,,,Added,goserelin,['goserelin']
goserelin,Hormones and antihormones,,Malignant neoplasms of prostate,,,Added,goserelin,['goserelin']
granisetron,Medicines for other common symptoms in palliative care,,Palliative care,,,Added,granisetron,['granisetron']
granisetron,Antiemetic medicines,,Nausea or vomiting,,,Added,granisetron,['granisetron']
griseofulvin,Antifungal medicines,"Oral > Liquid: 125 mg per 5 mL
Oral > Solid: 125 mg; 250 mg",Dermatophytosis,D01BA01,,Added,griseofulvin,['griseofulvin']
haemophilus influenzae type b vaccine,Recommendations for all immunization programmes,All vaccines should comply with the WHO requirements for biological substances.,Need for immunization against single bacterial diseases,J07AG01,,Added,haemophilus influenzae type b vaccine,"['b', 'haemophilus', 'type', 'haemophilus influenzae type b vaccine', 'influenzae', 'vaccine']"
haloperidol,Medicines for other common symptoms in palliative care,"Oral > Liquid: 2 mg per  mL
Oral > Solid: 0.5 mg; 2 mg; 5 mg
Parenteral > General injections > unspecified: 5 mg per  mL in 1-mL ampoule",Palliative care,N05AD01,,Added,haloperidol,['haloperidol']
haloperidol,Medicines for psychotic disorders,"Parenteral > General injections > IM: 5 mg per  mL in ampoule
Oral > Solid: 2 mg; 5 mg",Schizophrenia or other primary psychotic disorders,N05AD01,,Added,haloperidol,['haloperidol']
haloperidol decanoate,Medicines for psychotic disorders,,Schizophrenia or other primary psychotic disorders,,,Added,haloperidol decanoate,"['decanoate', 'haloperidol decanoate', 'haloperidol']"
halothane,General anaesthetics and oxygen > Inhalational medicines,Respiratory > Inhalation > liquid: ,Anaesthetics and therapeutic gases,N01AB01,,Added,halothane,['halothane']
heparin sodium,Medicines affecting coagulation,Parenteral > General injections > IV: 1000 IU per  mL in 1 mL ampoule; 20000 IU per  mL in 1 mL ampoule; 5000 IU per  mL in 1 mL ampoule,Acute ischaemic heart disease,B01AB01,,Added,heparin sodium,"['heparin sodium', 'heparin', 'sodium']"
heparin sodium,Medicines affecting coagulation,Parenteral > General injections > IV: 1000 IU per  mL in 1 mL ampoule; 20000 IU per  mL in 1 mL ampoule; 5000 IU per  mL in 1 mL ampoule,Unstable angina,B01AB01,,Added,heparin sodium,"['heparin sodium', 'heparin', 'sodium']"
heparin sodium,Medicines affecting coagulation,Parenteral > General injections > IV: 1000 IU per  mL in 1 mL ampoule; 20000 IU per  mL in 1 mL ampoule; 5000 IU per  mL in 1 mL ampoule,Venous thromboembolism,B01AB01,,Added,heparin sodium,"['heparin sodium', 'heparin', 'sodium']"
hepatitis A vaccine,Recommendations for some high-risk populations,All vaccines should comply with the WHO requirements for biological substances.,Need for immunization against viral hepatitis,J07BC02,,Added,hepatitis a vaccine,"['hepatitis a vaccine', 'vaccine', 'a', 'hepatitis']"
hepatitis B vaccine,Recommendations for all immunization programmes,All vaccines should comply with the WHO requirements for biological substances.,Need for immunization against viral hepatitis,J07BC01,,Added,hepatitis b vaccine,"['b', 'hepatitis b vaccine', 'vaccine', 'hepatitis']"
homatropine,Ophthalmological preparations > Mydriatics,"Local > Ophthalmological > Solution (eye drops): 2% (hydrobromide)
",Anterior uveitis,,,Added,homatropine,['homatropine']
human papilloma virus (HPV) vaccine,Recommendations for all immunization programmes,All vaccines should comply with the WHO requirements for biological substances.,Need for immunization against certain single viral diseases,J07BM01,,Added,human papilloma virus (hpv) vaccine,"['(hpv)', 'papilloma', 'human papilloma virus (hpv) vaccine', 'human', 'vaccine', 'virus']"
hydralazine,Antihypertensive medicines,"Parenteral > General injections > IV: 20 mg in ampoule powder for injection (hydrochloride)
Oral > Solid: 50 mg tablet; 25 mg tablet (hydrochloride)
Oral > Solid: 50 mg (hydrochloride); 25 mg (hydrochloride)",Gestational hypertension,C02DB02,,Added,hydralazine,['hydralazine']
hydrochlorothiazide,Antihypertensive medicines,"Oral > Liquid: 50 mg per 5 mL
Oral > Solid: 25 mg; 12.5 mg",Essential hypertension,C03AA03,,Added,hydrochlorothiazide,['hydrochlorothiazide']
hydrochlorothiazide,Medicines used in heart failure,"Oral > Liquid: 50 mg per 5 mL
Oral > Solid: 25 mg",Heart failure,C03AA03,,Added,hydrochlorothiazide,['hydrochlorothiazide']
hydrochlorothiazide,Diuretics,Oral > Solid: 25 mg,Oedema,C03AA03,,Added,hydrochlorothiazide,['hydrochlorothiazide']
hydrocortisone,Hormones and antihormones,Parenteral > General injections > unspecified: 100 mg in vial (as sodium succinate),"Lymphoid leukaemia, not elsewhere classified",H02AB09,,Added,hydrocortisone,['hydrocortisone']
hydrocortisone,Hormones and antihormones,Parenteral > General injections > unspecified: 100 mg in vial (as sodium succinate),Burkitt lymphoma including Burkitt leukaemia,H02AB09,,Added,hydrocortisone,['hydrocortisone']
hydrocortisone,Adrenal hormones and synthetic substitutes,Oral > Solid: 5 mg; 10 mg; 20 mg,Adrenocortical insufficiency,H02AB09,,Added,hydrocortisone,['hydrocortisone']
hydrocortisone,Antiallergics and medicines used in anaphylaxis,Parenteral > General injections > unspecified: 100 mg in vial powder for injection (as sodium succinate),Anaphylaxis,H02AB09,,Added,hydrocortisone,['hydrocortisone']
hydrocortisone,Anti-inflammatory medicines,"Local > Rectal > Suppository: 25 mg (acetate)
Local > Rectal > Retention enema: 100 mg per 60 mL",Crohn disease site,A07EA02,,Added,hydrocortisone,['hydrocortisone']
hydrocortisone,Anti-inflammatory medicines,"Local > Rectal > Suppository: 25 mg (acetate)
Local > Rectal > Retention enema: 100 mg per 60 mL",Ulcerative colitis,A07EA02,,Added,hydrocortisone,['hydrocortisone']
hydrocortisone,Dermatological medicines > Anti-inflammatory and antipruritic medicines,"Local > Topical > Cream: 1% (acetate)
Local > Topical > Ointment: 1% (acetate)",Dermatitis or eczema,D07AA02,,Added,hydrocortisone,['hydrocortisone']
hydrocortisone,Dermatological medicines > Anti-inflammatory and antipruritic medicines,"Local > Topical > Cream: 1% (acetate)
Local > Topical > Ointment: 1% (acetate)",Lichen planus,D07AA02,,Added,hydrocortisone,['hydrocortisone']
hydrocortisone,Dermatological medicines > Anti-inflammatory and antipruritic medicines,"Local > Topical > Cream: 1% (acetate)
Local > Topical > Ointment: 1% (acetate)",Pruritus due to skin disorder,D07AA02,,Added,hydrocortisone,['hydrocortisone']
hydrocortisone,Dermatological medicines > Anti-inflammatory and antipruritic medicines,"Local > Topical > Cream: 1% (acetate)
Local > Topical > Ointment: 1% (acetate)",Psoriasis of unspecified type,D07AA02,,Added,hydrocortisone,['hydrocortisone']
hydromorphone,Opioid analgesics,,Pain,,,Added,hydromorphone,['hydromorphone']
hydroxocobalamin,Antianaemia medicines,Parenteral > General injections > IM: 1 mg per  mL in 1 mL ampoule (as acetate); 1 mg per  mL in 1 mL ampoule (as hydrochloride); 1 mg per  mL in 1 mL ampoule (as sulfate),Megaloblastic anaemia due to vitamin B12 deficiency,B03BA03,,Added,hydroxocobalamin,['hydroxocobalamin']
hydroxycarbamide (hydroxyurea),Cytotoxic medicines,"Oral > Solid: 200 mg; 250 mg; 300 mg; 400 mg; 500 mg; 1 g
Oral > Solid > dosage form: 200 mg; 300 mg; 400 mg; 500 mg; 1 g; 100 mg","Chronic myeloid leukaemia, not elsewhere classified",L01XX05,,Added,hydroxycarbamide (hydroxyurea),"['hydroxycarbamide (hydroxyurea)', '(hydroxyurea)', 'hydroxycarbamide']"
hydroxycarbamide (hydroxyurea),Other medicines for haemoglobinopathies,Oral > Solid > dosage form: 200 mg; 500 mg; 1 g; 100 mg,Other specified sickle cell disorders or other haemoglobinopathies,L01XX05,,Added,hydroxycarbamide (hydroxyurea),"['hydroxycarbamide (hydroxyurea)', '(hydroxyurea)', 'hydroxycarbamide']"
hydroxychloroquine,Disease-modifying anti-rheumatic drugs (DMARDs),Oral > Solid: 200 mg (as sulfate),Systemic lupus erythematosus,P01BA02,,Added,hydroxychloroquine,['hydroxychloroquine']
hydroxychloroquine,Disease-modifying anti-rheumatic drugs (DMARDs),Oral > Solid: 200 mg (as sulfate),Cutaneous lupus erythematosus of unspecified type,P01BA02,,Added,hydroxychloroquine,['hydroxychloroquine']
hyoscine butylbromide,Medicines for other common symptoms in palliative care,Parenteral > General injections > unspecified: 20 mg per  mL injection,Palliative care,A03BB01,,Added,hyoscine butylbromide,"['hyoscine', 'hyoscine butylbromide', 'butylbromide']"
hyoscine hydrobromide,Medicines for other common symptoms in palliative care,"Local > Topical > Transdermal patch: 1 mg per 72 hours transdermal patch
Parenteral > General injections > unspecified: 400 µg per  mL injection; 600 µg per  mL injection",Palliative care,A04AD01,,Added,hyoscine hydrobromide,"['hyoscine', 'hyoscine hydrobromide', 'hydrobromide']"
ibrutinib,Targeted therapies,Oral > Solid: 140 mg,Chronic lymphocytic leukaemia or small lymphocytic lymphoma,L01EL01,,Added,ibrutinib,['ibrutinib']
ibuprofen,Medicines administered to the neonate [c],Parenteral > General injections > IV: 5 mg per  mL,Patent arterial duct,C01EB16,,Added,ibuprofen,['ibuprofen']
ibuprofen,Non-opioids and non-steroidal anti-inflammatory medicines (NSAIMs),"Oral > Liquid: 200 mg per 5 mL; 100 mg per 5 mL
Oral > Solid > tablet: 200 mg; 400 mg; 600 mg",Pain,M01AE01,,Added,ibuprofen,['ibuprofen']
ibuprofen,Antimigraine medicines > For treatment of acute attack,"Oral > Liquid: 100 mg per 5 mL; 200 mg per 5 mL
Oral > Solid > tablet: 200 mg; 400 mg",Migraine,M01AE01,,Added,ibuprofen,['ibuprofen']
ifosfamide,Cytotoxic medicines,"Parenteral > General injections > IV: 500 mg in vial powder for injection; 1 g in vial powder for injection; 2 g in vial powder for injection
Parenteral > General injections > IV: 1 g in vial powder for injection; 2 g in vial powder for injection",Other specified malignant neoplasms of the ovary,L01AA06,,Added,ifosfamide,['ifosfamide']
ifosfamide,Cytotoxic medicines,"Parenteral > General injections > IV: 500 mg in vial powder for injection; 1 g in vial powder for injection; 2 g in vial powder for injection
Parenteral > General injections > IV: 1 g in vial powder for injection; 2 g in vial powder for injection",Germ cell tumour of testis,L01AA06,,Added,ifosfamide,['ifosfamide']
ifosfamide,Cytotoxic medicines,"Parenteral > General injections > IV: 500 mg in vial powder for injection; 1 g in vial powder for injection; 2 g in vial powder for injection
Parenteral > General injections > IV: 1 g in vial powder for injection; 2 g in vial powder for injection",Ewing sarcoma of bone and articular cartilage of unspecified sites,L01AA06,,Added,ifosfamide,['ifosfamide']
ifosfamide,Cytotoxic medicines,"Parenteral > General injections > IV: 500 mg in vial powder for injection; 1 g in vial powder for injection; 2 g in vial powder for injection
Parenteral > General injections > IV: 1 g in vial powder for injection; 2 g in vial powder for injection",Osteosarcoma of bone and articular cartilage of unspecified sites,L01AA06,,Added,ifosfamide,['ifosfamide']
ifosfamide,Cytotoxic medicines,"Parenteral > General injections > IV: 500 mg in vial powder for injection; 1 g in vial powder for injection; 2 g in vial powder for injection
Parenteral > General injections > IV: 1 g in vial powder for injection; 2 g in vial powder for injection",Rhabdomyosarcoma primary site,L01AA06,,Added,ifosfamide,['ifosfamide']
ifosfamide,Cytotoxic medicines,"Parenteral > General injections > IV: 500 mg in vial powder for injection; 1 g in vial powder for injection; 2 g in vial powder for injection
Parenteral > General injections > IV: 1 g in vial powder for injection; 2 g in vial powder for injection",Burkitt lymphoma including Burkitt leukaemia,L01AA06,,Added,ifosfamide,['ifosfamide']
ifosfamide,Cytotoxic medicines,"Parenteral > General injections > IV: 500 mg in vial powder for injection; 1 g in vial powder for injection; 2 g in vial powder for injection
Parenteral > General injections > IV: 1 g in vial powder for injection; 2 g in vial powder for injection","Malignant neoplasms of kidney, except renal pelvis",L01AA06,,Added,ifosfamide,['ifosfamide']
ifosfamide,Cytotoxic medicines,"Parenteral > General injections > IV: 500 mg in vial powder for injection; 1 g in vial powder for injection; 2 g in vial powder for injection
Parenteral > General injections > IV: 1 g in vial powder for injection; 2 g in vial powder for injection","Anaplastic large cell lymphoma, ALK-negative",L01AA06,,Added,ifosfamide,['ifosfamide']
ifosfamide,Cytotoxic medicines,"Parenteral > General injections > IV: 500 mg in vial powder for injection; 1 g in vial powder for injection; 2 g in vial powder for injection
Parenteral > General injections > IV: 1 g in vial powder for injection; 2 g in vial powder for injection","Anaplastic large cell lymphoma, ALK-positive",L01AA06,,Added,ifosfamide,['ifosfamide']
imatinib,Targeted therapies,Oral > Solid: 100 mg; 400 mg,B lymphoblastic leukaemia or lymphoma with t(9:22) (q34;q11.2); BCR-ABL1,L01EA01,,Added,imatinib,['imatinib']
imatinib,Targeted therapies,Oral > Solid: 100 mg; 400 mg,Gastrointestinal stromal tumour of unspecified gastrointestinal sites,L01EA01,,Added,imatinib,['imatinib']
imatinib,Targeted therapies,Oral > Solid: 100 mg; 400 mg,"Chronic myeloid leukaemia, not elsewhere classified",L01EA01,,Added,imatinib,['imatinib']
imipenem + cilastatin,Watch group antibiotics,"Parenteral > General injections > IV: 250 mg (as monohydrate) + 250 mg (as sodium salt) powder for injection; 500 mg (as monohydrate) + 500 mg (as sodium salt) powder for injection
",Peritonitis (severe),J01DH02,,Added,imipenem + cilastatin,"['+', 'imipenem', 'cilastatin', 'imipenem + cilastatin']"
imipenem + cilastatin,Watch group antibiotics,"Parenteral > General injections > IV: 250 mg (as monohydrate) + 250 mg (as sodium salt) powder for injection; 500 mg (as monohydrate) + 500 mg (as sodium salt) powder for injection
",Peritoneal abscess (severe),J01DH02,,Added,imipenem + cilastatin,"['+', 'imipenem', 'cilastatin', 'imipenem + cilastatin']"
imipenem + cilastatin,Watch group antibiotics,"Parenteral > General injections > IV: 250 mg (as monohydrate) + 250 mg (as sodium salt) powder for injection; 500 mg (as monohydrate) + 500 mg (as sodium salt) powder for injection
",Neutropenia (high-risk),J01DH02,,Added,imipenem + cilastatin,"['+', 'imipenem', 'cilastatin', 'imipenem + cilastatin']"
imipenem + cilastatin,Antituberculosis medicines,,Multi-drug resistant Mycobacterium tuberculosis,,,Added,imipenem + cilastatin,"['+', 'imipenem', 'cilastatin', 'imipenem + cilastatin']"
indapamide,Antihypertensive medicines,,Essential hypertension,,,Added,indapamide,['indapamide']
indapamide,Medicines used in heart failure,,Heart failure,,,Added,indapamide,['indapamide']
indometacin,Medicines administered to the neonate [c],,Patent arterial duct,,,Added,indometacin,['indometacin']
infliximab,Immunomodulators for non-malignant disease,,Axial spondyloarthritis,,,Added,infliximab,['infliximab']
infliximab,Immunomodulators for non-malignant disease,,Crohn disease site,,,Added,infliximab,['infliximab']
infliximab,Immunomodulators for non-malignant disease,,Rheumatoid arthritis,,,Added,infliximab,['infliximab']
infliximab,Medicines for juvenile joint diseases,,Juvenile idiopathic arthritis,,,Added,infliximab,['infliximab']
influenza vaccine (seasonal),Recommendations for immunization programmes with certain characteristics,All vaccines should comply with the WHO requirements for biological substances.,Need for immunization against influenza,"J07BB01, J07BB02, J07BB03",,Added,influenza vaccine (seasonal),"['influenza vaccine (seasonal)', 'vaccine', '(seasonal)', 'influenza']"
insulin,Insulins,Parenteral > General injections > SC: 40 IU per  mL in 10 mL vial (soluble); 100 IU per  mL in 10 mL vial (soluble); 100 IU per  mL in 3 mL cartridge (soluble); 100 IU per  mL in 3 mL pre-filled pen (soluble),Type 2 diabetes mellitus,A10AC01,,Added,insulin,['insulin']
insulin,Insulins,Parenteral > General injections > SC: 40 IU per  mL in 10 mL vial (soluble); 100 IU per  mL in 10 mL vial (soluble); 100 IU per  mL in 3 mL cartridge (soluble); 100 IU per  mL in 3 mL pre-filled pen (soluble),Type 1 diabetes mellitus,A10AC01,,Added,insulin,['insulin']
insulin degludec,Insulins,"Parenteral > General injections > SC: 100 units per  mL
",Type 1 diabetes mellitus,,,Added,insulin degludec,"['degludec', 'insulin degludec', 'insulin']"
insulin degludec,Insulins,"Parenteral > General injections > SC: 100 units per  mL
",Type 2 diabetes mellitus,,,Added,insulin degludec,"['degludec', 'insulin degludec', 'insulin']"
insulin detemir,Insulins,,Type 1 diabetes mellitus,,,Added,insulin detemir,"['insulin detemir', 'detemir', 'insulin']"
insulin detemir,Insulins,,Type 2 diabetes mellitus,,,Added,insulin detemir,"['insulin detemir', 'detemir', 'insulin']"
insulin glargine,Insulins,"Parenteral > General injections > SC: 100 units per  mL
",Type 1 diabetes mellitus,,,Added,insulin glargine,"['insulin glargine', 'insulin', 'glargine']"
insulin glargine,Insulins,"Parenteral > General injections > SC: 100 units per  mL
",Type 2 diabetes mellitus,,,Added,insulin glargine,"['insulin glargine', 'insulin', 'glargine']"
intermediate-acting insulin,Insulins,Parenteral > General injections > SC: 40 IU per  mL in 10 mL vial as compound insulin zinc suspension or isophane insulin; 100 IU per  mL in 10 mL vial as compound insulin zinc suspension or isophane insulin; 100 IU per  mL in 3 mL cartridge as compound insulin zinc suspension or isophane insulin; 100 IU per  mL in 3 mL pre-filled pen as compound insulin zinc suspension or isophane insulin,Type 1 diabetes mellitus,A10AC01,,Added,intermediate-acting insulin,"['intermediate-acting insulin', 'intermediate-acting', 'insulin']"
intermediate-acting insulin,Insulins,Parenteral > General injections > SC: 40 IU per  mL in 10 mL vial as compound insulin zinc suspension or isophane insulin; 100 IU per  mL in 10 mL vial as compound insulin zinc suspension or isophane insulin; 100 IU per  mL in 3 mL cartridge as compound insulin zinc suspension or isophane insulin; 100 IU per  mL in 3 mL pre-filled pen as compound insulin zinc suspension or isophane insulin,Type 2 diabetes mellitus,A10AC01,,Added,intermediate-acting insulin,"['intermediate-acting insulin', 'intermediate-acting', 'insulin']"
intraperitoneal dialysis solution,Peritoneal dialysis solution,parenteral solution,Care involving peritoneal dialysis,,,Added,intraperitoneal dialysis solution,"['dialysis', 'intraperitoneal', 'solution', 'intraperitoneal dialysis solution']"
iodine,Vitamins and minerals,"Parenteral > General injections > IM: 0.5 mL (240 mg iodine) iodized oil in ampoule; 1 mL (480 mg iodine) iodized oil in ampoule
Oral > Liquid: 1 mL (480 mg iodine) iodized oil in ampoule; 0.5 mL (240 mg iodine) iodized oil in ampoule; 0.57 mL (308 mg iodine) iodized oil in dispenser bottle
Oral > Solid: 190 mg",Iodine deficiency,H03CA,,Added,iodine,['iodine']
iodine,Antiseptics,,Povidone iodine,,,Added,iodine,['iodine']
iohexol,Diagnostic agents > Radiocontrast media,Parenteral > General injections > unspecified: 140 to 350 mg iodine per  mL in 5 mL ampoule; 140 to 350 mg iodine per  mL in 10 mL ampoule; 140 to 350 mg iodine per  mL in 20 mL ampoule,"X-ray contrast media, iodinated",V08AB02,,Added,iohexol,['iohexol']
ipratropium bromide,Antiasthmatic and medicines for chronic obstructive pulmonary disease,Respiratory > Inhalation > aerosol: 20 µg per  dose,Asthma,R03BB01,,Added,ipratropium bromide,"['ipratropium', 'bromide', 'ipratropium bromide']"
ipratropium bromide,Antiasthmatic and medicines for chronic obstructive pulmonary disease,Respiratory > Inhalation > aerosol: 20 µg per  dose,Chronic obstructive pulmonary disease,R03BB01,,Added,ipratropium bromide,"['ipratropium', 'bromide', 'ipratropium bromide']"
irinotecan,Cytotoxic medicines,Parenteral > General injections > IV: 40 mg per 2 mL in 2 mL vial; 100 mg per 5 mL in 5 mL vial; 500 mg per 25 mL in 25 mL vial,Malignant neoplasm metastasis in large intestine,L01CE02,,Added,irinotecan,['irinotecan']
irinotecan,Cytotoxic medicines,Parenteral > General injections > IV: 40 mg per 2 mL in 2 mL vial; 100 mg per 5 mL in 5 mL vial; 500 mg per 25 mL in 25 mL vial,"Malignant neoplasms of kidney, except renal pelvis",L01CE02,,Added,irinotecan,['irinotecan']
irinotecan,Cytotoxic medicines,Parenteral > General injections > IV: 40 mg per 2 mL in 2 mL vial; 100 mg per 5 mL in 5 mL vial; 500 mg per 25 mL in 25 mL vial,Rhabdomyosarcoma primary site,L01CE02,,Added,irinotecan,['irinotecan']
isoflurane,General anaesthetics and oxygen > Inhalational medicines,Respiratory > Inhalation > liquid: ,Anaesthetics and therapeutic gases,N01AB06,,Added,isoflurane,['isoflurane']
isoniazid,Antituberculosis medicines,"Parenteral > General injections > IV: 100 mg per  mL
Oral > Solid > dispersible tablet: 100 mg
Oral > Solid > tablet: 100 mg; 300 mg",Tuberculosis,J04AC01,,Added,isoniazid,['isoniazid']
isoniazid + pyrazinamide + rifampicin,Antituberculosis medicines,Oral > Solid > dispersible tablet: 50 mg + 150 mg + 75 mg,Tuberculosis,J04AM05,,Added,isoniazid + pyrazinamide + rifampicin,"['isoniazid + pyrazinamide + rifampicin', 'rifampicin', 'isoniazid', '+', 'pyrazinamide']"
isoniazid + pyridoxine + sulfamethoxazole + trimethoprim,Medicines for prevention of HIV-related opportunistic infections,Oral > Solid: 300 mg + 25 mg + 800 mg + 160 mg tablet (scored),Other specified prophylactic measures,J04AC51,,Added,isoniazid + pyridoxine + sulfamethoxazole + trimethoprim,"['sulfamethoxazole', 'trimethoprim', 'isoniazid', 'isoniazid + pyridoxine + sulfamethoxazole + trimethoprim', '+', 'pyridoxine']"
isoniazid + rifampicin,Antituberculosis medicines,"Oral > Solid > dispersible tablet: 50 mg + 75 mg
Oral > Solid > tablet: 75 mg + 150 mg; 150 mg + 300 mg",Tuberculosis,J04AM02,,Added,isoniazid + rifampicin,"['rifampicin', '+', 'isoniazid + rifampicin', 'isoniazid']"
isoniazid + rifapentine,Antituberculosis medicines,Oral > Solid: 300 mg + 300 mg tablet (scored),Latent tuberculosis,J04AC51,,Added,isoniazid + rifapentine,"['isoniazid + rifapentine', '+', 'rifapentine', 'isoniazid']"
isosorbide dinitrate,Antianginal medicines,Oral > Solid: 5 mg sublingual tablet,Angina pectoris,C01DA08,,Added,isosorbide dinitrate,"['isosorbide', 'dinitrate', 'isosorbide dinitrate']"
itraconazole,Antifungal medicines,"Oral > Liquid: 10 mg per  mL
Oral > Solid: 100 mg",Chronic pulmonary aspergillosis,J02AC02,,Added,itraconazole,['itraconazole']
itraconazole,Antifungal medicines,"Oral > Liquid: 10 mg per  mL
Oral > Solid: 100 mg",Chromoblastomycosis,J02AC02,,Added,itraconazole,['itraconazole']
itraconazole,Antifungal medicines,"Oral > Liquid: 10 mg per  mL
Oral > Solid: 100 mg",Histoplasmosis,J02AC02,,Added,itraconazole,['itraconazole']
itraconazole,Antifungal medicines,"Oral > Liquid: 10 mg per  mL
Oral > Solid: 100 mg",Talaromycosis,J02AC02,,Added,itraconazole,['itraconazole']
itraconazole,Antifungal medicines,"Oral > Liquid: 10 mg per  mL
Oral > Solid: 100 mg",Sporotrichosis,J02AC02,,Added,itraconazole,['itraconazole']
itraconazole,Antifungal medicines,"Oral > Liquid: 10 mg per  mL
Oral > Solid: 100 mg",Paracoccidioidomycosis,J02AC02,,Added,itraconazole,['itraconazole']
ivermectin,Intestinal anthelminthics,Oral > Solid > tablet: 3 mg,Strongyloidiasis,P02CF01,,Added,ivermectin,['ivermectin']
ivermectin,Intestinal anthelminthics,Oral > Solid > tablet: 3 mg,Ascariasis,P02CF01,,Added,ivermectin,['ivermectin']
ivermectin,Intestinal anthelminthics,Oral > Solid > tablet: 3 mg,Trichuriasis,P02CF01,,Added,ivermectin,['ivermectin']
ivermectin,Intestinal anthelminthics,Oral > Solid > tablet: 3 mg,Hookworm diseases,P02CF01,,Added,ivermectin,['ivermectin']
ivermectin,Intestinal anthelminthics,Oral > Solid > tablet: 3 mg,Ancylostomiasis,P02CF01,,Added,ivermectin,['ivermectin']
ivermectin,Antifilarials,Oral > Solid > tablet: 3 mg,Onchocerciasis,P02CF01,,Added,ivermectin,['ivermectin']
ivermectin,Antifilarials,Oral > Solid > tablet: 3 mg,Lymphatic filariasis,P02CF01,,Added,ivermectin,['ivermectin']
ivermectin,Medicines for ectoparasitic infections,Oral > Solid > tablet: 3 mg,Scabies,P02CF01,,Added,ivermectin,['ivermectin']
kanamycin,Ophthalmological preparations > Anti-infective agents,,Other specified conjunctivitis,,,Added,kanamycin,['kanamycin']
kanamycin,Ophthalmological preparations > Anti-infective agents,,Infectious blepharitis,,,Added,kanamycin,['kanamycin']
ketamine,General anaesthetics and oxygen > Injectable medicines,Parenteral > General injections > unspecified: 50 mg per  mL in 10 mL vial (as hydrochloride),Anaesthetics and therapeutic gases,N01AX03,,Added,ketamine,['ketamine']
lactulose,Medicines for other common symptoms in palliative care,Oral > Liquid: 3.1 to 3.7 g per 5 mL oral liquid,Palliative care,A06AD11,,Added,lactulose,['lactulose']
lamivudine,Antiretrovirals > Nucleoside/Nucleotide reverse transcriptase inhibitors,"Oral > Liquid: 50 mg per 5 mL
Oral > Solid: 150 mg tablet","Human immunodeficiency virus disease without mention of associated disease or condition, clinical stage unspecified",J05AF05,,Added,lamivudine,['lamivudine']
lamivudine + tenofovir,Fixed-dose combinations of antiretrovirals,,"Human immunodeficiency virus disease without mention of associated disease or condition, clinical stage unspecified",,,Added,lamivudine + tenofovir,"['lamivudine + tenofovir', 'tenofovir', '+', 'lamivudine']"
lamivudine + tenofovir,Fixed-dose combinations of antiretrovirals,,Contact with or exposure to human immunodeficiency virus,,,Added,lamivudine + tenofovir,"['lamivudine + tenofovir', 'tenofovir', '+', 'lamivudine']"
lamivudine + zidovudine,Fixed-dose combinations of antiretrovirals,Oral > Solid: 30 mg + 60 mg Tablet; 150 mg + 300 mg Tablet,"Human immunodeficiency virus disease without mention of associated disease or condition, clinical stage unspecified",J05AR01,,Added,lamivudine + zidovudine,"['zidovudine', 'lamivudine + zidovudine', '+', 'lamivudine']"
lamotrigine,Antiseizure medicines,"Oral > Solid: 25 mg tablet; 50 mg tablet; 100 mg tablet; 200 mg tablet; 2 mg tablet (chewable, dispersible); 5 mg tablet (chewable, dispersible); 25 mg tablet (chewable, dispersible); 50 mg tablet (chewable, dispersible); 100 mg tablet (chewable, dispersible); 200 mg tablet (chewable, dispersible)",Epilepsy or seizures,N03AX09,,Added,lamotrigine,['lamotrigine']
latanoprost,Ophthalmological preparations > Miotics and antiglaucoma medicines,Local > Ophthalmological > Solution (eye drops): 50 µg per  mL eye drops,Primary open-angle glaucoma,S01EE01,,Added,latanoprost,['latanoprost']
ledipasvir + sofosbuvir,Medicines for hepatitis C > Non-pangenotypic direct-acting antiviral combinations,Oral > Solid: 90 mg + 400 mg tablet,Chronic hepatitis C,J05AP51,,Added,ledipasvir + sofosbuvir,"['sofosbuvir', 'ledipasvir + sofosbuvir', '+', 'ledipasvir']"
lenalidomide,Immunomodulators,Oral > Solid: 25 mg,Plasma cell myeloma,L04AX04,,Added,lenalidomide,['lenalidomide']
letrozole,Ovulation inducers,Oral > Solid > dosage form: 2.5 mg,Female infertility without specification whether primary or secondary,L02BG04,,Added,letrozole,['letrozole']
leuprorelin,Hormones and antihormones,Parenteral > General injections > IM: 7.5 mg in prefilled syringe; 22.5 mg in prefilled syringe,Malignant neoplasms of breast,L02AE02,,Added,leuprorelin,['leuprorelin']
leuprorelin,Hormones and antihormones,Parenteral > General injections > IM: 7.5 mg in prefilled syringe; 22.5 mg in prefilled syringe,Malignant neoplasms of prostate,L02AE02,,Added,leuprorelin,['leuprorelin']
levamisole,Intestinal anthelminthics,Oral > Solid > tablet: 50 mg  (as hydrochloride); 150 mg  (as hydrochloride),Ascariasis,P02CE01,,Added,levamisole,['levamisole']
levetiracetam,Antiseizure medicines,"Oral > Liquid: 100 mg per  mL
Oral > Solid > tablet: 250 mg; 500 mg; 750 mg; 1000 mg
Parenteral > General injections > IV: 500 mg per 5 mL in 5 mL vial; 5 mg per  mL in 100 mL bag; 10 mg per  mL in 100 mL bag; 15 mg per  mL in 100 mL bag",Epilepsy or seizures,N03AX14,,Added,levetiracetam,['levetiracetam']
levetiracetam,Antiseizure medicines,"Oral > Liquid: 100 mg per  mL
Oral > Solid > tablet: 250 mg; 500 mg; 750 mg; 1000 mg
Parenteral > General injections > IV: 500 mg per 5 mL in 5 mL vial; 5 mg per  mL in 100 mL bag; 10 mg per  mL in 100 mL bag; 15 mg per  mL in 100 mL bag",Status epilepticus,N03AX14,,Added,levetiracetam,['levetiracetam']
levodopa + benserazide,Medicines for parkinsonism,,Parkinson disease,,,Added,levodopa + benserazide,"['benserazide', 'levodopa', 'levodopa + benserazide', '+']"
levodopa + carbidopa,Medicines for parkinsonism,Oral > Solid: 100 mg + 10 mg tablet; 250 mg + 25 mg tablet; 100 mg + 25 mg tablet,Parkinson disease,N04BA02,,Added,levodopa + carbidopa,"['levodopa', 'carbidopa', 'levodopa + carbidopa', '+']"
levofloxacin,Antituberculosis medicines,"Oral > Solid > dispersible tablet: 100 mg
Oral > Solid > tablet: 250 mg; 500 mg; 750 mg",Multi-drug resistant Mycobacterium tuberculosis,J01MA12,,Added,levofloxacin,['levofloxacin']
levonorgestrel,Oral hormonal contraceptives,"Oral > Solid: 750 µg [2]; 1.5 mg [1]
Oral > Solid: 30 µg",Contact with health services for postcoital contraception,G03AD01,,Added,levonorgestrel,['levonorgestrel']
levonorgestrel,Oral hormonal contraceptives,"Oral > Solid: 750 µg [2]; 1.5 mg [1]
Oral > Solid: 30 µg",Contact with health services for contraceptive management,G03AC03,,Added,levonorgestrel,['levonorgestrel']
levonorgestrel,Intrauterine devices,Intrauterine system with reservoir containing 52 mg of levonorgestrel.,Contact with health services for insertion of contraceptive device,G02BA03,,Added,levonorgestrel,['levonorgestrel']
levonorgestrel-releasing implant,Implantable contraceptives,Implant > Subdermal: 75 mg per  rod (two-rods),Contact with health services for insertion of contraceptive device,G03AC03,,Added,levonorgestrel-releasing implant,"['levonorgestrel-releasing implant', 'levonorgestrel-releasing', 'implant']"
levothyroxine,Thyroid hormones and antithyroid medicines,Oral > Solid: 50 µg (sodium salt); 100 µg (sodium salt); 25 µg (sodium salt),Hypothyroidism,H03AA01,,Added,levothyroxine,['levothyroxine']
lidocaine,Antiarrhythmic medicines,Parenteral > General injections > IV: 20 mg per  mL in 5 mL ampoule (hydrochloride),Ventricular tachyarrhythmia,C01BB01,,Added,lidocaine,['lidocaine']
lidocaine,Local anaesthetics,"Parenteral > Locoregional injections > Spinal anaesthesia: 5% in 2 mL ampoule (hydrochloride) + 7.5% glucose solution
Parenteral > Locoregional injections > Other: 1% in vial (hydrochloride); 2% in vial (hydrochloride)
Local > Topical > unspecified: 2 to 4% (hydrochloride)",Local anaesthetics,N01BB02,,Added,lidocaine,['lidocaine']
lidocaine + epinephrine,Local anaesthetics,"Parenteral > Locoregional injections > Other: 1% (lidocaine hydrochloride OR lidocaine sulfate) + 1:200 000 epinephrine in vial; 2% (lidocaine hydrochloride OR lidocaine sulfate) + 1:200 000 epinephrine in vial
Local > Dental > Cartridge: 2% (lidocaine hydrochloride) + 1:80 000 epinephrine",Local anaesthetics,N01BB52,,Added,lidocaine + epinephrine,"['lidocaine + epinephrine', 'lidocaine', 'epinephrine', '+']"
linezolid,Reserve group antibiotics,"Parenteral > General injections > IV: 2 mg per  mL in 300 mL bag
Oral > Liquid: 100 mg per 5 mL powder for oral liquid
Oral > Solid: 400 mg tablet; 600 mg tablet
Oral > Solid > dispersible tablet: 150 mg
Oral > Solid > tablet: 600 mg",Methicillin resistant Staphylococcus aureus,J01XX08,,Added,linezolid,['linezolid']
linezolid,Reserve group antibiotics,"Parenteral > General injections > IV: 2 mg per  mL in 300 mL bag
Oral > Liquid: 100 mg per 5 mL powder for oral liquid
Oral > Solid: 400 mg tablet; 600 mg tablet
Oral > Solid > dispersible tablet: 150 mg
Oral > Solid > tablet: 600 mg",Vancomycin resistant Staphylococcus aureus,J01XX08,,Added,linezolid,['linezolid']
linezolid,Reserve group antibiotics,"Parenteral > General injections > IV: 2 mg per  mL in 300 mL bag
Oral > Liquid: 100 mg per 5 mL powder for oral liquid
Oral > Solid: 400 mg tablet; 600 mg tablet
Oral > Solid > dispersible tablet: 150 mg
Oral > Solid > tablet: 600 mg",Vancomycin resistant Enterococcus,J01XX08,,Added,linezolid,['linezolid']
linezolid,Antituberculosis medicines,"Oral > Solid > dispersible tablet: 150 mg
Oral > Solid > tablet: 600 mg",Multi-drug resistant Mycobacterium tuberculosis,J01XX08,,Added,linezolid,['linezolid']
lisinopril + amlodipine,Antihypertensive medicines,Oral > Solid: 10 mg + 5 mg; 20 mg + 5 mg; 20 mg + 10 mg,Essential hypertension,C09BB03,,Added,lisinopril + amlodipine,"['amlodipine', 'lisinopril + amlodipine', 'lisinopril', '+']"
lisinopril + hydrochlorothiazide,Antihypertensive medicines,Oral > Solid: 10 mg + 12.5 mg; 20 mg + 12.5 mg; 20 mg + 25 mg,Essential hypertension,C09BA03,,Added,lisinopril + hydrochlorothiazide,"['lisinopril + hydrochlorothiazide', 'hydrochlorothiazide', 'lisinopril', '+']"
lithium carbonate,Medicines for bipolar disorders,Oral > Solid: 300 mg,Bipolar or related disorders,N05AN01,,Added,lithium carbonate,"['lithium', 'lithium carbonate', 'carbonate']"
long-acting insulin analogues,Insulins,Parenteral > General injections > SC: 100 IU per  mL in 3 mL cartridge; 100 IU per  mL in 3 mL pre-filled pen,Type 1 diabetes mellitus,"A10AE06, A10AE05, A10AE04",,Added,long-acting insulin analogues,"['analogues', 'insulin', 'long-acting insulin analogues', 'long-acting']"
long-acting insulin analogues,Insulins,Parenteral > General injections > SC: 100 IU per  mL in 3 mL cartridge; 100 IU per  mL in 3 mL pre-filled pen,Type 2 diabetes mellitus,"A10AE06, A10AE05, A10AE04",,Added,long-acting insulin analogues,"['analogues', 'insulin', 'long-acting insulin analogues', 'long-acting']"
loperamide,Medicines for other common symptoms in palliative care,Oral > Solid > dosage form: 2 mg,Palliative care,A07DA03,,Added,loperamide,['loperamide']
lopinavir + ritonavir,Antiretrovirals > Protease inhibitors,"Oral > Solid > tablet: 100 mg + 25 mg tablet (heat-stable); 200 mg + 50 mg tablet (heat-stable)
Oral > Solid > dosage form: 40 mg + 10 mg","Human immunodeficiency virus disease without mention of associated disease or condition, clinical stage unspecified",J05AR10,,Added,lopinavir + ritonavir,"['+', 'ritonavir', 'lopinavir + ritonavir', 'lopinavir']"
loratadine,Antiallergics and medicines used in anaphylaxis,"Oral > Liquid: 1 mg per  mL
Oral > Solid: 10 mg",Allergic or hypersensitivity conditions of unspecified type,R06AX13,,Added,loratadine,['loratadine']
lorazepam,Antiseizure medicines,Parenteral > General injections > IV: 2 mg per  mL in 1 mL ampoule; 4 mg per  mL in 1 mL ampoule,Status epilepticus,N05BA06,,Added,lorazepam,['lorazepam']
lorazepam,Medicines for anxiety disorders ,,Anxiety,,,Added,lorazepam,['lorazepam']
losartan,Antihypertensive medicines,Oral > Solid: 25 mg tablet; 50 mg tablet; 100 mg tablet,Essential hypertension,C09CA01,,Added,losartan,['losartan']
losartan,Medicines used in heart failure,Oral > Solid: 25 mg tablet; 50 mg tablet; 100 mg tablet,Heart failure,C09CA01,,Added,losartan,['losartan']
lovastatin,Lipid-lowering agents,,Mixed hyperlipidaemia,,,Added,lovastatin,['lovastatin']
lovastatin,Lipid-lowering agents,,Coronary atherosclerosis,,,Added,lovastatin,['lovastatin']
lugol's solution,Thyroid hormones and antithyroid medicines,Oral > Liquid: 13% w/v (about 130 mg/mL total iodine),Thyrotoxicosis,H03CA,,Added,lugol's solution,"['solution', ""lugol's solution"", ""lugol's""]"
magnesium sulfate,Antiseizure medicines,"Parenteral > General injections > IV: 500 mg per  mL in 2 mL ampoule (equivalent to 1 g in 2 mL; 50% weight/volume)
Parenteral > General injections > IM: 500 mg per  mL in 10 mL ampoule (equivalent to 5 g in 10 mL; 50% weight/volume)",Severe pre-eclampsia,B05XA05,,Added,magnesium sulfate,"['magnesium sulfate', 'magnesium', 'sulfate']"
magnesium sulfate,Antiseizure medicines,"Parenteral > General injections > IV: 500 mg per  mL in 2 mL ampoule (equivalent to 1 g in 2 mL; 50% weight/volume)
Parenteral > General injections > IM: 500 mg per  mL in 10 mL ampoule (equivalent to 5 g in 10 mL; 50% weight/volume)",Eclampsia,B05XA05,,Added,magnesium sulfate,"['magnesium sulfate', 'magnesium', 'sulfate']"
mannitol,Diuretics,Parenteral > General injections > IV: 10% solution; 20% solution,Ocular hypertension,B05BC01,,Added,mannitol,['mannitol']
mannitol,Diuretics,Parenteral > General injections > IV: 10% solution; 20% solution,Cerebral oedema,B05BC01,,Added,mannitol,['mannitol']
measles vaccine,Recommendations for all immunization programmes,All vaccines should comply with the WHO requirements for biological substances.,Need for immunization against measles alone,J07BD01,,Added,measles vaccine,"['measles vaccine', 'vaccine', 'measles']"
mebendazole,Intestinal anthelminthics,Oral > Solid > tablet: 100 mg (chewable); 500 mg (chewable),Ascariasis,P02CA01,,Added,mebendazole,['mebendazole']
mebendazole,Intestinal anthelminthics,Oral > Solid > tablet: 100 mg (chewable); 500 mg (chewable),Enterobiasis,P02CA01,,Added,mebendazole,['mebendazole']
mebendazole,Intestinal anthelminthics,Oral > Solid > tablet: 100 mg (chewable); 500 mg (chewable),Trichuriasis,P02CA01,,Added,mebendazole,['mebendazole']
mebendazole,Intestinal anthelminthics,Oral > Solid > tablet: 100 mg (chewable); 500 mg (chewable),Hookworm diseases,P02CA01,,Added,mebendazole,['mebendazole']
mebendazole,Cysticidal medicines,Oral > Solid > tablet: 100 mg (chewable); 500 mg (chewable),Other specified echinococcosis,P02CA01,,Added,mebendazole,['mebendazole']
medroxyprogesterone acetate,Injectable hormonal contraceptives,"Parenteral > General injections > IM: 150 mg per  mL in 1 mL vial
Parenteral > General injections > SC: 104 mg per 0.65 mL in pre-filled syringe; 104 mg per 0.65 mL in single dose injection delivery system",Contact with health services for reasons associated with reproduction,G03AC06,,Added,medroxyprogesterone acetate,"['acetate', 'medroxyprogesterone acetate', 'medroxyprogesterone']"
medroxyprogesterone acetate,Progestogens,Oral > Solid: 5 mg,Excessive menstruation with irregular cycle,G03DA02,,Added,medroxyprogesterone acetate,"['acetate', 'medroxyprogesterone acetate', 'medroxyprogesterone']"
mefloquine,Antimalarial medicines > For curative treatment,Oral > Solid: 250 mg tablet (hydrochloride),Malaria due to Plasmodium falciparum,P01BC02,,Added,mefloquine,['mefloquine']
mefloquine,Antimalarial medicines > For curative treatment,Oral > Solid: 250 mg tablet (hydrochloride),Malaria due to Plasmodium vivax,P01BC02,,Added,mefloquine,['mefloquine']
mefloquine,Antimalarial medicines > For chemoprevention,Oral > Solid: 250 mg tablet (hydrochloride),Malaria due to Plasmodium falciparum,P01BC02,,Added,mefloquine,['mefloquine']
meglumine antimoniate,Antileishmaniasis medicines,Parenteral > General injections > IM: 1.5 g per 5 mL in 5 mL ampoule,Visceral leishmaniasis,P01CB01,,Added,meglumine antimoniate,"['meglumine antimoniate', 'antimoniate', 'meglumine']"
meglumine antimoniate,Antileishmaniasis medicines,Parenteral > General injections > IM: 1.5 g per 5 mL in 5 mL ampoule,Cutaneous leishmaniasis,P01CB01,,Added,meglumine antimoniate,"['meglumine antimoniate', 'antimoniate', 'meglumine']"
meglumine antimoniate,Antileishmaniasis medicines,Parenteral > General injections > IM: 1.5 g per 5 mL in 5 mL ampoule,Mucocutaneous leishmaniasis,P01CB01,,Added,meglumine antimoniate,"['meglumine antimoniate', 'antimoniate', 'meglumine']"
meglumine iotroxate,Diagnostic agents > Radiocontrast media,Parenteral > General injections > IV: 5 to 8 g iodine (as meglumine) in 100 to 250 mL,"X-ray contrast media, iodinated",V08AC02,,Added,meglumine iotroxate,"['meglumine', 'iotroxate', 'meglumine iotroxate']"
melarsoprol,Medicines for the treatment of 2nd stage African trypanosomiasis,Parenteral > General injections > IV: 3.6% in 5 mL ampoule solution (180 mg of active compound),African trypanosomiasis,P01CD01,,Added,melarsoprol,['melarsoprol']
melphalan,Cytotoxic medicines,"Parenteral > General injections > IV: 50 mg in vial powder for injection
Oral > Solid: 2 mg",Plasma cell myeloma,L01AA03,,Added,melphalan,['melphalan']
meningococcal meningitis vaccine,Recommendations for some high-risk populations,All vaccines should comply with the WHO requirements for biological substances.,Need for immunization against single bacterial diseases,"J07AH01, J07AH02, J07AH03, J07AH04, J07AH05, J07AH06, J07AH07, J07AH08, J07AH09, J07AH10",,Added,meningococcal meningitis vaccine,"['meningococcal meningitis vaccine', 'vaccine', 'meningitis', 'meningococcal']"
mercaptopurine,Cytotoxic medicines,"Oral > Solid: 50 mg tablet
Oral > Liquid: 20 mg per  mL",Acute myeloid leukaemia with recurrent genetic abnormalities,L01BB02,,Added,mercaptopurine,['mercaptopurine']
mercaptopurine,Cytotoxic medicines,"Oral > Solid: 50 mg tablet
Oral > Liquid: 20 mg per  mL","Lymphoid leukaemia, not elsewhere classified",L01BB02,,Added,mercaptopurine,['mercaptopurine']
mercaptopurine,Cytotoxic medicines,"Oral > Solid: 50 mg tablet
Oral > Liquid: 20 mg per  mL",Langerhans cell histiocytosis,L01BB02,,Added,mercaptopurine,['mercaptopurine']
meropenem,Watch group antibiotics,Parenteral > General injections > IV: 500 mg in vial (as trihydrate) powder for injection; 1 g in vial (as trihydrate) powder for injection,Neonatal meningitis,J01DH02,,Added,meropenem,['meropenem']
meropenem,Watch group antibiotics,Parenteral > General injections > IV: 500 mg in vial (as trihydrate) powder for injection; 1 g in vial (as trihydrate) powder for injection,Peritonitis (severe),J01DH02,,Added,meropenem,['meropenem']
meropenem,Watch group antibiotics,Parenteral > General injections > IV: 500 mg in vial (as trihydrate) powder for injection; 1 g in vial (as trihydrate) powder for injection,Peritoneal abscess (severe),J01DH02,,Added,meropenem,['meropenem']
meropenem,Watch group antibiotics,Parenteral > General injections > IV: 500 mg in vial (as trihydrate) powder for injection; 1 g in vial (as trihydrate) powder for injection,Neutropenia (high-risk),J01DH02,,Added,meropenem,['meropenem']
meropenem,Antituberculosis medicines,Parenteral > General injections > IV: 500 mg in vial (as trihydrate) powder for injection; 1 g in vial (as trihydrate) powder for injection,Multi-drug resistant Mycobacterium tuberculosis,J01DH02,,Added,meropenem,['meropenem']
meropenem + vaborbactam,Reserve group antibiotics,Parenteral > General injections > IV: 1 g in vial + 1 g in vial powder for injection,Carbapenem-resistant Pseudomonas aeruginosa,J01DH52,,Added,meropenem + vaborbactam,"['meropenem', 'meropenem + vaborbactam', 'vaborbactam', '+']"
meropenem + vaborbactam,Reserve group antibiotics,Parenteral > General injections > IV: 1 g in vial + 1 g in vial powder for injection,Carbapenem resistant Enterobacterales,J01DH52,,Added,meropenem + vaborbactam,"['meropenem', 'meropenem + vaborbactam', 'vaborbactam', '+']"
meropenem + vaborbactam,Reserve group antibiotics,Parenteral > General injections > IV: 1 g in vial + 1 g in vial powder for injection,Carbapenem resistant Acinetobacter baumannii,J01DH52,,Added,meropenem + vaborbactam,"['meropenem', 'meropenem + vaborbactam', 'vaborbactam', '+']"
mesalazine,Anti-inflammatory medicines,,Crohn disease site,,,Added,mesalazine,['mesalazine']
mesalazine,Anti-inflammatory medicines,,Ulcerative colitis,,,Added,mesalazine,['mesalazine']
mesna,Supportive medicines,"Parenteral > General injections > IV: 100 mg per  mL in 4 mL ampoule; 100 mg per  mL in 10 mL ampoule
Oral > Solid: 400 mg; 600 mg",Osteosarcoma of bone and articular cartilage of other specified sites,V03AF01,,Added,mesna,['mesna']
mesna,Supportive medicines,"Parenteral > General injections > IV: 100 mg per  mL in 4 mL ampoule; 100 mg per  mL in 10 mL ampoule
Oral > Solid: 400 mg; 600 mg",Other specified malignant neoplasms of the ovary,V03AF01,,Added,mesna,['mesna']
mesna,Supportive medicines,"Parenteral > General injections > IV: 100 mg per  mL in 4 mL ampoule; 100 mg per  mL in 10 mL ampoule
Oral > Solid: 400 mg; 600 mg",Germ cell tumour of testis,V03AF01,,Added,mesna,['mesna']
mesna,Supportive medicines,"Parenteral > General injections > IV: 100 mg per  mL in 4 mL ampoule; 100 mg per  mL in 10 mL ampoule
Oral > Solid: 400 mg; 600 mg",Ewing sarcoma of bone and articular cartilage of unspecified sites,V03AF01,,Added,mesna,['mesna']
mesna,Supportive medicines,"Parenteral > General injections > IV: 100 mg per  mL in 4 mL ampoule; 100 mg per  mL in 10 mL ampoule
Oral > Solid: 400 mg; 600 mg",Rhabdomyosarcoma primary site,V03AF01,,Added,mesna,['mesna']
mesna,Supportive medicines,"Parenteral > General injections > IV: 100 mg per  mL in 4 mL ampoule; 100 mg per  mL in 10 mL ampoule
Oral > Solid: 400 mg; 600 mg",Burkitt lymphoma including Burkitt leukaemia,V03AF01,,Added,mesna,['mesna']
mesna,Supportive medicines,"Parenteral > General injections > IV: 100 mg per  mL in 4 mL ampoule; 100 mg per  mL in 10 mL ampoule
Oral > Solid: 400 mg; 600 mg","Malignant neoplasms of kidney, except renal pelvis",V03AF01,,Added,mesna,['mesna']
metformin,Oral hypoglycaemic agents,Oral > Solid: 500 mg (hydrochloride),Type 2 diabetes mellitus,A10BA02,,Added,metformin,['metformin']
methadone,Medicines for opioid use disorders,Oral > Liquid: 5 mg per 5 mL (methadone hydrochloride); 10 mg per 5 mL (methadone hydrochloride); 5 mg per  mL concentrate for oral liquid (methadone hydrochloride); 10 mg per  mL concentrate for oral liquid (methadone hydrochloride),Opioid dependence,N07BC02,,Added,methadone,['methadone']
methadone,Opioid analgesics,"Oral > Liquid: 5 mg per 5 mL (methadone hydrochloride); 10 mg per 5 mL (methadone hydrochloride); 5 mg per  mL concentrate for oral liquid (methadone hydrochloride); 10 mg per  mL concentrate for oral liquid (methadone hydrochloride)
Oral > Solid: 5 mg (methadone hydrochloride); 10 mg (methadone hydrochloride)",Chronic cancer pain,N07BC02,,Added,methadone,['methadone']
methimazole,Thyroid hormones and antithyroid medicines,Oral > Solid: 5 mg; 10 mg; 20 mg,Thyrotoxicosis,H03BB02,,Added,methimazole,['methimazole']
methotrexate,Cytotoxic medicines,"Parenteral > General injections > IV: 50 mg in vial (as sodium salt)
Oral > Solid: 2.5 mg (as sodium salt)
Parenteral > General injections > IV: 50 mg in vial (as sodium salt); 50 mg per 2 mL; 1000 mg per 10 mL concentrated injection","Lymphoid leukaemia, not elsewhere classified",L01BA01,,Added,methotrexate,['methotrexate']
methotrexate,Cytotoxic medicines,"Parenteral > General injections > IV: 50 mg in vial (as sodium salt)
Oral > Solid: 2.5 mg (as sodium salt)
Parenteral > General injections > IV: 50 mg in vial (as sodium salt); 50 mg per 2 mL; 1000 mg per 10 mL concentrated injection",Acute myeloid leukaemia with recurrent genetic abnormalities,L01BA01,,Added,methotrexate,['methotrexate']
methotrexate,Cytotoxic medicines,"Parenteral > General injections > IV: 50 mg in vial (as sodium salt)
Oral > Solid: 2.5 mg (as sodium salt)
Parenteral > General injections > IV: 50 mg in vial (as sodium salt); 50 mg per 2 mL; 1000 mg per 10 mL concentrated injection",Malignant trophoblastic neoplasms of placenta,L01BA01,,Added,methotrexate,['methotrexate']
methotrexate,Cytotoxic medicines,"Parenteral > General injections > IV: 50 mg in vial (as sodium salt)
Oral > Solid: 2.5 mg (as sodium salt)
Parenteral > General injections > IV: 50 mg in vial (as sodium salt); 50 mg per 2 mL; 1000 mg per 10 mL concentrated injection",Burkitt lymphoma including Burkitt leukaemia,L01BA01,,Added,methotrexate,['methotrexate']
methotrexate,Cytotoxic medicines,"Parenteral > General injections > IV: 50 mg in vial (as sodium salt)
Oral > Solid: 2.5 mg (as sodium salt)
Parenteral > General injections > IV: 50 mg in vial (as sodium salt); 50 mg per 2 mL; 1000 mg per 10 mL concentrated injection",Malignant neoplasms of breast,L01BA01,,Added,methotrexate,['methotrexate']
methotrexate,Cytotoxic medicines,"Parenteral > General injections > IV: 50 mg in vial (as sodium salt)
Oral > Solid: 2.5 mg (as sodium salt)
Parenteral > General injections > IV: 50 mg in vial (as sodium salt); 50 mg per 2 mL; 1000 mg per 10 mL concentrated injection",Osteosarcoma of bone and articular cartilage of unspecified sites,L01BA01,,Added,methotrexate,['methotrexate']
methotrexate,Cytotoxic medicines,"Parenteral > General injections > IV: 50 mg in vial (as sodium salt)
Oral > Solid: 2.5 mg (as sodium salt)
Parenteral > General injections > IV: 50 mg in vial (as sodium salt); 50 mg per 2 mL; 1000 mg per 10 mL concentrated injection","Anaplastic large cell lymphoma, ALK-negative",L01BA01,,Added,methotrexate,['methotrexate']
methotrexate,Cytotoxic medicines,"Parenteral > General injections > IV: 50 mg in vial (as sodium salt)
Oral > Solid: 2.5 mg (as sodium salt)
Parenteral > General injections > IV: 50 mg in vial (as sodium salt); 50 mg per 2 mL; 1000 mg per 10 mL concentrated injection","Anaplastic large cell lymphoma, ALK-positive",L01BA01,,Added,methotrexate,['methotrexate']
methotrexate,Cytotoxic medicines,"Parenteral > General injections > IV: 50 mg in vial (as sodium salt)
Oral > Solid: 2.5 mg (as sodium salt)
Parenteral > General injections > IV: 50 mg in vial (as sodium salt); 50 mg per 2 mL; 1000 mg per 10 mL concentrated injection",Langerhans cell histiocytosis,L01BA01,,Added,methotrexate,['methotrexate']
methotrexate,Dermatological medicines > Medicines affecting skin differentiation and proliferation,Oral > Solid > tablet: 2.5 mg (as sodium salt); 10 mg (as sodium salt),Psoriasis of unspecified type,L04AX03,,Added,methotrexate,['methotrexate']
methotrexate,Disease-modifying anti-rheumatic drugs (DMARDs),Oral > Solid > tablet: 2.5 mg (as sodium salt),"Rheumatoid arthritis, serology unspecified",L04AX03,,Added,methotrexate,['methotrexate']
methotrexate,Medicines for juvenile joint diseases,Oral > Solid > tablet: 2.5 mg (as sodium salt),Juvenile idiopathic arthritis,L04AX03,,Added,methotrexate,['methotrexate']
methoxy polyethylene glycol-epoetin beta,Antianaemia medicines,,Anaemia due to chronic disease,,,Added,methoxy polyethylene glycol-epoetin beta,"['methoxy', 'polyethylene', 'glycol-epoetin', 'methoxy polyethylene glycol-epoetin beta', 'beta']"
methyldopa,Antihypertensive medicines,Oral > Solid: 250 mg,Gestational hypertension,C02AB01,,Added,methyldopa,['methyldopa']
methylergometrine,Uterotonics,,Postpartum haemorrhage,,,Added,methylergometrine,['methylergometrine']
methylprednisolone,Hormones and antihormones,Parenteral > General injections > IV: 40 mg per  mL in 1 mL single-dose vial (as sodium succinate); 40 mg per  mL in 5 mL multi-dose vial (as sodium succinate); 80 mg per  mL in 1 mL single-dose vial (as sodium succinate),"Lymphoid leukaemia, not elsewhere classified",H02AB04,,Added,methylprednisolone,['methylprednisolone']
methylprednisolone,Hormones and antihormones,Parenteral > General injections > IV: 40 mg per  mL in 1 mL single-dose vial (as sodium succinate); 40 mg per  mL in 5 mL multi-dose vial (as sodium succinate); 80 mg per  mL in 1 mL single-dose vial (as sodium succinate),Burkitt lymphoma including Burkitt leukaemia,H02AB04,,Added,methylprednisolone,['methylprednisolone']
methylthioninium chloride,Antidotes and other substances used in poisonings > Specific,Parenteral > General injections > IV: 10 mg per  mL in 10 mL ampoule,Acquired methaemoglobinaemia,V03AB17,,Added,methylthioninium chloride,"['chloride', 'methylthioninium', 'methylthioninium chloride']"
metoclopramide,Medicines for other common symptoms in palliative care,"Oral > Liquid: 5 mg per 5 mL
Oral > Solid: 10 mg (hydrochloride)
Parenteral > General injections > unspecified: 5 mg per  mL in 2 mL ampoule (hydrochloride)",Palliative care,A03FA01,,Added,metoclopramide,['metoclopramide']
metoclopramide,Antiemetic medicines,"Oral > Liquid: 5 mg per 5 mL
Oral > Solid: 10 mg (hydrochloride)
Parenteral > General injections > unspecified: 5 mg per  mL in 2 mL ampoule (hydrochloride)",Nausea or vomiting,A03FA01,,Added,metoclopramide,['metoclopramide']
metoprolol,Antianginal medicines,,Angina pectoris,,,Added,metoprolol,['metoprolol']
metoprolol,Medicines used in heart failure,,Heart failure,,,Added,metoprolol,['metoprolol']
metoprolol,Antihypertensive medicines,,Essential hypertension,,,Added,metoprolol,['metoprolol']
metoprolol,Antiarrhythmic medicines,,Cardiac arrhythmia,,,Added,metoprolol,['metoprolol']
metronidazole,Access group antibiotics,"Oral > Liquid: 200 mg per 5 mL (as benzoate)
Oral > Solid: 200 to 500 mg tablet
Parenteral > General injections > unspecified: 500 mg per 100 mL in vial Injection
Local > Rectal > Suppository: 500 mg; 1 g
Parenteral > General injections > unspecified: 500 mg per 100 mL in vial
Oral > Solid > tablet: 200 mg; 250 mg; 400 mg; 500 mg",Peritoneal abscess (mild-moderate),A01AB17,cefotaxime,Added,metronidazole,['metronidazole']
metronidazole,Access group antibiotics,"Oral > Liquid: 200 mg per 5 mL (as benzoate)
Oral > Solid: 200 to 500 mg tablet
Parenteral > General injections > unspecified: 500 mg per 100 mL in vial Injection
Local > Rectal > Suppository: 500 mg; 1 g
Parenteral > General injections > unspecified: 500 mg per 100 mL in vial
Oral > Solid > tablet: 200 mg; 250 mg; 400 mg; 500 mg",Peritoneal abscess (severe),A01AB17,cefotaxime,Added,metronidazole,['metronidazole']
metronidazole,Access group antibiotics,"Oral > Liquid: 200 mg per 5 mL (as benzoate)
Oral > Solid: 200 to 500 mg tablet
Parenteral > General injections > unspecified: 500 mg per 100 mL in vial Injection
Local > Rectal > Suppository: 500 mg; 1 g
Parenteral > General injections > unspecified: 500 mg per 100 mL in vial
Oral > Solid > tablet: 200 mg; 250 mg; 400 mg; 500 mg",Peritoneal abscess (mild-moderate),A01AB17,ceftriaxone,Added,metronidazole,['metronidazole']
metronidazole,Access group antibiotics,"Oral > Liquid: 200 mg per 5 mL (as benzoate)
Oral > Solid: 200 to 500 mg tablet
Parenteral > General injections > unspecified: 500 mg per 100 mL in vial Injection
Local > Rectal > Suppository: 500 mg; 1 g
Parenteral > General injections > unspecified: 500 mg per 100 mL in vial
Oral > Solid > tablet: 200 mg; 250 mg; 400 mg; 500 mg",Peritoneal abscess (severe),A01AB17,ceftriaxone,Added,metronidazole,['metronidazole']
metronidazole,Access group antibiotics,"Oral > Liquid: 200 mg per 5 mL (as benzoate)
Oral > Solid: 200 to 500 mg tablet
Parenteral > General injections > unspecified: 500 mg per 100 mL in vial Injection
Local > Rectal > Suppository: 500 mg; 1 g
Parenteral > General injections > unspecified: 500 mg per 100 mL in vial
Oral > Solid > tablet: 200 mg; 250 mg; 400 mg; 500 mg",Peritonitis (mild-moderate),A01AB17,ceftriaxone,Added,metronidazole,['metronidazole']
metronidazole,Access group antibiotics,"Oral > Liquid: 200 mg per 5 mL (as benzoate)
Oral > Solid: 200 to 500 mg tablet
Parenteral > General injections > unspecified: 500 mg per 100 mL in vial Injection
Local > Rectal > Suppository: 500 mg; 1 g
Parenteral > General injections > unspecified: 500 mg per 100 mL in vial
Oral > Solid > tablet: 200 mg; 250 mg; 400 mg; 500 mg",Peritonitis (severe),A01AB17,ceftriaxone,Added,metronidazole,['metronidazole']
metronidazole,Access group antibiotics,"Oral > Liquid: 200 mg per 5 mL (as benzoate)
Oral > Solid: 200 to 500 mg tablet
Parenteral > General injections > unspecified: 500 mg per 100 mL in vial Injection
Local > Rectal > Suppository: 500 mg; 1 g
Parenteral > General injections > unspecified: 500 mg per 100 mL in vial
Oral > Solid > tablet: 200 mg; 250 mg; 400 mg; 500 mg",Peritonitis (mild-moderate),A01AB17,cefotaxime,Added,metronidazole,['metronidazole']
metronidazole,Access group antibiotics,"Oral > Liquid: 200 mg per 5 mL (as benzoate)
Oral > Solid: 200 to 500 mg tablet
Parenteral > General injections > unspecified: 500 mg per 100 mL in vial Injection
Local > Rectal > Suppository: 500 mg; 1 g
Parenteral > General injections > unspecified: 500 mg per 100 mL in vial
Oral > Solid > tablet: 200 mg; 250 mg; 400 mg; 500 mg",Peritonitis (severe),A01AB17,cefotaxime,Added,metronidazole,['metronidazole']
metronidazole,Access group antibiotics,"Oral > Liquid: 200 mg per 5 mL (as benzoate)
Oral > Solid: 200 to 500 mg tablet
Parenteral > General injections > unspecified: 500 mg per 100 mL in vial Injection
Local > Rectal > Suppository: 500 mg; 1 g
Parenteral > General injections > unspecified: 500 mg per 100 mL in vial
Oral > Solid > tablet: 200 mg; 250 mg; 400 mg; 500 mg",Intestinal infections due to Clostridioides difficile,A01AB17,,Added,metronidazole,['metronidazole']
metronidazole,Access group antibiotics,"Oral > Liquid: 200 mg per 5 mL (as benzoate)
Oral > Solid: 200 to 500 mg tablet
Parenteral > General injections > unspecified: 500 mg per 100 mL in vial Injection
Local > Rectal > Suppository: 500 mg; 1 g
Parenteral > General injections > unspecified: 500 mg per 100 mL in vial
Oral > Solid > tablet: 200 mg; 250 mg; 400 mg; 500 mg",Other specified prophylactic measures,A01AB17,cefazolin,Added,metronidazole,['metronidazole']
metronidazole,Access group antibiotics,"Oral > Liquid: 200 mg per 5 mL (as benzoate)
Oral > Solid: 200 to 500 mg tablet
Parenteral > General injections > unspecified: 500 mg per 100 mL in vial Injection
Local > Rectal > Suppository: 500 mg; 1 g
Parenteral > General injections > unspecified: 500 mg per 100 mL in vial
Oral > Solid > tablet: 200 mg; 250 mg; 400 mg; 500 mg",Trichomoniasis,P01AB01,,Added,metronidazole,['metronidazole']
metronidazole,Access group antibiotics,"Oral > Liquid: 200 mg per 5 mL (as benzoate)
Oral > Solid: 200 to 500 mg tablet
Parenteral > General injections > unspecified: 500 mg per 100 mL in vial Injection
Local > Rectal > Suppository: 500 mg; 1 g
Parenteral > General injections > unspecified: 500 mg per 100 mL in vial
Oral > Solid > tablet: 200 mg; 250 mg; 400 mg; 500 mg",Necrotising fasciitis,"J01XD01, A01AB17",ceftriaxone,Added,metronidazole,['metronidazole']
metronidazole,Access group antibiotics,"Oral > Liquid: 200 mg per 5 mL (as benzoate)
Oral > Solid: 200 to 500 mg tablet
Parenteral > General injections > unspecified: 500 mg per 100 mL in vial Injection
Local > Rectal > Suppository: 500 mg; 1 g
Parenteral > General injections > unspecified: 500 mg per 100 mL in vial
Oral > Solid > tablet: 200 mg; 250 mg; 400 mg; 500 mg",Peritoneal abscess (mild-moderate),A01AB17,ciprofloxacin,Added,metronidazole,['metronidazole']
metronidazole,Access group antibiotics,"Oral > Liquid: 200 mg per 5 mL (as benzoate)
Oral > Solid: 200 to 500 mg tablet
Parenteral > General injections > unspecified: 500 mg per 100 mL in vial Injection
Local > Rectal > Suppository: 500 mg; 1 g
Parenteral > General injections > unspecified: 500 mg per 100 mL in vial
Oral > Solid > tablet: 200 mg; 250 mg; 400 mg; 500 mg",Peritonitis (mild-moderate),A01AB17,ciprofloxacin,Added,metronidazole,['metronidazole']
metronidazole,Antiamoebic and antigiardiasis medicines,"Oral > Liquid: 200 mg per 5 mL (as benzoate)
Parenteral > General injections > unspecified: 500 mg in 100 mL vial
Oral > Solid > tablet: 200 mg; 250 mg; 400 mg; 500 mg",Amoebiasis,P01AB01,,Added,metronidazole,['metronidazole']
micafungin,Antifungal medicines,Parenteral > General injections > IV: 50 mg in vial (as sodium) powder for injection; 100 mg in vial (as sodium) powder for injection,Systemic or invasive candidosis,J02AX05,,Added,micafungin,['micafungin']
miconazole,Dermatological medicines > Antifungal medicines,"Local > Topical > Cream: 2% (nitrate)
Local > Topical > Ointment: 2% (nitrate)",Fungal infection of the skin,D01AC02,,Added,miconazole,['miconazole']
midazolam,Antiseizure medicines,"
Parenteral > General injections > unspecified: 1 mg per  mL in 5 mL vial (for buccal administration); 5 mg per  mL in 1 mL vial (for buccal administration); 5 mg per  mL in 3 mL vial (for buccal administration)
Local > Buccal > Solution: 5 mg per  mL in 0.5 mL pre-filled syringe (for oromucosal administration); 5 mg per  mL in 1 mL pre-filled syringe (for oromucosal administration); 5 mg per  mL in 1.5 mL pre-filled syringe (for oromucosal administration); 5 mg per  mL in 2 mL pre-filled syringe (for oromucosal administration); 10 mg per  mL in 0.25 mL pre-filled syringe (for oromucosal administration); 10 mg per  mL in 0.5 mL pre-filled syringe (for oromucosal administration); 10 mg per  mL in 0.75 mL pre-filled syringe; 10 mg per  mL in 1 mL pre-filled syringe (for oromucosal administration)",Status epilepticus,,,Added,midazolam,['midazolam']
midazolam,Antiseizure medicines,"
Parenteral > General injections > unspecified: 1 mg per  mL in 5 mL vial (for buccal administration); 5 mg per  mL in 1 mL vial (for buccal administration); 5 mg per  mL in 3 mL vial (for buccal administration)
Local > Buccal > Solution: 5 mg per  mL in 0.5 mL pre-filled syringe (for oromucosal administration); 5 mg per  mL in 1 mL pre-filled syringe (for oromucosal administration); 5 mg per  mL in 1.5 mL pre-filled syringe (for oromucosal administration); 5 mg per  mL in 2 mL pre-filled syringe (for oromucosal administration); 10 mg per  mL in 0.25 mL pre-filled syringe (for oromucosal administration); 10 mg per  mL in 0.5 mL pre-filled syringe (for oromucosal administration); 10 mg per  mL in 0.75 mL pre-filled syringe; 10 mg per  mL in 1 mL pre-filled syringe (for oromucosal administration)",Status epilepticus,N05CD08,,Added,midazolam,['midazolam']
midazolam,Preoperative medication and sedation for short-term procedures,"Parenteral > General injections > IV: 1 mg per  mL
Oral > Liquid: 2 mg per  mL
Oral > Solid > dosage form: 15 mg; 7.5 mg",Sedative-hypnotic and anxiolytic drugs,N05CD08,,Added,midazolam,['midazolam']
midazolam,Medicines for other common symptoms in palliative care,"Oral > Liquid: 2 mg per  mL
Parenteral > General injections > unspecified: 1 mg per  mL; 5 mg per  mL
Oral > Solid > dosage form: 7.5 mg; 15 mg",Palliative care,N05CD08,,Added,midazolam,['midazolam']
mifepristone - misoprostol,Uterotonics,Oral > Solid: 200 mg + 200 µg; 200 mg [1] + 200 µg [4] in co-package,Induced abortion,G03XB51,,Added,mifepristone - misoprostol,"['misoprostol', 'mifepristone - misoprostol', 'mifepristone', '-']"
mifepristone - misoprostol,Uterotonics,Oral > Solid: 200 mg + 200 µg; 200 mg [1] + 200 µg [4] in co-package,"Unspecified time of fetal death, cause not specified",G03XB51,,Added,mifepristone - misoprostol,"['misoprostol', 'mifepristone - misoprostol', 'mifepristone', '-']"
miltefosine,Antileishmaniasis medicines,Oral > Solid: 10 mg; 50 mg,Visceral leishmaniasis,P01CX04,,Added,miltefosine,['miltefosine']
miltefosine,Antileishmaniasis medicines,Oral > Solid: 10 mg; 50 mg,Mucocutaneous leishmaniasis,P01CX04,,Added,miltefosine,['miltefosine']
miltefosine,Antileishmaniasis medicines,Oral > Solid: 10 mg; 50 mg,Cutaneous leishmaniasis,P01CX04,,Added,miltefosine,['miltefosine']
misoprostol,Uterotonics,"Oral > Solid: 200 µg
Local > Vaginal > tablet: 25 µg","Spontaneous abortion, incomplete, without complication",G02AD06,,Added,misoprostol,['misoprostol']
misoprostol,Uterotonics,"Oral > Solid: 200 µg
Local > Vaginal > tablet: 25 µg",Unspecified obstetric condition,G02AD06,,Added,misoprostol,['misoprostol']
misoprostol,Uterotonics,"Oral > Solid: 200 µg
Local > Vaginal > tablet: 25 µg",Postpartum haemorrhage,G02AD06,,Added,misoprostol,['misoprostol']
mometasone,Antiasthmatic and medicines for chronic obstructive pulmonary disease,,Asthma,,,Added,mometasone,['mometasone']
mometasone + formoterol,Antiasthmatic and medicines for chronic obstructive pulmonary disease,,Asthma,,,Added,mometasone + formoterol,"['formoterol', 'mometasone + formoterol', '+', 'mometasone']"
morphine,Opioid analgesics,"Oral > Liquid: 10 mg per 5 mL (morphine hydrochloride or morphine sulfate)
Oral > Solid: 10 mg immediate release (morphine sulfate); 10 to 200 mg slow release (morphine hydrochloride or morphine sulfate)
Oral > Other: 20 to 200 mg slow release granules to mix with water (morphine sulfate)
Parenteral > General injections > unspecified: 10 mg in 1 mL ampoule (morphine hydrochloride or morphine sulfate)",Pain,N02AA01,,Added,morphine,['morphine']
morphine,Preoperative medication and sedation for short-term procedures,Parenteral > General injections > IV: 10 mg in 1 mL ampoule (morphine hydrochloride or morphine sulfate),Opioids or related analgesics and agents affecting opioid receptors,N02AA01,,Added,morphine,['morphine']
moxifloxacin,Antituberculosis medicines,"Oral > Solid > dispersible tablet: 100 mg
Oral > Solid > tablet: 400 mg",Multi-drug resistant Mycobacterium tuberculosis,J01MA14,,Added,moxifloxacin,['moxifloxacin']
moxifloxacin,Antituberculosis medicines,"Oral > Solid > dispersible tablet: 100 mg
Oral > Solid > tablet: 400 mg",Tuberculosis,J01MA14,,Added,moxifloxacin,['moxifloxacin']
multiple micronutrient powder,Vitamins and minerals,"Sachets containing:
- iron (elemental) 12.5 mg (as coated ferrous fumarate)
- zinc (elemental) 5 mg 
- vitamin A 300 micrograms
- with or without other micronutrients at recommended daily values",Iron deficiency anaemia,A11AA01,,Added,multiple micronutrient powder,"['powder', 'multiple', 'micronutrient', 'multiple micronutrient powder']"
multiple micronutrient supplement,Other medicines administered to the mother,"Tablet containing: 
Vit A: 800 mcg retinol activity equivalent
Vit C: 70 mg
Vit D: 5 mcg (200 IU)
Vit E: 10 mg alpha tocopherol equivalent
Vit B1: 1.4 mg
Vit B2: 1.4 mg
Vit B3: 18 mg niacin equivalent
Vit B6: 1.9 mg
Folic acid: 400 mcg
Vit B12: 2.6 mcg
Iron: 30 mg
Iodine: 150 mcg
Zinc: 15 mg
Selenium: 65 mcg
Copper: 2 mg",Maternal care for other specified conditions predominantly related to pregnancy,A11AA01,,Added,multiple micronutrient supplement,"['multiple', 'supplement', 'micronutrient', 'multiple micronutrient supplement']"
mumps vaccine,Recommendations for immunization programmes with certain characteristics,All vaccines should comply with the WHO requirements for biological substances.,Need for immunization against mumps alone,J07BE01,,Added,mumps vaccine,"['vaccine', 'mumps vaccine', 'mumps']"
mupirocin,Dermatological medicines > Anti-infective medicines,"Local > Topical > Cream: 2% (as mupirocin calcium)
Local > Topical > Ointment: 2%",Superficial bacterial folliculitis,D06AX09,,Added,mupirocin,['mupirocin']
mupirocin,Dermatological medicines > Anti-infective medicines,"Local > Topical > Cream: 2% (as mupirocin calcium)
Local > Topical > Ointment: 2%",Impetigo,D06AX09,,Added,mupirocin,['mupirocin']
nadroparin,Medicines affecting coagulation,,Acute ischaemic heart disease,,,Added,nadroparin,['nadroparin']
nadroparin,Medicines affecting coagulation,,Venous thromboembolism,,,Added,nadroparin,['nadroparin']
naloxone,Antidotes and other substances used in poisonings > Specific,Parenteral > General injections > unspecified: 400 µg per 1 mL in ampoule (naloxone hydrochloride),Unintentional exposure to or harmful effects of opioids or related analgesics,V03AB15,,Added,naloxone,['naloxone']
naltrexone,Medicines for alcohol use disorders,"Parenteral > General injections > IM: 380 mg in vial (extended-release)
Oral > Solid > tablet: 50 mg",Disorders due to use of alcohol,N07BB04,,Added,naltrexone,['naltrexone']
natamycin,Ophthalmological preparations > Anti-infective agents,Local > Ophthalmological > Suspension: 5% eye drops,Infectious keratitis,S01AA10,,Added,natamycin,['natamycin']
neostigmine,Muscle relaxants (peripherally-acting) and cholinesterase inhibitors,"Oral > Solid: 15 mg (neostigmine bromide)
Parenteral > General injections > unspecified: 0.5 mg per  mL in 1 mL ampoule (neostigmine metilsulfate); 2.5 mg per  mL in 1 mL ampoule (neostigmine metilsulfate)",Myasthenia gravis,N07AA01,,Added,neostigmine,['neostigmine']
neostigmine,Muscle relaxants (peripherally-acting) and cholinesterase inhibitors,"Oral > Solid: 15 mg (neostigmine bromide)
Parenteral > General injections > unspecified: 0.5 mg per  mL in 1 mL ampoule (neostigmine metilsulfate); 2.5 mg per  mL in 1 mL ampoule (neostigmine metilsulfate)",Anticholinesterase reversible,N07AA01,,Added,neostigmine,['neostigmine']
netilmicin,Ophthalmological preparations > Anti-infective agents,,Other specified conjunctivitis,,,Added,netilmicin,['netilmicin']
netilmicin,Ophthalmological preparations > Anti-infective agents,,Infectious blepharitis,,,Added,netilmicin,['netilmicin']
nevirapine,Antiretrovirals > Non-nucleoside reverse transcriptase inhibitors,"Oral > Liquid: 50 mg per 5 mL
Oral > Solid > dispersible tablet: 50 mg
Oral > Solid > tablet: 200 mg","Human immunodeficiency virus disease without mention of associated disease or condition, clinical stage unspecified",J05AG01,,Added,nevirapine,['nevirapine']
niclosamide,Intestinal anthelminthics,Oral > Solid: 500 mg tablet (chewable),Hymenolepiasis,P02DA01,,Added,niclosamide,['niclosamide']
niclosamide,Intestinal anthelminthics,Oral > Solid: 500 mg tablet (chewable),Diphyllobothriasis,P02DA01,,Added,niclosamide,['niclosamide']
niclosamide,Intestinal anthelminthics,Oral > Solid: 500 mg tablet (chewable),Taeniasis due to Taenia saginata,P02DA01,,Added,niclosamide,['niclosamide']
niclosamide,Intestinal anthelminthics,Oral > Solid: 500 mg tablet (chewable),Taeniasis due to Taenia solium,P02DA01,,Added,niclosamide,['niclosamide']
nicotinamide,Vitamins and minerals,Oral > Solid: 50 mg,Pellagra,A11HA01,,Added,nicotinamide,['nicotinamide']
nicotine replacement therapy,Medicines for nicotine use disorders,"Local > Topical > Transdermal patch: 5 to 30 mg per 16 hour; 7 to 21 mg per 24 hour
Oral > Solid > lozenge: 2 mg; 4 mg lozenge
Local > Buccal > Oral spray: 1 mg per  actuation
Local > Buccal > Chewing gum: 2 mg; 4 mg",Nicotine dependence,N07BA01,,Added,nicotine replacement therapy,"['nicotine replacement therapy', 'nicotine', 'therapy', 'replacement']"
nifedipine,Antioxytocics (tocolytics),Oral > Solid: 10 mg (immediate-release),Preterm labour without delivery,C08CA05,,Added,nifedipine,['nifedipine']
nifurtimox,American trypanosomiasis,Oral > Solid > tablet: 30 mg (scored); 120 mg (scored),Chagas disease,P01CC01,,Added,nifurtimox,['nifurtimox']
nifurtimox,Medicines for the treatment of 2nd stage African trypanosomiasis,Oral > Solid > tablet: 30 mg (scored); 120 mg (scored),African trypanosomiasis,P01CC01,,Added,nifurtimox,['nifurtimox']
nilotinib,Targeted therapies,Oral > Solid > capsule: 150 mg; 200 mg,"Chronic myeloid leukaemia, not elsewhere classified",L01EA03,,Added,nilotinib,['nilotinib']
nilutamide,Hormones and antihormones,,Malignant neoplasms of prostate,,,Added,nilutamide,['nilutamide']
nitrofurantoin,Access group antibiotics,"Oral > Liquid: 25 mg per 5 mL oral liquid
Oral > Solid > dosage form: 100 mg; 50 mg",Infectious cystitis,J01XE01,,Added,nitrofurantoin,['nitrofurantoin']
nitrous oxide,General anaesthetics and oxygen > Inhalational medicines,Respiratory > Inhalation: ,Anaesthetics and therapeutic gases,N01AX13,,Added,nitrous oxide,"['nitrous oxide', 'oxide', 'nitrous']"
nivolumab,Immunomodulators,Parenteral > General injections > IV: 10 mg per  mL concentrate solution for infusion,Melanoma of skin,L01FF01,,Added,nivolumab,['nivolumab']
norethisterone,Progestogens,"Oral > Solid: 5 mg
",Excessive menstruation with irregular cycle,,,Added,norethisterone,['norethisterone']
norethisterone enantate,Injectable hormonal contraceptives,Parenteral > General injections > IM: 200 mg per  mL in 1 mL ampoule oily solution,Contact with health services for reasons associated with reproduction,G03AC01,,Added,norethisterone enantate,"['enantate', 'norethisterone', 'norethisterone enantate']"
normal immunoglobulin,Human immunoglobulins,"Parenteral > General injections > IV: 5% protein solution; 10% protein solution
Parenteral > General injections > IM: 16% protein solution
Parenteral > General injections > SC: 15% protein solution; 16% protein solution",Primary immunodeficiencies,J06BA02,,Added,normal immunoglobulin,"['normal immunoglobulin', 'normal', 'immunoglobulin']"
normal immunoglobulin,Human immunoglobulins,"Parenteral > General injections > IV: 5% protein solution; 10% protein solution
Parenteral > General injections > IM: 16% protein solution
Parenteral > General injections > SC: 15% protein solution; 16% protein solution",Langerhans cell histiocytosis,J06BA02,,Added,normal immunoglobulin,"['normal immunoglobulin', 'normal', 'immunoglobulin']"
normal immunoglobulin,Human immunoglobulins,"Parenteral > General injections > IV: 5% protein solution; 10% protein solution
Parenteral > General injections > IM: 16% protein solution
Parenteral > General injections > SC: 15% protein solution; 16% protein solution",Mucocutaneous lymph node syndrome,J06BA02,,Added,normal immunoglobulin,"['normal immunoglobulin', 'normal', 'immunoglobulin']"
nystatin,Antifungal medicines,"Oral > Liquid: 100000 IU per  mL
Local > Topical > Other: 100000 IU pessary
Oral > Solid > dosage form: 500000 IU
Oral > Solid > lozenge: 100000 IU",Candidosis,A07AA02,,Added,nystatin,['nystatin']
octreotide,Medicines for disorders of the pituitary hormone system,"Parenteral > General injections > IM: 20 mg in vial (modified-release, as acetate) plus diluent
Parenteral > General injections > SC: 0.05 mg per  mL in 1 mL vial (immediate-release, as acetate); 0.1 mg per  mL in 1 mL vial (immediate-release, as acetate); 0.5 mg per  mL in 1 mL vial (immediate-release, as acetate)",Acromegaly or pituitary gigantism,H01CB02,,Added,octreotide,['octreotide']
ofloxacin,"Ear, nose and throat medicines [c]",,Infectious diseases of external ear,,,Added,ofloxacin,['ofloxacin']
ofloxacin,Ophthalmological preparations > Anti-infective agents,Local > Ophthalmological > Solution (eye drops): 0.3%,Other specified conjunctivitis,S01AE01,,Added,ofloxacin,['ofloxacin']
ofloxacin,Ophthalmological preparations > Anti-infective agents,Local > Ophthalmological > Solution (eye drops): 0.3%,Infectious keratitis,S01AE01,,Added,ofloxacin,['ofloxacin']
olanzapine,Medicines for psychotic disorders,"
Parenteral > General injections > IM: 10 mg in vial powder for injection",Schizophrenia or other primary psychotic disorders,,,Added,olanzapine,['olanzapine']
olanzapine,Medicines for psychotic disorders,"
Parenteral > General injections > IM: 10 mg in vial powder for injection",Schizophrenia or other primary psychotic disorders,N05AH03,,Added,olanzapine,['olanzapine']
omeprazole,Antiulcer medicines,"Oral > Liquid: 20 mg powder for oral liquid; 40 mg powder for oral liquid
Oral > Solid: 10 mg; 20 mg; 40 mg
Parenteral > General injections > IV: 40 mg in vial","Peptic ulcer, site unspecified",A02BC01,,Added,omeprazole,['omeprazole']
omeprazole,Antiulcer medicines,"Oral > Liquid: 20 mg powder for oral liquid; 40 mg powder for oral liquid
Oral > Solid: 10 mg; 20 mg; 40 mg
Parenteral > General injections > IV: 40 mg in vial",Gastro-oesophageal reflux disease,A02BC01,,Added,omeprazole,['omeprazole']
omeprazole,Antiulcer medicines,"Oral > Liquid: 20 mg powder for oral liquid; 40 mg powder for oral liquid
Oral > Solid: 10 mg; 20 mg; 40 mg
Parenteral > General injections > IV: 40 mg in vial",Gastrointestinal bleeding,A02BC01,,Added,omeprazole,['omeprazole']
ondansetron,Medicines for other common symptoms in palliative care,"Parenteral > General injections > IV: 2 mg per  mL in 2 mL ampoule (ondansetron base, as hydrochloride)
Oral > Liquid: 4 mg per 5 mL (ondansetron base)
Oral > Solid: 4 mg (ondansetron base); 8 mg (ondansetron base)",Palliative care,A04AA01,,Added,ondansetron,['ondansetron']
ondansetron,Antiemetic medicines,"Parenteral > General injections > IV: 2 mg per  mL in 2 mL ampoule (ondansetron base, as hydrochloride)
Oral > Liquid: 4 mg per 5 mL (ondansetron base)
Oral > Solid: 4 mg (ondansetron base); 8 mg (ondansetron base); 24 mg (ondansetron base)",Nausea or vomiting,A04AA01,,Added,ondansetron,['ondansetron']
oral rehydration salts,Oral rehydration,"Powder for dilution in 200 mL, 500 mL, 1 L:

- glucose 75 mEq
- sodium 75 mEq or mmol/L
- chloride 65 mEq or mmol/L
- potassium 20 mEq or mmol/L
- citrate 10 mmol/L
- osmolarity 245 mOsm/L
- glucose 13.5 g/L
- sodium chloride 2.6 g/L
- potassium chloride 1.5 g/L
- trisodium citrate dihydrate 2.9 g/L",Diarrhoea,A07CA,,Added,oral rehydration salts,"['oral rehydration salts', 'salts', 'rehydration', 'oral']"
oral rehydration salts,"Solutions correcting water, electrolyte and acid-base disturbances > Oral","Powder for dilution in 200 mL, 500 mL, 1 L:

- glucose 75 mEq
- sodium 75 mEq or mmol/L
- chloride 65 mEq or mmol/L
- potassium 20 mEq or mmol/L
- citrate 10 mmol/L
- osmolarity 245 mOsm/L
- glucose 13.5 g/L
- sodium chloride 2.6 g/L
- potassium chloride 1.5 g/L
- trisodium citrate dihydrate 2.9 g/L","Other specified disorders of fluid, electrolyte or acid-base balance",A07CA,,Added,oral rehydration salts,"['oral rehydration salts', 'salts', 'rehydration', 'oral']"
oral rehydration salts - zinc sulfate,Medicines used in diarrhoea,Oral > Other: ORS powder for dilution and zinc sulfate solid oral dosage form 20 mg (co-packaged),Diarrhoea,A07CA,,Added,oral rehydration salts - zinc sulfate,"['oral', 'oral rehydration salts - zinc sulfate', 'rehydration', 'zinc', 'salts', 'sulfate', '-']"
oseltamivir,Other antivirals,Oral > Solid: 30 mg capsule (as phosphate); 45 mg capsule (as phosphate); 75 mg capsule (as phosphate),Influenza due to identified seasonal influenza virus,J05AH02,,Added,oseltamivir,['oseltamivir']
oxaliplatin,Cytotoxic medicines,Parenteral > General injections > IV: 50 mg in vial powder for injection; 100 mg in vial powder for injection; 50 mg per 10 mL in 10 mL vial; 100 mg per 20 mL in 20 mL vial; 200 mg per 40 mL in 40 mL vial,Malignant neoplasm metastasis in large intestine,L01XA03,,Added,oxaliplatin,['oxaliplatin']
oxaliplatin,Cytotoxic medicines,Parenteral > General injections > IV: 50 mg in vial powder for injection; 100 mg in vial powder for injection; 50 mg per 10 mL in 10 mL vial; 100 mg per 20 mL in 20 mL vial; 200 mg per 40 mL in 40 mL vial,Malignant neoplasms of colon,L01XA03,,Added,oxaliplatin,['oxaliplatin']
oxamniquine,Antischistosomals and other antitrematode medicines,"Oral > Liquid: 250 mg per 5 mL
Oral > Solid > capsule: 250 mg",Schistosomiasis due to Schistosoma mansoni,P02BA02,,Added,oxamniquine,['oxamniquine']
oxycodone,Opioid analgesics,,Pain,,,Added,oxycodone,['oxycodone']
oxygen,General anaesthetics and oxygen > Inhalational medicines,Respiratory > Inhalation: (medical gas),Anaesthetics and therapeutic gases,V03AN01,,Added,oxygen,['oxygen']
oxygen,Medical gases,Respiratory > Inhalation: ,Respiratory failure as acute or chronic,V03AN01,,Added,oxygen,['oxygen']
oxytetracycline,Ophthalmological preparations > Anti-infective agents,,Other specified conjunctivitis,,,Added,oxytetracycline,['oxytetracycline']
oxytetracycline,Ophthalmological preparations > Anti-infective agents,,Infectious keratitis,,,Added,oxytetracycline,['oxytetracycline']
oxytetracycline,Ophthalmological preparations > Anti-infective agents,,Infectious blepharitis,,,Added,oxytetracycline,['oxytetracycline']
oxytetracycline,Ophthalmological preparations > Anti-infective agents,,Trachoma,,,Added,oxytetracycline,['oxytetracycline']
oxytocin,Uterotonics,Parenteral > General injections > unspecified: 10 IU per  mL,Postpartum haemorrhage,H01BB02,,Added,oxytocin,['oxytocin']
p-aminosalicylate sodium,Antituberculosis medicines,Oral > Liquid: 5.52 g in sachet (equivalent to 4 g p-aminosalicylic acid) powder for oral solution,Multi-drug resistant Mycobacterium tuberculosis,J04AA01,,Added,p-aminosalicylate sodium,"['sodium', 'p-aminosalicylate', 'p-aminosalicylate sodium']"
paclitaxel,Cytotoxic medicines,Parenteral > General injections > IV: 6 mg per  mL,Other specified malignant neoplasms of the ovary,L01CD01,,Added,paclitaxel,['paclitaxel']
paclitaxel,Cytotoxic medicines,Parenteral > General injections > IV: 6 mg per  mL,Other specified malignant neoplasms of bronchus or lung,L01CD01,,Added,paclitaxel,['paclitaxel']
paclitaxel,Cytotoxic medicines,Parenteral > General injections > IV: 6 mg per  mL,Malignant neoplasms of nasopharynx,L01CD01,,Added,paclitaxel,['paclitaxel']
paclitaxel,Cytotoxic medicines,Parenteral > General injections > IV: 6 mg per  mL,Kaposi sarcoma of unspecified primary site,L01CD01,,Added,paclitaxel,['paclitaxel']
paclitaxel,Cytotoxic medicines,Parenteral > General injections > IV: 6 mg per  mL,Other specified malignant neoplasms of breast,L01CD01,,Added,paclitaxel,['paclitaxel']
paclitaxel,Cytotoxic medicines,Parenteral > General injections > IV: 6 mg per  mL,Other specified carcinomas of ovary,L01CD01,,Added,paclitaxel,['paclitaxel']
paclitaxel,Cytotoxic medicines,Parenteral > General injections > IV: 6 mg per  mL,Malignant neoplasms of breast,L01CD01,,Added,paclitaxel,['paclitaxel']
paclitaxel,Cytotoxic medicines,Parenteral > General injections > IV: 6 mg per  mL,Malignant neoplasms of cervix uteri,L01CD01,,Added,paclitaxel,['paclitaxel']
paliperidone,Medicines for psychotic disorders,"
Parenteral > General injections > IM: 25 mg in pre-filled syringe (as palmitate); 50 mg in pre-filled syringe (as palmitate); 75 mg in pre-filled syringe (as palmitate); 100 mg in pre-filled syringe (as palmitate); 150 mg in pre-filled syringe (as palmitate)",Schizophrenia or other primary psychotic disorders,,,Added,paliperidone,['paliperidone']
paliperidone,Medicines for psychotic disorders,"
Parenteral > General injections > IM: 25 mg in pre-filled syringe (as palmitate); 50 mg in pre-filled syringe (as palmitate); 75 mg in pre-filled syringe (as palmitate); 100 mg in pre-filled syringe (as palmitate); 150 mg in pre-filled syringe (as palmitate)",Schizophrenia or other primary psychotic disorders,N05AX13,,Added,paliperidone,['paliperidone']
palonosetron,Medicines for other common symptoms in palliative care,,Palliative care,,,Added,palonosetron,['palonosetron']
palonosetron,Antiemetic medicines,,Nausea or vomiting,,,Added,palonosetron,['palonosetron']
pancreatic enzymes,Pancreatic enzymes,"Oral > Solid: Age-appropriate formulations and doses including lipase, protease and amylase.",Enzyme intestinal,A09AA02,,Added,pancreatic enzymes,"['pancreatic enzymes', 'pancreatic', 'enzymes']"
paracetamol (acetaminophen),Non-opioids and non-steroidal anti-inflammatory medicines (NSAIMs),"Oral > Liquid: 125 mg per 5 mL; 120 mg per 5 mL; 250 mg per 5 mL
Local > Rectal > Suppository: 100 mg; 250 mg
Oral > Solid > dispersible tablet: 100 mg; 250 mg
Oral > Solid > tablet: 250 mg; 325 mg; 500 mg",Pain,N02BE01,,Added,paracetamol (acetaminophen),"['paracetamol', 'paracetamol (acetaminophen)', '(acetaminophen)']"
paracetamol (acetaminophen),Antimigraine medicines > For treatment of acute attack,"Oral > Liquid: 125 mg per 5 mL; 120 mg per 5 mL; 250 mg per 5 mL
Local > Rectal > Suppository: 250 mg
Oral > Solid > dispersible tablet: 100 mg; 250 mg
Oral > Solid > tablet: 250 mg; 325 mg; 500 mg",Migraine,N02BE01,,Added,paracetamol (acetaminophen),"['paracetamol', 'paracetamol (acetaminophen)', '(acetaminophen)']"
paromomycin,Antileishmaniasis medicines,Parenteral > General injections > IM: 750 mg paromomycin base (as sulfate),Visceral leishmaniasis,A07AA06,,Added,paromomycin,['paromomycin']
pegaspargase,Cytotoxic medicines,Parenteral > General injections > IV: 3750 units per 5 mL in vial; 3750 units in vial powder for injection,"Lymphoid leukaemia, not elsewhere classified",L01XX24,,Added,pegaspargase,['pegaspargase']
pegfilgrastim,Immunomodulators,Parenteral > General injections > SC: 6 mg per 0.6 mL in pre-filled syringe,Acquired neutropaenia,L03AA13,,Added,pegfilgrastim,['pegfilgrastim']
pembrolizumab,Immunomodulators,"
Parenteral > General injections > IV: 50 mg powder for injection",Melanoma of skin,,,Added,pembrolizumab,['pembrolizumab']
penicillamine,Antidotes and other substances used in poisonings > Specific,Oral > Solid: 250 mg,"Harmful effects of or exposure to noxious substances, chiefly nonmedicinal as to source, not elsewhere classified",M01CC01,,Added,penicillamine,['penicillamine']
penicillamine,Disease-modifying anti-rheumatic drugs (DMARDs),Oral > Solid: 250 mg,"Rheumatoid arthritis, serology unspecified",M01CC01,,Added,penicillamine,['penicillamine']
pentamidine,Medicines for the treatment of 1st stage African trypanosomiasis,Parenteral > General injections > IM: 300 mg in vial (as isetionate) powder for injection,African trypanosomiasis,P01CX01,,Added,pentamidine,['pentamidine']
pentamidine,Antipneumocystosis and antitoxoplasmosis medicines,Oral > Solid > tablet: 200 mg (as isethionate); 300 mg (as isethionate),Pneumocystosis,P01CX01,,Added,pentamidine,['pentamidine']
permethrin,Dermatological medicines > Scabicides and pediculicides,"Local > Topical > Lotion: 1%
Local > Topical > Cream: 5%",Pediculosis corporis,P03AC04,,Added,permethrin,['permethrin']
permethrin,Dermatological medicines > Scabicides and pediculicides,"Local > Topical > Lotion: 1%
Local > Topical > Cream: 5%",Pediculosis capitis,P03AC04,,Added,permethrin,['permethrin']
permethrin,Dermatological medicines > Scabicides and pediculicides,"Local > Topical > Lotion: 1%
Local > Topical > Cream: 5%",Scabies,P03AC04,,Added,permethrin,['permethrin']
pertussis vaccine,Recommendations for all immunization programmes,All vaccines should comply with the WHO requirements for biological substances.,Need for immunization against pertussis alone,J07AJ02,,Added,pertussis vaccine,"['pertussis vaccine', 'vaccine', 'pertussis']"
phenobarbital,Antiseizure medicines,"Oral > Liquid: 15 mg per 5 mL
Oral > Solid: 15 to 100 mg
Parenteral > General injections > IV: 200 mg per  mL (phenobarbital sodium); 30 mg per  mL (phenobarbital sodium); 60 mg per  mL (phenobarbital sodium)",Epilepsy or seizures,N03AA02,,Added,phenobarbital,['phenobarbital']
phenobarbital,Antiseizure medicines,"Oral > Liquid: 15 mg per 5 mL
Oral > Solid: 15 to 100 mg
Parenteral > General injections > IV: 200 mg per  mL (phenobarbital sodium); 30 mg per  mL (phenobarbital sodium); 60 mg per  mL (phenobarbital sodium)",Status epilepticus,N03AA02,,Added,phenobarbital,['phenobarbital']
phenoxymethylpenicillin,Access group antibiotics,"Oral > Liquid: 250 mg per 5 mL (as potassium salt) powder for oral liquid
Oral > Solid: 250 mg (as potassium salt) tablet
Oral > Solid: 250 mg (as potassium salt); 500 mg (as potassium salt)",Bacterial pneumonia (Community-acquired pneumonia - mild to moderate),J01CE02,,Added,phenoxymethylpenicillin,['phenoxymethylpenicillin']
phenoxymethylpenicillin,Access group antibiotics,"Oral > Liquid: 250 mg per 5 mL (as potassium salt) powder for oral liquid
Oral > Solid: 250 mg (as potassium salt) tablet
Oral > Solid: 250 mg (as potassium salt); 500 mg (as potassium salt)",Periapical abscess without sinus,J01CE02,,Added,phenoxymethylpenicillin,['phenoxymethylpenicillin']
phenoxymethylpenicillin,Access group antibiotics,"Oral > Liquid: 250 mg per 5 mL (as potassium salt) powder for oral liquid
Oral > Solid: 250 mg (as potassium salt) tablet
Oral > Solid: 250 mg (as potassium salt); 500 mg (as potassium salt)",Acute pharyngitis,J01CE02,,Added,phenoxymethylpenicillin,['phenoxymethylpenicillin']
phenytoin,Antiseizure medicines,"Oral > Liquid: 30 mg per 5 mL (phenytoin)
Parenteral > General injections > unspecified: 50 mg per  mL in vial (phenytoin sodium)
Oral > Solid > tablet: 50 mg (phenytoin) (chewable)
Oral > Solid > dosage form: 25 mg (phenytoin sodium); 50 mg (phenytoin sodium); 100 mg (phenytoin sodium)",Epilepsy or seizures,N03AB02,,Added,phenytoin,['phenytoin']
phytomenadione,Medicines affecting coagulation,"Parenteral > General injections > IV: 10 mg per  mL in ampoule; 1 mg per  mL in ampoule
Oral > Solid: 10 mg tablet",Haemorrhagic disorder due to other specified circulating anticoagulants,B02BA01,,Added,phytomenadione,['phytomenadione']
phytomenadione,Medicines affecting coagulation,"Parenteral > General injections > IV: 10 mg per  mL in ampoule; 1 mg per  mL in ampoule
Oral > Solid: 10 mg tablet",Haemorrhagic or haematological disorders of fetus or newborn,B02BA01,,Added,phytomenadione,['phytomenadione']
pilocarpine,Ophthalmological preparations > Miotics and antiglaucoma medicines,Local > Ophthalmological > Solution (eye drops): 2% (hydrochloride or nitrate); 4% (hydrochloride or nitrate),Acute angle closure with pupillary block,S01EB01,,Added,pilocarpine,['pilocarpine']
pilocarpine,Ophthalmological preparations > Miotics and antiglaucoma medicines,Local > Ophthalmological > Solution (eye drops): 2% (hydrochloride or nitrate); 4% (hydrochloride or nitrate),Ocular hypertension,S01EB01,,Added,pilocarpine,['pilocarpine']
pilocarpine,Ophthalmological preparations > Miotics and antiglaucoma medicines,Local > Ophthalmological > Solution (eye drops): 2% (hydrochloride or nitrate); 4% (hydrochloride or nitrate),Primary open-angle glaucoma,S01EB01,,Added,pilocarpine,['pilocarpine']
piperacillin + tazobactam,Watch group antibiotics,Parenteral > General injections > IV: 2 g (as sodium salt) + 250 mg (as sodium salt) powder for injection; 4 g (as sodium salt) + 500 mg (as sodium salt) powder for injection,Other specified pneumonia (Hospital-acquired pneumonia),J01CR05,,Added,piperacillin + tazobactam,"['piperacillin', 'piperacillin + tazobactam', '+', 'tazobactam']"
piperacillin + tazobactam,Watch group antibiotics,Parenteral > General injections > IV: 2 g (as sodium salt) + 250 mg (as sodium salt) powder for injection; 4 g (as sodium salt) + 500 mg (as sodium salt) powder for injection,Peritonitis (severe),J01CR05,,Added,piperacillin + tazobactam,"['piperacillin', 'piperacillin + tazobactam', '+', 'tazobactam']"
piperacillin + tazobactam,Watch group antibiotics,Parenteral > General injections > IV: 2 g (as sodium salt) + 250 mg (as sodium salt) powder for injection; 4 g (as sodium salt) + 500 mg (as sodium salt) powder for injection,Neutropenia (high-risk),J01CR05,,Added,piperacillin + tazobactam,"['piperacillin', 'piperacillin + tazobactam', '+', 'tazobactam']"
piperacillin + tazobactam,Watch group antibiotics,Parenteral > General injections > IV: 2 g (as sodium salt) + 250 mg (as sodium salt) powder for injection; 4 g (as sodium salt) + 500 mg (as sodium salt) powder for injection,Peritoneal abscess (severe),J01CR05,,Added,piperacillin + tazobactam,"['piperacillin', 'piperacillin + tazobactam', '+', 'tazobactam']"
piperacillin + tazobactam,Watch group antibiotics,Parenteral > General injections > IV: 2 g (as sodium salt) + 250 mg (as sodium salt) powder for injection; 4 g (as sodium salt) + 500 mg (as sodium salt) powder for injection,Necrotising fasciitis,J01CR05,clindamycin,Added,piperacillin + tazobactam,"['piperacillin', 'piperacillin + tazobactam', '+', 'tazobactam']"
platelets,Blood and blood components,Parenteral > General injections > IV: ,Blood transfusion without reported diagnosis,B05AX02,,Added,platelets,['platelets']
plazomicin,Reserve group antibiotics,Parenteral > General injections > IV: 500 mg per 10 mL,Carbapenem resistant Acinetobacter baumannii,J01GB14,,Added,plazomicin,['plazomicin']
plazomicin,Reserve group antibiotics,Parenteral > General injections > IV: 500 mg per 10 mL,Carbapenem-resistant Pseudomonas aeruginosa,J01GB14,,Added,plazomicin,['plazomicin']
plazomicin,Reserve group antibiotics,Parenteral > General injections > IV: 500 mg per 10 mL,Carbapenem resistant Enterobacterales,J01GB14,,Added,plazomicin,['plazomicin']
pneumococcal vaccine,Recommendations for all immunization programmes,All vaccines should comply with the WHO requirements for biological substances.,Need for immunization against single bacterial diseases,J07AL01,,Added,pneumococcal vaccine,"['pneumococcal', 'vaccine', 'pneumococcal vaccine']"
podophyllotoxin,Dermatological medicines > Medicines affecting skin differentiation and proliferation,,Anogenital warts,,,Added,podophyllotoxin,['podophyllotoxin']
podophyllotoxin,Dermatological medicines > Medicines affecting skin differentiation and proliferation,,Plantar warts,,,Added,podophyllotoxin,['podophyllotoxin']
podophyllum resin,Dermatological medicines > Medicines affecting skin differentiation and proliferation,Local > Topical > Solution: 10 to 25%,Anogenital warts,D06BB04,,Added,podophyllum resin,"['podophyllum resin', 'podophyllum', 'resin']"
podophyllum resin,Dermatological medicines > Medicines affecting skin differentiation and proliferation,Local > Topical > Solution: 10 to 25%,Plantar warts,D06BB04,,Added,podophyllum resin,"['podophyllum resin', 'podophyllum', 'resin']"
poliomyelitis vaccine,Recommendations for all immunization programmes,All vaccines should comply with the WHO requirements for biological substances.,Need for immunization against poliomyelitis,"J07BF01, J07BF02, J07BF03, J07BF04",,Added,poliomyelitis vaccine,"['poliomyelitis vaccine', 'vaccine', 'poliomyelitis']"
polygeline,Plasma substitutes,"Parenteral > General injections > IV: 3.5% injectable solution
Parenteral > General injections > IV: 3.5% in solution",Hypovolaemia,,,Added,polygeline,['polygeline']
polymyxin B (injection),Reserve group antibiotics,Parenteral > General injections > IV: 500000 IU in vial powder for injection (equivalent to 50 mg polymyxin B base),Carbapenem resistant Acinetobacter baumannii,J01XB02,,Added,polymyxin b (injection),"['(injection)', 'b', 'polymyxin b (injection)', 'polymyxin']"
polymyxin B (injection),Reserve group antibiotics,Parenteral > General injections > IV: 500000 IU in vial powder for injection (equivalent to 50 mg polymyxin B base),Carbapenem-resistant Pseudomonas aeruginosa,J01XB02,,Added,polymyxin b (injection),"['(injection)', 'b', 'polymyxin b (injection)', 'polymyxin']"
polymyxin B (injection),Reserve group antibiotics,Parenteral > General injections > IV: 500000 IU in vial powder for injection (equivalent to 50 mg polymyxin B base),Carbapenem resistant Enterobacterales,J01XB02,,Added,polymyxin b (injection),"['(injection)', 'b', 'polymyxin b (injection)', 'polymyxin']"
potassium chloride,"Solutions correcting water, electrolyte and acid-base disturbances > Oral",Oral > Liquid: powder for solution,Hypokalaemia,A12BA01,,Added,potassium chloride,"['chloride', 'potassium', 'potassium chloride']"
potassium chloride,"Solutions correcting water, electrolyte and acid-base disturbances > Parenteral",Parenteral > General injections > IV: 11.2% in 20 mL ampoule (equivalent to K+ 1.5 mmol/mL and Cl- 1.5 mmol/mL); 7.5% solution for dilution (equivalent to K+ 1 mmol/mL and Cl- 2 mmol/mL); 15% solution for dilution (equivalent to K+ 2 mmol/mL and Cl- 2 mmol/mL),Hypokalaemia,B05XA01,,Added,potassium chloride,"['chloride', 'potassium', 'potassium chloride']"
potassium ferric hexacyanoferrate (Prussian blue),Antidotes and other substances used in poisonings > Specific,Oral > Solid: Powder for oral administration,"Harmful effects of or exposure to noxious substances, chiefly nonmedicinal as to source, not elsewhere classified",V03AB31,,Added,potassium ferric hexacyanoferrate (prussian blue),"['hexacyanoferrate', '(prussian', 'potassium ferric hexacyanoferrate (prussian blue)', 'potassium', 'blue)', 'ferric']"
potassium iodide,Thyroid hormones and antithyroid medicines,Oral > Solid: 60 mg,Thyrotoxicosis,V03AB21,,Added,potassium iodide,"['potassium iodide', 'potassium', 'iodide']"
potassium iodide,Antifungal medicines,Local > Topical > Solution: Saturated solution,Sporotrichosis,D08AG03,,Added,potassium iodide,"['potassium iodide', 'potassium', 'iodide']"
potassium permanganate,Dermatological medicines > Anti-infective medicines,Local > Topical > Solution: aqueous solution: 1:10 000,Tropical phagedaenic ulcer,D08AX06,,Added,potassium permanganate,"['permanganate', 'potassium permanganate', 'potassium']"
potassium permanganate,Dermatological medicines > Anti-infective medicines,Local > Topical > Solution: aqueous solution: 1:10 000,Pemphigus,D08AX06,,Added,potassium permanganate,"['permanganate', 'potassium permanganate', 'potassium']"
potassium permanganate,Dermatological medicines > Anti-infective medicines,Local > Topical > Solution: aqueous solution: 1:10 000,Other specified pyogenic bacterial infection of skin and subcutaneous tissue,D08AX06,,Added,potassium permanganate,"['permanganate', 'potassium permanganate', 'potassium']"
potassium permanganate,Dermatological medicines > Anti-infective medicines,Local > Topical > Solution: aqueous solution: 1:10 000,Impetigo,D08AX06,,Added,potassium permanganate,"['permanganate', 'potassium permanganate', 'potassium']"
povidone iodine,Antiseptics,Local > Topical > Solution: 10% (equivalent to 1% available iodine),Povidone iodine,D08AG02,,Added,povidone iodine,"['povidone iodine', 'iodine', 'povidone']"
pravastatin,Lipid-lowering agents,,Mixed hyperlipidaemia,,,Added,pravastatin,['pravastatin']
pravastatin,Lipid-lowering agents,,Coronary atherosclerosis,,,Added,pravastatin,['pravastatin']
praziquantel,Antischistosomals and other antitrematode medicines,Oral > Solid > tablet: 600 mg (scored); 500 mg; 150 mg,Paragonimiasis,P02BA01,,Added,praziquantel,['praziquantel']
praziquantel,Antischistosomals and other antitrematode medicines,Oral > Solid > tablet: 600 mg (scored); 500 mg; 150 mg,Clonorchiasis,P02BA01,,Added,praziquantel,['praziquantel']
praziquantel,Antischistosomals and other antitrematode medicines,Oral > Solid > tablet: 600 mg (scored); 500 mg; 150 mg,Opisthorchiasis,P02BA01,,Added,praziquantel,['praziquantel']
praziquantel,Antischistosomals and other antitrematode medicines,Oral > Solid > tablet: 600 mg (scored); 500 mg; 150 mg,Schistosomiasis,P02BA01,,Added,praziquantel,['praziquantel']
praziquantel,Intestinal anthelminthics,Oral > Solid > tablet: 600 mg (scored); 500 mg; 150 mg,Taeniasis due to Taenia saginata,P02BA01,,Added,praziquantel,['praziquantel']
praziquantel,Intestinal anthelminthics,Oral > Solid > tablet: 600 mg (scored); 500 mg; 150 mg,Taeniasis due to Taenia solium,P02BA01,,Added,praziquantel,['praziquantel']
praziquantel,Intestinal anthelminthics,Oral > Solid > tablet: 600 mg (scored); 500 mg; 150 mg,Hymenolepiasis,P02BA01,,Added,praziquantel,['praziquantel']
praziquantel,Intestinal anthelminthics,Oral > Solid > tablet: 600 mg (scored); 500 mg; 150 mg,Diphyllobothriasis,P02BA01,,Added,praziquantel,['praziquantel']
praziquantel,Cysticidal medicines,Oral > Solid > tablet: 600 mg (scored); 500 mg; 150 mg,Cysticercosis of central nervous system,P02BA01,,Added,praziquantel,['praziquantel']
precipitated sulfur,Dermatological medicines > Scabicides and pediculicides,Local > Topical > Ointment: ,Pthiriasis,,,Added,precipitated sulfur,"['precipitated', 'sulfur', 'precipitated sulfur']"
precipitated sulfur,Dermatological medicines > Scabicides and pediculicides,Local > Topical > Ointment: ,Pediculosis corporis,,,Added,precipitated sulfur,"['precipitated', 'sulfur', 'precipitated sulfur']"
precipitated sulfur,Dermatological medicines > Scabicides and pediculicides,Local > Topical > Ointment: ,Pediculosis capitis,,,Added,precipitated sulfur,"['precipitated', 'sulfur', 'precipitated sulfur']"
precipitated sulfur,Dermatological medicines > Scabicides and pediculicides,Local > Topical > Ointment: ,Scabies,,,Added,precipitated sulfur,"['precipitated', 'sulfur', 'precipitated sulfur']"
prednisolone,Hormones and antihormones,"Oral > Liquid: 5 mg per  mL
Oral > Solid: 5 mg; 25 mg",Plasma cell myeloma,H02AB06,,Added,prednisolone,['prednisolone']
prednisolone,Hormones and antihormones,"Oral > Liquid: 5 mg per  mL
Oral > Solid: 5 mg; 25 mg",Follicular lymphoma,H02AB06,,Added,prednisolone,['prednisolone']
prednisolone,Hormones and antihormones,"Oral > Liquid: 5 mg per  mL
Oral > Solid: 5 mg; 25 mg","Lymphoid leukaemia, not elsewhere classified",H02AB06,,Added,prednisolone,['prednisolone']
prednisolone,Hormones and antihormones,"Oral > Liquid: 5 mg per  mL
Oral > Solid: 5 mg; 25 mg",Malignant neoplasms of prostate,H02AB06,,Added,prednisolone,['prednisolone']
prednisolone,Hormones and antihormones,"Oral > Liquid: 5 mg per  mL
Oral > Solid: 5 mg; 25 mg",Chronic lymphocytic leukaemia or small lymphocytic lymphoma,H02AB06,,Added,prednisolone,['prednisolone']
prednisolone,Hormones and antihormones,"Oral > Liquid: 5 mg per  mL
Oral > Solid: 5 mg; 25 mg",Hodgkin lymphoma,H02AB06,,Added,prednisolone,['prednisolone']
prednisolone,Hormones and antihormones,"Oral > Liquid: 5 mg per  mL
Oral > Solid: 5 mg; 25 mg",Diffuse large B-cell lymphomas,H02AB06,,Added,prednisolone,['prednisolone']
prednisolone,Hormones and antihormones,"Oral > Liquid: 5 mg per  mL
Oral > Solid: 5 mg; 25 mg",Burkitt lymphoma including Burkitt leukaemia,H02AB06,,Added,prednisolone,['prednisolone']
prednisolone,Hormones and antihormones,"Oral > Liquid: 5 mg per  mL
Oral > Solid: 5 mg; 25 mg","Anaplastic large cell lymphoma, ALK-negative",H02AB06,,Added,prednisolone,['prednisolone']
prednisolone,Hormones and antihormones,"Oral > Liquid: 5 mg per  mL
Oral > Solid: 5 mg; 25 mg","Anaplastic large cell lymphoma, ALK-positive",H02AB06,,Added,prednisolone,['prednisolone']
prednisolone,Hormones and antihormones,"Oral > Liquid: 5 mg per  mL
Oral > Solid: 5 mg; 25 mg",Langerhans cell histiocytosis,H02AB06,,Added,prednisolone,['prednisolone']
prednisolone,Anti-inflammatory medicines,"Local > Rectal > Retention enema: 
Local > Rectal > Retention enema: 20 mg per 100 mL (as sodium phosphate)",Crohn disease site,,,Added,prednisolone,['prednisolone']
prednisolone,Anti-inflammatory medicines,"Local > Rectal > Retention enema: 
Local > Rectal > Retention enema: 20 mg per 100 mL (as sodium phosphate)",Crohn disease site,A07EA01,,Added,prednisolone,['prednisolone']
prednisolone,Anti-inflammatory medicines,"Local > Rectal > Retention enema: 
Local > Rectal > Retention enema: 20 mg per 100 mL (as sodium phosphate)",Ulcerative colitis,A07EA01,,Added,prednisolone,['prednisolone']
prednisolone,Antiallergics and medicines used in anaphylaxis,"Oral > Liquid: 5 mg per  mL
Oral > Solid: 5 mg; 25 mg",Allergic or hypersensitivity conditions of unspecified type,H02AB06,,Added,prednisolone,['prednisolone']
prednisolone,Ophthalmological preparations > Anti-inflammatory agents,Local > Ophthalmological > Solution (eye drops): 0.5% (sodium phosphate),Scleritis,S01BA04,,Added,prednisolone,['prednisolone']
prednisolone,Ophthalmological preparations > Anti-inflammatory agents,Local > Ophthalmological > Solution (eye drops): 0.5% (sodium phosphate),Anterior uveitis,S01BA04,,Added,prednisolone,['prednisolone']
prednisone,Hormones and antihormones,,Plasma cell myeloma,,,Added,prednisone,['prednisone']
prednisone,Hormones and antihormones,,Follicular lymphoma,,,Added,prednisone,['prednisone']
prednisone,Hormones and antihormones,,"Lymphoid leukaemia, not elsewhere classified",,,Added,prednisone,['prednisone']
prednisone,Hormones and antihormones,,Malignant neoplasms of prostate,,,Added,prednisone,['prednisone']
prednisone,Hormones and antihormones,,Chronic lymphocytic leukaemia or small lymphocytic lymphoma,,,Added,prednisone,['prednisone']
prednisone,Hormones and antihormones,,Hodgkin lymphoma,,,Added,prednisone,['prednisone']
prednisone,Hormones and antihormones,,Diffuse large B-cell lymphomas,,,Added,prednisone,['prednisone']
prednisone,Hormones and antihormones,,"Anaplastic large cell lymphoma, ALK-negative",,,Added,prednisone,['prednisone']
prednisone,Hormones and antihormones,,"Anaplastic large cell lymphoma, ALK-positive",,,Added,prednisone,['prednisone']
prednisone,Hormones and antihormones,,Langerhans cell histiocytosis,,,Added,prednisone,['prednisone']
prednisone,Antiallergics and medicines used in anaphylaxis,,Allergic or hypersensitivity conditions of unspecified type,,,Added,prednisone,['prednisone']
pretomanid,Antituberculosis medicines,Oral > Solid > tablet: 200 mg,Multi-drug resistant Mycobacterium tuberculosis,J04AK08,,Added,pretomanid,['pretomanid']
primaquine,Antimalarial medicines > For curative treatment,Oral > Solid: 7.5 mg tablet (as phosphate); 15 mg tablet (as phosphate),Malaria due to Plasmodium ovale,P01BA03,,Added,primaquine,['primaquine']
primaquine,Antimalarial medicines > For curative treatment,Oral > Solid: 7.5 mg tablet (as phosphate); 15 mg tablet (as phosphate),Malaria due to Plasmodium vivax,P01BA03,,Added,primaquine,['primaquine']
procaine benzylpenicillin,Access group antibiotics,Parenteral > General injections > IM: 1 g in vial (=1 million IU) powder for injection; 3 g in vial (=3 million IU) powder for injection,Congenital syphilis [children],J01CE09,,Added,procaine benzylpenicillin,"['procaine benzylpenicillin', 'procaine', 'benzylpenicillin']"
procaine benzylpenicillin,Access group antibiotics,Parenteral > General injections > IM: 1 g in vial (=1 million IU) powder for injection; 3 g in vial (=3 million IU) powder for injection,Syphilis,J01CE09,,Added,procaine benzylpenicillin,"['procaine benzylpenicillin', 'procaine', 'benzylpenicillin']"
procarbazine,Cytotoxic medicines,"Oral > Solid: 50 mg (as hydrochloride)
Oral > Solid > capsule: 50 mg (as hydrochloride)",Hodgkin lymphoma,L01XB01,,Added,procarbazine,['procarbazine']
progesterone vaginal ring,Intravaginal contraceptives,Local > Vaginal > vaginal ring: 2.074 g micronized progesterone,Contact with health services for contraceptive management,G03DA04,,Added,progesterone vaginal ring,"['progesterone', 'ring', 'vaginal', 'progesterone vaginal ring']"
proguanil,Antimalarial medicines > For chemoprevention,Oral > Solid: 100 mg tablet (hydrochloride),Malaria due to Plasmodium falciparum,P01BB01,,Added,proguanil,['proguanil']
propanol,Antiseptics,,Denatured alcohol,,,Added,propanol,['propanol']
propofol,General anaesthetics and oxygen > Injectable medicines,Parenteral > General injections > IV: 10 mg per  mL; 20 mg per  mL,Anaesthetics and therapeutic gases,N01AX10,,Added,propofol,['propofol']
propranolol,Antimigraine medicines > For prophylaxis,Oral > Solid: 40 mg tablet (hydrochloride); 20 mg tablet (hydrochloride),Migraine,C07AA05,,Added,propranolol,['propranolol']
propylthiouracil,Thyroid hormones and antithyroid medicines,Oral > Solid: 50 mg,Thyrotoxicosis,H03BA02,,Added,propylthiouracil,['propylthiouracil']
prostaglandin E1,Medicines administered to the neonate [c],Parenteral > General injections > IV: 0.5 mg per  mL in alcohol,Other specified congenital anomaly of great arteries including arterial duct,C01EA01,,Added,prostaglandin e1,"['e1', 'prostaglandin', 'prostaglandin e1']"
prostaglandin E2,Medicines administered to the neonate [c],Parenteral > General injections > IV: 1 mg per  mL,Other specified congenital anomaly of great arteries including arterial duct,,,Added,prostaglandin e2,"['prostaglandin', 'prostaglandin e2', 'e2']"
protamine sulfate,Medicines affecting coagulation,Parenteral > General injections > IV: 10 mg per  mL in 5 mL ampoule,Haemorrhagic disorder due to other specified circulating anticoagulants,V03AB14,,Added,protamine sulfate,"['sulfate', 'protamine sulfate', 'protamine']"
protionamide,Antituberculosis medicines,,Multi-drug resistant Mycobacterium tuberculosis,,,Added,protionamide,['protionamide']
pyrantel,Intestinal anthelminthics,Oral > Solid > tablet: 250 mg (chewable) (as embonate or pamoate),Ascariasis,P02CC01,,Added,pyrantel,['pyrantel']
pyrantel,Intestinal anthelminthics,Oral > Solid > tablet: 250 mg (chewable) (as embonate or pamoate),Trichuriasis,P02CC01,,Added,pyrantel,['pyrantel']
pyrantel,Intestinal anthelminthics,Oral > Solid > tablet: 250 mg (chewable) (as embonate or pamoate),Enterobiasis,P02CC01,,Added,pyrantel,['pyrantel']
pyrantel,Intestinal anthelminthics,Oral > Solid > tablet: 250 mg (chewable) (as embonate or pamoate),Hookworm diseases,P02CC01,,Added,pyrantel,['pyrantel']
pyrazinamide,Antituberculosis medicines,"Oral > Solid > dispersible tablet: 150 mg
Oral > Solid > tablet: 400 mg; 500 mg",Tuberculosis,J04AK01,,Added,pyrazinamide,['pyrazinamide']
pyridostigmine,Muscle relaxants (peripherally-acting) and cholinesterase inhibitors,"Parenteral > General injections > IV: 1 mg in 1 mL ampoule (pyridostigmine bromide)
Oral > Solid: 60 mg (pyridostigmine bromide)",Myasthenia gravis,N07AA02,,Added,pyridostigmine,['pyridostigmine']
pyridoxine,Vitamins and minerals,Oral > Solid: 25 mg (hydrochloride),Vitamin B6 deficiency,A11HA02,,Added,pyridoxine,['pyridoxine']
pyridoxine,Vitamins and minerals,Oral > Solid: 25 mg (hydrochloride),Sideroblastic anaemia,A11HA02,,Added,pyridoxine,['pyridoxine']
pyridoxine,Vitamins and minerals,Oral > Solid: 25 mg (hydrochloride),Other specified polyneuropathy,A11HA02,,Added,pyridoxine,['pyridoxine']
pyrimethamine,Antipneumocystosis and antitoxoplasmosis medicines,Oral > Solid: 25 mg,Toxoplasmosis,P01BD01,,Added,pyrimethamine,['pyrimethamine']
quetiapine,Medicines for psychotic disorders,,Schizophrenia or other primary psychotic disorders,,,Added,quetiapine,['quetiapine']
quetiapine,Medicines for bipolar disorders,Oral > Solid > tablet: 25 mg (immediate-release); 100 mg (immediate-release); 150 mg (immediate-release); 200 mg (immediate-release); 300 mg (immediate-release); 50 mg (modified-release); 150 mg (modified-release); 200 mg (modified-release); 300 mg (modified-release); 400 mg (modified-release),Bipolar or related disorders,N05AH04,,Added,quetiapine,['quetiapine']
quinine,Antimalarial medicines > For curative treatment,"Parenteral > General injections > IV: 300 mg per  mL in 2 mL ampoule (quinine hydrochloride)
Oral > Solid: 300 mg (quinine sulfate or quinine bisulfate)",Malaria due to Plasmodium falciparum,P01BC01,,Added,quinine,['quinine']
rabies vaccine,Recommendations for some high-risk populations,All vaccines should comply with the WHO requirements for biological substances.,Need for immunization against rabies,J07BG01,,Added,rabies vaccine,"['vaccine', 'rabies vaccine', 'rabies']"
raltegravir,Antiretrovirals > Integrase inhibitors,"Oral > Liquid: 100 mg granules for oral suspension
Oral > Solid: 400 mg tablet; 25 mg tablet (chewable)","Human immunodeficiency virus disease without mention of associated disease or condition, clinical stage unspecified",J05AJ01,,Added,raltegravir,['raltegravir']
ranitidine,Antiulcer medicines,"Oral > Liquid: 75 mg per 5 mL (as hydrochloride)
Oral > Solid: 150 mg (as hydrochloride)
Parenteral > General injections > unspecified: 25 mg per  mL in 2 mL ampoule (as hydrochloride)",Gastro-oesophageal reflux disease,A02BA02,,Added,ranitidine,['ranitidine']
ranitidine,Antiulcer medicines,"Oral > Liquid: 75 mg per 5 mL (as hydrochloride)
Oral > Solid: 150 mg (as hydrochloride)
Parenteral > General injections > unspecified: 25 mg per  mL in 2 mL ampoule (as hydrochloride)","Peptic ulcer, site unspecified",A02BA02,,Added,ranitidine,['ranitidine']
rasburicase,Supportive medicines,Parenteral > General injections > IV: 1.5 mg in vial powder and solvent for solution; 7.5 mg in vial powder and solvent for solution,Tumour lysis syndrome,V03AF07,,Added,rasburicase,['rasburicase']
ravidasvir,Medicines for hepatitis C > Pangenotypic direct-acting antiviral combinations,Oral > Solid > tablet: 200 mg,Chronic hepatitis C,J05AP13,,Added,ravidasvir,['ravidasvir']
ready to use therapeutic food,Therapeutic foods,Biscuit or paste of nutritional composition as determined by the UN joint statement on the community-based management of severe acute malnutrition and Codex alimentarius guidelines.,"Acute malnutrition in infants, children or adolescents",,,Added,ready to use therapeutic food,"['ready to use therapeutic food', 'food', 'therapeutic', 'to', 'ready', 'use']"
realgar-indigo naturalis formulation,Cytotoxic medicines,Oral > Solid: 270 mg (containing tetra-arsenic tetra-sulfide 30 mg),Acute myeloid leukaemia with recurrent genetic abnormalities,,,Added,realgar-indigo naturalis formulation,"['realgar-indigo', 'realgar-indigo naturalis formulation', 'naturalis', 'formulation']"
red blood cells,Blood and blood components,Parenteral > General injections > IV: ,Blood transfusion without reported diagnosis,B05AX01,,Added,red blood cells,"['red blood cells', 'red', 'cells', 'blood']"
resin-based composite (high-viscosity),Dental medicines and preparations,Local > Topical > Other: Single-use capsule or multi-use syringe,Dental caries,,,Added,resin-based composite (high-viscosity),"['resin-based', '(high-viscosity)', 'composite', 'resin-based composite (high-viscosity)']"
resin-based composite (low-viscosity),Dental medicines and preparations,Local > Topical > Other: Single-use applicator or multi-use bottle,Dental caries,,,Added,resin-based composite (low-viscosity),"['resin-based', 'resin-based composite (low-viscosity)', 'composite', '(low-viscosity)']"
retinol,Vitamins and minerals,"Parenteral > General injections > IM: 100000 IU in 2 mL ampoule (as palmitate) water-miscible injection
Oral > Liquid: 100000 IU per  mL (as palmitate) oral oily solution in multidose dispenser
Oral > Solid: 10000 IU (as palmitate) sugar-coated tablet; 200000 IU (as palmitate) capsule; 50000 IU (as palmitate) capsule; 100000 IU (as palmitate) capsule",Vitamin A deficiency,A11CA01,,Added,retinol,['retinol']
ribavirin,Other antivirals,"Parenteral > General injections > IV: 1000 mg per 10 mL phosphate buffer solution; 800 mg per 10 mL phosphate buffer solution
Oral > Solid: 200 mg; 400 mg; 600 mg","Viral haemorrhagic fever, not elsewhere classified",J05AB04,,Added,ribavirin,['ribavirin']
ribavirin,Medicines for hepatitis C > Other antivirals for hepatitis C,"Parenteral > General injections > IV: 1000 mg per 10 mL phosphate buffer solution; 800 mg per 10 mL phosphate buffer solution
Oral > Solid: 200 mg; 400 mg; 600 mg",Chronic hepatitis C,J05AP01,,Added,ribavirin,['ribavirin']
riboflavin,Vitamins and minerals,Oral > Solid: 5 mg,Vitamin B2 deficiency,A11HA04,,Added,riboflavin,['riboflavin']
rifabutin,Antituberculosis medicines,Oral > Solid: 150 mg,Tuberculosis,J04AB04,,Added,rifabutin,['rifabutin']
rifampicin,Antituberculosis medicines,"Oral > Liquid: 20 mg per  mL
Oral > Solid: 150 mg; 300 mg
Parenteral > General injections > IV: 600 mg in vial powder for injection",Tuberculosis,J04AB02,,Added,rifampicin,['rifampicin']
rifampicin,Antileprosy medicines,"Oral > Liquid: 20 mg per  mL
Oral > Solid: 150 mg; 300 mg",Leprosy,J04AB02,,Added,rifampicin,['rifampicin']
rifapentine,Antituberculosis medicines,Oral > Solid > tablet: 150 mg; 300 mg,Tuberculosis,J04AB05,,Added,rifapentine,['rifapentine']
rifapentine,Antituberculosis medicines,Oral > Solid > tablet: 150 mg; 300 mg,Latent tuberculosis,J04AB05,,Added,rifapentine,['rifapentine']
risperidone,Medicines for psychotic disorders,"Oral > Solid: 0.25 mg; 0.5 mg; 1 mg; 2 mg; 3 mg; 4 mg; 6 mg
Parenteral > General injections > IM: ",Schizophrenia or other primary psychotic disorders,N05AX08,,Added,risperidone,['risperidone']
risperidone,Medicines for psychotic disorders,"Oral > Solid: 0.25 mg; 0.5 mg; 1 mg; 2 mg; 3 mg; 4 mg; 6 mg
Parenteral > General injections > IM: ",Schizophrenia or other primary psychotic disorders,,,Added,risperidone,['risperidone']
ritonavir,Antiretrovirals > Protease inhibitors,Oral > Solid: 25 mg tablet (heat stable); 100 mg tablet (heat stable),"Human immunodeficiency virus disease without mention of associated disease or condition, clinical stage unspecified",J05AE03,,Added,ritonavir,['ritonavir']
rituximab,Targeted therapies,Parenteral > General injections > IV: 100 mg per 10 mL in 10 mL vial; 500 mg per 50 mL in 50 mL vial,Follicular lymphoma,L01FA01,,Added,rituximab,['rituximab']
rituximab,Targeted therapies,Parenteral > General injections > IV: 100 mg per 10 mL in 10 mL vial; 500 mg per 50 mL in 50 mL vial,Chronic lymphocytic leukaemia or small lymphocytic lymphoma,L01FA01,,Added,rituximab,['rituximab']
rituximab,Targeted therapies,Parenteral > General injections > IV: 100 mg per 10 mL in 10 mL vial; 500 mg per 50 mL in 50 mL vial,Diffuse large B-cell lymphomas,L01FA01,,Added,rituximab,['rituximab']
rituximab,Targeted therapies,Parenteral > General injections > IV: 100 mg per 10 mL in 10 mL vial; 500 mg per 50 mL in 50 mL vial,Burkitt lymphoma including Burkitt leukaemia,L01FA01,,Added,rituximab,['rituximab']
rituximab,Medicines for multiple sclerosis,Parenteral > General injections > IV: 500 mg per 50 mL in 50 mL vial,Multiple sclerosis,L01FA01,,Added,rituximab,['rituximab']
rivaroxaban,Medicines affecting coagulation,,Venous thromboembolism,,,Added,rivaroxaban,['rivaroxaban']
rivaroxaban,Medicines affecting coagulation,,Other specified atrial fibrillation,,,Added,rivaroxaban,['rivaroxaban']
rotavirus vaccine,Recommendations for all immunization programmes,All vaccines should comply with the WHO requirements for biological substances.,Need for immunization against certain single viral diseases,"J07BH01, J07BH02",,Added,rotavirus vaccine,"['rotavirus', 'vaccine', 'rotavirus vaccine']"
rubella vaccine,Recommendations for all immunization programmes,All vaccines should comply with the WHO requirements for biological substances.,Need for immunization against rubella alone,J07BJ01,,Added,rubella vaccine,"['vaccine', 'rubella vaccine', 'rubella']"
salbutamol,Antiasthmatic and medicines for chronic obstructive pulmonary disease,"Parenteral > General injections > IV: 50 µg per  mL in 5 mL ampoule (as sulfate)
Respiratory > Inhalation > aerosol: 100 µg per  dose (as sulfate); 100 µg per  dose (as sulfate) metered-dose inhaler
Respiratory > Inhalation > solution: 5 mg per  mL (as sulfate) for use in nebulizers",Chronic obstructive pulmonary disease,R03AC02,,Added,salbutamol,['salbutamol']
salbutamol,Antiasthmatic and medicines for chronic obstructive pulmonary disease,"Parenteral > General injections > IV: 50 µg per  mL in 5 mL ampoule (as sulfate)
Respiratory > Inhalation > aerosol: 100 µg per  dose (as sulfate); 100 µg per  dose (as sulfate) metered-dose inhaler
Respiratory > Inhalation > solution: 5 mg per  mL (as sulfate) for use in nebulizers",Asthma,R03AC02,,Added,salbutamol,['salbutamol']
salicylic acid,Dermatological medicines > Medicines affecting skin differentiation and proliferation,Local > Topical > Solution: 5%,Seborrhoeic dermatitis,D01AE12,,Added,salicylic acid,"['salicylic acid', 'salicylic', 'acid']"
salicylic acid,Dermatological medicines > Medicines affecting skin differentiation and proliferation,Local > Topical > Solution: 5%,Psoriasis of unspecified type,D01AE12,,Added,salicylic acid,"['salicylic acid', 'salicylic', 'acid']"
salicylic acid,Dermatological medicines > Medicines affecting skin differentiation and proliferation,Local > Topical > Solution: 5%,Ichthyoses,D01AE12,,Added,salicylic acid,"['salicylic acid', 'salicylic', 'acid']"
selenium sulfide,Dermatological medicines > Antifungal medicines,Local > Topical > Suspension: 2% detergent-based,Seborrhoeic dermatitis,D01AE13,,Added,selenium sulfide,"['sulfide', 'selenium', 'selenium sulfide']"
selenium sulfide,Dermatological medicines > Antifungal medicines,Local > Topical > Suspension: 2% detergent-based,Pityriasis versicolor,D01AE13,,Added,selenium sulfide,"['sulfide', 'selenium', 'selenium sulfide']"
senna,Medicines for other common symptoms in palliative care,Oral > Liquid: 7.5 mg per 5 mL oral liquid,Palliative care,A06AB06,,Added,senna,['senna']
senna,Laxatives,Oral > Solid: 7.5 mg (sennosides) (or traditional dosage forms),Constipation,A06AB06,,Added,senna,['senna']
sevoflurane,General anaesthetics and oxygen > Inhalational medicines,Respiratory > Inhalation > liquid: ,Anaesthetics and therapeutic gases,N01AB08,,Added,sevoflurane,['sevoflurane']
silver diamine fluoride,Dental medicines and preparations,Local > Dental > Solution: 38% w/v,Dental caries,,,Added,silver diamine fluoride,"['silver', 'diamine', 'silver diamine fluoride', 'fluoride']"
silver sulfadiazine,Dermatological medicines > Anti-infective medicines,Local > Topical > Cream: 1%,Burns,D06BA01,,Added,silver sulfadiazine,"['silver sulfadiazine', 'silver', 'sulfadiazine']"
simvastatin,Lipid-lowering agents,Oral > Solid: 5 mg; 10 mg; 20 mg; 40 mg,Mixed hyperlipidaemia,C10AA01,,Added,simvastatin,['simvastatin']
simvastatin,Lipid-lowering agents,Oral > Solid: 5 mg; 10 mg; 20 mg; 40 mg,Coronary atherosclerosis,C10AA01,,Added,simvastatin,['simvastatin']
sodium calcium edetate,Antidotes and other substances used in poisonings > Specific,Parenteral > General injections > IV: 200 mg per  mL in 5 mL ampoule,"Harmful effects of or exposure to noxious substances, chiefly nonmedicinal as to source, not elsewhere classified",V03AB03,,Added,sodium calcium edetate,"['calcium', 'sodium', 'edetate', 'sodium calcium edetate']"
sodium chloride,"Solutions correcting water, electrolyte and acid-base disturbances > Parenteral",Parenteral > General injections > IV: 0.9% isotonic (equivalent to Na+ 154 mmol/L and Cl- 154 mmol/L),"Other specified disorders of fluid, electrolyte or acid-base balance",B05XA03,,Added,sodium chloride,"['chloride', 'sodium', 'sodium chloride']"
sodium hydrogen carbonate,"Solutions correcting water, electrolyte and acid-base disturbances > Parenteral",Parenteral > General injections > IV: 1.4% isotonic (equivalent to Na+ 167 mmol/L and HCO3- 167 mmol/L); 8.4% in 10 mL ampoule (equivalent to Na+ 1000 mmol/L and HCO3- 1000 mmol/L),Acidosis,B05XA02,,Added,sodium hydrogen carbonate,"['hydrogen', 'sodium', 'carbonate', 'sodium hydrogen carbonate']"
sodium nitrite,Antidotes and other substances used in poisonings > Specific,Parenteral > General injections > IV: 30 mg per  mL in 10 mL ampoule,"Harmful effects of or exposure to noxious substances, chiefly nonmedicinal as to source, not elsewhere classified",V03AB08,,Added,sodium nitrite,"['nitrite', 'sodium', 'sodium nitrite']"
sodium nitroprusside,Antihypertensive medicines,Parenteral > General injections > IV: 50 mg in ampoule powder for infusion,Hypertensive crisis,C02DD01,,Added,sodium nitroprusside,"['sodium nitroprusside', 'nitroprusside', 'sodium']"
sodium stibogluconate,Antileishmaniasis medicines,Parenteral > General injections > unspecified: 100 mg per  mL in 30 mL vial,Visceral leishmaniasis,P01CB02,,Added,sodium stibogluconate,"['stibogluconate', 'sodium', 'sodium stibogluconate']"
sodium stibogluconate,Antileishmaniasis medicines,Parenteral > General injections > unspecified: 100 mg per  mL in 30 mL vial,Mucocutaneous leishmaniasis,P01CB02,,Added,sodium stibogluconate,"['stibogluconate', 'sodium', 'sodium stibogluconate']"
sodium stibogluconate,Antileishmaniasis medicines,Parenteral > General injections > unspecified: 100 mg per  mL in 30 mL vial,Cutaneous leishmaniasis,P01CB02,,Added,sodium stibogluconate,"['stibogluconate', 'sodium', 'sodium stibogluconate']"
sodium thiosulfate,Dermatological medicines > Antifungal medicines,Local > Topical > Solution: 15%,Pityriasis versicolor,V03AB06,,Added,sodium thiosulfate,"['thiosulfate', 'sodium thiosulfate', 'sodium']"
sodium thiosulfate,Antidotes and other substances used in poisonings > Specific,Parenteral > General injections > IV: 250 mg per  mL in 50 mL ampoule,"Harmful effects of or exposure to noxious substances, chiefly nonmedicinal as to source, not elsewhere classified",V03AB06,,Added,sodium thiosulfate,"['thiosulfate', 'sodium thiosulfate', 'sodium']"
sofosbuvir,Medicines for hepatitis C > Pangenotypic direct-acting antiviral combinations,Oral > Solid > tablet: 200 mg; 400 mg,Chronic hepatitis C,J05AP08,,Added,sofosbuvir,['sofosbuvir']
sofosbuvir + velpatasvir,Medicines for hepatitis C > Pangenotypic direct-acting antiviral combinations,Oral > Solid > tablet: 200 mg + 50 mg; 400 mg + 100 mg,Chronic hepatitis C,J05AP55,,Added,sofosbuvir + velpatasvir,"['velpatasvir', 'sofosbuvir + velpatasvir', '+', 'sofosbuvir']"
spectinomycin,Access group antibiotics,Parenteral > General injections > unspecified: 2 g in vial (as hydrochloride) powder for injection,Gonococcal infection,J01XX04,,Added,spectinomycin,['spectinomycin']
spironolactone,Medicines used in heart failure,Oral > Solid > tablet: 25 mg,Heart failure,C03DA01,,Added,spironolactone,['spironolactone']
spironolactone,Diuretics,"Oral > Liquid: 5 mg per 5 mL; 10 mg per 5 mL; 25 mg per 5 mL
Oral > Solid > tablet: 25 mg",Oedema,C03DA01,,Added,spironolactone,['spironolactone']
spironolactone,Diuretics,"Oral > Liquid: 5 mg per 5 mL; 10 mg per 5 mL; 25 mg per 5 mL
Oral > Solid > tablet: 25 mg",Ascites,C03DA01,,Added,spironolactone,['spironolactone']
streptokinase,Thrombolytic medicines,Parenteral > General injections > IV: 1.5 million IU in vial powder for injection,Acute myocardial infarction,B01AD01,,Added,streptokinase,['streptokinase']
streptomycin (injection),Antituberculosis medicines,Parenteral > General injections > IV: 1 g powder for injection (as sulfate) as vial,Multi-drug resistant Mycobacterium tuberculosis,J01GA01,,Added,streptomycin (injection),"['(injection)', 'streptomycin (injection)', 'streptomycin']"
succimer,Antidotes and other substances used in poisonings > Specific,Oral > Solid: 100 mg,"Harmful effects of or exposure to noxious substances, chiefly nonmedicinal as to source, not elsewhere classified",,,Added,succimer,['succimer']
sulfadiazine,Antipneumocystosis and antitoxoplasmosis medicines,Oral > Solid: 500 mg,Toxoplasmosis,J01EC02,,Added,sulfadiazine,['sulfadiazine']
sulfadoxine + pyrimethamine,Antimalarial medicines > For curative treatment,Oral > Solid: 500 mg + 25 mg tablet,Malaria due to Plasmodium falciparum,P01BD51,,Added,sulfadoxine + pyrimethamine,"['sulfadoxine + pyrimethamine', 'sulfadoxine', 'pyrimethamine', '+']"
sulfadoxine + pyrimethamine,Antimalarial medicines > For curative treatment,Oral > Solid: 500 mg + 25 mg tablet,Malaria due to Plasmodium vivax,P01BD51,,Added,sulfadoxine + pyrimethamine,"['sulfadoxine + pyrimethamine', 'sulfadoxine', 'pyrimethamine', '+']"
sulfadoxine + pyrimethamine,Antimalarial medicines > For chemoprevention,"Oral > Solid: 500 mg + 25 mg tablet
Oral > Solid: 250 mg + 12.5 mg tablet",Malaria due to Plasmodium falciparum,P01BD51,,Added,sulfadoxine + pyrimethamine,"['sulfadoxine + pyrimethamine', 'sulfadoxine', 'pyrimethamine', '+']"
sulfadoxine + pyrimethamine,Antimalarial medicines > For chemoprevention,"Oral > Solid: 500 mg + 25 mg tablet
Oral > Solid: 250 mg + 12.5 mg tablet",Malaria,P01BD51,,Added,sulfadoxine + pyrimethamine,"['sulfadoxine + pyrimethamine', 'sulfadoxine', 'pyrimethamine', '+']"
sulfamethoxazole + trimethoprim,Access group antibiotics,"Parenteral > General injections > IV: 80 mg + 16 mg per  mL in 10 mL ampoule; 80 mg + 16 mg per  mL in 5 mL ampoule
Oral > Liquid: 200 mg + 40 mg per 5 mL oral liquid
Oral > Solid: 100 mg + 20 mg tablet; 400 mg + 80 mg tablet; 800 mg + 160 mg tablet
Oral > Solid > dispersible tablet: 100 mg + 20 mg",Infectious cystitis,J01EE01,,Added,sulfamethoxazole + trimethoprim,"['sulfamethoxazole', 'trimethoprim', 'sulfamethoxazole + trimethoprim', '+']"
sulfamethoxazole + trimethoprim,Access group antibiotics,"Parenteral > General injections > IV: 80 mg + 16 mg per  mL in 10 mL ampoule; 80 mg + 16 mg per  mL in 5 mL ampoule
Oral > Liquid: 200 mg + 40 mg per 5 mL oral liquid
Oral > Solid: 100 mg + 20 mg tablet; 400 mg + 80 mg tablet; 800 mg + 160 mg tablet
Oral > Solid > dispersible tablet: 100 mg + 20 mg",Infectious gastroenteritis or colitis without specification of infectious agent,J01EE01,,Added,sulfamethoxazole + trimethoprim,"['sulfamethoxazole', 'trimethoprim', 'sulfamethoxazole + trimethoprim', '+']"
sulfamethoxazole + trimethoprim,Antipneumocystosis and antitoxoplasmosis medicines,"Parenteral > General injections > IV: 80 mg + 16 mg per  mL in 5 mL ampoule; 80 mg + 16 mg per  mL in 10 mL ampoule
Oral > Liquid: 200 mg + 40 mg per 5 mL oral liquid
Oral > Solid: 100 mg + 20 mg tablet; 400 mg + 80 mg tablet; 800 mg + 160 mg tablet
Oral > Solid > dispersible tablet: 100 mg + 20 mg",Pneumocystosis,J01EE01,,Added,sulfamethoxazole + trimethoprim,"['sulfamethoxazole', 'trimethoprim', 'sulfamethoxazole + trimethoprim', '+']"
sulfasalazine,Disease-modifying anti-rheumatic drugs (DMARDs),Oral > Solid: 500 mg,"Rheumatoid arthritis, serology unspecified",A07EC01,,Added,sulfasalazine,['sulfasalazine']
sulfasalazine,Anti-inflammatory medicines,"Oral > Solid: 500 mg
Local > Rectal > Suppository: 500 mg
Local > Rectal > Retention enema: 3 g per 100 mL",Crohn disease site,A07EC01,,Added,sulfasalazine,['sulfasalazine']
sulfasalazine,Anti-inflammatory medicines,"Oral > Solid: 500 mg
Local > Rectal > Suppository: 500 mg
Local > Rectal > Retention enema: 3 g per 100 mL",Ulcerative colitis,A07EC01,,Added,sulfasalazine,['sulfasalazine']
sumatriptan,Antimigraine medicines > For treatment of acute attack,Oral > Solid: 50 mg,Migraine,N02CC01,,Added,sumatriptan,['sumatriptan']
suramin sodium,Medicines for the treatment of 1st stage African trypanosomiasis,Parenteral > General injections > IV: 1 g in vial,African trypanosomiasis,P01CX02,,Added,suramin sodium,"['suramin', 'sodium', 'suramin sodium']"
surfactant,Medicines administered to the neonate [c],Respiratory > Suspension: 80 mg per  mL for intratracheal instillation; 25 mg per  mL for intratracheal instillation,Respiratory distress syndrome of newborn,R07AA02,,Added,surfactant,['surfactant']
suxamethonium,Muscle relaxants (peripherally-acting) and cholinesterase inhibitors,Parenteral > General injections > IV: 50 mg per  mL in 2 mL ampoule (suxamethonium chloride); powder for injection (suxamethonium chloride) in vial,Muscle relaxants,M03AB01,,Added,suxamethonium,['suxamethonium']
tacalcitol,Dermatological medicines > Medicines affecting skin differentiation and proliferation,,Psoriasis of unspecified type,,,Added,tacalcitol,['tacalcitol']
tacrolimus,Immunomodulators for non-malignant disease,"Parenteral > General injections > IV: 5 mg per  mL in 1 mL vial
Oral > Liquid: 0.2 mg granules for oral suspension; 1 mg granules for oral suspension
Oral > Solid: 0.5 mg (immediate-release); 0.75 mg (immediate-release); 1 mg (immediate-release); 2 mg (immediate-release); 5 mg (immediate-release)",Failure or rejection of transplanted organs or tissues,L04AD02,,Added,tacrolimus,['tacrolimus']
tamoxifen,Hormones and antihormones,Oral > Solid: 10 mg (as citrate); 20 mg (as citrate),Other specified malignant neoplasms of breast,L02BA01,,Added,tamoxifen,['tamoxifen']
tamoxifen,Hormones and antihormones,Oral > Solid: 10 mg (as citrate); 20 mg (as citrate),Malignant neoplasms of breast,L02BA01,,Added,tamoxifen,['tamoxifen']
tedizolid,Reserve group antibiotics,,Methicillin resistant Staphylococcus aureus,,,Added,tedizolid,['tedizolid']
tedizolid,Reserve group antibiotics,,Vancomycin resistant Staphylococcus aureus,,,Added,tedizolid,['tedizolid']
tedizolid,Reserve group antibiotics,,Vancomycin resistant Enterococcus,,,Added,tedizolid,['tedizolid']
telmisartan + amlodipine,Antihypertensive medicines,Oral > Solid: 40 mg + 5 mg; 80 mg + 5 mg; 80 mg + 10 mg,Essential hypertension,C09DB04,,Added,telmisartan + amlodipine,"['amlodipine', 'telmisartan', '+', 'telmisartan + amlodipine']"
telmisartan + hydrochlorothiazide,Antihypertensive medicines,Oral > Solid: 40 mg + 12.5 mg; 80 mg + 12.5 mg; 80 mg + 25 mg,Essential hypertension,C09DA07,,Added,telmisartan + hydrochlorothiazide,"['hydrochlorothiazide', 'telmisartan + hydrochlorothiazide', 'telmisartan', '+']"
tenofovir disoproxil fumarate,Antiretrovirals > Nucleoside/Nucleotide reverse transcriptase inhibitors,Oral > Solid: 300 mg tablet (equivalent to 245 mg tenofovir disoproxil),"Human immunodeficiency virus disease without mention of associated disease or condition, clinical stage unspecified",J05AF07,,Added,tenofovir disoproxil fumarate,"['tenofovir disoproxil fumarate', 'disoproxil', 'fumarate', 'tenofovir']"
tenofovir disoproxil fumarate,Antiretrovirals > Nucleoside/Nucleotide reverse transcriptase inhibitors,Oral > Solid: 300 mg tablet (equivalent to 245 mg tenofovir disoproxil),Contact with or exposure to human immunodeficiency virus,J05AF07,,Added,tenofovir disoproxil fumarate,"['tenofovir disoproxil fumarate', 'disoproxil', 'fumarate', 'tenofovir']"
tenofovir disoproxil fumarate,Medicines for hepatitis B > Nucleoside/Nucleotide reverse transcriptase inhibitors,Oral > Solid: 300 mg tablet (equivalent to 245 mg tenofovir disoproxil),Chronic hepatitis B,J05AF07,,Added,tenofovir disoproxil fumarate,"['tenofovir disoproxil fumarate', 'disoproxil', 'fumarate', 'tenofovir']"
terbinafine,Dermatological medicines > Antifungal medicines,"Local > Topical > Cream: 1% terbinafine hydrochloride
Local > Topical > Ointment: 1% terbinafine hydrochloride",Fungal infection of the skin,D01AE15,,Added,terbinafine,['terbinafine']
terbutaline,Antiasthmatic and medicines for chronic obstructive pulmonary disease,,Chronic obstructive pulmonary disease,,,Added,terbutaline,['terbutaline']
terbutaline,Antiasthmatic and medicines for chronic obstructive pulmonary disease,,Asthma,,,Added,terbutaline,['terbutaline']
terizidone,Antituberculosis medicines,,Multi-drug resistant Mycobacterium tuberculosis,,,Added,terizidone,['terizidone']
testosterone,Androgens,Parenteral > General injections > IM: 200 mg per  mL in 1 mL ampoule (enantate),Testicular dysfunction or testosterone-related disorders,G03BA03,,Added,testosterone,['testosterone']
tetanus vaccine,Recommendations for all immunization programmes,All vaccines should comply with the WHO requirements for biological substances.,Need for immunization against tetanus alone,J07AM01,,Added,tetanus vaccine,"['vaccine', 'tetanus vaccine', 'tetanus']"
tetracaine,Ophthalmological preparations > Local anaesthetics,Local > Ophthalmological > Solution (eye drops): 0.5% (hydrochloride),Local anaesthetics,S01HA03,,Added,tetracaine,['tetracaine']
tetracycline,Ophthalmological preparations > Anti-infective agents,Local > Ophthalmological > Ointment: 1% (tetracycline hydrochloride),Other specified conjunctivitis,S01AA09,,Added,tetracycline,['tetracycline']
tetracycline,Ophthalmological preparations > Anti-infective agents,Local > Ophthalmological > Ointment: 1% (tetracycline hydrochloride),Infectious keratitis,S01AA09,,Added,tetracycline,['tetracycline']
tetracycline,Ophthalmological preparations > Anti-infective agents,Local > Ophthalmological > Ointment: 1% (tetracycline hydrochloride),Infectious blepharitis,S01AA09,,Added,tetracycline,['tetracycline']
tetracycline,Ophthalmological preparations > Anti-infective agents,Local > Ophthalmological > Ointment: 1% (tetracycline hydrochloride),Trachoma,S01AA09,,Added,tetracycline,['tetracycline']
thalidomide,Immunomodulators,Oral > Solid: 50 mg,Plasma cell myeloma,L04AX02,,Added,thalidomide,['thalidomide']
thiamine,Vitamins and minerals,Oral > Solid: 50 mg (hydrochloride),Vitamin B1 deficiency,A11DA01,,Added,thiamine,['thiamine']
thiopental,General anaesthetics and oxygen > Injectable medicines,,Anaesthetics and therapeutic gases,,,Added,thiopental,['thiopental']
tick-borne encephalitis vaccine,Recommendations for certain regions,All vaccines should comply with the WHO requirements for biological substances.,Need for immunization against arthropod-borne viral encephalitis,J07BA01,,Added,tick-borne encephalitis vaccine,"['tick-borne', 'vaccine', 'encephalitis', 'tick-borne encephalitis vaccine']"
timolol,Ophthalmological preparations > Miotics and antiglaucoma medicines,Local > Ophthalmological > Solution (eye drops): 0.25% (hydrogen maleate); 0.5% (hydrogen maleate),Primary open-angle glaucoma,S01ED01,,Added,timolol,['timolol']
timolol,Ophthalmological preparations > Miotics and antiglaucoma medicines,Local > Ophthalmological > Solution (eye drops): 0.25% (hydrogen maleate); 0.5% (hydrogen maleate),Ocular hypertension,S01ED01,,Added,timolol,['timolol']
tinidazole,Antiamoebic and antigiardiasis medicines,,Amoebiasis,,,Added,tinidazole,['tinidazole']
tioguanine,Cytotoxic medicines,Oral > Solid: 40 mg,"Lymphoid leukaemia, not elsewhere classified",L01BB03,,Added,tioguanine,['tioguanine']
tiotropium bromide,Antiasthmatic and medicines for chronic obstructive pulmonary disease,"Respiratory > Inhalation > dry powder: 18 µg capsule
Respiratory > Inhalation > solution: 1.25 µg per  actuation; 2.5 µg per  actuation",Chronic obstructive pulmonary disease,R03BB04,,Added,tiotropium bromide,"['tiotropium', 'tiotropium bromide', 'bromide']"
tobramycin,Ophthalmological preparations > Anti-infective agents,,Other specified conjunctivitis,,,Added,tobramycin,['tobramycin']
tobramycin,Ophthalmological preparations > Anti-infective agents,,Infectious blepharitis,,,Added,tobramycin,['tobramycin']
torasemide,Medicines used in heart failure,,Heart failure,,,Added,torasemide,['torasemide']
torasemide,Diuretics,,Anuria or oliguria,,,Added,torasemide,['torasemide']
torasemide,Diuretics,,Oedema,,,Added,torasemide,['torasemide']
tranexamic acid,Medicines affecting coagulation,Parenteral > General injections > IV: 100 mg per  mL in 10 mL ampoule,"Haemorrhage, not elsewhere classified",B02AA02,,Added,tranexamic acid,"['tranexamic acid', 'tranexamic', 'acid']"
tranexamic acid,Other medicines administered to the mother,Parenteral > General injections > IV: 100 mg per  mL in 10 mL ampoule,Postpartum haemorrhage,B02AA02,,Added,tranexamic acid,"['tranexamic acid', 'tranexamic', 'acid']"
trastuzumab,Targeted therapies,Parenteral > General injections > IV: 60 mg in vial powder for injection; 150 mg in vial powder for injection; 440 mg in vial powder for injection,"Carcinoma of breast, specialised type",L01FD01,,Added,trastuzumab,['trastuzumab']
triamcinolone hexacetonide,Medicines for juvenile joint diseases,Parenteral > Locoregional injections > Intra-articular: 20 mg per  mL in vial,Juvenile idiopathic arthritis,H02AB08,,Added,triamcinolone hexacetonide,"['hexacetonide', 'triamcinolone', 'triamcinolone hexacetonide']"
triclabendazole,Antischistosomals and other antitrematode medicines,Oral > Solid > tablet: 250 mg (scored),Paragonimiasis,P02BX04,,Added,triclabendazole,['triclabendazole']
triclabendazole,Antischistosomals and other antitrematode medicines,Oral > Solid > tablet: 250 mg (scored),Fascioliasis,P02BX04,,Added,triclabendazole,['triclabendazole']
trihexyphenidyl,Medicines for parkinsonism,,Parkinson disease,,,Added,trihexyphenidyl,['trihexyphenidyl']
trimethoprim,Access group antibiotics,"Oral > Liquid: 50 mg per  mL
Oral > Solid: 100 mg; 200 mg",Infectious cystitis,J01EA01,,Added,trimethoprim,['trimethoprim']
triptorelin,Hormones and antihormones,,Malignant neoplasms of breast,,,Added,triptorelin,['triptorelin']
triptorelin,Hormones and antihormones,,Malignant neoplasms of prostate,,,Added,triptorelin,['triptorelin']
tropicamide,Diagnostic agents > Ophthalmic medicines,Local > Ophthalmological > Solution (eye drops): 0.5%,Cycloplegic drug,S01FA06,,Added,tropicamide,['tropicamide']
tropisetron,Medicines for other common symptoms in palliative care,,Palliative care,,,Added,tropisetron,['tropisetron']
tropisetron,Antiemetic medicines,,Nausea or vomiting,,,Added,tropisetron,['tropisetron']
"tuberculin, purified protein derivative",Immunologicals > Diagnostic agents,Parenteral > Locoregional injections > Intradermal: ,Mycobacterial diseases,V04CF01,,Added,"tuberculin, purified protein derivative","['tuberculin', 'purified protein derivative', 'derivative', 'purified', 'tuberculin,', 'protein', 'tuberculin, purified protein derivative']"
typhoid vaccine,Recommendations for some high-risk populations,All vaccines should comply with the WHO requirements for biological substances.,Need for immunization against typhoid-paratyphoid alone,J07AP03,,Added,typhoid vaccine,"['typhoid vaccine', 'typhoid', 'vaccine']"
ulipristal,Oral hormonal contraceptives,Oral > Solid: 30 mg tablet (ulipristal acetate),Contact with health services for postcoital contraception,G03AD02,,Added,ulipristal,['ulipristal']
umeclidinium,Antiasthmatic and medicines for chronic obstructive pulmonary disease,,Chronic obstructive pulmonary disease,,,Added,umeclidinium,['umeclidinium']
urea,Dermatological medicines > Medicines affecting skin differentiation and proliferation,"Local > Topical > Cream: 10%; 5%
Local > Topical > Ointment: 10%; 5%",Xerosis cutis or asteatosis,D02AE01,,Added,urea,['urea']
valaciclovir,Antiherpes medicines,,Zoster,,,Added,valaciclovir,['valaciclovir']
valaciclovir,Antiherpes medicines,,Varicella,,,Added,valaciclovir,['valaciclovir']
valaciclovir,Antiherpes medicines,,Herpes simplex infections,,,Added,valaciclovir,['valaciclovir']
valganciclovir,Other antivirals,"Oral > Liquid: 50 mg per  mL powder for oral solution
Oral > Solid > tablet: 450 mg",Cytomegaloviral retinitis,J05AB14,,Added,valganciclovir,['valganciclovir']
valproic acid (sodium valproate),Antiseizure medicines,"Oral > Liquid: 200 mg per 5 mL
Oral > Solid: 200 mg tablet (enteric-coated); 500 mg tablet (enteric-coated); 100 mg tablet (crushable)
Parenteral > General injections > IV: 100 mg per  mL in 4 mL ampoule; 100 mg per  mL in 10 mL ampoule; 100 mg per  mL in 3 mL ampoule",Epilepsy or seizures,N03AG01,,Added,valproic acid (sodium valproate),"['valproic', 'valproate)', '(sodium', 'valproic acid (sodium valproate)', 'acid']"
valproic acid (sodium valproate),Antiseizure medicines,"Oral > Liquid: 200 mg per 5 mL
Oral > Solid: 200 mg tablet (enteric-coated); 500 mg tablet (enteric-coated); 100 mg tablet (crushable)
Parenteral > General injections > IV: 100 mg per  mL in 4 mL ampoule; 100 mg per  mL in 10 mL ampoule; 100 mg per  mL in 3 mL ampoule",Status epilepticus,N03AG01,,Added,valproic acid (sodium valproate),"['valproic', 'valproate)', '(sodium', 'valproic acid (sodium valproate)', 'acid']"
valproic acid (sodium valproate),Medicines for bipolar disorders,Oral > Solid: 200 mg tablet (enteric-coated); 500 mg tablet (enteric-coated),Bipolar or related disorders,N03AG01,,Added,valproic acid (sodium valproate),"['valproic', 'valproate)', '(sodium', 'valproic acid (sodium valproate)', 'acid']"
vancomycin,Watch group antibiotics,"Parenteral > General injections > IV: 250 mg in vial (as hydrochloride) powder for injection
Oral > Solid > capsule: 125 mg (as hydrochloride); 250 mg (as hydrochloride)
Parenteral > General injections > IV: 250 mg in vial (as hydrochloride) powder for injection; 500 mg in vial (as hydrochloride) powder for injection; 1 g in vial (as hydrochloride) powder for injection
Parenteral > Locoregional injections > Intravitreal: 250 mg in vial (as hydrochloride) powder for injection; 500 mg in vial (as hydrochloride) powder for injection; 1 g in vial (as hydrochloride) powder for injection",Necrotising fasciitis,J01XA01,,Added,vancomycin,['vancomycin']
vancomycin,Watch group antibiotics,"Parenteral > General injections > IV: 250 mg in vial (as hydrochloride) powder for injection
Oral > Solid > capsule: 125 mg (as hydrochloride); 250 mg (as hydrochloride)
Parenteral > General injections > IV: 250 mg in vial (as hydrochloride) powder for injection; 500 mg in vial (as hydrochloride) powder for injection; 1 g in vial (as hydrochloride) powder for injection
Parenteral > Locoregional injections > Intravitreal: 250 mg in vial (as hydrochloride) powder for injection; 500 mg in vial (as hydrochloride) powder for injection; 1 g in vial (as hydrochloride) powder for injection",Endophthalmitis,J01XA01,ceftazidime,Added,vancomycin,['vancomycin']
vancomycin,Watch group antibiotics,"Parenteral > General injections > IV: 250 mg in vial (as hydrochloride) powder for injection
Oral > Solid > capsule: 125 mg (as hydrochloride); 250 mg (as hydrochloride)
Parenteral > General injections > IV: 250 mg in vial (as hydrochloride) powder for injection; 500 mg in vial (as hydrochloride) powder for injection; 1 g in vial (as hydrochloride) powder for injection
Parenteral > Locoregional injections > Intravitreal: 250 mg in vial (as hydrochloride) powder for injection; 500 mg in vial (as hydrochloride) powder for injection; 1 g in vial (as hydrochloride) powder for injection",Endophthalmitis,J01XA01,ceftriaxone,Added,vancomycin,['vancomycin']
vancomycin,Watch group antibiotics,"Parenteral > General injections > IV: 250 mg in vial (as hydrochloride) powder for injection
Oral > Solid > capsule: 125 mg (as hydrochloride); 250 mg (as hydrochloride)
Parenteral > General injections > IV: 250 mg in vial (as hydrochloride) powder for injection; 500 mg in vial (as hydrochloride) powder for injection; 1 g in vial (as hydrochloride) powder for injection
Parenteral > Locoregional injections > Intravitreal: 250 mg in vial (as hydrochloride) powder for injection; 500 mg in vial (as hydrochloride) powder for injection; 1 g in vial (as hydrochloride) powder for injection",Intestinal infections due to Clostridioides difficile,A07AA09,,Added,vancomycin,['vancomycin']
vancomycin,Watch group antibiotics,"Parenteral > General injections > IV: 250 mg in vial (as hydrochloride) powder for injection
Oral > Solid > capsule: 125 mg (as hydrochloride); 250 mg (as hydrochloride)
Parenteral > General injections > IV: 250 mg in vial (as hydrochloride) powder for injection; 500 mg in vial (as hydrochloride) powder for injection; 1 g in vial (as hydrochloride) powder for injection
Parenteral > Locoregional injections > Intravitreal: 250 mg in vial (as hydrochloride) powder for injection; 500 mg in vial (as hydrochloride) powder for injection; 1 g in vial (as hydrochloride) powder for injection",Neutropenia (high-risk),J01XA01,,Added,vancomycin,['vancomycin']
varenicline,Medicines for nicotine use disorders,Oral > Solid: 0.5 mg; 1 mg,Nicotine dependence,N07BA03,,Added,varenicline,['varenicline']
varicella vaccine,Recommendations for immunization programmes with certain characteristics,All vaccines should comply with the WHO requirements for biological substances.,Need for immunization against certain single viral diseases,J07BK01,,Added,varicella vaccine,"['varicella vaccine', 'varicella', 'vaccine']"
vecuronium,Muscle relaxants (peripherally-acting) and cholinesterase inhibitors,Parenteral > General injections > IV: 10 mg in vial powder for injection (vecuronium bromide),Muscle relaxants,M03AC03,,Added,vecuronium,['vecuronium']
verapamil,Antiarrhythmic medicines,"Parenteral > General injections > IV: 2.5 mg per  mL in 2 mL ampoule (hydrochloride)
Oral > Solid: 40 mg (hydrochloride); 80 mg (hydrochloride)",Supraventricular tachyarrhythmia,C08DA01,,Added,verapamil,['verapamil']
verapamil,Antianginal medicines,Oral > Solid: 40 mg (hydrochloride); 80 mg (hydrochloride),Angina pectoris,C08DA01,,Added,verapamil,['verapamil']
vinblastine,Cytotoxic medicines,"Parenteral > General injections > IV: 10 mg in vial (vinblastine sulfate)
Parenteral > General injections > IV: 10 mg in vial (vinblastine sulfate); 10 mg per 10 mL in vial (vinblastine sulfate)",Other specified gliomas of brain,L01CA01,,Added,vinblastine,['vinblastine']
vinblastine,Cytotoxic medicines,"Parenteral > General injections > IV: 10 mg in vial (vinblastine sulfate)
Parenteral > General injections > IV: 10 mg in vial (vinblastine sulfate); 10 mg per 10 mL in vial (vinblastine sulfate)",Kaposi sarcoma of unspecified primary site,L01CA01,,Added,vinblastine,['vinblastine']
vinblastine,Cytotoxic medicines,"Parenteral > General injections > IV: 10 mg in vial (vinblastine sulfate)
Parenteral > General injections > IV: 10 mg in vial (vinblastine sulfate); 10 mg per 10 mL in vial (vinblastine sulfate)",Hodgkin lymphoma,L01CA01,,Added,vinblastine,['vinblastine']
vinblastine,Cytotoxic medicines,"Parenteral > General injections > IV: 10 mg in vial (vinblastine sulfate)
Parenteral > General injections > IV: 10 mg in vial (vinblastine sulfate); 10 mg per 10 mL in vial (vinblastine sulfate)",Other specified malignant neoplasms of the ovary,L01CA01,,Added,vinblastine,['vinblastine']
vinblastine,Cytotoxic medicines,"Parenteral > General injections > IV: 10 mg in vial (vinblastine sulfate)
Parenteral > General injections > IV: 10 mg in vial (vinblastine sulfate); 10 mg per 10 mL in vial (vinblastine sulfate)",Germ cell tumour of testis,L01CA01,,Added,vinblastine,['vinblastine']
vinblastine,Cytotoxic medicines,"Parenteral > General injections > IV: 10 mg in vial (vinblastine sulfate)
Parenteral > General injections > IV: 10 mg in vial (vinblastine sulfate); 10 mg per 10 mL in vial (vinblastine sulfate)","Anaplastic large cell lymphoma, ALK-positive",L01CA01,,Added,vinblastine,['vinblastine']
vinblastine,Cytotoxic medicines,"Parenteral > General injections > IV: 10 mg in vial (vinblastine sulfate)
Parenteral > General injections > IV: 10 mg in vial (vinblastine sulfate); 10 mg per 10 mL in vial (vinblastine sulfate)","Anaplastic large cell lymphoma, ALK-negative",L01CA01,,Added,vinblastine,['vinblastine']
vinblastine,Cytotoxic medicines,"Parenteral > General injections > IV: 10 mg in vial (vinblastine sulfate)
Parenteral > General injections > IV: 10 mg in vial (vinblastine sulfate); 10 mg per 10 mL in vial (vinblastine sulfate)",Langerhans cell histiocytosis,L01CA01,,Added,vinblastine,['vinblastine']
vincristine,Cytotoxic medicines,"Parenteral > General injections > IV: 1 mg in vial (vincristine sulfate); 5 mg in vial (vincristine sulfate)
Parenteral > General injections > IV: 1 mg in vial (vincristine sulfate); 5 mg in vial (vincristine sulfate); 1 mg per  mL in vial (vincristine sulfate); 2 mg per 2 mL in vial (vincristine sulfate)",Other specified gliomas of brain,L01CA02,,Added,vincristine,['vincristine']
vincristine,Cytotoxic medicines,"Parenteral > General injections > IV: 1 mg in vial (vincristine sulfate); 5 mg in vial (vincristine sulfate)
Parenteral > General injections > IV: 1 mg in vial (vincristine sulfate); 5 mg in vial (vincristine sulfate); 1 mg per  mL in vial (vincristine sulfate); 2 mg per 2 mL in vial (vincristine sulfate)",Malignant trophoblastic neoplasms of placenta,L01CA02,,Added,vincristine,['vincristine']
vincristine,Cytotoxic medicines,"Parenteral > General injections > IV: 1 mg in vial (vincristine sulfate); 5 mg in vial (vincristine sulfate)
Parenteral > General injections > IV: 1 mg in vial (vincristine sulfate); 5 mg in vial (vincristine sulfate); 1 mg per  mL in vial (vincristine sulfate); 2 mg per 2 mL in vial (vincristine sulfate)",Follicular lymphoma,L01CA02,,Added,vincristine,['vincristine']
vincristine,Cytotoxic medicines,"Parenteral > General injections > IV: 1 mg in vial (vincristine sulfate); 5 mg in vial (vincristine sulfate)
Parenteral > General injections > IV: 1 mg in vial (vincristine sulfate); 5 mg in vial (vincristine sulfate); 1 mg per  mL in vial (vincristine sulfate); 2 mg per 2 mL in vial (vincristine sulfate)",Kaposi sarcoma of unspecified primary site,L01CA02,,Added,vincristine,['vincristine']
vincristine,Cytotoxic medicines,"Parenteral > General injections > IV: 1 mg in vial (vincristine sulfate); 5 mg in vial (vincristine sulfate)
Parenteral > General injections > IV: 1 mg in vial (vincristine sulfate); 5 mg in vial (vincristine sulfate); 1 mg per  mL in vial (vincristine sulfate); 2 mg per 2 mL in vial (vincristine sulfate)",Rhabdomyosarcoma primary site,L01CA02,,Added,vincristine,['vincristine']
vincristine,Cytotoxic medicines,"Parenteral > General injections > IV: 1 mg in vial (vincristine sulfate); 5 mg in vial (vincristine sulfate)
Parenteral > General injections > IV: 1 mg in vial (vincristine sulfate); 5 mg in vial (vincristine sulfate); 1 mg per  mL in vial (vincristine sulfate); 2 mg per 2 mL in vial (vincristine sulfate)",Hodgkin lymphoma,L01CA02,,Added,vincristine,['vincristine']
vincristine,Cytotoxic medicines,"Parenteral > General injections > IV: 1 mg in vial (vincristine sulfate); 5 mg in vial (vincristine sulfate)
Parenteral > General injections > IV: 1 mg in vial (vincristine sulfate); 5 mg in vial (vincristine sulfate); 1 mg per  mL in vial (vincristine sulfate); 2 mg per 2 mL in vial (vincristine sulfate)",Diffuse large B-cell lymphomas,L01CA02,,Added,vincristine,['vincristine']
vincristine,Cytotoxic medicines,"Parenteral > General injections > IV: 1 mg in vial (vincristine sulfate); 5 mg in vial (vincristine sulfate)
Parenteral > General injections > IV: 1 mg in vial (vincristine sulfate); 5 mg in vial (vincristine sulfate); 1 mg per  mL in vial (vincristine sulfate); 2 mg per 2 mL in vial (vincristine sulfate)",Retinoblastoma,L01CA02,,Added,vincristine,['vincristine']
vincristine,Cytotoxic medicines,"Parenteral > General injections > IV: 1 mg in vial (vincristine sulfate); 5 mg in vial (vincristine sulfate)
Parenteral > General injections > IV: 1 mg in vial (vincristine sulfate); 5 mg in vial (vincristine sulfate); 1 mg per  mL in vial (vincristine sulfate); 2 mg per 2 mL in vial (vincristine sulfate)",Burkitt lymphoma including Burkitt leukaemia,L01CA02,,Added,vincristine,['vincristine']
vincristine,Cytotoxic medicines,"Parenteral > General injections > IV: 1 mg in vial (vincristine sulfate); 5 mg in vial (vincristine sulfate)
Parenteral > General injections > IV: 1 mg in vial (vincristine sulfate); 5 mg in vial (vincristine sulfate); 1 mg per  mL in vial (vincristine sulfate); 2 mg per 2 mL in vial (vincristine sulfate)","Malignant neoplasms of kidney, except renal pelvis",L01CA02,,Added,vincristine,['vincristine']
vincristine,Cytotoxic medicines,"Parenteral > General injections > IV: 1 mg in vial (vincristine sulfate); 5 mg in vial (vincristine sulfate)
Parenteral > General injections > IV: 1 mg in vial (vincristine sulfate); 5 mg in vial (vincristine sulfate); 1 mg per  mL in vial (vincristine sulfate); 2 mg per 2 mL in vial (vincristine sulfate)",Ewing sarcoma of bone and articular cartilage of unspecified sites,L01CA02,,Added,vincristine,['vincristine']
vincristine,Cytotoxic medicines,"Parenteral > General injections > IV: 1 mg in vial (vincristine sulfate); 5 mg in vial (vincristine sulfate)
Parenteral > General injections > IV: 1 mg in vial (vincristine sulfate); 5 mg in vial (vincristine sulfate); 1 mg per  mL in vial (vincristine sulfate); 2 mg per 2 mL in vial (vincristine sulfate)","Lymphoid leukaemia, not elsewhere classified",L01CA02,,Added,vincristine,['vincristine']
vincristine,Cytotoxic medicines,"Parenteral > General injections > IV: 1 mg in vial (vincristine sulfate); 5 mg in vial (vincristine sulfate)
Parenteral > General injections > IV: 1 mg in vial (vincristine sulfate); 5 mg in vial (vincristine sulfate); 1 mg per  mL in vial (vincristine sulfate); 2 mg per 2 mL in vial (vincristine sulfate)",Langerhans cell histiocytosis,L01CA02,,Added,vincristine,['vincristine']
vinorelbine,Cytotoxic medicines,"Parenteral > General injections > IV: 10 mg per  mL in 1 mL vial; 10 mg per   mL in 5 mL vial
Parenteral > General injections > IV: 10 mg per  mL in 1 mL vial; 10 mg per  mL in 5 mL vial
Oral > Solid > capsule: 20 mg; 30 mg; 80 mg",Other specified malignant neoplasms of bronchus or lung,L01CA04,,Added,vinorelbine,['vinorelbine']
vinorelbine,Cytotoxic medicines,"Parenteral > General injections > IV: 10 mg per  mL in 1 mL vial; 10 mg per   mL in 5 mL vial
Parenteral > General injections > IV: 10 mg per  mL in 1 mL vial; 10 mg per  mL in 5 mL vial
Oral > Solid > capsule: 20 mg; 30 mg; 80 mg",Other specified malignant neoplasms of breast,L01CA04,,Added,vinorelbine,['vinorelbine']
vinorelbine,Cytotoxic medicines,"Parenteral > General injections > IV: 10 mg per  mL in 1 mL vial; 10 mg per   mL in 5 mL vial
Parenteral > General injections > IV: 10 mg per  mL in 1 mL vial; 10 mg per  mL in 5 mL vial
Oral > Solid > capsule: 20 mg; 30 mg; 80 mg",Rhabdomyosarcoma primary site,L01CA04,,Added,vinorelbine,['vinorelbine']
voriconazole,Antifungal medicines,"Parenteral > General injections > IV: 200 mg in vial powder for injection
Oral > Liquid: 40 mg per  mL powder for oral liquid
Oral > Solid: 50 mg tablet; 200 mg tablet",Chronic pulmonary aspergillosis,J02AC03,,Added,voriconazole,['voriconazole']
voriconazole,Antifungal medicines,"Parenteral > General injections > IV: 200 mg in vial powder for injection
Oral > Liquid: 40 mg per  mL powder for oral liquid
Oral > Solid: 50 mg tablet; 200 mg tablet",Invasive aspergillosis,J02AC03,,Added,voriconazole,['voriconazole']
warfarin,Medicines affecting coagulation,Oral > Solid: 5 mg (sodium salt); 1 mg (sodium salt); 2 mg (sodium salt); 0.5 mg (sodium salt),Other specified diseases of arteries or arterioles,B01AA03,,Added,warfarin,['warfarin']
warfarin,Medicines affecting coagulation,Oral > Solid: 5 mg (sodium salt); 1 mg (sodium salt); 2 mg (sodium salt); 0.5 mg (sodium salt),Cerebral ischaemic stroke due to embolic occlusion,B01AA03,,Added,warfarin,['warfarin']
warfarin,Medicines affecting coagulation,Oral > Solid: 5 mg (sodium salt); 1 mg (sodium salt); 2 mg (sodium salt); 0.5 mg (sodium salt),Venous thromboembolism,B01AA03,,Added,warfarin,['warfarin']
warfarin,Medicines affecting coagulation,Oral > Solid: 5 mg (sodium salt); 1 mg (sodium salt); 2 mg (sodium salt); 0.5 mg (sodium salt),Atrial fibrillation,B01AA03,,Added,warfarin,['warfarin']
water for injection,"Solutions correcting water, electrolyte and acid-base disturbances > Miscellaneous",Parenteral > General injections > unspecified: 2 mL ampoule; 5 mL ampoule; 10 mL ampoule,Unspecified appropriateness of dosing or administration without injury or harm,,,Added,water for injection,"['injection', 'water', 'water for injection', 'for']"
whole blood,Blood and blood components,Parenteral > General injections > IV: ,Blood transfusion without reported diagnosis,,,Added,whole blood,"['whole', 'whole blood', 'blood']"
xylometazoline,"Ear, nose and throat medicines [c]",Local > Nasal > Spray: 0.05% w/v equivalent to 0.5 mg per mL,Nasal congestion,R01AA07,,Added,xylometazoline,['xylometazoline']
yellow fever vaccine,Recommendations for certain regions,All vaccines should comply with the WHO requirements for biological substances.,Need for immunization against certain single viral diseases,J07BL01,,Added,yellow fever vaccine,"['yellow fever vaccine', 'vaccine', 'fever', 'yellow']"
zidovudine,Antiretrovirals > Nucleoside/Nucleotide reverse transcriptase inhibitors,"Parenteral > General injections > IV: 10 mg per  mL in 20 mL vial solution for IV infusion
Oral > Liquid: 50 mg per 5 mL
Oral > Solid > tablet: 300 mg
Oral > Solid > capsule: 250 mg","Human immunodeficiency virus disease without mention of associated disease or condition, clinical stage unspecified",J05AF01,,Added,zidovudine,['zidovudine']
zinc sulfate,Medicines for diarrhoea,Oral > Solid: 20 mg,Diarrhoea,A12CB01,,Added,zinc sulfate,"['sulfate', 'zinc sulfate', 'zinc']"
zoledronic acid,Supportive medicines,Parenteral > General injections > IV: 4 mg per 5 mL in 5 mL vial; 4 mg per 100 mL in 100 mL bottle,Malignant neoplasm metastasis in bone or bone marrow,M05BA08,,Added,zoledronic acid,"['zoledronic acid', 'zoledronic', 'acid']"
zuclopenthixol decanoate,Medicines for psychotic disorders,,Schizophrenia or other primary psychotic disorders,,,Added,zuclopenthixol decanoate,"['decanoate', 'zuclopenthixol', 'zuclopenthixol decanoate']"
